{"asset": "dea-controlled-substance-schedule-by-drug", "asset_type": "classification", "body": "Every substance named in the federal drug schedules at 21 CFR 1308.11-1308.15, with the schedule it sits in, its DEA Controlled Substances Code Number, the class it is listed under, and the exact paragraph of the regulation the entry comes from. One record is one substance at one paragraph, quoted from the regulation itself. A drug can sit in more than one schedule at the same time, and the difference is usually the preparation rather than the drug: codeine is Schedule II on its own, Schedule III in a limited-strength compound, and Schedule V at not more than 200 milligrams per 100 millilitres. Each of those is a separate record, so the answer is not silently collapsed into whichever listing came first. Marijuana is split the same way: Schedule I as a plant, and Schedule III in an FDA-approved product or when subject to a state medical marijuana licence. Substances placed in Schedule I on an emergency temporary basis carry the date that placement runs until. Two limits are worth knowing: the anabolic steroids in 1308.13(f) share a single code number for the whole class, so individual steroids are published with no code rather than an invented one, and a few entries print XXXX where a code would go. Answers what schedule a given drug is in, whether marijuana is Schedule I or III, what the DEA code number for a substance is, and when a temporary listing expires.\n", "description": "Every substance named in the federal drug schedules at 21 CFR 1308.11-1308.15, with the schedule it sits in, its DEA Controlled Substances Code Number, the class it is listed under, and the exact paragraph of the regulation the entry comes from. One record is one substance at one paragraph, quoted from the regulation itself. A drug can sit in more than one schedule at the same time, and the difference is usually the preparation rather than the drug: codeine is Schedule II on its own, Schedule III in a limited-strength compound, and Schedule V at not more than 200 milligrams per 100 millilitres. Each of those is a separate record, so the answer is not silently collapsed into whichever listing came first. Marijuana is split the same way: Schedule I as a plant, and Schedule III in an FDA-approved product or when subject to a state medical marijuana licence. Substances placed in Schedule I on an emergency temporary basis carry the date that placement runs until. Two limits are worth knowing: the anabolic steroids in 1308.13(f) share a single code number for the whole class, so individual steroids are published with no code rather than an invented one, and a few entries print XXXX where a code would go. Answers what schedule a given drug is in, whether marijuana is Schedule I or III, what the DEA code number for a substance is, and when a temporary listing expires.", "file": "index.md", "generated": true, "harvested": "2026-09-01", "key_field": "substance_name", "licence": "Federal regulatory text (21 CFR), not copyrightable", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "title": "Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "dataset", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-5,6-dichloro-1,3-dihydro-2H-benzo[d]imidazol-2-one, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: 5,6-dichloro brorphine; SR-14968)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Temporary listing of substances subject to emergency scheduling\n\n> (h) Temporary listing of substances subject to emergency scheduling.\n\n**DEA code number:** 9097\n\n**Temporary listing expires:** Aug. 27, 2028\n\n> adding paragraphs (h)(92) through (h)(95), effective Aug. 27, 2026 through Aug. 27, 2028\n\n**CFR citation:** 21 CFR 1308.11(h)(92)\n\n> (92) 1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-5,6-dichloro-1,3-dihydro-2H-benzo[d]imidazol-2-one, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: 5,6-dichloro brorphine; SR-14968) | 9097 |\n\nSource: \n", "category": "Temporary listing of substances subject to emergency scheduling", "citation": "21 CFR 1308.11(h)(92)", "dea_code_number": "9097", "file": "1-1-1-4-bromophenyl-ethyl-piperidin-4-yl-5-6-dichloro-1-3-dihydro-2h-benzo-d-imi.md", "generated": true, "harvested": "2026-09-01", "id": "1-1-1-4-bromophenyl-ethyl-piperidin-4-yl-5-6-dichloro-1-3-dihydro-2h-benzo-d-imi", "quote_category": "(h) Temporary listing of substances subject to emergency scheduling.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "quote_temporary_expiry": "adding paragraphs (h)(92) through (h)(95), effective Aug. 27, 2026 through Aug. 27, 2028", "schedule": "Schedule I", "source_quote": "(92) 1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-5,6-dichloro-1,3-dihydro-2H-benzo[d]imidazol-2-one, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: 5,6-dichloro brorphine; SR-14968) | 9097 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-5,6-dichloro-1,3-dihydro-2H-benzo[d]imidazol-2-one, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: 5,6-dichloro brorphine; SR-14968)", "temporary_expiry": "Aug. 27, 2028", "title": "1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-5,6-dichloro-1,3-dihydro-2H-benzo[d]imidazol-2-one, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: 5,6-dichloro brorphine; SR-14968) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 1-[1-(2-thienyl)cyclohexyl]pyrrolidine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7473\n\n**CFR citation:** 21 CFR 1308.11(d)(35)\n\n> (35) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine | 7473 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(35)", "dea_code_number": "7473", "file": "1-1-2-thienyl-cyclohexyl-pyrrolidine.md", "generated": true, "harvested": "2026-09-01", "id": "1-1-2-thienyl-cyclohexyl-pyrrolidine", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(35) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine | 7473 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "1-[1-(2-thienyl)cyclohexyl]pyrrolidine", "title": "1-[1-(2-thienyl)cyclohexyl]pyrrolidine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)pentan-1-one (other names: dipentylone; N,N-dimethylpentylone)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7552\n\n**CFR citation:** 21 CFR 1308.11(d)(105)\n\n> (105) 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)pentan-1-one (other names: dipentylone; N,N-dimethylpentylone) | 7552 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(105)", "dea_code_number": "7552", "file": "1-1-3-benzodioxol-5-yl-2-dimethylamino-pentan-1-one-other-names-dipentylone-n-n-.md", "generated": true, "harvested": "2026-09-01", "id": "1-1-3-benzodioxol-5-yl-2-dimethylamino-pentan-1-one-other-names-dipentylone-n-n-", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(105) 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)pentan-1-one (other names: dipentylone; N,N-dimethylpentylone) | 7552 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)pentan-1-one (other names: dipentylone; N,N-dimethylpentylone)", "title": "1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)pentan-1-one (other names: dipentylone; N,N-dimethylpentylone) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-one (other names: eutylone; bk-EBDB)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7549\n\n**CFR citation:** 21 CFR 1308.11(d)(101)\n\n> (101) 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-one (other names: eutylone; bk-EBDB) | 7549 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(101)", "dea_code_number": "7549", "file": "1-1-3-benzodioxol-5-yl-2-ethylamino-butan-1-one-other-names-eutylone-bk-ebdb.md", "generated": true, "harvested": "2026-09-01", "id": "1-1-3-benzodioxol-5-yl-2-ethylamino-butan-1-one-other-names-eutylone-bk-ebdb", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(101) 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-one (other names: eutylone; bk-EBDB) | 7549 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "1-(1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-one (other names: eutylone; bk-EBDB)", "title": "1-(1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-one (other names: eutylone; bk-EBDB) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)propan-1-one (ethylone)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7547\n\n**CFR citation:** 21 CFR 1308.11(d)(80)\n\n> (80) 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)propan-1-one (ethylone) | 7547 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(80)", "dea_code_number": "7547", "file": "1-1-3-benzodioxol-5-yl-2-ethylamino-propan-1-one-ethylone.md", "generated": true, "harvested": "2026-09-01", "id": "1-1-3-benzodioxol-5-yl-2-ethylamino-propan-1-one-ethylone", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(80) 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)propan-1-one (ethylone) | 7547 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "1-(1,3-benzodioxol-5-yl)-2-(ethylamino)propan-1-one (ethylone)", "title": "1-(1,3-benzodioxol-5-yl)-2-(ethylamino)propan-1-one (ethylone) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one (butylone, bk-MBDB)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7541\n\n**CFR citation:** 21 CFR 1308.11(d)(62)\n\n> (62) 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one (butylone, bk-MBDB) | (7541) |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(62)", "dea_code_number": "7541", "file": "1-1-3-benzodioxol-5-yl-2-methylamino-butan-1-one-butylone-bk-mbdb.md", "generated": true, "harvested": "2026-09-01", "id": "1-1-3-benzodioxol-5-yl-2-methylamino-butan-1-one-butylone-bk-mbdb", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(62) 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one (butylone, bk-MBDB) | (7541) |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one (butylone, bk-MBDB)", "title": "1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one (butylone, bk-MBDB) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one (pentylone, bk-MBDP)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7542\n\n**CFR citation:** 21 CFR 1308.11(d)(64)\n\n> (64) 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one (pentylone, bk-MBDP) | (7542) |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(64)", "dea_code_number": "7542", "file": "1-1-3-benzodioxol-5-yl-2-methylamino-pentan-1-one-pentylone-bk-mbdp.md", "generated": true, "harvested": "2026-09-01", "id": "1-1-3-benzodioxol-5-yl-2-methylamino-pentan-1-one-pentylone-bk-mbdp", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(64) 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one (pentylone, bk-MBDP) | (7542) |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one (pentylone, bk-MBDP)", "title": "1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one (pentylone, bk-MBDP) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (Other names: 4-CN-CUMYL-BUTINACA; 4-cyano-CUMYL-BUTINACA; 4-CN-CUMYL BINACA; CUMYL-4CN-BINACA; SGT-78)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7089\n\n**CFR citation:** 21 CFR 1308.11(d)(83)\n\n> (83) 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (Other names: 4-CN-CUMYL-BUTINACA; 4-cyano-CUMYL-BUTINACA; 4-CN-CUMYL BINACA; CUMYL-4CN-BINACA; SGT-78) | 7089 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(83)", "dea_code_number": "7089", "file": "1-4-cyanobutyl-n-2-phenylpropan-2-yl-1h-indazole-3-carboxamide-other-names-4-cn-.md", "generated": true, "harvested": "2026-09-01", "id": "1-4-cyanobutyl-n-2-phenylpropan-2-yl-1h-indazole-3-carboxamide-other-names-4-cn-", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(83) 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (Other names: 4-CN-CUMYL-BUTINACA; 4-cyano-CUMYL-BUTINACA; 4-CN-CUMYL BINACA; CUMYL-4CN-BINACA; SGT-78) | 7089 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (Other names: 4-CN-CUMYL-BUTINACA; 4-cyano-CUMYL-BUTINACA; 4-CN-CUMYL BINACA; CUMYL-4CN-BINACA; SGT-78)", "title": "1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (Other names: 4-CN-CUMYL-BUTINACA; 4-cyano-CUMYL-BUTINACA; 4-CN-CUMYL BINACA; CUMYL-4CN-BINACA; SGT-78) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (other name: FUB-144)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7014\n\n**CFR citation:** 21 CFR 1308.11(d)(93)\n\n> (93) (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (other name: FUB-144) | 7014 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(93)", "dea_code_number": "7014", "file": "1-4-fluorobenzyl-1h-indol-3-yl-2-2-3-3-tetramethylcyclopropyl-methanone-other-na.md", "generated": true, "harvested": "2026-09-01", "id": "1-4-fluorobenzyl-1h-indol-3-yl-2-2-3-3-tetramethylcyclopropyl-methanone-other-na", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(93) (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (other name: FUB-144) | 7014 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "(1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (other name: FUB-144)", "title": "(1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (other name: FUB-144) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 1-(4-methoxyphenyl)-N-methylpropan-2-amine (other names: para-methoxymethamphetamine, PMMA)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 1245\n\n**CFR citation:** 21 CFR 1308.11(d)(88)\n\n> (88) 1-(4-methoxyphenyl)-N-methylpropan-2-amine (other names: para-methoxymethamphetamine, PMMA) | (1245) |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(88)", "dea_code_number": "1245", "file": "1-4-methoxyphenyl-n-methylpropan-2-amine-other-names-para-methoxymethamphetamine.md", "generated": true, "harvested": "2026-09-01", "id": "1-4-methoxyphenyl-n-methylpropan-2-amine-other-names-para-methoxymethamphetamine", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(88) 1-(4-methoxyphenyl)-N-methylpropan-2-amine (other names: para-methoxymethamphetamine, PMMA) | (1245) |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "1-(4-methoxyphenyl)-N-methylpropan-2-amine (other names: para-methoxymethamphetamine, PMMA)", "title": "1-(4-methoxyphenyl)-N-methylpropan-2-amine (other names: para-methoxymethamphetamine, PMMA) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** [1-(5-fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone (5-fluoro-UR-144, XLR11)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7011\n\n**CFR citation:** 21 CFR 1308.11(d)(49)\n\n> (49) [1-(5-fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone (5-fluoro-UR-144, XLR11) | (7011) |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(49)", "dea_code_number": "7011", "file": "1-5-fluoro-pentyl-1h-indol-3-yl-2-2-3-3-tetramethylcyclopropyl-methanone-5-fluor.md", "generated": true, "harvested": "2026-09-01", "id": "1-5-fluoro-pentyl-1h-indol-3-yl-2-2-3-3-tetramethylcyclopropyl-methanone-5-fluor", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(49) [1-(5-fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone (5-fluoro-UR-144, XLR11) | (7011) |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "[1-(5-fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone (5-fluoro-UR-144, XLR11)", "title": "[1-(5-fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone (5-fluoro-UR-144, XLR11) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone (THJ-2201)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7024\n\n**CFR citation:** 21 CFR 1308.11(d)(71)\n\n> (71) [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone (THJ-2201) | (7024) |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(71)", "dea_code_number": "7024", "file": "1-5-fluoropentyl-1h-indazol-3-yl-naphthalen-1-yl-methanone-thj-2201.md", "generated": true, "harvested": "2026-09-01", "id": "1-5-fluoropentyl-1h-indazol-3-yl-naphthalen-1-yl-methanone-thj-2201", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(71) [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone (THJ-2201) | (7024) |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "[1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone (THJ-2201)", "title": "[1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone (THJ-2201) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7201\n\n**CFR citation:** 21 CFR 1308.11(d)(108)\n\n> (108) 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201) | 7201 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(108)", "dea_code_number": "7201", "file": "1-5-fluoropentyl-3-1-naphthoyl-indole-am2201.md", "generated": true, "harvested": "2026-09-01", "id": "1-5-fluoropentyl-3-1-naphthoyl-indole-am2201", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(108) 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201) | 7201 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201)", "title": "1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (other names: 5F-CUMYL-PINACA; SGT-25)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7083\n\n**CFR citation:** 21 CFR 1308.11(d)(92)\n\n> (92) 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (other names: 5F-CUMYL-PINACA; SGT-25) | 7083 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(92)", "dea_code_number": "7083", "file": "1-5-fluoropentyl-n-2-phenylpropan-2-yl-1h-indazole-3-carboxamide-other-names-5f-.md", "generated": true, "harvested": "2026-09-01", "id": "1-5-fluoropentyl-n-2-phenylpropan-2-yl-1h-indazole-3-carboxamide-other-names-5f-", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(92) 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (other names: 5F-CUMYL-PINACA; SGT-25) | 7083 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (other names: 5F-CUMYL-PINACA; SGT-25)", "title": "1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (other names: 5F-CUMYL-PINACA; SGT-25) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide (Other name: 5F-CUMYL-P7AICA)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7085\n\n**CFR citation:** 21 CFR 1308.11(d)(85)\n\n> (85) 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide (Other name: 5F-CUMYL-P7AICA) | 7085 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(85)", "dea_code_number": "7085", "file": "1-5-fluoropentyl-n-2-phenylpropan-2-yl-1h-pyrrolo-2-3-b-pyridine-3-carboxamide-o.md", "generated": true, "harvested": "2026-09-01", "id": "1-5-fluoropentyl-n-2-phenylpropan-2-yl-1h-pyrrolo-2-3-b-pyridine-3-carboxamide-o", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(85) 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide (Other name: 5F-CUMYL-P7AICA) | 7085 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide (Other name: 5F-CUMYL-P7AICA)", "title": "1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide (Other name: 5F-CUMYL-P7AICA) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 1-androstenediol (3\u03b1,17\u03b2-dihydroxy-5\u03b1-androst-1-ene)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(4)\n\n> (4) 1-androstenediol (3\u03b1,17\u03b2-dihydroxy-5\u03b1-androst-1-ene);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(4)", "file": "1-androstenediol-3-17-dihydroxy-5-androst-1-ene-2.md", "generated": true, "harvested": "2026-09-01", "id": "1-androstenediol-3-17-dihydroxy-5-androst-1-ene-2", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(4) 1-androstenediol (3\u03b1,17\u03b2-dihydroxy-5\u03b1-androst-1-ene);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "1-androstenediol (3\u03b1,17\u03b2-dihydroxy-5\u03b1-androst-1-ene)", "title": "1-androstenediol (3\u03b1,17\u03b2-dihydroxy-5\u03b1-androst-1-ene) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 1-androstenediol (3\u03b2,17\u03b2-dihydroxy-5\u03b1-androst-1-ene)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(3)\n\n> (3) 1-androstenediol (3\u03b2,17\u03b2-dihydroxy-5\u03b1-androst-1-ene);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(3)", "file": "1-androstenediol-3-17-dihydroxy-5-androst-1-ene.md", "generated": true, "harvested": "2026-09-01", "id": "1-androstenediol-3-17-dihydroxy-5-androst-1-ene", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(3) 1-androstenediol (3\u03b2,17\u03b2-dihydroxy-5\u03b1-androst-1-ene);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "1-androstenediol (3\u03b2,17\u03b2-dihydroxy-5\u03b1-androst-1-ene)", "title": "1-androstenediol (3\u03b2,17\u03b2-dihydroxy-5\u03b1-androst-1-ene) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 1-androstenedione (5\u03b1-androst-1-en-3,17-dione)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(7)\n\n> (7) 1-androstenedione (5\u03b1-androst-1-en-3,17-dione);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(7)", "file": "1-androstenedione-5-androst-1-en-3-17-dione.md", "generated": true, "harvested": "2026-09-01", "id": "1-androstenedione-5-androst-1-en-3-17-dione", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(7) 1-androstenedione (5\u03b1-androst-1-en-3,17-dione);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "1-androstenedione (5\u03b1-androst-1-en-3,17-dione)", "title": "1-androstenedione (5\u03b1-androst-1-en-3,17-dione) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** \u03941-dihydrotestosterone (a.k.a. \u201c1-testosterone\u201d) (17\u03b2-hydroxy-5\u03b1-androst-1-en-3-one)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(24)\n\n> (24) \u03941-dihydrotestosterone (a.k.a. \u201c1-testosterone\u201d) (17\u03b2-hydroxy-5\u03b1-androst-1-en-3-one);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(24)", "file": "1-dihydrotestosterone-a-k-a-1-testosterone-17-hydroxy-5-androst-1-en-3-one.md", "generated": true, "harvested": "2026-09-01", "id": "1-dihydrotestosterone-a-k-a-1-testosterone-17-hydroxy-5-androst-1-en-3-one", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(24) \u03941-dihydrotestosterone (a.k.a. \u201c1-testosterone\u201d) (17\u03b2-hydroxy-5\u03b1-androst-1-en-3-one);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "\u03941-dihydrotestosterone (a.k.a. \u201c1-testosterone\u201d) (17\u03b2-hydroxy-5\u03b1-androst-1-en-3-one)", "title": "\u03941-dihydrotestosterone (a.k.a. \u201c1-testosterone\u201d) (17\u03b2-hydroxy-5\u03b1-androst-1-en-3-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one (naphyrone)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 1258\n\n**CFR citation:** 21 CFR 1308.11(d)(67)\n\n> (67) 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one (naphyrone) | (1258) |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(67)", "dea_code_number": "1258", "file": "1-naphthalen-2-yl-2-pyrrolidin-1-yl-pentan-1-one-naphyrone.md", "generated": true, "harvested": "2026-09-01", "id": "1-naphthalen-2-yl-2-pyrrolidin-1-yl-pentan-1-one-naphyrone", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(67) 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one (naphyrone) | (1258) |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one (naphyrone)", "title": "1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one (naphyrone) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (UR-144)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7144\n\n**CFR citation:** 21 CFR 1308.11(d)(48)\n\n> (48) (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (UR-144) | (7144) |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(48)", "dea_code_number": "7144", "file": "1-pentyl-1h-indol-3-yl-2-2-3-3-tetramethylcyclopropyl-methanone-ur-144.md", "generated": true, "harvested": "2026-09-01", "id": "1-pentyl-1h-indol-3-yl-2-2-3-3-tetramethylcyclopropyl-methanone-ur-144", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(48) (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (UR-144) | (7144) |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "(1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (UR-144)", "title": "(1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (UR-144) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 1-pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7118\n\n**CFR citation:** 21 CFR 1308.11(d)(107)\n\n> (107) 1-pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678) | 7118 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(107)", "dea_code_number": "7118", "file": "1-pentyl-3-1-naphthoyl-indole-jwh-018-and-am678.md", "generated": true, "harvested": "2026-09-01", "id": "1-pentyl-3-1-naphthoyl-indole-jwh-018-and-am678", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(107) 1-pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678) | 7118 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "1-pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678)", "title": "1-pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 1-phenylcyclohexylamine\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Immediate precursors\n\n> (g) Immediate precursors.\n\n**DEA code number:** 7460\n\n**CFR citation:** 21 CFR 1308.12(g)(2)(i)\n\n> (i) 1-phenylcyclohexylamine | 7460 |\n\nSource: \n", "category": "Immediate precursors", "citation": "21 CFR 1308.12(g)(2)(i)", "dea_code_number": "7460", "file": "1-phenylcyclohexylamine.md", "generated": true, "harvested": "2026-09-01", "id": "1-phenylcyclohexylamine", "quote_category": "(g) Immediate precursors.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(i) 1-phenylcyclohexylamine | 7460 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "1-phenylcyclohexylamine", "title": "1-phenylcyclohexylamine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 1-piperidinocyclohexanecarbonitrile (PCC)\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Immediate precursors\n\n> (g) Immediate precursors.\n\n**DEA code number:** 8603\n\n**CFR citation:** 21 CFR 1308.12(g)(2)(ii)\n\n> (ii) 1-piperidinocyclohexanecarbonitrile (PCC) | 8603 |\n\nSource: \n", "category": "Immediate precursors", "citation": "21 CFR 1308.12(g)(2)(ii)", "dea_code_number": "8603", "file": "1-piperidinocyclohexanecarbonitrile-pcc.md", "generated": true, "harvested": "2026-09-01", "id": "1-piperidinocyclohexanecarbonitrile-pcc", "quote_category": "(g) Immediate precursors.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(ii) 1-piperidinocyclohexanecarbonitrile (PCC) | 8603 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "1-piperidinocyclohexanecarbonitrile (PCC)", "title": "1-piperidinocyclohexanecarbonitrile (PCC) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 13\u03b2-ethyl-17\u03b2-hydroxygon-4-en-3-one\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(31)\n\n> (31) 13\u03b2-ethyl-17\u03b2-hydroxygon-4-en-3-one;\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(31)", "file": "13-ethyl-17-hydroxygon-4-en-3-one.md", "generated": true, "harvested": "2026-09-01", "id": "13-ethyl-17-hydroxygon-4-en-3-one", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(31) 13\u03b2-ethyl-17\u03b2-hydroxygon-4-en-3-one;", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "13\u03b2-ethyl-17\u03b2-hydroxygon-4-en-3-one", "title": "13\u03b2-ethyl-17\u03b2-hydroxygon-4-en-3-one \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 17\u03b2-hydroxy-androstano[2,3-d]isoxazole\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(40)\n\n> (40) 17\u03b2-hydroxy-androstano[2,3-d]isoxazole;\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(40)", "file": "17-hydroxy-androstano-2-3-d-isoxazole.md", "generated": true, "harvested": "2026-09-01", "id": "17-hydroxy-androstano-2-3-d-isoxazole", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(40) 17\u03b2-hydroxy-androstano[2,3-d]isoxazole;", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "17\u03b2-hydroxy-androstano[2,3-d]isoxazole", "title": "17\u03b2-hydroxy-androstano[2,3-d]isoxazole \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 17\u03b2-hydroxy-androstano[3,2-c]isoxazole\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(41)\n\n> (41) 17\u03b2-hydroxy-androstano[3,2-c]isoxazole;\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(41)", "file": "17-hydroxy-androstano-3-2-c-isoxazole.md", "generated": true, "harvested": "2026-09-01", "id": "17-hydroxy-androstano-3-2-c-isoxazole", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(41) 17\u03b2-hydroxy-androstano[3,2-c]isoxazole;", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "17\u03b2-hydroxy-androstano[3,2-c]isoxazole", "title": "17\u03b2-hydroxy-androstano[3,2-c]isoxazole \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 17\u03b1-methyl-\u03941-dihydrotestosterone (17\u03b2-hydroxy-17\u03b1-methyl-5\u03b1-androst-1-en-3-one) (a.k.a. \u201c17-\u03b1-methyl-1-testosterone\u201d)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(60)\n\n> (60) 17\u03b1-methyl-\u03941-dihydrotestosterone (17\u03b2-hydroxy-17\u03b1-methyl-5\u03b1-androst-1-en-3-one) (a.k.a. \u201c17-\u03b1-methyl-1-testosterone\u201d);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(60)", "file": "17-methyl-1-dihydrotestosterone-17-hydroxy-17-methyl-5-androst-1-en-3-one-a-k-a-.md", "generated": true, "harvested": "2026-09-01", "id": "17-methyl-1-dihydrotestosterone-17-hydroxy-17-methyl-5-androst-1-en-3-one-a-k-a-", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(60) 17\u03b1-methyl-\u03941-dihydrotestosterone (17\u03b2-hydroxy-17\u03b1-methyl-5\u03b1-androst-1-en-3-one) (a.k.a. \u201c17-\u03b1-methyl-1-testosterone\u201d);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "17\u03b1-methyl-\u03941-dihydrotestosterone (17\u03b2-hydroxy-17\u03b1-methyl-5\u03b1-androst-1-en-3-one) (a.k.a. \u201c17-\u03b1-methyl-1-testosterone\u201d)", "title": "17\u03b1-methyl-\u03941-dihydrotestosterone (17\u03b2-hydroxy-17\u03b1-methyl-5\u03b1-androst-1-en-3-one) (a.k.a. \u201c17-\u03b1-methyl-1-testosterone\u201d) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 17\u03b1-methyl-3\u03b1,17\u03b2-dihydroxy-5\u03b1-androstane\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(56)\n\n> (56) 17\u03b1-methyl-3\u03b1,17\u03b2-dihydroxy-5\u03b1-androstane;\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(56)", "file": "17-methyl-3-17-dihydroxy-5-androstane-2.md", "generated": true, "harvested": "2026-09-01", "id": "17-methyl-3-17-dihydroxy-5-androstane-2", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(56) 17\u03b1-methyl-3\u03b1,17\u03b2-dihydroxy-5\u03b1-androstane;", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "17\u03b1-methyl-3\u03b1,17\u03b2-dihydroxy-5\u03b1-androstane", "title": "17\u03b1-methyl-3\u03b1,17\u03b2-dihydroxy-5\u03b1-androstane \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 17\u03b1-methyl-3\u03b2,17\u03b2-dihydroxy-5\u03b1-androstane\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(55)\n\n> (55) 17\u03b1-methyl-3\u03b2,17\u03b2-dihydroxy-5\u03b1-androstane;\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(55)", "file": "17-methyl-3-17-dihydroxy-5-androstane.md", "generated": true, "harvested": "2026-09-01", "id": "17-methyl-3-17-dihydroxy-5-androstane", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(55) 17\u03b1-methyl-3\u03b2,17\u03b2-dihydroxy-5\u03b1-androstane;", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "17\u03b1-methyl-3\u03b2,17\u03b2-dihydroxy-5\u03b1-androstane", "title": "17\u03b1-methyl-3\u03b2,17\u03b2-dihydroxy-5\u03b1-androstane \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 17\u03b1-methyl-3\u03b2,17\u03b2-dihydroxyandrost-4-ene\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(57)\n\n> (57) 17\u03b1-methyl-3\u03b2,17\u03b2-dihydroxyandrost-4-ene;\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(57)", "file": "17-methyl-3-17-dihydroxyandrost-4-ene.md", "generated": true, "harvested": "2026-09-01", "id": "17-methyl-3-17-dihydroxyandrost-4-ene", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(57) 17\u03b1-methyl-3\u03b2,17\u03b2-dihydroxyandrost-4-ene;", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "17\u03b1-methyl-3\u03b2,17\u03b2-dihydroxyandrost-4-ene", "title": "17\u03b1-methyl-3\u03b2,17\u03b2-dihydroxyandrost-4-ene \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 17\u03b1-methyl-4-hydroxynandrolone (17\u03b1-methyl-4-hydroxy-17\u03b2-hydroxyestr-4-en-3-one)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(58)\n\n> (58) 17\u03b1-methyl-4-hydroxynandrolone (17\u03b1-methyl-4-hydroxy-17\u03b2-hydroxyestr-4-en-3-one);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(58)", "file": "17-methyl-4-hydroxynandrolone-17-methyl-4-hydroxy-17-hydroxyestr-4-en-3-one.md", "generated": true, "harvested": "2026-09-01", "id": "17-methyl-4-hydroxynandrolone-17-methyl-4-hydroxy-17-hydroxyestr-4-en-3-one", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(58) 17\u03b1-methyl-4-hydroxynandrolone (17\u03b1-methyl-4-hydroxy-17\u03b2-hydroxyestr-4-en-3-one);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "17\u03b1-methyl-4-hydroxynandrolone (17\u03b1-methyl-4-hydroxy-17\u03b2-hydroxyestr-4-en-3-one)", "title": "17\u03b1-methyl-4-hydroxynandrolone (17\u03b1-methyl-4-hydroxy-17\u03b2-hydroxyestr-4-en-3-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 17\u03b1-methyl-5\u03b1-androstan-17\u03b2-ol\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(51)\n\n> (51) 17\u03b1-methyl-5\u03b1-androstan-17\u03b2-ol;\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(51)", "file": "17-methyl-5-androstan-17-ol.md", "generated": true, "harvested": "2026-09-01", "id": "17-methyl-5-androstan-17-ol", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(51) 17\u03b1-methyl-5\u03b1-androstan-17\u03b2-ol;", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "17\u03b1-methyl-5\u03b1-androstan-17\u03b2-ol", "title": "17\u03b1-methyl-5\u03b1-androstan-17\u03b2-ol \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 17\u03b1-methyl-androst-2-ene-3,17\u03b2-diol\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(54)\n\n> (54) 17\u03b1-methyl-androst-2-ene-3,17\u03b2-diol;\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(54)", "file": "17-methyl-androst-2-ene-3-17-diol.md", "generated": true, "harvested": "2026-09-01", "id": "17-methyl-androst-2-ene-3-17-diol", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(54) 17\u03b1-methyl-androst-2-ene-3,17\u03b2-diol;", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "17\u03b1-methyl-androst-2-ene-3,17\u03b2-diol", "title": "17\u03b1-methyl-androst-2-ene-3,17\u03b2-diol \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 17\u03b1-methyl-androsta-1,4-diene-3,17\u03b2-diol\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(50)\n\n> (50) 17\u03b1-methyl-androsta-1,4-diene-3,17\u03b2-diol;\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(50)", "file": "17-methyl-androsta-1-4-diene-3-17-diol.md", "generated": true, "harvested": "2026-09-01", "id": "17-methyl-androsta-1-4-diene-3-17-diol", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(50) 17\u03b1-methyl-androsta-1,4-diene-3,17\u03b2-diol;", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "17\u03b1-methyl-androsta-1,4-diene-3,17\u03b2-diol", "title": "17\u03b1-methyl-androsta-1,4-diene-3,17\u03b2-diol \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 17\u03b1-methyl-androstan-3-hydroxyimine-17\u03b2-ol\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(52)\n\n> (52) 17\u03b1-methyl-androstan-3-hydroxyimine-17\u03b2-ol;\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(52)", "file": "17-methyl-androstan-3-hydroxyimine-17-ol.md", "generated": true, "harvested": "2026-09-01", "id": "17-methyl-androstan-3-hydroxyimine-17-ol", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(52) 17\u03b1-methyl-androstan-3-hydroxyimine-17\u03b2-ol;", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "17\u03b1-methyl-androstan-3-hydroxyimine-17\u03b2-ol", "title": "17\u03b1-methyl-androstan-3-hydroxyimine-17\u03b2-ol \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 18a-homo-3-hydroxy-estra-2,5(10)-dien-17-one\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(37)\n\n> (37) 18a-homo-3-hydroxy-estra-2,5(10)-dien-17-one;\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(37)", "file": "18a-homo-3-hydroxy-estra-2-5-10-dien-17-one.md", "generated": true, "harvested": "2026-09-01", "id": "18a-homo-3-hydroxy-estra-2-5-10-dien-17-one", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(37) 18a-homo-3-hydroxy-estra-2,5(10)-dien-17-one;", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "18a-homo-3-hydroxy-estra-2,5(10)-dien-17-one", "title": "18a-homo-3-hydroxy-estra-2,5(10)-dien-17-one \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 19-nor-4,9(10)-androstadienedione (estra-4,9(10)-diene-3,17-dione)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(69)\n\n> (69) 19-nor-4,9(10)-androstadienedione (estra-4,9(10)-diene-3,17-dione);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(69)", "file": "19-nor-4-9-10-androstadienedione-estra-4-9-10-diene-3-17-dione.md", "generated": true, "harvested": "2026-09-01", "id": "19-nor-4-9-10-androstadienedione-estra-4-9-10-diene-3-17-dione", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(69) 19-nor-4,9(10)-androstadienedione (estra-4,9(10)-diene-3,17-dione);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "19-nor-4,9(10)-androstadienedione (estra-4,9(10)-diene-3,17-dione)", "title": "19-nor-4,9(10)-androstadienedione (estra-4,9(10)-diene-3,17-dione) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 19-nor-4-androstenediol (3\u03b1,17\u03b2-dihydroxyestr-4-ene)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(66)\n\n> (66) 19-nor-4-androstenediol (3\u03b1,17\u03b2-dihydroxyestr-4-ene);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(66)", "file": "19-nor-4-androstenediol-3-17-dihydroxyestr-4-ene-2.md", "generated": true, "harvested": "2026-09-01", "id": "19-nor-4-androstenediol-3-17-dihydroxyestr-4-ene-2", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(66) 19-nor-4-androstenediol (3\u03b1,17\u03b2-dihydroxyestr-4-ene);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "19-nor-4-androstenediol (3\u03b1,17\u03b2-dihydroxyestr-4-ene)", "title": "19-nor-4-androstenediol (3\u03b1,17\u03b2-dihydroxyestr-4-ene) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 19-nor-4-androstenediol (3\u03b2,17\u03b2-dihydroxyestr-4-ene)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(65)\n\n> (65) 19-nor-4-androstenediol (3\u03b2,17\u03b2-dihydroxyestr-4-ene);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(65)", "file": "19-nor-4-androstenediol-3-17-dihydroxyestr-4-ene.md", "generated": true, "harvested": "2026-09-01", "id": "19-nor-4-androstenediol-3-17-dihydroxyestr-4-ene", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(65) 19-nor-4-androstenediol (3\u03b2,17\u03b2-dihydroxyestr-4-ene);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "19-nor-4-androstenediol (3\u03b2,17\u03b2-dihydroxyestr-4-ene)", "title": "19-nor-4-androstenediol (3\u03b2,17\u03b2-dihydroxyestr-4-ene) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 19-nor-4-androstenedione (estr-4-en-3,17-dione)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(70)\n\n> (70) 19-nor-4-androstenedione (estr-4-en-3,17-dione);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(70)", "file": "19-nor-4-androstenedione-estr-4-en-3-17-dione.md", "generated": true, "harvested": "2026-09-01", "id": "19-nor-4-androstenedione-estr-4-en-3-17-dione", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(70) 19-nor-4-androstenedione (estr-4-en-3,17-dione);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "19-nor-4-androstenedione (estr-4-en-3,17-dione)", "title": "19-nor-4-androstenedione (estr-4-en-3,17-dione) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 19-nor-5-androstenediol (3\u03b1,17\u03b2-dihydroxyestr-5-ene)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(68)\n\n> (68) 19-nor-5-androstenediol (3\u03b1,17\u03b2-dihydroxyestr-5-ene);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(68)", "file": "19-nor-5-androstenediol-3-17-dihydroxyestr-5-ene-2.md", "generated": true, "harvested": "2026-09-01", "id": "19-nor-5-androstenediol-3-17-dihydroxyestr-5-ene-2", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(68) 19-nor-5-androstenediol (3\u03b1,17\u03b2-dihydroxyestr-5-ene);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "19-nor-5-androstenediol (3\u03b1,17\u03b2-dihydroxyestr-5-ene)", "title": "19-nor-5-androstenediol (3\u03b1,17\u03b2-dihydroxyestr-5-ene) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 19-nor-5-androstenediol (3\u03b2,17\u03b2-dihydroxyestr-5-ene)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(67)\n\n> (67) 19-nor-5-androstenediol (3\u03b2,17\u03b2-dihydroxyestr-5-ene);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(67)", "file": "19-nor-5-androstenediol-3-17-dihydroxyestr-5-ene.md", "generated": true, "harvested": "2026-09-01", "id": "19-nor-5-androstenediol-3-17-dihydroxyestr-5-ene", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(67) 19-nor-5-androstenediol (3\u03b2,17\u03b2-dihydroxyestr-5-ene);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "19-nor-5-androstenediol (3\u03b2,17\u03b2-dihydroxyestr-5-ene)", "title": "19-nor-5-androstenediol (3\u03b2,17\u03b2-dihydroxyestr-5-ene) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 19-nor-5-androstenedione (estr-5-en-3,17-dione)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(71)\n\n> (71) 19-nor-5-androstenedione (estr-5-en-3,17-dione);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(71)", "file": "19-nor-5-androstenedione-estr-5-en-3-17-dione.md", "generated": true, "harvested": "2026-09-01", "id": "19-nor-5-androstenedione-estr-5-en-3-17-dione", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(71) 19-nor-5-androstenedione (estr-5-en-3,17-dione);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "19-nor-5-androstenedione (estr-5-en-3,17-dione)", "title": "19-nor-5-androstenedione (estr-5-en-3,17-dione) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 2\u03b1,17\u03b1-dimethyl-17\u03b2-hydroxy-5\u03b2-androstan-3-one\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(27)\n\n> (27) 2\u03b1,17\u03b1-dimethyl-17\u03b2-hydroxy-5\u03b2-androstan-3-one;\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(27)", "file": "2-17-dimethyl-17-hydroxy-5-androstan-3-one.md", "generated": true, "harvested": "2026-09-01", "id": "2-17-dimethyl-17-hydroxy-5-androstan-3-one", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(27) 2\u03b1,17\u03b1-dimethyl-17\u03b2-hydroxy-5\u03b2-androstan-3-one;", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "2\u03b1,17\u03b1-dimethyl-17\u03b2-hydroxy-5\u03b2-androstan-3-one", "title": "2\u03b1,17\u03b1-dimethyl-17\u03b2-hydroxy-5\u03b2-androstan-3-one \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 2-(2-((2,3-dihydrobenzofuran-5-yl)methyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: Ethyleneoxynitazene)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Temporary listing of substances subject to emergency scheduling\n\n> (h) Temporary listing of substances subject to emergency scheduling.\n\n**DEA code number:** 9770\n\n**Temporary listing expires:** Oct. 15, 2027\n\n> adding paragraphs (h)(79) through (85), effective Oct. 15, 2025, until Oct. 15, 2027\n\n**CFR citation:** 21 CFR 1308.11(h)(79)\n\n> (79) 2-(2-((2,3-dihydrobenzofuran-5-yl)methyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: Ethyleneoxynitazene) | 9770 |\n\nSource: \n", "category": "Temporary listing of substances subject to emergency scheduling", "citation": "21 CFR 1308.11(h)(79)", "dea_code_number": "9770", "file": "2-2-2-3-dihydrobenzofuran-5-yl-methyl-5-nitro-1h-benzimidazol-1-yl-n-n-diethylet.md", "generated": true, "harvested": "2026-09-01", "id": "2-2-2-3-dihydrobenzofuran-5-yl-methyl-5-nitro-1h-benzimidazol-1-yl-n-n-diethylet", "quote_category": "(h) Temporary listing of substances subject to emergency scheduling.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "quote_temporary_expiry": "adding paragraphs (h)(79) through (85), effective Oct. 15, 2025, until Oct. 15, 2027", "schedule": "Schedule I", "source_quote": "(79) 2-(2-((2,3-dihydrobenzofuran-5-yl)methyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: Ethyleneoxynitazene) | 9770 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "2-(2-((2,3-dihydrobenzofuran-5-yl)methyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: Ethyleneoxynitazene)", "temporary_expiry": "Oct. 15, 2027", "title": "2-(2-((2,3-dihydrobenzofuran-5-yl)methyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: Ethyleneoxynitazene) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine (Other names: etodesnitazene; etazene)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9765\n\n**CFR citation:** 21 CFR 1308.11(b)(42)\n\n> (42) 2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine (Other names: etodesnitazene; etazene) | 9765 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(42)", "dea_code_number": "9765", "file": "2-2-4-ethoxybenzyl-1h-benzimidazol-1-yl-n-n-diethylethan-1-amine-other-names-eto.md", "generated": true, "harvested": "2026-09-01", "id": "2-2-4-ethoxybenzyl-1h-benzimidazol-1-yl-n-n-diethylethan-1-amine-other-names-eto", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(42) 2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine (Other names: etodesnitazene; etazene) | 9765 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine (Other names: etodesnitazene; etazene)", "title": "2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine (Other names: etodesnitazene; etazene) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 2-(2-(4-ethoxybenzyl)-5-methyl-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: 5-methyl etodesnitazene)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Temporary listing of substances subject to emergency scheduling\n\n> (h) Temporary listing of substances subject to emergency scheduling.\n\n**DEA code number:** 9767\n\n**Temporary listing expires:** Oct. 15, 2027\n\n> adding paragraphs (h)(79) through (85), effective Oct. 15, 2025, until Oct. 15, 2027\n\n**CFR citation:** 21 CFR 1308.11(h)(81)\n\n> (81) 2-(2-(4-ethoxybenzyl)-5-methyl-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: 5-methyl etodesnitazene) | 9767 |\n\nSource: \n", "category": "Temporary listing of substances subject to emergency scheduling", "citation": "21 CFR 1308.11(h)(81)", "dea_code_number": "9767", "file": "2-2-4-ethoxybenzyl-5-methyl-1h-benzimidazol-1-yl-n-n-diethylethan-1-amine-its-is.md", "generated": true, "harvested": "2026-09-01", "id": "2-2-4-ethoxybenzyl-5-methyl-1h-benzimidazol-1-yl-n-n-diethylethan-1-amine-its-is", "quote_category": "(h) Temporary listing of substances subject to emergency scheduling.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "quote_temporary_expiry": "adding paragraphs (h)(79) through (85), effective Oct. 15, 2025, until Oct. 15, 2027", "schedule": "Schedule I", "source_quote": "(81) 2-(2-(4-ethoxybenzyl)-5-methyl-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: 5-methyl etodesnitazene) | 9767 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "2-(2-(4-ethoxybenzyl)-5-methyl-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: 5-methyl etodesnitazene)", "temporary_expiry": "Oct. 15, 2027", "title": "2-(2-(4-ethoxybenzyl)-5-methyl-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: 5-methyl etodesnitazene) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 2-(2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N-ethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N-desethyl etonitazene)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Temporary listing of substances subject to emergency scheduling\n\n> (h) Temporary listing of substances subject to emergency scheduling.\n\n**DEA code number:** 9768\n\n**Temporary listing expires:** Oct. 15, 2027\n\n> adding paragraphs (h)(79) through (85), effective Oct. 15, 2025, until Oct. 15, 2027\n\n**CFR citation:** 21 CFR 1308.11(h)(82)\n\n> (82) 2-(2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N-ethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N-desethyl etonitazene) | 9768 |\n\nSource: \n", "category": "Temporary listing of substances subject to emergency scheduling", "citation": "21 CFR 1308.11(h)(82)", "dea_code_number": "9768", "file": "2-2-4-ethoxybenzyl-5-nitro-1h-benzimidazol-1-yl-n-ethylethan-1-amine-its-isomers.md", "generated": true, "harvested": "2026-09-01", "id": "2-2-4-ethoxybenzyl-5-nitro-1h-benzimidazol-1-yl-n-ethylethan-1-amine-its-isomers", "quote_category": "(h) Temporary listing of substances subject to emergency scheduling.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "quote_temporary_expiry": "adding paragraphs (h)(79) through (85), effective Oct. 15, 2025, until Oct. 15, 2027", "schedule": "Schedule I", "source_quote": "(82) 2-(2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N-ethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N-desethyl etonitazene) | 9768 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "2-(2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N-ethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N-desethyl etonitazene)", "temporary_expiry": "Oct. 15, 2027", "title": "2-(2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N-ethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N-desethyl etonitazene) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 2-(2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-dimethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N,N-dimethylamino etonitazene)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Temporary listing of substances subject to emergency scheduling\n\n> (h) Temporary listing of substances subject to emergency scheduling.\n\n**DEA code number:** 9771\n\n**Temporary listing expires:** Oct. 15, 2027\n\n> adding paragraphs (h)(79) through (85), effective Oct. 15, 2025, until Oct. 15, 2027\n\n**CFR citation:** 21 CFR 1308.11(h)(84)\n\n> (84) 2-(2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-dimethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N,N-dimethylamino etonitazene) | 9771 |\n\nSource: \n", "category": "Temporary listing of substances subject to emergency scheduling", "citation": "21 CFR 1308.11(h)(84)", "dea_code_number": "9771", "file": "2-2-4-ethoxybenzyl-5-nitro-1h-benzimidazol-1-yl-n-n-dimethylethan-1-amine-its-is.md", "generated": true, "harvested": "2026-09-01", "id": "2-2-4-ethoxybenzyl-5-nitro-1h-benzimidazol-1-yl-n-n-dimethylethan-1-amine-its-is", "quote_category": "(h) Temporary listing of substances subject to emergency scheduling.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "quote_temporary_expiry": "adding paragraphs (h)(79) through (85), effective Oct. 15, 2025, until Oct. 15, 2027", "schedule": "Schedule I", "source_quote": "(84) 2-(2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-dimethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N,N-dimethylamino etonitazene) | 9771 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "2-(2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-dimethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N,N-dimethylamino etonitazene)", "temporary_expiry": "Oct. 15, 2027", "title": "2-(2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-dimethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N,N-dimethylamino etonitazene) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7509\n\n**CFR citation:** 21 CFR 1308.11(d)(38)\n\n> (38) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E) | 7509 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(38)", "dea_code_number": "7509", "file": "2-2-5-dimethoxy-4-ethylphenyl-ethanamine-2c-e.md", "generated": true, "harvested": "2026-09-01", "id": "2-2-5-dimethoxy-4-ethylphenyl-ethanamine-2c-e", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(38) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E) | 7509 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E)", "title": "2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7508\n\n**CFR citation:** 21 CFR 1308.11(d)(39)\n\n> (39) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D) | 7508 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(39)", "dea_code_number": "7508", "file": "2-2-5-dimethoxy-4-methylphenyl-ethanamine-2c-d.md", "generated": true, "harvested": "2026-09-01", "id": "2-2-5-dimethoxy-4-methylphenyl-ethanamine-2c-d", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(39) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D) | 7508 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D)", "title": "2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7524\n\n**CFR citation:** 21 CFR 1308.11(d)(46)\n\n> (46) 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P) | 7524 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(46)", "dea_code_number": "7524", "file": "2-2-5-dimethoxy-4-n-propylphenyl-ethanamine-2c-p.md", "generated": true, "harvested": "2026-09-01", "id": "2-2-5-dimethoxy-4-n-propylphenyl-ethanamine-2c-p", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(46) 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P) | 7524 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P)", "title": "2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7521\n\n**CFR citation:** 21 CFR 1308.11(d)(45)\n\n> (45) 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N) | 7521 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(45)", "dea_code_number": "7521", "file": "2-2-5-dimethoxy-4-nitro-phenyl-ethanamine-2c-n.md", "generated": true, "harvested": "2026-09-01", "id": "2-2-5-dimethoxy-4-nitro-phenyl-ethanamine-2c-n", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(45) 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N) | 7521 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N)", "title": "2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7517\n\n**CFR citation:** 21 CFR 1308.11(d)(44)\n\n> (44) 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H) | 7517 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(44)", "dea_code_number": "7517", "file": "2-2-5-dimethoxyphenyl-ethanamine-2c-h.md", "generated": true, "harvested": "2026-09-01", "id": "2-2-5-dimethoxyphenyl-ethanamine-2c-h", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(44) 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H) | 7517 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "2-(2,5-Dimethoxyphenyl)ethanamine (2C-H)", "title": "2-(2,5-Dimethoxyphenyl)ethanamine (2C-H) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 2-(2-(benzodioxol-5-ylmethyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other names: Methylenedioxynitazene; 3\u2032,4\u2032-methylenedioxynitazene)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Temporary listing of substances subject to emergency scheduling\n\n> (h) Temporary listing of substances subject to emergency scheduling.\n\n**DEA code number:** 9766\n\n**Temporary listing expires:** Oct. 15, 2027\n\n> adding paragraphs (h)(79) through (85), effective Oct. 15, 2025, until Oct. 15, 2027\n\n**CFR citation:** 21 CFR 1308.11(h)(80)\n\n> (80) 2-(2-(benzodioxol-5-ylmethyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other names: Methylenedioxynitazene; 3\u2032,4\u2032-methylenedioxynitazene) | 9766 |\n\nSource: \n", "category": "Temporary listing of substances subject to emergency scheduling", "citation": "21 CFR 1308.11(h)(80)", "dea_code_number": "9766", "file": "2-2-benzodioxol-5-ylmethyl-5-nitro-1h-benzimidazol-1-yl-n-n-diethylethan-1-amine.md", "generated": true, "harvested": "2026-09-01", "id": "2-2-benzodioxol-5-ylmethyl-5-nitro-1h-benzimidazol-1-yl-n-n-diethylethan-1-amine", "quote_category": "(h) Temporary listing of substances subject to emergency scheduling.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "quote_temporary_expiry": "adding paragraphs (h)(79) through (85), effective Oct. 15, 2025, until Oct. 15, 2027", "schedule": "Schedule I", "source_quote": "(80) 2-(2-(benzodioxol-5-ylmethyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other names: Methylenedioxynitazene; 3\u2032,4\u2032-methylenedioxynitazene) | 9766 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "2-(2-(benzodioxol-5-ylmethyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other names: Methylenedioxynitazene; 3\u2032,4\u2032-methylenedioxynitazene)", "temporary_expiry": "Oct. 15, 2027", "title": "2-(2-(benzodioxol-5-ylmethyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other names: Methylenedioxynitazene; 3\u2032,4\u2032-methylenedioxynitazene) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 2\u03b1,3\u03b1-epithio-17\u03b1-methyl-5\u03b1-androstan-17\u03b2-ol\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(29)\n\n> (29) 2\u03b1,3\u03b1-epithio-17\u03b1-methyl-5\u03b1-androstan-17\u03b2-ol;\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(29)", "file": "2-3-epithio-17-methyl-5-androstan-17-ol.md", "generated": true, "harvested": "2026-09-01", "id": "2-3-epithio-17-methyl-5-androstan-17-ol", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(29) 2\u03b1,3\u03b1-epithio-17\u03b1-methyl-5\u03b1-androstan-17\u03b2-ol;", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "2\u03b1,3\u03b1-epithio-17\u03b1-methyl-5\u03b1-androstan-17\u03b2-ol", "title": "2\u03b1,3\u03b1-epithio-17\u03b1-methyl-5\u03b1-androstan-17\u03b2-ol \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B-NBOMe, 2C-B-NBOMe)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7536\n\n**CFR citation:** 21 CFR 1308.11(d)(57)\n\n> (57) 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B-NBOMe, 2C-B-NBOMe) | (7536) |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(57)", "dea_code_number": "7536", "file": "2-4-bromo-2-5-dimethoxyphenyl-n-2-methoxybenzyl-ethanamine-25b-nbome-2c-b-nbome.md", "generated": true, "harvested": "2026-09-01", "id": "2-4-bromo-2-5-dimethoxyphenyl-n-2-methoxybenzyl-ethanamine-25b-nbome-2c-b-nbome", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(57) 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B-NBOMe, 2C-B-NBOMe) | (7536) |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B-NBOMe, 2C-B-NBOMe)", "title": "2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B-NBOMe, 2C-B-NBOMe) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7519\n\n**CFR citation:** 21 CFR 1308.11(d)(40)\n\n> (40) 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C) | 7519 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(40)", "dea_code_number": "7519", "file": "2-4-chloro-2-5-dimethoxyphenyl-ethanamine-2c-c.md", "generated": true, "harvested": "2026-09-01", "id": "2-4-chloro-2-5-dimethoxyphenyl-ethanamine-2c-c", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(40) 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C) | 7519 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C)", "title": "2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe, 2C-C-NBOMe)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7537\n\n**CFR citation:** 21 CFR 1308.11(d)(56)\n\n> (56) 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe, 2C-C-NBOMe) | (7537) |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(56)", "dea_code_number": "7537", "file": "2-4-chloro-2-5-dimethoxyphenyl-n-2-methoxybenzyl-ethanamine-25c-nbome-2c-c-nbome.md", "generated": true, "harvested": "2026-09-01", "id": "2-4-chloro-2-5-dimethoxyphenyl-n-2-methoxybenzyl-ethanamine-25c-nbome-2c-c-nbome", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(56) 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe, 2C-C-NBOMe) | (7537) |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe, 2C-C-NBOMe)", "title": "2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe, 2C-C-NBOMe) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (Other names: N-pyrrolidino etonitazene; etonitazepyne)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9758\n\n**CFR citation:** 21 CFR 1308.11(b)(78)\n\n> (78) 2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (Other names: N-pyrrolidino etonitazene; etonitazepyne) | 9758 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(78)", "dea_code_number": "9758", "file": "2-4-ethoxybenzyl-5-nitro-1-2-pyrrolidin-1-yl-ethyl-1h-benzimidazole-other-names-.md", "generated": true, "harvested": "2026-09-01", "id": "2-4-ethoxybenzyl-5-nitro-1-2-pyrrolidin-1-yl-ethyl-1h-benzimidazole-other-names-", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(78) 2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (Other names: N-pyrrolidino etonitazene; etonitazepyne) | 9758 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (Other names: N-pyrrolidino etonitazene; etonitazepyne)", "title": "2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (Other names: N-pyrrolidino etonitazene; etonitazepyne) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7385\n\n**CFR citation:** 21 CFR 1308.11(d)(42)\n\n> (42) 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2) | 7385 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(42)", "dea_code_number": "7385", "file": "2-4-ethylthio-2-5-dimethoxyphenyl-ethanamine-2c-t-2.md", "generated": true, "harvested": "2026-09-01", "id": "2-4-ethylthio-2-5-dimethoxyphenyl-ethanamine-2c-t-2", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(42) 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2) | 7385 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2)", "title": "2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7518\n\n**CFR citation:** 21 CFR 1308.11(d)(41)\n\n> (41) 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I) | 7518 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(41)", "dea_code_number": "7518", "file": "2-4-iodo-2-5-dimethoxyphenyl-ethanamine-2c-i.md", "generated": true, "harvested": "2026-09-01", "id": "2-4-iodo-2-5-dimethoxyphenyl-ethanamine-2c-i", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(41) 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I) | 7518 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I)", "title": "2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe, 2C-I-NBOMe)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7538\n\n**CFR citation:** 21 CFR 1308.11(d)(55)\n\n> (55) 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe, 2C-I-NBOMe) | (7538) |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(55)", "dea_code_number": "7538", "file": "2-4-iodo-2-5-dimethoxyphenyl-n-2-methoxybenzyl-ethanamine-25i-nbome-2c-i-nbome.md", "generated": true, "harvested": "2026-09-01", "id": "2-4-iodo-2-5-dimethoxyphenyl-n-2-methoxybenzyl-ethanamine-25i-nbome-2c-i-nbome", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(55) 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe, 2C-I-NBOMe) | (7538) |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe, 2C-I-NBOMe)", "title": "2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe, 2C-I-NBOMe) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 2-(4-isopropoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N-pyrrolidino isotonitazene)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Temporary listing of substances subject to emergency scheduling\n\n> (h) Temporary listing of substances subject to emergency scheduling.\n\n**DEA code number:** 9772\n\n**Temporary listing expires:** Oct. 15, 2027\n\n> adding paragraphs (h)(79) through (85), effective Oct. 15, 2025, until Oct. 15, 2027\n\n**CFR citation:** 21 CFR 1308.11(h)(85)\n\n> (85) 2-(4-isopropoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N-pyrrolidino isotonitazene) | 9772 |\n\nSource: \n", "category": "Temporary listing of substances subject to emergency scheduling", "citation": "21 CFR 1308.11(h)(85)", "dea_code_number": "9772", "file": "2-4-isopropoxybenzyl-5-nitro-1-2-pyrrolidin-1-yl-ethyl-1h-benzimidazole-its-isom.md", "generated": true, "harvested": "2026-09-01", "id": "2-4-isopropoxybenzyl-5-nitro-1-2-pyrrolidin-1-yl-ethyl-1h-benzimidazole-its-isom", "quote_category": "(h) Temporary listing of substances subject to emergency scheduling.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "quote_temporary_expiry": "adding paragraphs (h)(79) through (85), effective Oct. 15, 2025, until Oct. 15, 2027", "schedule": "Schedule I", "source_quote": "(85) 2-(4-isopropoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N-pyrrolidino isotonitazene) | 9772 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "2-(4-isopropoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N-pyrrolidino isotonitazene)", "temporary_expiry": "Oct. 15, 2027", "title": "2-(4-isopropoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N-pyrrolidino isotonitazene) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7532\n\n**CFR citation:** 21 CFR 1308.11(d)(43)\n\n> (43) 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4) | 7532 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(43)", "dea_code_number": "7532", "file": "2-4-isopropylthio-2-5-dimethoxyphenyl-ethanamine-2c-t-4.md", "generated": true, "harvested": "2026-09-01", "id": "2-4-isopropylthio-2-5-dimethoxyphenyl-ethanamine-2c-t-4", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(43) 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4) | 7532 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4)", "title": "2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 2-(4-methoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (Other names: N-pyrrolidino metonitazene; metonitazepyne)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9762\n\n**CFR citation:** 21 CFR 1308.11(b)(79)\n\n> (79) 2-(4-methoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (Other names: N-pyrrolidino metonitazene; metonitazepyne) | 9762 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(79)", "dea_code_number": "9762", "file": "2-4-methoxybenzyl-5-nitro-1-2-pyrrolidin-1-yl-ethyl-1h-benzimidazole-other-names.md", "generated": true, "harvested": "2026-09-01", "id": "2-4-methoxybenzyl-5-nitro-1-2-pyrrolidin-1-yl-ethyl-1h-benzimidazole-other-names", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(79) 2-(4-methoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (Other names: N-pyrrolidino metonitazene; metonitazepyne) | 9762 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "2-(4-methoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (Other names: N-pyrrolidino metonitazene; metonitazepyne)", "title": "2-(4-methoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (Other names: N-pyrrolidino metonitazene; metonitazepyne) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 2,5-dimethoxy-4-ethylamphet-amine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7399\n\n**CFR citation:** 21 CFR 1308.11(d)(5)\n\n> (5) 2,5-dimethoxy-4-ethylamphet-amine | 7399 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(5)", "dea_code_number": "7399", "file": "2-5-dimethoxy-4-ethylamphet-amine.md", "generated": true, "harvested": "2026-09-01", "id": "2-5-dimethoxy-4-ethylamphet-amine", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(5) 2,5-dimethoxy-4-ethylamphet-amine | 7399 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "2,5-dimethoxy-4-ethylamphet-amine", "title": "2,5-dimethoxy-4-ethylamphet-amine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 2,5-dimethoxy-4-(n)-propylthiophenethylamine (other name: 2C-T-7)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7348\n\n**CFR citation:** 21 CFR 1308.11(d)(6)\n\n> (6) 2,5-dimethoxy-4-(n)-propylthiophenethylamine (other name: 2C-T-7) | 7348 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(6)", "dea_code_number": "7348", "file": "2-5-dimethoxy-4-n-propylthiophenethylamine-other-name-2c-t-7.md", "generated": true, "harvested": "2026-09-01", "id": "2-5-dimethoxy-4-n-propylthiophenethylamine-other-name-2c-t-7", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(6) 2,5-dimethoxy-4-(n)-propylthiophenethylamine (other name: 2C-T-7) | 7348 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "2,5-dimethoxy-4-(n)-propylthiophenethylamine (other name: 2C-T-7)", "title": "2,5-dimethoxy-4-(n)-propylthiophenethylamine (other name: 2C-T-7) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 2,5-dimethoxyamphetamine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7396\n\n**CFR citation:** 21 CFR 1308.11(d)(4)\n\n> (4) 2,5-dimethoxyamphetamine | 7396 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(4)", "dea_code_number": "7396", "file": "2-5-dimethoxyamphetamine.md", "generated": true, "harvested": "2026-09-01", "id": "2-5-dimethoxyamphetamine", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(4) 2,5-dimethoxyamphetamine | 7396 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "2,5-dimethoxyamphetamine", "title": "2,5-dimethoxyamphetamine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 2\u2032,5\u2032-Dimethoxyfentanyl (N-(1-(2,5-dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9861\n\n**CFR citation:** 21 CFR 1308.11(b)(37)\n\n> (37) 2\u2032,5\u2032-Dimethoxyfentanyl (N-(1-(2,5-dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide) | 9861 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(37)", "dea_code_number": "9861", "file": "2-5-dimethoxyfentanyl-n-1-2-5-dimethoxyphenethyl-piperidin-4-yl-n-phenylpropiona.md", "generated": true, "harvested": "2026-09-01", "id": "2-5-dimethoxyfentanyl-n-1-2-5-dimethoxyphenethyl-piperidin-4-yl-n-phenylpropiona", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(37) 2\u2032,5\u2032-Dimethoxyfentanyl (N-(1-(2,5-dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide) | 9861 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "2\u2032,5\u2032-Dimethoxyfentanyl (N-(1-(2,5-dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide)", "title": "2\u2032,5\u2032-Dimethoxyfentanyl (N-(1-(2,5-dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol, its salts, optical and geometric isomers and salts of these isomers (including tramadol)\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Narcotic drugs\n\n> (b) Narcotic drugs.\n\n**DEA code number:** 9752\n\n**CFR citation:** 21 CFR 1308.14(b)(3)\n\n> (3) 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol, its salts, optical and geometric isomers and salts of these isomers (including tramadol) | 9752 |\n\nSource: \n", "category": "Narcotic drugs", "citation": "21 CFR 1308.14(b)(3)", "dea_code_number": "9752", "file": "2-dimethylamino-methyl-1-3-methoxyphenyl-cyclohexanol-its-salts-optical-and-geom.md", "generated": true, "harvested": "2026-09-01", "id": "2-dimethylamino-methyl-1-3-methoxyphenyl-cyclohexanol-its-salts-optical-and-geom", "quote_category": "(b) Narcotic drugs.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(3) 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol, its salts, optical and geometric isomers and salts of these isomers (including tramadol) | 9752 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol, its salts, optical and geometric isomers and salts of these isomers (including tramadol)", "title": "2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol, its salts, optical and geometric isomers and salts of these isomers (including tramadol) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one (methoxetamine, MXE)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7286\n\n**CFR citation:** 21 CFR 1308.11(d)(100)\n\n> (100) 2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one (methoxetamine, MXE) | 7286 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(100)", "dea_code_number": "7286", "file": "2-ethylamino-2-3-methoxyphenyl-cyclohexan-1-one-methoxetamine-mxe.md", "generated": true, "harvested": "2026-09-01", "id": "2-ethylamino-2-3-methoxyphenyl-cyclohexan-1-one-methoxetamine-mxe", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(100) 2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one (methoxetamine, MXE) | 7286 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one (methoxetamine, MXE)", "title": "2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one (methoxetamine, MXE) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 2\u2032-Fluoro ortho-fluorofentanyl (N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide; also known as 2\u2032-fluoro 2-fluorofentanyl)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9855\n\n**CFR citation:** 21 CFR 1308.11(b)(48)\n\n> (48) 2\u2032-Fluoro ortho-fluorofentanyl (N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide; also known as 2\u2032-fluoro 2-fluorofentanyl) | 9855 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(48)", "dea_code_number": "9855", "file": "2-fluoro-ortho-fluorofentanyl-n-1-2-fluorophenethyl-piperidin-4-yl-n-2-fluorophe.md", "generated": true, "harvested": "2026-09-01", "id": "2-fluoro-ortho-fluorofentanyl-n-1-2-fluorophenethyl-piperidin-4-yl-n-2-fluorophe", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(48) 2\u2032-Fluoro ortho-fluorofentanyl (N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide; also known as 2\u2032-fluoro 2-fluorofentanyl) | 9855 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "2\u2032-Fluoro ortho-fluorofentanyl (N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide; also known as 2\u2032-fluoro 2-fluorofentanyl)", "title": "2\u2032-Fluoro ortho-fluorofentanyl (N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide; also known as 2\u2032-fluoro 2-fluorofentanyl) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 2-Fluorodeschloroketamine, its salts, isomers, and salts of isomers (other name: 2-(2-fluorophenyl)-2-(methylamino)cyclohexan-1-one; also known as 2-FDCK)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Temporary listing of substances subject to emergency scheduling\n\n> (h) Temporary listing of substances subject to emergency scheduling.\n\n**DEA code number:** 7284\n\n**Temporary listing expires:** May 22, 2028\n\n> adding paragraph (h)(87), effective May 22, 2026 through May 22, 2028\n\n**CFR citation:** 21 CFR 1308.11(h)(87)\n\n> (87) 2-Fluorodeschloroketamine, its salts, isomers, and salts of isomers (other name: 2-(2-fluorophenyl)-2-(methylamino)cyclohexan-1-one; also known as 2-FDCK) | 7284 |\n\nSource: \n", "category": "Temporary listing of substances subject to emergency scheduling", "citation": "21 CFR 1308.11(h)(87)", "dea_code_number": "7284", "file": "2-fluorodeschloroketamine-its-salts-isomers-and-salts-of-isomers-other-name-2-2-.md", "generated": true, "harvested": "2026-09-01", "id": "2-fluorodeschloroketamine-its-salts-isomers-and-salts-of-isomers-other-name-2-2-", "quote_category": "(h) Temporary listing of substances subject to emergency scheduling.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "quote_temporary_expiry": "adding paragraph (h)(87), effective May 22, 2026 through May 22, 2028", "schedule": "Schedule I", "source_quote": "(87) 2-Fluorodeschloroketamine, its salts, isomers, and salts of isomers (other name: 2-(2-fluorophenyl)-2-(methylamino)cyclohexan-1-one; also known as 2-FDCK) | 7284 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "2-Fluorodeschloroketamine, its salts, isomers, and salts of isomers (other name: 2-(2-fluorophenyl)-2-(methylamino)cyclohexan-1-one; also known as 2-FDCK)", "temporary_expiry": "May 22, 2028", "title": "2-Fluorodeschloroketamine, its salts, isomers, and salts of isomers (other name: 2-(2-fluorophenyl)-2-(methylamino)cyclohexan-1-one; also known as 2-FDCK) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 2-Methyl AP-237 (1-(2-methyl-4-(3-phenylprop-2-en-1-yl)piperazin-1-yl)butan-1-one)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9664\n\n**CFR citation:** 21 CFR 1308.11(b)(64)\n\n> (64) 2-Methyl AP-237 (1-(2-methyl-4-(3-phenylprop-2-en-1-yl)piperazin-1-yl)butan-1-one) | 9664 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(64)", "dea_code_number": "9664", "file": "2-methyl-ap-237-1-2-methyl-4-3-phenylprop-2-en-1-yl-piperazin-1-yl-butan-1-one.md", "generated": true, "harvested": "2026-09-01", "id": "2-methyl-ap-237-1-2-methyl-4-3-phenylprop-2-en-1-yl-piperazin-1-yl-butan-1-one", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(64) 2-Methyl AP-237 (1-(2-methyl-4-(3-phenylprop-2-en-1-yl)piperazin-1-yl)butan-1-one) | 9664 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "2-Methyl AP-237 (1-(2-methyl-4-(3-phenylprop-2-en-1-yl)piperazin-1-yl)butan-1-one)", "title": "2-Methyl AP-237 (1-(2-methyl-4-(3-phenylprop-2-en-1-yl)piperazin-1-yl)butan-1-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 2-(methylamino)-1-(3-methylphenyl)propan-1-one (other names: 3-MMC; 3-methylmethcathinone)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 1259\n\n**CFR citation:** 21 CFR 1308.11(d)(104)\n\n> (104) 2-(methylamino)-1-(3-methylphenyl)propan-1-one (other names: 3-MMC; 3-methylmethcathinone) | 1259 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(104)", "dea_code_number": "1259", "file": "2-methylamino-1-3-methylphenyl-propan-1-one-other-names-3-mmc-3-methylmethcathin.md", "generated": true, "harvested": "2026-09-01", "id": "2-methylamino-1-3-methylphenyl-propan-1-one-other-names-3-mmc-3-methylmethcathin", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(104) 2-(methylamino)-1-(3-methylphenyl)propan-1-one (other names: 3-MMC; 3-methylmethcathinone) | 1259 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "2-(methylamino)-1-(3-methylphenyl)propan-1-one (other names: 3-MMC; 3-methylmethcathinone)", "title": "2-(methylamino)-1-(3-methylphenyl)propan-1-one (other names: 3-MMC; 3-methylmethcathinone) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 2-(methylamino)-1-phenylpentan-1-one (pentedrone)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 1246\n\n**CFR citation:** 21 CFR 1308.11(d)(63)\n\n> (63) 2-(methylamino)-1-phenylpentan-1-one (pentedrone) | (1246) |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(63)", "dea_code_number": "1246", "file": "2-methylamino-1-phenylpentan-1-one-pentedrone.md", "generated": true, "harvested": "2026-09-01", "id": "2-methylamino-1-phenylpentan-1-one-pentedrone", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(63) 2-(methylamino)-1-phenylpentan-1-one (pentedrone) | (1246) |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "2-(methylamino)-1-phenylpentan-1-one (pentedrone)", "title": "2-(methylamino)-1-phenylpentan-1-one (pentedrone) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 3\u03b1,17\u03b2-dihydroxy-5\u03b1-androstane\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(26)\n\n> (26) 3\u03b1,17\u03b2-dihydroxy-5\u03b1-androstane;\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(26)", "file": "3-17-dihydroxy-5-androstane-2.md", "generated": true, "harvested": "2026-09-01", "id": "3-17-dihydroxy-5-androstane-2", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(26) 3\u03b1,17\u03b2-dihydroxy-5\u03b1-androstane;", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "3\u03b1,17\u03b2-dihydroxy-5\u03b1-androstane", "title": "3\u03b1,17\u03b2-dihydroxy-5\u03b1-androstane \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 3\u03b2,17\u03b2-dihydroxy-5\u03b1-androstane\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(25)\n\n> (25) 3\u03b2,17\u03b2-dihydroxy-5\u03b1-androstane;\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(25)", "file": "3-17-dihydroxy-5-androstane.md", "generated": true, "harvested": "2026-09-01", "id": "3-17-dihydroxy-5-androstane", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(25) 3\u03b2,17\u03b2-dihydroxy-5\u03b1-androstane;", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "3\u03b2,17\u03b2-dihydroxy-5\u03b1-androstane", "title": "3\u03b2,17\u03b2-dihydroxy-5\u03b1-androstane \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** [3,2-c]furazan-5\u03b1-androstan-17\u03b2-ol\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(36)\n\n> (36) [3,2-c]furazan-5\u03b1-androstan-17\u03b2-ol;\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(36)", "file": "3-2-c-furazan-5-androstan-17-ol.md", "generated": true, "harvested": "2026-09-01", "id": "3-2-c-furazan-5-androstan-17-ol", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(36) [3,2-c]furazan-5\u03b1-androstan-17\u03b2-ol;", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "[3,2-c]furazan-5\u03b1-androstan-17\u03b2-ol", "title": "[3,2-c]furazan-5\u03b1-androstan-17\u03b2-ol \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** [3,2-c]pyrazole-androst-4-en-17\u03b2-ol\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(80)\n\n> (80) [3,2-c]pyrazole-androst-4-en-17\u03b2-ol;\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(80)", "file": "3-2-c-pyrazole-androst-4-en-17-ol.md", "generated": true, "harvested": "2026-09-01", "id": "3-2-c-pyrazole-androst-4-en-17-ol", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(80) [3,2-c]pyrazole-androst-4-en-17\u03b2-ol;", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "[3,2-c]pyrazole-androst-4-en-17\u03b2-ol", "title": "[3,2-c]pyrazole-androst-4-en-17\u03b2-ol \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 3-(3-(1-(1-(4-chlorophenyl)ethyl)piperidin-4-yl)-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)propanenitrile, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: N-propionitrile chlorphine; cychlorphine)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Temporary listing of substances subject to emergency scheduling\n\n> (h) Temporary listing of substances subject to emergency scheduling.\n\n**DEA code number:** 9094\n\n**Temporary listing expires:** Aug. 27, 2028\n\n> adding paragraphs (h)(92) through (h)(95), effective Aug. 27, 2026 through Aug. 27, 2028\n\n**CFR citation:** 21 CFR 1308.11(h)(94)\n\n> (94) 3-(3-(1-(1-(4-chlorophenyl)ethyl)piperidin-4-yl)-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)propanenitrile, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: N-propionitrile chlorphine; cychlorphine) | 9094 |\n\nSource: \n", "category": "Temporary listing of substances subject to emergency scheduling", "citation": "21 CFR 1308.11(h)(94)", "dea_code_number": "9094", "file": "3-3-1-1-4-chlorophenyl-ethyl-piperidin-4-yl-2-oxo-2-3-dihydro-1h-benzo-d-imidazo.md", "generated": true, "harvested": "2026-09-01", "id": "3-3-1-1-4-chlorophenyl-ethyl-piperidin-4-yl-2-oxo-2-3-dihydro-1h-benzo-d-imidazo", "quote_category": "(h) Temporary listing of substances subject to emergency scheduling.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "quote_temporary_expiry": "adding paragraphs (h)(92) through (h)(95), effective Aug. 27, 2026 through Aug. 27, 2028", "schedule": "Schedule I", "source_quote": "(94) 3-(3-(1-(1-(4-chlorophenyl)ethyl)piperidin-4-yl)-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)propanenitrile, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: N-propionitrile chlorphine; cychlorphine) | 9094 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "3-(3-(1-(1-(4-chlorophenyl)ethyl)piperidin-4-yl)-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)propanenitrile, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: N-propionitrile chlorphine; cychlorphine)", "temporary_expiry": "Aug. 27, 2028", "title": "3-(3-(1-(1-(4-chlorophenyl)ethyl)piperidin-4-yl)-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)propanenitrile, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: N-propionitrile chlorphine; cychlorphine) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 3,4,5-trimethoxy amphetamine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7390\n\n**CFR citation:** 21 CFR 1308.11(d)(14)\n\n> (14) 3,4,5-trimethoxy amphetamine | 7390 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(14)", "dea_code_number": "7390", "file": "3-4-5-trimethoxy-amphetamine.md", "generated": true, "harvested": "2026-09-01", "id": "3-4-5-trimethoxy-amphetamine", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(14) 3,4,5-trimethoxy amphetamine | 7390 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "3,4,5-trimethoxy amphetamine", "title": "3,4,5-trimethoxy amphetamine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 3,4-methylenedioxy amphetamine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7400\n\n**CFR citation:** 21 CFR 1308.11(d)(10)\n\n> (10) 3,4-methylenedioxy amphetamine | 7400 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(10)", "dea_code_number": "7400", "file": "3-4-methylenedioxy-amphetamine.md", "generated": true, "harvested": "2026-09-01", "id": "3-4-methylenedioxy-amphetamine", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(10) 3,4-methylenedioxy amphetamine | 7400 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "3,4-methylenedioxy amphetamine", "title": "3,4-methylenedioxy amphetamine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 3,4-methylenedioxy-N-ethylamphetamine (also known as N-ethyl-alpha-methyl-3,4(methylenedioxy)-phenethylamine, N-ethyl MDA, MDE, MDEA\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7404\n\n**CFR citation:** 21 CFR 1308.11(d)(12)\n\n> (12) 3,4-methylenedioxy-N-ethylamphetamine (also known as N-ethyl-alpha-methyl-3,4(methylenedioxy)-phenethylamine, N-ethyl MDA, MDE, MDEA | 7404 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(12)", "dea_code_number": "7404", "file": "3-4-methylenedioxy-n-ethylamphetamine-also-known-as-n-ethyl-alpha-methyl-3-4-met.md", "generated": true, "harvested": "2026-09-01", "id": "3-4-methylenedioxy-n-ethylamphetamine-also-known-as-n-ethyl-alpha-methyl-3-4-met", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(12) 3,4-methylenedioxy-N-ethylamphetamine (also known as N-ethyl-alpha-methyl-3,4(methylenedioxy)-phenethylamine, N-ethyl MDA, MDE, MDEA | 7404 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "3,4-methylenedioxy-N-ethylamphetamine (also known as N-ethyl-alpha-methyl-3,4(methylenedioxy)-phenethylamine, N-ethyl MDA, MDE, MDEA", "title": "3,4-methylenedioxy-N-ethylamphetamine (also known as N-ethyl-alpha-methyl-3,4(methylenedioxy)-phenethylamine, N-ethyl MDA, MDE, MDEA \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 3,4-Methylenedioxy-N-methylcathinone (Methylone)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7540\n\n**CFR citation:** 21 CFR 1308.11(d)(47)\n\n> (47) 3,4-Methylenedioxy-N-methylcathinone (Methylone) | 7540 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(47)", "dea_code_number": "7540", "file": "3-4-methylenedioxy-n-methylcathinone-methylone.md", "generated": true, "harvested": "2026-09-01", "id": "3-4-methylenedioxy-n-methylcathinone-methylone", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(47) 3,4-Methylenedioxy-N-methylcathinone (Methylone) | 7540 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "3,4-Methylenedioxy-N-methylcathinone (Methylone)", "title": "3,4-Methylenedioxy-N-methylcathinone (Methylone) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 3,4-methylenedioxymethamphetamine (MDMA)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7405\n\n**CFR citation:** 21 CFR 1308.11(d)(11)\n\n> (11) 3,4-methylenedioxymethamphetamine (MDMA) | 7405 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(11)", "dea_code_number": "7405", "file": "3-4-methylenedioxymethamphetamine-mdma.md", "generated": true, "harvested": "2026-09-01", "id": "3-4-methylenedioxymethamphetamine-mdma", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(11) 3,4-methylenedioxymethamphetamine (MDMA) | 7405 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "3,4-methylenedioxymethamphetamine (MDMA)", "title": "3,4-methylenedioxymethamphetamine (MDMA) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 3,4-methylenedioxypyrovalerone (MDPV)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7535\n\n**CFR citation:** 21 CFR 1308.11(d)(37)\n\n> (37) 3,4-methylenedioxypyrovalerone (MDPV) | 7535 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(37)", "dea_code_number": "7535", "file": "3-4-methylenedioxypyrovalerone-mdpv.md", "generated": true, "harvested": "2026-09-01", "id": "3-4-methylenedioxypyrovalerone-mdpv", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(37) 3,4-methylenedioxypyrovalerone (MDPV) | 7535 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "3,4-methylenedioxypyrovalerone (MDPV)", "title": "3,4-methylenedioxypyrovalerone (MDPV) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 3-fluoro-N-methylcathinone (3-FMC)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 1233\n\n**CFR citation:** 21 CFR 1308.11(d)(66)\n\n> (66) 3-fluoro-N-methylcathinone (3-FMC) | (1233) |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(66)", "dea_code_number": "1233", "file": "3-fluoro-n-methylcathinone-3-fmc.md", "generated": true, "harvested": "2026-09-01", "id": "3-fluoro-n-methylcathinone-3-fmc", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(66) 3-fluoro-N-methylcathinone (3-FMC) | (1233) |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "3-fluoro-N-methylcathinone (3-FMC)", "title": "3-fluoro-N-methylcathinone (3-FMC) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 3-Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-3-carboxamide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9860\n\n**CFR citation:** 21 CFR 1308.11(b)(50)\n\n> (50) 3-Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-3-carboxamide) | 9860 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(50)", "dea_code_number": "9860", "file": "3-furanyl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylfuran-3-carboxamide.md", "generated": true, "harvested": "2026-09-01", "id": "3-furanyl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylfuran-3-carboxamide", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(50) 3-Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-3-carboxamide) | 9860 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "3-Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-3-carboxamide)", "title": "3-Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-3-carboxamide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 3\u03b2-hydroxy-estra-4,9,11-trien-17-one\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(42)\n\n> (42) 3\u03b2-hydroxy-estra-4,9,11-trien-17-one;\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(42)", "file": "3-hydroxy-estra-4-9-11-trien-17-one.md", "generated": true, "harvested": "2026-09-01", "id": "3-hydroxy-estra-4-9-11-trien-17-one", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(42) 3\u03b2-hydroxy-estra-4,9,11-trien-17-one;", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "3\u03b2-hydroxy-estra-4,9,11-trien-17-one", "title": "3\u03b2-hydroxy-estra-4,9,11-trien-17-one \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 3-methoxyphencyclidine (Other names: 1-(1-(3-methoxyphenyl)cyclohexyl)piperidine; 3-MeO-PCP)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7457\n\n**CFR citation:** 21 CFR 1308.11(d)(109)\n\n> (109) 3-methoxyphencyclidine (Other names: 1-(1-(3-methoxyphenyl)cyclohexyl)piperidine; 3-MeO-PCP) | 7457 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(109)", "dea_code_number": "7457", "file": "3-methoxyphencyclidine-other-names-1-1-3-methoxyphenyl-cyclohexyl-piperidine-3-m.md", "generated": true, "harvested": "2026-09-01", "id": "3-methoxyphencyclidine-other-names-1-1-3-methoxyphenyl-cyclohexyl-piperidine-3-m", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(109) 3-methoxyphencyclidine (Other names: 1-(1-(3-methoxyphenyl)cyclohexyl)piperidine; 3-MeO-PCP) | 7457 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "3-methoxyphencyclidine (Other names: 1-(1-(3-methoxyphenyl)cyclohexyl)piperidine; 3-MeO-PCP)", "title": "3-methoxyphencyclidine (Other names: 1-(1-(3-methoxyphenyl)cyclohexyl)piperidine; 3-MeO-PCP) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9813\n\n**CFR citation:** 21 CFR 1308.11(b)(65)\n\n> (65) 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide) | 9813 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(65)", "dea_code_number": "9813", "file": "3-methylfentanyl-n-3-methyl-1-2-phenylethyl-4-piperidyl-n-phenylpropanamide.md", "generated": true, "harvested": "2026-09-01", "id": "3-methylfentanyl-n-3-methyl-1-2-phenylethyl-4-piperidyl-n-phenylpropanamide", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(65) 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide) | 9813 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide)", "title": "3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 3-Methylthiofentanyl (N-[3-methyl-1-(2-thienylethyl)-4-piperidinyl]-N-phenylpropanamide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9833\n\n**CFR citation:** 21 CFR 1308.11(b)(66)\n\n> (66) 3-Methylthiofentanyl (N-[3-methyl-1-(2-thienylethyl)-4-piperidinyl]-N-phenylpropanamide) | 9833 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(66)", "dea_code_number": "9833", "file": "3-methylthiofentanyl-n-3-methyl-1-2-thienylethyl-4-piperidinyl-n-phenylpropanami.md", "generated": true, "harvested": "2026-09-01", "id": "3-methylthiofentanyl-n-3-methyl-1-2-thienylethyl-4-piperidinyl-n-phenylpropanami", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(66) 3-Methylthiofentanyl (N-[3-methyl-1-(2-thienylethyl)-4-piperidinyl]-N-phenylpropanamide) | 9833 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "3-Methylthiofentanyl (N-[3-methyl-1-(2-thienylethyl)-4-piperidinyl]-N-phenylpropanamide)", "title": "3-Methylthiofentanyl (N-[3-methyl-1-(2-thienylethyl)-4-piperidinyl]-N-phenylpropanamide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 4,4\u2032-Dimethylaminorex (4,4\u2032-DMAR; 4,5-dihydro-4-methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Stimulants\n\n> (f) Stimulants.\n\n**DEA code number:** 1595\n\n**CFR citation:** 21 CFR 1308.11(f)(5)\n\n> (5) 4,4\u2032-Dimethylaminorex (4,4\u2032-DMAR; 4,5-dihydro-4-methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine) | 1595 |\n\nSource: \n", "category": "Stimulants", "citation": "21 CFR 1308.11(f)(5)", "dea_code_number": "1595", "file": "4-4-dimethylaminorex-4-4-dmar-4-5-dihydro-4-methyl-5-4-methylphenyl-2-oxazolamin.md", "generated": true, "harvested": "2026-09-01", "id": "4-4-dimethylaminorex-4-4-dmar-4-5-dihydro-4-methyl-5-4-methylphenyl-2-oxazolamin", "quote_category": "(f) Stimulants.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(5) 4,4\u2032-Dimethylaminorex (4,4\u2032-DMAR; 4,5-dihydro-4-methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine) | 1595 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "4,4\u2032-Dimethylaminorex (4,4\u2032-DMAR; 4,5-dihydro-4-methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine)", "title": "4,4\u2032-Dimethylaminorex (4,4\u2032-DMAR; 4,5-dihydro-4-methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 4-androstenediol (3\u03b2,17\u03b2-dihydroxy-androst-4-ene)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(5)\n\n> (5) 4-androstenediol (3\u03b2,17\u03b2-dihydroxy-androst-4-ene);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(5)", "file": "4-androstenediol-3-17-dihydroxy-androst-4-ene.md", "generated": true, "harvested": "2026-09-01", "id": "4-androstenediol-3-17-dihydroxy-androst-4-ene", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(5) 4-androstenediol (3\u03b2,17\u03b2-dihydroxy-androst-4-ene);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "4-androstenediol (3\u03b2,17\u03b2-dihydroxy-androst-4-ene)", "title": "4-androstenediol (3\u03b2,17\u03b2-dihydroxy-androst-4-ene) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 4-androstenedione (androst-4-en-3,17-dione)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(8)\n\n> (8) 4-androstenedione (androst-4-en-3,17-dione);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(8)", "file": "4-androstenedione-androst-4-en-3-17-dione.md", "generated": true, "harvested": "2026-09-01", "id": "4-androstenedione-androst-4-en-3-17-dione", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(8) 4-androstenedione (androst-4-en-3,17-dione);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "4-androstenedione (androst-4-en-3,17-dione)", "title": "4-androstenedione (androst-4-en-3,17-dione) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 4-anilino-N-phenethylpiperidine (ANPP)\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Immediate precursors\n\n> (g) Immediate precursors.\n\n**DEA code number:** 8333\n\n**CFR citation:** 21 CFR 1308.12(g)(3)(i)\n\n> (i) 4-anilino-N-phenethylpiperidine (ANPP) | 8333 |\n\nSource: \n", "category": "Immediate precursors", "citation": "21 CFR 1308.12(g)(3)(i)", "dea_code_number": "8333", "file": "4-anilino-n-phenethylpiperidine-anpp.md", "generated": true, "harvested": "2026-09-01", "id": "4-anilino-n-phenethylpiperidine-anpp", "quote_category": "(g) Immediate precursors.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(i) 4-anilino-N-phenethylpiperidine (ANPP) | 8333 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "4-anilino-N-phenethylpiperidine (ANPP)", "title": "4-anilino-N-phenethylpiperidine (ANPP) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 4-bromo-2,5-dimethoxy-amphetamine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7391\n\n**CFR citation:** 21 CFR 1308.11(d)(2)\n\n> (2) 4-bromo-2,5-dimethoxy-amphetamine | 7391 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(2)", "dea_code_number": "7391", "file": "4-bromo-2-5-dimethoxy-amphetamine.md", "generated": true, "harvested": "2026-09-01", "id": "4-bromo-2-5-dimethoxy-amphetamine", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(2) 4-bromo-2,5-dimethoxy-amphetamine | 7391 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "4-bromo-2,5-dimethoxy-amphetamine", "title": "4-bromo-2,5-dimethoxy-amphetamine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 4-Bromo-2,5-dimethoxyphenethylamine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7392\n\n**CFR citation:** 21 CFR 1308.11(d)(3)\n\n> (3) 4-Bromo-2,5-dimethoxyphenethylamine | 7392 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(3)", "dea_code_number": "7392", "file": "4-bromo-2-5-dimethoxyphenethylamine.md", "generated": true, "harvested": "2026-09-01", "id": "4-bromo-2-5-dimethoxyphenethylamine", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(3) 4-Bromo-2,5-dimethoxyphenethylamine | 7392 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "4-Bromo-2,5-dimethoxyphenethylamine", "title": "4-Bromo-2,5-dimethoxyphenethylamine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 4-chloro-17\u03b1-methyl-17\u03b2-hydroxy-androst-4-en-3-one\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(18)\n\n> (18) 4-chloro-17\u03b1-methyl-17\u03b2-hydroxy-androst-4-en-3-one;\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(18)", "file": "4-chloro-17-methyl-17-hydroxy-androst-4-en-3-one.md", "generated": true, "harvested": "2026-09-01", "id": "4-chloro-17-methyl-17-hydroxy-androst-4-en-3-one", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(18) 4-chloro-17\u03b1-methyl-17\u03b2-hydroxy-androst-4-en-3-one;", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "4-chloro-17\u03b1-methyl-17\u03b2-hydroxy-androst-4-en-3-one", "title": "4-chloro-17\u03b1-methyl-17\u03b2-hydroxy-androst-4-en-3-one \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 4-chloro-17\u03b1-methyl-17\u03b2-hydroxy-androst-4-ene-3,11-dione\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(19)\n\n> (19) 4-chloro-17\u03b1-methyl-17\u03b2-hydroxy-androst-4-ene-3,11-dione;\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(19)", "file": "4-chloro-17-methyl-17-hydroxy-androst-4-ene-3-11-dione.md", "generated": true, "harvested": "2026-09-01", "id": "4-chloro-17-methyl-17-hydroxy-androst-4-ene-3-11-dione", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(19) 4-chloro-17\u03b1-methyl-17\u03b2-hydroxy-androst-4-ene-3,11-dione;", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "4-chloro-17\u03b1-methyl-17\u03b2-hydroxy-androst-4-ene-3,11-dione", "title": "4-chloro-17\u03b1-methyl-17\u03b2-hydroxy-androst-4-ene-3,11-dione \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 4-chloro-17\u03b1-methyl-androst-4-ene-3\u03b2,17\u03b2-diol\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(17)\n\n> (17) 4-chloro-17\u03b1-methyl-androst-4-ene-3\u03b2,17\u03b2-diol;\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(17)", "file": "4-chloro-17-methyl-androst-4-ene-3-17-diol.md", "generated": true, "harvested": "2026-09-01", "id": "4-chloro-17-methyl-androst-4-ene-3-17-diol", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(17) 4-chloro-17\u03b1-methyl-androst-4-ene-3\u03b2,17\u03b2-diol;", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "4-chloro-17\u03b1-methyl-androst-4-ene-3\u03b2,17\u03b2-diol", "title": "4-chloro-17\u03b1-methyl-androst-4-ene-3\u03b2,17\u03b2-diol \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 4-chloro-17\u03b1-methyl-androsta-1,4-diene-3,17\u03b2-diol\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(16)\n\n> (16) 4-chloro-17\u03b1-methyl-androsta-1,4-diene-3,17\u03b2-diol;\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(16)", "file": "4-chloro-17-methyl-androsta-1-4-diene-3-17-diol.md", "generated": true, "harvested": "2026-09-01", "id": "4-chloro-17-methyl-androsta-1-4-diene-3-17-diol", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(16) 4-chloro-17\u03b1-methyl-androsta-1,4-diene-3,17\u03b2-diol;", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "4-chloro-17\u03b1-methyl-androsta-1,4-diene-3,17\u03b2-diol", "title": "4-chloro-17\u03b1-methyl-androsta-1,4-diene-3,17\u03b2-diol \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 4\u2032-Chloro-alpha-pyrrolidinovalerophenone (Other names: 4-chloro-\u03b1-PVP; 4\u2032-chloro-\u03b1-pyrrolidinopentiophenone; 1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7443\n\n**CFR citation:** 21 CFR 1308.11(d)(99)\n\n> (99) 4\u2032-Chloro-alpha-pyrrolidinovalerophenone (Other names: 4-chloro-\u03b1-PVP; 4\u2032-chloro-\u03b1-pyrrolidinopentiophenone; 1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one) | 7443 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(99)", "dea_code_number": "7443", "file": "4-chloro-alpha-pyrrolidinovalerophenone-other-names-4-chloro-pvp-4-chloro-pyrrol.md", "generated": true, "harvested": "2026-09-01", "id": "4-chloro-alpha-pyrrolidinovalerophenone-other-names-4-chloro-pvp-4-chloro-pyrrol", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(99) 4\u2032-Chloro-alpha-pyrrolidinovalerophenone (Other names: 4-chloro-\u03b1-PVP; 4\u2032-chloro-\u03b1-pyrrolidinopentiophenone; 1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one) | 7443 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "4\u2032-Chloro-alpha-pyrrolidinovalerophenone (Other names: 4-chloro-\u03b1-PVP; 4\u2032-chloro-\u03b1-pyrrolidinopentiophenone; 1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one)", "title": "4\u2032-Chloro-alpha-pyrrolidinovalerophenone (Other names: 4-chloro-\u03b1-PVP; 4\u2032-chloro-\u03b1-pyrrolidinopentiophenone; 1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 4-Chloromethcathinone (4-CMC, 1-(4-chlorophenyl)-2-(methylamino)propan-1-one)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 1239\n\n**CFR citation:** 21 CFR 1308.11(d)(106)\n\n> (106) 4-Chloromethcathinone (4-CMC, 1-(4-chlorophenyl)-2-(methylamino)propan-1-one) | 1239 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(106)", "dea_code_number": "1239", "file": "4-chloromethcathinone-4-cmc-1-4-chlorophenyl-2-methylamino-propan-1-one.md", "generated": true, "harvested": "2026-09-01", "id": "4-chloromethcathinone-4-cmc-1-4-chlorophenyl-2-methylamino-propan-1-one", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(106) 4-Chloromethcathinone (4-CMC, 1-(4-chlorophenyl)-2-(methylamino)propan-1-one) | 1239 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "4-Chloromethcathinone (4-CMC, 1-(4-chlorophenyl)-2-(methylamino)propan-1-one)", "title": "4-Chloromethcathinone (4-CMC, 1-(4-chlorophenyl)-2-(methylamino)propan-1-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 4-dihydrotestosterone (17\u03b2-hydroxy-androstan-3-one)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(23)\n\n> (23) 4-dihydrotestosterone (17\u03b2-hydroxy-androstan-3-one);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(23)", "file": "4-dihydrotestosterone-17-hydroxy-androstan-3-one.md", "generated": true, "harvested": "2026-09-01", "id": "4-dihydrotestosterone-17-hydroxy-androstan-3-one", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(23) 4-dihydrotestosterone (17\u03b2-hydroxy-androstan-3-one);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "4-dihydrotestosterone (17\u03b2-hydroxy-androstan-3-one)", "title": "4-dihydrotestosterone (17\u03b2-hydroxy-androstan-3-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 4-fluoro-N-methylcathinone (4-FMC; flephedrone)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 1238\n\n**CFR citation:** 21 CFR 1308.11(d)(65)\n\n> (65) 4-fluoro-N-methylcathinone (4-FMC; flephedrone) | (1238) |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(65)", "dea_code_number": "1238", "file": "4-fluoro-n-methylcathinone-4-fmc-flephedrone.md", "generated": true, "harvested": "2026-09-01", "id": "4-fluoro-n-methylcathinone-4-fmc-flephedrone", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(65) 4-fluoro-N-methylcathinone (4-FMC; flephedrone) | (1238) |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "4-fluoro-N-methylcathinone (4-FMC; flephedrone)", "title": "4-fluoro-N-methylcathinone (4-FMC; flephedrone) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 4-Fluoroamphetamine (4-FA, 1-(4-fluorophenyl)propan-2-amine, para-fluoroamphetamine)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Stimulants\n\n> (f) Stimulants.\n\n**DEA code number:** 1476\n\n**CFR citation:** 21 CFR 1308.11(f)(8)\n\n> (8) 4-Fluoroamphetamine (4-FA, 1-(4-fluorophenyl)propan-2-amine, para-fluoroamphetamine) | 1476 |\n\nSource: \n", "category": "Stimulants", "citation": "21 CFR 1308.11(f)(8)", "dea_code_number": "1476", "file": "4-fluoroamphetamine-4-fa-1-4-fluorophenyl-propan-2-amine-para-fluoroamphetamine.md", "generated": true, "harvested": "2026-09-01", "id": "4-fluoroamphetamine-4-fa-1-4-fluorophenyl-propan-2-amine-para-fluoroamphetamine", "quote_category": "(f) Stimulants.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(8) 4-Fluoroamphetamine (4-FA, 1-(4-fluorophenyl)propan-2-amine, para-fluoroamphetamine) | 1476 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "4-Fluoroamphetamine (4-FA, 1-(4-fluorophenyl)propan-2-amine, para-fluoroamphetamine)", "title": "4-Fluoroamphetamine (4-FA, 1-(4-fluorophenyl)propan-2-amine, para-fluoroamphetamine) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide; also known as para-fluoroisobutyryl fentanyl)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9824\n\n**CFR citation:** 21 CFR 1308.11(b)(47)\n\n> (47) 4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide; also known as para-fluoroisobutyryl fentanyl) | 9824 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(47)", "dea_code_number": "9824", "file": "4-fluoroisobutyryl-fentanyl-n-4-fluorophenyl-n-1-phenethylpiperidin-4-yl-isobuty.md", "generated": true, "harvested": "2026-09-01", "id": "4-fluoroisobutyryl-fentanyl-n-4-fluorophenyl-n-1-phenethylpiperidin-4-yl-isobuty", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(47) 4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide; also known as para-fluoroisobutyryl fentanyl) | 9824 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide; also known as para-fluoroisobutyryl fentanyl)", "title": "4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide; also known as para-fluoroisobutyryl fentanyl) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 4-hydroxy-19-nortestosterone (4,17\u03b2-dihydroxy-estr-4-en-3-one)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(38)\n\n> (38) 4-hydroxy-19-nortestosterone (4,17\u03b2-dihydroxy-estr-4-en-3-one);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(38)", "file": "4-hydroxy-19-nortestosterone-4-17-dihydroxy-estr-4-en-3-one.md", "generated": true, "harvested": "2026-09-01", "id": "4-hydroxy-19-nortestosterone-4-17-dihydroxy-estr-4-en-3-one", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(38) 4-hydroxy-19-nortestosterone (4,17\u03b2-dihydroxy-estr-4-en-3-one);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "4-hydroxy-19-nortestosterone (4,17\u03b2-dihydroxy-estr-4-en-3-one)", "title": "4-hydroxy-19-nortestosterone (4,17\u03b2-dihydroxy-estr-4-en-3-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 4-hydroxy-androst-4-ene-3,17-dione\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(39)\n\n> (39) 4-hydroxy-androst-4-ene-3,17-dione;\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(39)", "file": "4-hydroxy-androst-4-ene-3-17-dione.md", "generated": true, "harvested": "2026-09-01", "id": "4-hydroxy-androst-4-ene-3-17-dione", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(39) 4-hydroxy-androst-4-ene-3,17-dione;", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "4-hydroxy-androst-4-ene-3,17-dione", "title": "4-hydroxy-androst-4-ene-3,17-dione \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 4-hydroxytestosterone (4,17\u03b2-dihydroxy-androst-4-en-3-one)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(43)\n\n> (43) 4-hydroxytestosterone (4,17\u03b2-dihydroxy-androst-4-en-3-one);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(43)", "file": "4-hydroxytestosterone-4-17-dihydroxy-androst-4-en-3-one.md", "generated": true, "harvested": "2026-09-01", "id": "4-hydroxytestosterone-4-17-dihydroxy-androst-4-en-3-one", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(43) 4-hydroxytestosterone (4,17\u03b2-dihydroxy-androst-4-en-3-one);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "4-hydroxytestosterone (4,17\u03b2-dihydroxy-androst-4-en-3-one)", "title": "4-hydroxytestosterone (4,17\u03b2-dihydroxy-androst-4-en-3-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 4-methoxyamphetamine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7411\n\n**CFR citation:** 21 CFR 1308.11(d)(7)\n\n> (7) 4-methoxyamphetamine | 7411 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(7)", "dea_code_number": "7411", "file": "4-methoxyamphetamine.md", "generated": true, "harvested": "2026-09-01", "id": "4-methoxyamphetamine", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(7) 4-methoxyamphetamine | 7411 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "4-methoxyamphetamine", "title": "4-methoxyamphetamine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (other names: \u03b1-PiHP; alpha-PiHP)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7551\n\n**CFR citation:** 21 CFR 1308.11(d)(103)\n\n> (103) 4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (other names: \u03b1-PiHP; alpha-PiHP) | 7551 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(103)", "dea_code_number": "7551", "file": "4-methyl-1-phenyl-2-pyrrolidin-1-yl-pentan-1-one-other-names-pihp-alpha-pihp.md", "generated": true, "harvested": "2026-09-01", "id": "4-methyl-1-phenyl-2-pyrrolidin-1-yl-pentan-1-one-other-names-pihp-alpha-pihp", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(103) 4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (other names: \u03b1-PiHP; alpha-PiHP) | 7551 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (other names: \u03b1-PiHP; alpha-PiHP)", "title": "4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (other names: \u03b1-PiHP; alpha-PiHP) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 4-methyl-2,5-dimethoxy-amphetamine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7395\n\n**CFR citation:** 21 CFR 1308.11(d)(9)\n\n> (9) 4-methyl-2,5-dimethoxy-amphetamine | 7395 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(9)", "dea_code_number": "7395", "file": "4-methyl-2-5-dimethoxy-amphetamine.md", "generated": true, "harvested": "2026-09-01", "id": "4-methyl-2-5-dimethoxy-amphetamine", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(9) 4-methyl-2,5-dimethoxy-amphetamine | 7395 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "4-methyl-2,5-dimethoxy-amphetamine", "title": "4-methyl-2,5-dimethoxy-amphetamine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 4\u2032-Methyl acetyl fentanyl (N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9819\n\n**CFR citation:** 21 CFR 1308.11(b)(63)\n\n> (63) 4\u2032-Methyl acetyl fentanyl (N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide) | 9819 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(63)", "dea_code_number": "9819", "file": "4-methyl-acetyl-fentanyl-n-1-4-methylphenethyl-piperidin-4-yl-n-phenylacetamide.md", "generated": true, "harvested": "2026-09-01", "id": "4-methyl-acetyl-fentanyl-n-1-4-methylphenethyl-piperidin-4-yl-n-phenylacetamide", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(63) 4\u2032-Methyl acetyl fentanyl (N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide) | 9819 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "4\u2032-Methyl acetyl fentanyl (N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide)", "title": "4\u2032-Methyl acetyl fentanyl (N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 4-Methyl-alpha-ethylaminopentiophenone (Other names: 4-MEAP; 2-(ethylamino)-1-(4-methylphenyl)pentan-1-one)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7245\n\n**CFR citation:** 21 CFR 1308.11(d)(96)\n\n> (96) 4-Methyl-alpha-ethylaminopentiophenone (Other names: 4-MEAP; 2-(ethylamino)-1-(4-methylphenyl)pentan-1-one) | 7245 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(96)", "dea_code_number": "7245", "file": "4-methyl-alpha-ethylaminopentiophenone-other-names-4-meap-2-ethylamino-1-4-methy.md", "generated": true, "harvested": "2026-09-01", "id": "4-methyl-alpha-ethylaminopentiophenone-other-names-4-meap-2-ethylamino-1-4-methy", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(96) 4-Methyl-alpha-ethylaminopentiophenone (Other names: 4-MEAP; 2-(ethylamino)-1-(4-methylphenyl)pentan-1-one) | 7245 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "4-Methyl-alpha-ethylaminopentiophenone (Other names: 4-MEAP; 2-(ethylamino)-1-(4-methylphenyl)pentan-1-one)", "title": "4-Methyl-alpha-ethylaminopentiophenone (Other names: 4-MEAP; 2-(ethylamino)-1-(4-methylphenyl)pentan-1-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 4\u2032-Methyl-alpha-pyrrolidinohexiophenone (Other names: MPHP; 4\u2032-methyl-alpha-pyrrolidinohexanophenone; 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7446\n\n**CFR citation:** 21 CFR 1308.11(d)(97)\n\n> (97) 4\u2032-Methyl-alpha-pyrrolidinohexiophenone (Other names: MPHP; 4\u2032-methyl-alpha-pyrrolidinohexanophenone; 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one) | 7446 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(97)", "dea_code_number": "7446", "file": "4-methyl-alpha-pyrrolidinohexiophenone-other-names-mphp-4-methyl-alpha-pyrrolidi.md", "generated": true, "harvested": "2026-09-01", "id": "4-methyl-alpha-pyrrolidinohexiophenone-other-names-mphp-4-methyl-alpha-pyrrolidi", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(97) 4\u2032-Methyl-alpha-pyrrolidinohexiophenone (Other names: MPHP; 4\u2032-methyl-alpha-pyrrolidinohexanophenone; 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one) | 7446 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "4\u2032-Methyl-alpha-pyrrolidinohexiophenone (Other names: MPHP; 4\u2032-methyl-alpha-pyrrolidinohexanophenone; 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one)", "title": "4\u2032-Methyl-alpha-pyrrolidinohexiophenone (Other names: MPHP; 4\u2032-methyl-alpha-pyrrolidinohexanophenone; 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 4-methyl-alpha-pyrrolidinopropiophenone (4-MePPP)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7498\n\n**CFR citation:** 21 CFR 1308.11(d)(60)\n\n> (60) 4-methyl-alpha-pyrrolidinopropiophenone (4-MePPP) | (7498) |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(60)", "dea_code_number": "7498", "file": "4-methyl-alpha-pyrrolidinopropiophenone-4-meppp.md", "generated": true, "harvested": "2026-09-01", "id": "4-methyl-alpha-pyrrolidinopropiophenone-4-meppp", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(60) 4-methyl-alpha-pyrrolidinopropiophenone (4-MePPP) | (7498) |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "4-methyl-alpha-pyrrolidinopropiophenone (4-MePPP)", "title": "4-methyl-alpha-pyrrolidinopropiophenone (4-MePPP) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 4-methyl-N-ethylcathinone (4-MEC)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 1249\n\n**CFR citation:** 21 CFR 1308.11(d)(59)\n\n> (59) 4-methyl-N-ethylcathinone (4-MEC) | (1249) |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(59)", "dea_code_number": "1249", "file": "4-methyl-n-ethylcathinone-4-mec.md", "generated": true, "harvested": "2026-09-01", "id": "4-methyl-n-ethylcathinone-4-mec", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(59) 4-methyl-N-ethylcathinone (4-MEC) | (1249) |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "4-methyl-N-ethylcathinone (4-MEC)", "title": "4-methyl-N-ethylcathinone (4-MEC) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 4-methylmethcathinone (Mephedrone)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 1248\n\n**CFR citation:** 21 CFR 1308.11(d)(36)\n\n> (36) 4-methylmethcathinone (Mephedrone) | 1248 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(36)", "dea_code_number": "1248", "file": "4-methylmethcathinone-mephedrone.md", "generated": true, "harvested": "2026-09-01", "id": "4-methylmethcathinone-mephedrone", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(36) 4-methylmethcathinone (Mephedrone) | 1248 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "4-methylmethcathinone (Mephedrone)", "title": "4-methylmethcathinone (Mephedrone) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 5,6-dichloro-1-(1-(4-chlorobenzyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: 5,6-dichloro desmethylchlorphine; SR-17018)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Temporary listing of substances subject to emergency scheduling\n\n> (h) Temporary listing of substances subject to emergency scheduling.\n\n**DEA code number:** 9096\n\n**Temporary listing expires:** Aug. 27, 2028\n\n> adding paragraphs (h)(92) through (h)(95), effective Aug. 27, 2026 through Aug. 27, 2028\n\n**CFR citation:** 21 CFR 1308.11(h)(93)\n\n> (93) 5,6-dichloro-1-(1-(4-chlorobenzyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: 5,6-dichloro desmethylchlorphine; SR-17018) | 9096 |\n\nSource: \n", "category": "Temporary listing of substances subject to emergency scheduling", "citation": "21 CFR 1308.11(h)(93)", "dea_code_number": "9096", "file": "5-6-dichloro-1-1-4-chlorobenzyl-piperidin-4-yl-1-3-dihydro-2h-benzo-d-imidazol-2.md", "generated": true, "harvested": "2026-09-01", "id": "5-6-dichloro-1-1-4-chlorobenzyl-piperidin-4-yl-1-3-dihydro-2h-benzo-d-imidazol-2", "quote_category": "(h) Temporary listing of substances subject to emergency scheduling.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "quote_temporary_expiry": "adding paragraphs (h)(92) through (h)(95), effective Aug. 27, 2026 through Aug. 27, 2028", "schedule": "Schedule I", "source_quote": "(93) 5,6-dichloro-1-(1-(4-chlorobenzyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: 5,6-dichloro desmethylchlorphine; SR-17018) | 9096 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "5,6-dichloro-1-(1-(4-chlorobenzyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: 5,6-dichloro desmethylchlorphine; SR-17018)", "temporary_expiry": "Aug. 27, 2028", "title": "5,6-dichloro-1-(1-(4-chlorobenzyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: 5,6-dichloro desmethylchlorphine; SR-17018) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 5\u03b1-androstan-3,17-dione\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(1)\n\n> (1) 5\u03b1-androstan-3,17-dione;\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(1)", "file": "5-androstan-3-17-dione.md", "generated": true, "harvested": "2026-09-01", "id": "5-androstan-3-17-dione", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(1) 5\u03b1-androstan-3,17-dione;", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "5\u03b1-androstan-3,17-dione", "title": "5\u03b1-androstan-3,17-dione \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 5\u03b1-androstan-3,6,17-trione\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(2)\n\n> (2) 5\u03b1-androstan-3,6,17-trione;\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(2)", "file": "5-androstan-3-6-17-trione.md", "generated": true, "harvested": "2026-09-01", "id": "5-androstan-3-6-17-trione", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(2) 5\u03b1-androstan-3,6,17-trione;", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "5\u03b1-androstan-3,6,17-trione", "title": "5\u03b1-androstan-3,6,17-trione \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 5-androstenediol (3\u03b2,17\u03b2-dihydroxy-androst-5-ene)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(6)\n\n> (6) 5-androstenediol (3\u03b2,17\u03b2-dihydroxy-androst-5-ene);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(6)", "file": "5-androstenediol-3-17-dihydroxy-androst-5-ene.md", "generated": true, "harvested": "2026-09-01", "id": "5-androstenediol-3-17-dihydroxy-androst-5-ene", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(6) 5-androstenediol (3\u03b2,17\u03b2-dihydroxy-androst-5-ene);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "5-androstenediol (3\u03b2,17\u03b2-dihydroxy-androst-5-ene)", "title": "5-androstenediol (3\u03b2,17\u03b2-dihydroxy-androst-5-ene) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 5-androstenedione (androst-5-en-3,17-dione)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(9)\n\n> (9) 5-androstenedione (androst-5-en-3,17-dione);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(9)", "file": "5-androstenedione-androst-5-en-3-17-dione.md", "generated": true, "harvested": "2026-09-01", "id": "5-androstenedione-androst-5-en-3-17-dione", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(9) 5-androstenedione (androst-5-en-3,17-dione);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "5-androstenedione (androst-5-en-3,17-dione)", "title": "5-androstenedione (androst-5-en-3,17-dione) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 5-methoxy-3,4-methylenedioxy-amphetamine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7401\n\n**CFR citation:** 21 CFR 1308.11(d)(8)\n\n> (8) 5-methoxy-3,4-methylenedioxy-amphetamine | 7401 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(8)", "dea_code_number": "7401", "file": "5-methoxy-3-4-methylenedioxy-amphetamine.md", "generated": true, "harvested": "2026-09-01", "id": "5-methoxy-3-4-methylenedioxy-amphetamine", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(8) 5-methoxy-3,4-methylenedioxy-amphetamine | 7401 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "5-methoxy-3,4-methylenedioxy-amphetamine", "title": "5-methoxy-3,4-methylenedioxy-amphetamine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 5-methoxy-N,N-diisopropyltryptamine (other name: 5-MeO-DIPT)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7439\n\n**CFR citation:** 21 CFR 1308.11(d)(20)\n\n> (20) 5-methoxy-N,N-diisopropyltryptamine (other name: 5-MeO-DIPT) | 7439 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(20)", "dea_code_number": "7439", "file": "5-methoxy-n-n-diisopropyltryptamine-other-name-5-meo-dipt.md", "generated": true, "harvested": "2026-09-01", "id": "5-methoxy-n-n-diisopropyltryptamine-other-name-5-meo-dipt", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(20) 5-methoxy-N,N-diisopropyltryptamine (other name: 5-MeO-DIPT) | 7439 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "5-methoxy-N,N-diisopropyltryptamine (other name: 5-MeO-DIPT)", "title": "5-methoxy-N,N-diisopropyltryptamine (other name: 5-MeO-DIPT) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 5-methoxy-N,N-dimethyltryptamine Some trade or other names: 5-methoxy-3-[2-(dimethylamino)ethyl]indole; 5-MeO-DMT\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7431\n\n**CFR citation:** 21 CFR 1308.11(d)(15)\n\n> (15) 5-methoxy-N,N-dimethyltryptamine Some trade or other names: 5-methoxy-3-[2-(dimethylamino)ethyl]indole; 5-MeO-DMT | 7431 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(15)", "dea_code_number": "7431", "file": "5-methoxy-n-n-dimethyltryptamine-some-trade-or-other-names-5-methoxy-3-2-dimethy.md", "generated": true, "harvested": "2026-09-01", "id": "5-methoxy-n-n-dimethyltryptamine-some-trade-or-other-names-5-methoxy-3-2-dimethy", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(15) 5-methoxy-N,N-dimethyltryptamine Some trade or other names: 5-methoxy-3-[2-(dimethylamino)ethyl]indole; 5-MeO-DMT | 7431 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "5-methoxy-N,N-dimethyltryptamine Some trade or other names: 5-methoxy-3-[2-(dimethylamino)ethyl]indole; 5-MeO-DMT", "title": "5-methoxy-N,N-dimethyltryptamine Some trade or other names: 5-methoxy-3-[2-(dimethylamino)ethyl]indole; 5-MeO-DMT \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 5-nitro-2-(4-propoxybenzyl)-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (other names: N-pyrrolidino protonitazene; protonitazepyne)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9763\n\n**CFR citation:** 21 CFR 1308.11(b)(80)\n\n> (80) 5-nitro-2-(4-propoxybenzyl)-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (other names: N-pyrrolidino protonitazene; protonitazepyne) | 9763 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(80)", "dea_code_number": "9763", "file": "5-nitro-2-4-propoxybenzyl-1-2-pyrrolidin-1-yl-ethyl-1h-benzimidazole-other-names.md", "generated": true, "harvested": "2026-09-01", "id": "5-nitro-2-4-propoxybenzyl-1-2-pyrrolidin-1-yl-ethyl-1h-benzimidazole-other-names", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(80) 5-nitro-2-(4-propoxybenzyl)-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (other names: N-pyrrolidino protonitazene; protonitazepyne) | 9763 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "5-nitro-2-(4-propoxybenzyl)-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (other names: N-pyrrolidino protonitazene; protonitazepyne)", "title": "5-nitro-2-(4-propoxybenzyl)-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (other names: N-pyrrolidino protonitazene; protonitazepyne) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 5-Pentyl-2-(2-phenylpropan-2-yl)pyrido[4,3-b]indol-1-one (other names: CUMYL-PEGACLONE; SGT-151)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7093\n\n**CFR citation:** 21 CFR 1308.11(d)(116)\n\n> (116) 5-Pentyl-2-(2-phenylpropan-2-yl)pyrido[4,3-b]indol-1-one (other names: CUMYL-PEGACLONE; SGT-151) | 7093 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(116)", "dea_code_number": "7093", "file": "5-pentyl-2-2-phenylpropan-2-yl-pyrido-4-3-b-indol-1-one-other-names-cumyl-pegacl.md", "generated": true, "harvested": "2026-09-01", "id": "5-pentyl-2-2-phenylpropan-2-yl-pyrido-4-3-b-indol-1-one-other-names-cumyl-pegacl", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(116) 5-Pentyl-2-(2-phenylpropan-2-yl)pyrido[4,3-b]indol-1-one (other names: CUMYL-PEGACLONE; SGT-151) | 7093 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "5-Pentyl-2-(2-phenylpropan-2-yl)pyrido[4,3-b]indol-1-one (other names: CUMYL-PEGACLONE; SGT-151)", "title": "5-Pentyl-2-(2-phenylpropan-2-yl)pyrido[4,3-b]indol-1-one (other names: CUMYL-PEGACLONE; SGT-151) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 6,6,9-trimethyl-3-pentyl-6a,7,8,9,10,10a-hexahydro-6H-benzo[c]chromen-1-ol (other names: hexahydrocannabinol, HHC)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7220\n\n**CFR citation:** 21 CFR 1308.11(d)(115)\n\n> (115) 6,6,9-trimethyl-3-pentyl-6a,7,8,9,10,10a-hexahydro-6H-benzo[c]chromen-1-ol (other names: hexahydrocannabinol, HHC) | 7220 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(115)", "dea_code_number": "7220", "file": "6-6-9-trimethyl-3-pentyl-6a-7-8-9-10-10a-hexahydro-6h-benzo-c-chromen-1-ol-other.md", "generated": true, "harvested": "2026-09-01", "id": "6-6-9-trimethyl-3-pentyl-6a-7-8-9-10-10a-hexahydro-6h-benzo-c-chromen-1-ol-other", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(115) 6,6,9-trimethyl-3-pentyl-6a,7,8,9,10,10a-hexahydro-6H-benzo[c]chromen-1-ol (other names: hexahydrocannabinol, HHC) | 7220 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "6,6,9-trimethyl-3-pentyl-6a,7,8,9,10,10a-hexahydro-6H-benzo[c]chromen-1-ol (other names: hexahydrocannabinol, HHC)", "title": "6,6,9-trimethyl-3-pentyl-6a,7,8,9,10,10a-hexahydro-6H-benzo[c]chromen-1-ol (other names: hexahydrocannabinol, HHC) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 6-bromo-androsta-1,4-diene-3,17-dione\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(13)\n\n> (13) 6-bromo-androsta-1,4-diene-3,17-dione;\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(13)", "file": "6-bromo-androsta-1-4-diene-3-17-dione.md", "generated": true, "harvested": "2026-09-01", "id": "6-bromo-androsta-1-4-diene-3-17-dione", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(13) 6-bromo-androsta-1,4-diene-3,17-dione;", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "6-bromo-androsta-1,4-diene-3,17-dione", "title": "6-bromo-androsta-1,4-diene-3,17-dione \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 6-bromo-androstan-3,17-dione\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(14)\n\n> (14) 6-bromo-androstan-3,17-dione;\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(14)", "file": "6-bromo-androstan-3-17-dione.md", "generated": true, "harvested": "2026-09-01", "id": "6-bromo-androstan-3-17-dione", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(14) 6-bromo-androstan-3,17-dione;", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "6-bromo-androstan-3,17-dione", "title": "6-bromo-androstan-3,17-dione \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 6\u03b1-methyl-androst-4-ene-3,17-dione\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(53)\n\n> (53) 6\u03b1-methyl-androst-4-ene-3,17-dione;\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(53)", "file": "6-methyl-androst-4-ene-3-17-dione.md", "generated": true, "harvested": "2026-09-01", "id": "6-methyl-androst-4-ene-3-17-dione", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(53) 6\u03b1-methyl-androst-4-ene-3,17-dione;", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "6\u03b1-methyl-androst-4-ene-3,17-dione", "title": "6\u03b1-methyl-androst-4-ene-3,17-dione \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 8-(1-(4-chlorophenyl)ethyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: spirochlorphine; R-6890)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Temporary listing of substances subject to emergency scheduling\n\n> (h) Temporary listing of substances subject to emergency scheduling.\n\n**DEA code number:** 9093\n\n**Temporary listing expires:** Aug. 27, 2028\n\n> adding paragraphs (h)(92) through (h)(95), effective Aug. 27, 2026 through Aug. 27, 2028\n\n**CFR citation:** 21 CFR 1308.11(h)(95)\n\n> (95) 8-(1-(4-chlorophenyl)ethyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: spirochlorphine; R-6890) | 9093 |\n\nSource: \n", "category": "Temporary listing of substances subject to emergency scheduling", "citation": "21 CFR 1308.11(h)(95)", "dea_code_number": "9093", "file": "8-1-4-chlorophenyl-ethyl-1-phenyl-1-3-8-triazaspiro-4-5-decan-4-one-its-isomers-.md", "generated": true, "harvested": "2026-09-01", "id": "8-1-4-chlorophenyl-ethyl-1-phenyl-1-3-8-triazaspiro-4-5-decan-4-one-its-isomers-", "quote_category": "(h) Temporary listing of substances subject to emergency scheduling.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "quote_temporary_expiry": "adding paragraphs (h)(92) through (h)(95), effective Aug. 27, 2026 through Aug. 27, 2028", "schedule": "Schedule I", "source_quote": "(95) 8-(1-(4-chlorophenyl)ethyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: spirochlorphine; R-6890) | 9093 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "8-(1-(4-chlorophenyl)ethyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: spirochlorphine; R-6890)", "temporary_expiry": "Aug. 27, 2028", "title": "8-(1-(4-chlorophenyl)ethyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: spirochlorphine; R-6890) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** 8-bromo-1-methyl-6-phenyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine, its salts, isomers, and salts of isomers (Other name: bromazolam)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Temporary listing of substances subject to emergency scheduling\n\n> (h) Temporary listing of substances subject to emergency scheduling.\n\n**DEA code number:** 2778\n\n**Temporary listing expires:** Mar. 16, 2028\n\n> adding paragraph (h)(86), effective from Mar. 16, 2026, until Mar. 16, 2028\n\n**CFR citation:** 21 CFR 1308.11(h)(86)\n\n> (86) 8-bromo-1-methyl-6-phenyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine, its salts, isomers, and salts of isomers (Other name: bromazolam) | 2778 |\n\nSource: \n", "category": "Temporary listing of substances subject to emergency scheduling", "citation": "21 CFR 1308.11(h)(86)", "dea_code_number": "2778", "file": "8-bromo-1-methyl-6-phenyl-4h-benzo-f-1-2-4-triazolo-4-3-a-1-4-diazepine-its-salt.md", "generated": true, "harvested": "2026-09-01", "id": "8-bromo-1-methyl-6-phenyl-4h-benzo-f-1-2-4-triazolo-4-3-a-1-4-diazepine-its-salt", "quote_category": "(h) Temporary listing of substances subject to emergency scheduling.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "quote_temporary_expiry": "adding paragraph (h)(86), effective from Mar. 16, 2026, until Mar. 16, 2028", "schedule": "Schedule I", "source_quote": "(86) 8-bromo-1-methyl-6-phenyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine, its salts, isomers, and salts of isomers (Other name: bromazolam) | 2778 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "8-bromo-1-methyl-6-phenyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine, its salts, isomers, and salts of isomers (Other name: bromazolam)", "temporary_expiry": "Mar. 16, 2028", "title": "8-bromo-1-methyl-6-phenyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine, its salts, isomers, and salts of isomers (Other name: bromazolam) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Acetorphine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opium derivatives\n\n> (c) Opium derivatives.\n\n**DEA code number:** 9319\n\n**CFR citation:** 21 CFR 1308.11(c)(1)\n\n> (1) Acetorphine | 9319 |\n\nSource: \n", "category": "Opium derivatives", "citation": "21 CFR 1308.11(c)(1)", "dea_code_number": "9319", "file": "acetorphine.md", "generated": true, "harvested": "2026-09-01", "id": "acetorphine", "quote_category": "(c) Opium derivatives.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(1) Acetorphine | 9319 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Acetorphine", "title": "Acetorphine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9815\n\n**CFR citation:** 21 CFR 1308.11(b)(1)\n\n> (1) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide) | 9815 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(1)", "dea_code_number": "9815", "file": "acetyl-alpha-methylfentanyl-n-1-1-methyl-2-phenethyl-4-piperidinyl-n-phenylaceta.md", "generated": true, "harvested": "2026-09-01", "id": "acetyl-alpha-methylfentanyl-n-1-1-methyl-2-phenethyl-4-piperidinyl-n-phenylaceta", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(1) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide) | 9815 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide)", "title": "Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9821\n\n**CFR citation:** 21 CFR 1308.11(b)(3)\n\n> (3) Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) | 9821 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(3)", "dea_code_number": "9821", "file": "acetyl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylacetamide.md", "generated": true, "harvested": "2026-09-01", "id": "acetyl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylacetamide", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(3) Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) | 9821 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide)", "title": "Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Acetyldihydrocodeine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opium derivatives\n\n> (c) Opium derivatives.\n\n**DEA code number:** 9051\n\n**CFR citation:** 21 CFR 1308.11(c)(2)\n\n> (2) Acetyldihydrocodeine | 9051 |\n\nSource: \n", "category": "Opium derivatives", "citation": "21 CFR 1308.11(c)(2)", "dea_code_number": "9051", "file": "acetyldihydrocodeine.md", "generated": true, "harvested": "2026-09-01", "id": "acetyldihydrocodeine", "quote_category": "(c) Opium derivatives.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(2) Acetyldihydrocodeine | 9051 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Acetyldihydrocodeine", "title": "Acetyldihydrocodeine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Acetylmethadol\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9601\n\n**CFR citation:** 21 CFR 1308.11(b)(2)\n\n> (2) Acetylmethadol | 9601 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(2)", "dea_code_number": "9601", "file": "acetylmethadol.md", "generated": true, "harvested": "2026-09-01", "id": "acetylmethadol", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(2) Acetylmethadol | 9601 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Acetylmethadol", "title": "Acetylmethadol \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide; also known as acryloylfentanyl)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9811\n\n**CFR citation:** 21 CFR 1308.11(b)(4)\n\n> (4) Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide; also known as acryloylfentanyl) | 9811 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(4)", "dea_code_number": "9811", "file": "acryl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylacrylamide-also-known-as-acry.md", "generated": true, "harvested": "2026-09-01", "id": "acryl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylacrylamide-also-known-as-acry", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(4) Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide; also known as acryloylfentanyl) | 9811 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide; also known as acryloylfentanyl)", "title": "Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide; also known as acryloylfentanyl) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9551\n\n**CFR citation:** 21 CFR 1308.11(b)(5)\n\n> (5) AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide) | 9551 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(5)", "dea_code_number": "9551", "file": "ah-7921-3-4-dichloro-n-1-dimethylamino-cyclohexylmethyl-benzamide.md", "generated": true, "harvested": "2026-09-01", "id": "ah-7921-3-4-dichloro-n-1-dimethylamino-cyclohexylmethyl-benzamide", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(5) AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide) | 9551 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)", "title": "AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Alfaxalone\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2731\n\n**CFR citation:** 21 CFR 1308.14(c)(1)\n\n> (1) Alfaxalone | 2731 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(1)", "dea_code_number": "2731", "file": "alfaxalone.md", "generated": true, "harvested": "2026-09-01", "id": "alfaxalone", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(1) Alfaxalone | 2731 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Alfaxalone", "title": "Alfaxalone \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Alfentanil\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Opiates\n\n> (c) Opiates.\n\n**DEA code number:** 9737\n\n**CFR citation:** 21 CFR 1308.12(c)(1)\n\n> (1) Alfentanil | 9737 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.12(c)(1)", "dea_code_number": "9737", "file": "alfentanil.md", "generated": true, "harvested": "2026-09-01", "id": "alfentanil", "quote_category": "(c) Opiates.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(1) Alfentanil | 9737 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Alfentanil", "title": "Alfentanil \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Allylprodine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9602\n\n**CFR citation:** 21 CFR 1308.11(b)(6)\n\n> (6) Allylprodine | 9602 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(6)", "dea_code_number": "9602", "file": "allylprodine.md", "generated": true, "harvested": "2026-09-01", "id": "allylprodine", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(6) Allylprodine | 9602 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Allylprodine", "title": "Allylprodine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Alpha-ethyltryptamine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7249\n\n**CFR citation:** 21 CFR 1308.11(d)(1)\n\n> (1) Alpha-ethyltryptamine | 7249 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(1)", "dea_code_number": "7249", "file": "alpha-ethyltryptamine.md", "generated": true, "harvested": "2026-09-01", "id": "alpha-ethyltryptamine", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(1) Alpha-ethyltryptamine | 7249 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Alpha-ethyltryptamine", "title": "Alpha-ethyltryptamine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** alpha\u2032-Methyl butyryl fentanyl (2-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9864\n\n**CFR citation:** 21 CFR 1308.11(b)(10)\n\n> (10) alpha\u2032-Methyl butyryl fentanyl (2-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide) | 9864 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(10)", "dea_code_number": "9864", "file": "alpha-methyl-butyryl-fentanyl-2-methyl-n-1-phenethylpiperidin-4-yl-n-phenylbutan.md", "generated": true, "harvested": "2026-09-01", "id": "alpha-methyl-butyryl-fentanyl-2-methyl-n-1-phenethylpiperidin-4-yl-n-phenylbutan", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(10) alpha\u2032-Methyl butyryl fentanyl (2-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide) | 9864 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "alpha\u2032-Methyl butyryl fentanyl (2-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide)", "title": "alpha\u2032-Methyl butyryl fentanyl (2-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** alpha-Methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido)piperidine)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9814\n\n**CFR citation:** 21 CFR 1308.11(b)(11)\n\n> (11) alpha-Methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido)piperidine) | 9814 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(11)", "dea_code_number": "9814", "file": "alpha-methylfentanyl-n-1-alpha-methyl-beta-phenyl-ethyl-4-piperidyl-propionanili.md", "generated": true, "harvested": "2026-09-01", "id": "alpha-methylfentanyl-n-1-alpha-methyl-beta-phenyl-ethyl-4-piperidyl-propionanili", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(11) alpha-Methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido)piperidine) | 9814 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "alpha-Methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido)piperidine)", "title": "alpha-Methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido)piperidine) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** alpha-Methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9832\n\n**CFR citation:** 21 CFR 1308.11(b)(12)\n\n> (12) alpha-Methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide) | 9832 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(12)", "dea_code_number": "9832", "file": "alpha-methylthiofentanyl-n-1-methyl-2-2-thienyl-ethyl-4-piperidinyl-n-phenylprop.md", "generated": true, "harvested": "2026-09-01", "id": "alpha-methylthiofentanyl-n-1-methyl-2-2-thienyl-ethyl-4-piperidinyl-n-phenylprop", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(12) alpha-Methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide) | 9832 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "alpha-Methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide)", "title": "alpha-Methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Alpha-methyltryptamine (other name: AMT)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7432\n\n**CFR citation:** 21 CFR 1308.11(d)(16)\n\n> (16) Alpha-methyltryptamine (other name: AMT) | 7432 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(16)", "dea_code_number": "7432", "file": "alpha-methyltryptamine-other-name-amt.md", "generated": true, "harvested": "2026-09-01", "id": "alpha-methyltryptamine-other-name-amt", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(16) Alpha-methyltryptamine (other name: AMT) | 7432 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Alpha-methyltryptamine (other name: AMT)", "title": "Alpha-methyltryptamine (other name: AMT) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** alpha-pyrrolidinobutiophenone (\u03b1-PBP)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7546\n\n**CFR citation:** 21 CFR 1308.11(d)(68)\n\n> (68) alpha-pyrrolidinobutiophenone (\u03b1-PBP) | (7546) |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(68)", "dea_code_number": "7546", "file": "alpha-pyrrolidinobutiophenone-pbp.md", "generated": true, "harvested": "2026-09-01", "id": "alpha-pyrrolidinobutiophenone-pbp", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(68) alpha-pyrrolidinobutiophenone (\u03b1-PBP) | (7546) |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "alpha-pyrrolidinobutiophenone (\u03b1-PBP)", "title": "alpha-pyrrolidinobutiophenone (\u03b1-PBP) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** alpha-Pyrrolidinoheptaphenone (Other names: PV8; 1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7548\n\n**CFR citation:** 21 CFR 1308.11(d)(98)\n\n> (98) alpha-Pyrrolidinoheptaphenone (Other names: PV8; 1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one) | 7548 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(98)", "dea_code_number": "7548", "file": "alpha-pyrrolidinoheptaphenone-other-names-pv8-1-phenyl-2-pyrrolidin-1-yl-heptan-.md", "generated": true, "harvested": "2026-09-01", "id": "alpha-pyrrolidinoheptaphenone-other-names-pv8-1-phenyl-2-pyrrolidin-1-yl-heptan-", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(98) alpha-Pyrrolidinoheptaphenone (Other names: PV8; 1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one) | 7548 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "alpha-Pyrrolidinoheptaphenone (Other names: PV8; 1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one)", "title": "alpha-Pyrrolidinoheptaphenone (Other names: PV8; 1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** alpha-Pyrrolidinohexanophenone (Other names: \u03b1-PHP; \u03b1-pyrrolidinohexanophenone; 1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7544\n\n**CFR citation:** 21 CFR 1308.11(d)(95)\n\n> (95) alpha-Pyrrolidinohexanophenone (Other names: \u03b1-PHP; \u03b1-pyrrolidinohexanophenone; 1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one) | 7544 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(95)", "dea_code_number": "7544", "file": "alpha-pyrrolidinohexanophenone-other-names-php-pyrrolidinohexanophenone-1-phenyl.md", "generated": true, "harvested": "2026-09-01", "id": "alpha-pyrrolidinohexanophenone-other-names-php-pyrrolidinohexanophenone-1-phenyl", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(95) alpha-Pyrrolidinohexanophenone (Other names: \u03b1-PHP; \u03b1-pyrrolidinohexanophenone; 1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one) | 7544 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "alpha-Pyrrolidinohexanophenone (Other names: \u03b1-PHP; \u03b1-pyrrolidinohexanophenone; 1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one)", "title": "alpha-Pyrrolidinohexanophenone (Other names: \u03b1-PHP; \u03b1-pyrrolidinohexanophenone; 1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** alpha-pyrrolidinopentiophenone (\u03b1-PVP)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7545\n\n**CFR citation:** 21 CFR 1308.11(d)(61)\n\n> (61) alpha-pyrrolidinopentiophenone (\u03b1-PVP) | (7545) |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(61)", "dea_code_number": "7545", "file": "alpha-pyrrolidinopentiophenone-pvp.md", "generated": true, "harvested": "2026-09-01", "id": "alpha-pyrrolidinopentiophenone-pvp", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(61) alpha-pyrrolidinopentiophenone (\u03b1-PVP) | (7545) |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "alpha-pyrrolidinopentiophenone (\u03b1-PVP)", "title": "alpha-pyrrolidinopentiophenone (\u03b1-PVP) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Alphacetylmethadol (except levo-alphacetylmethadol also known as levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9603\n\n**CFR citation:** 21 CFR 1308.11(b)(7)\n\n> (7) Alphacetylmethadol (except levo-alphacetylmethadol also known as levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM) | 9603 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(7)", "dea_code_number": "9603", "file": "alphacetylmethadol-except-levo-alphacetylmethadol-also-known-as-levo-alpha-acety.md", "generated": true, "harvested": "2026-09-01", "id": "alphacetylmethadol-except-levo-alphacetylmethadol-also-known-as-levo-alpha-acety", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(7) Alphacetylmethadol (except levo-alphacetylmethadol also known as levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM) | 9603 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Alphacetylmethadol (except levo-alphacetylmethadol also known as levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM)", "title": "Alphacetylmethadol (except levo-alphacetylmethadol also known as levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Alphameprodine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9604\n\n**CFR citation:** 21 CFR 1308.11(b)(8)\n\n> (8) Alphameprodine | 9604 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(8)", "dea_code_number": "9604", "file": "alphameprodine.md", "generated": true, "harvested": "2026-09-01", "id": "alphameprodine", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(8) Alphameprodine | 9604 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Alphameprodine", "title": "Alphameprodine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Alphamethadol\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9605\n\n**CFR citation:** 21 CFR 1308.11(b)(9)\n\n> (9) Alphamethadol | 9605 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(9)", "dea_code_number": "9605", "file": "alphamethadol.md", "generated": true, "harvested": "2026-09-01", "id": "alphamethadol", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(9) Alphamethadol | 9605 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Alphamethadol", "title": "Alphamethadol \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Alphaprodine\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Opiates\n\n> (c) Opiates.\n\n**DEA code number:** 9010\n\n**CFR citation:** 21 CFR 1308.12(c)(2)\n\n> (2) Alphaprodine | 9010 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.12(c)(2)", "dea_code_number": "9010", "file": "alphaprodine.md", "generated": true, "harvested": "2026-09-01", "id": "alphaprodine", "quote_category": "(c) Opiates.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(2) Alphaprodine | 9010 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Alphaprodine", "title": "Alphaprodine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Alprazolam\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2882\n\n**CFR citation:** 21 CFR 1308.14(c)(2)\n\n> (2) Alprazolam | 2882 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(2)", "dea_code_number": "2882", "file": "alprazolam.md", "generated": true, "harvested": "2026-09-01", "id": "alprazolam", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(2) Alprazolam | 2882 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Alprazolam", "title": "Alprazolam \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Amineptine (7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Stimulants\n\n> (f) Stimulants.\n\n**DEA code number:** 1219\n\n**CFR citation:** 21 CFR 1308.11(f)(1)\n\n> (1) Amineptine (7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid) | 1219 |\n\nSource: \n", "category": "Stimulants", "citation": "21 CFR 1308.11(f)(1)", "dea_code_number": "1219", "file": "amineptine-7-10-11-dihydro-5h-dibenzo-a-d-cyclohepten-5-yl-amino-heptanoic-acid.md", "generated": true, "harvested": "2026-09-01", "id": "amineptine-7-10-11-dihydro-5h-dibenzo-a-d-cyclohepten-5-yl-amino-heptanoic-acid", "quote_category": "(f) Stimulants.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(1) Amineptine (7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid) | 1219 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Amineptine (7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid)", "title": "Amineptine (7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Aminorex (Some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; or 4,5-dihydro-5-phenly-2-oxazolamine)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Stimulants\n\n> (f) Stimulants.\n\n**DEA code number:** 1585\n\n**CFR citation:** 21 CFR 1308.11(f)(2)\n\n> (2) Aminorex (Some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; or 4,5-dihydro-5-phenly-2-oxazolamine) | 1585 |\n\nSource: \n", "category": "Stimulants", "citation": "21 CFR 1308.11(f)(2)", "dea_code_number": "1585", "file": "aminorex-some-other-names-aminoxaphen-2-amino-5-phenyl-2-oxazoline-or-4-5-dihydr.md", "generated": true, "harvested": "2026-09-01", "id": "aminorex-some-other-names-aminoxaphen-2-amino-5-phenyl-2-oxazoline-or-4-5-dihydr", "quote_category": "(f) Stimulants.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(2) Aminorex (Some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; or 4,5-dihydro-5-phenly-2-oxazolamine) | 1585 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Aminorex (Some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; or 4,5-dihydro-5-phenly-2-oxazolamine)", "title": "Aminorex (Some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; or 4,5-dihydro-5-phenly-2-oxazolamine) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Amobarbital\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2126\n\n**Only when:** Any compound, mixture or preparation containing\n\n> (1) Any compound, mixture or preparation containing:\n\n**CFR citation:** 21 CFR 1308.13(c)(1)(i)\n\n> (1) Any compound, mixture or preparation containing: | | (i) Amobarbital | 2126 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.13(c)(1)(i)", "dea_code_number": "2126", "file": "amobarbital-2.md", "generated": true, "harvested": "2026-09-01", "id": "amobarbital-2", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "quote_scope_qualifier": "(1) Any compound, mixture or preparation containing:", "schedule": "Schedule III", "scope_qualifier": "Any compound, mixture or preparation containing", "source_quote": "(1) Any compound, mixture or preparation containing: | | (i) Amobarbital | 2126 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Amobarbital", "title": "Amobarbital \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Amobarbital\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2126\n\n**Only when:** Any suppository dosage form containing\n\n> (2) Any suppository dosage form containing:\n\n**CFR citation:** 21 CFR 1308.13(c)(2)(i)\n\n> (2) Any suppository dosage form containing: | | (i) Amobarbital | 2126 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.13(c)(2)(i)", "dea_code_number": "2126", "file": "amobarbital-3.md", "generated": true, "harvested": "2026-09-01", "id": "amobarbital-3", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "quote_scope_qualifier": "(2) Any suppository dosage form containing:", "schedule": "Schedule III", "scope_qualifier": "Any suppository dosage form containing", "source_quote": "(2) Any suppository dosage form containing: | | (i) Amobarbital | 2126 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Amobarbital", "title": "Amobarbital \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Amobarbital\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Depressants\n\n> (e) Depressants.\n\n**DEA code number:** 2125\n\n**CFR citation:** 21 CFR 1308.12(e)(1)\n\n> (1) Amobarbital | 2125 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.12(e)(1)", "dea_code_number": "2125", "file": "amobarbital.md", "generated": true, "harvested": "2026-09-01", "id": "amobarbital", "quote_category": "(e) Depressants.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(1) Amobarbital | 2125 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Amobarbital", "title": "Amobarbital \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Amphetamine, its salts, optical isomers, and salts of its optical isomers\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Stimulants\n\n> (d) Stimulants.\n\n**DEA code number:** 1100\n\n**CFR citation:** 21 CFR 1308.12(d)(1)\n\n> (1) Amphetamine, its salts, optical isomers, and salts of its optical isomers | 1100 |\n\nSource: \n", "category": "Stimulants", "citation": "21 CFR 1308.12(d)(1)", "dea_code_number": "1100", "file": "amphetamine-its-salts-optical-isomers-and-salts-of-its-optical-isomers.md", "generated": true, "harvested": "2026-09-01", "id": "amphetamine-its-salts-optical-isomers-and-salts-of-its-optical-isomers", "quote_category": "(d) Stimulants.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(1) Amphetamine, its salts, optical isomers, and salts of its optical isomers | 1100 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Amphetamine, its salts, optical isomers, and salts of its optical isomers", "title": "Amphetamine, its salts, optical isomers, and salts of its optical isomers \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Anileridine\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Opiates\n\n> (c) Opiates.\n\n**DEA code number:** 9020\n\n**CFR citation:** 21 CFR 1308.12(c)(3)\n\n> (3) Anileridine | 9020 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.12(c)(3)", "dea_code_number": "9020", "file": "anileridine.md", "generated": true, "harvested": "2026-09-01", "id": "anileridine", "quote_category": "(c) Opiates.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(3) Anileridine | 9020 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Anileridine", "title": "Anileridine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Any drug product containing gamma hydroxybutyric acid, including its salts, isomers, and salts of isomers, for which an application is approved under section 505 of the Federal Food, Drug, and Cosmetic Act\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2012\n\n**CFR citation:** 21 CFR 1308.13(c)(6)\n\n> (6) Any drug product containing gamma hydroxybutyric acid, including its salts, isomers, and salts of isomers, for which an application is approved under section 505 of the Federal Food, Drug, and Cosmetic Act | 2012 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.13(c)(6)", "dea_code_number": "2012", "file": "any-drug-product-containing-gamma-hydroxybutyric-acid-including-its-salts-isomer.md", "generated": true, "harvested": "2026-09-01", "id": "any-drug-product-containing-gamma-hydroxybutyric-acid-including-its-salts-isomer", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(6) Any drug product containing gamma hydroxybutyric acid, including its salts, isomers, and salts of isomers, for which an application is approved under section 505 of the Federal Food, Drug, and Cosmetic Act | 2012 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Any drug product containing gamma hydroxybutyric acid, including its salts, isomers, and salts of isomers, for which an application is approved under section 505 of the Federal Food, Drug, and Cosmetic Act", "title": "Any drug product containing gamma hydroxybutyric acid, including its salts, isomers, and salts of isomers, for which an application is approved under section 505 of the Federal Food, Drug, and Cosmetic Act \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of the substances referred to in paragraph (b) (1) of this section, except that these substances shall not include the isoquinoline alkaloids of opium\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Substances, vegetable origin or chemical synthesis\n\n> (b) Substances, vegetable origin or chemical synthesis.\n\n**CFR citation:** 21 CFR 1308.12(b)(2)\n\n> (2) Any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of the substances referred to in paragraph (b) (1) of this section, except that these substances shall not include the isoquinoline alkaloids of opium.\n\nSource: \n", "category": "Substances, vegetable origin or chemical synthesis", "citation": "21 CFR 1308.12(b)(2)", "file": "any-salt-compound-derivative-or-preparation-thereof-which-is-chemically-equivale.md", "generated": true, "harvested": "2026-09-01", "id": "any-salt-compound-derivative-or-preparation-thereof-which-is-chemically-equivale", "quote_category": "(b) Substances, vegetable origin or chemical synthesis.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(2) Any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of the substances referred to in paragraph (b) (1) of this section, except that these substances shall not include the isoquinoline alkaloids of opium.", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of the substances referred to in paragraph (b) (1) of this section, except that these substances shall not include the isoquinoline alkaloids of opium", "title": "Any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of the substances referred to in paragraph (b) (1) of this section, except that these substances shall not include the isoquinoline alkaloids of opium \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Any substance which contains any quantity of a derivative of barbituric acid or any salt thereof\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2100\n\n**CFR citation:** 21 CFR 1308.13(c)(3)\n\n> (3) Any substance which contains any quantity of a derivative of barbituric acid or any salt thereof | 2100 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.13(c)(3)", "dea_code_number": "2100", "file": "any-substance-which-contains-any-quantity-of-a-derivative-of-barbituric-acid-or-.md", "generated": true, "harvested": "2026-09-01", "id": "any-substance-which-contains-any-quantity-of-a-derivative-of-barbituric-acid-or-", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(3) Any substance which contains any quantity of a derivative of barbituric acid or any salt thereof | 2100 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Any substance which contains any quantity of a derivative of barbituric acid or any salt thereof", "title": "Any substance which contains any quantity of a derivative of barbituric acid or any salt thereof \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Barbital\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2145\n\n**CFR citation:** 21 CFR 1308.14(c)(3)\n\n> (3) Barbital | 2145 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(3)", "dea_code_number": "2145", "file": "barbital.md", "generated": true, "harvested": "2026-09-01", "id": "barbital", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(3) Barbital | 2145 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Barbital", "title": "Barbital \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Benzethidine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9606\n\n**CFR citation:** 21 CFR 1308.11(b)(13)\n\n> (13) Benzethidine | 9606 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(13)", "dea_code_number": "9606", "file": "benzethidine.md", "generated": true, "harvested": "2026-09-01", "id": "benzethidine", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(13) Benzethidine | 9606 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Benzethidine", "title": "Benzethidine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Benzphetamine\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Stimulants\n\n> (b) Stimulants.\n\n**DEA code number:** 1228\n\n**CFR citation:** 21 CFR 1308.13(b)(2)\n\n> (2) Benzphetamine | 1228 |\n\nSource: \n", "category": "Stimulants", "citation": "21 CFR 1308.13(b)(2)", "dea_code_number": "1228", "file": "benzphetamine.md", "generated": true, "harvested": "2026-09-01", "id": "benzphetamine", "quote_category": "(b) Stimulants.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(2) Benzphetamine | 1228 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Benzphetamine", "title": "Benzphetamine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Benzylmorphine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opium derivatives\n\n> (c) Opium derivatives.\n\n**DEA code number:** 9052\n\n**CFR citation:** 21 CFR 1308.11(c)(3)\n\n> (3) Benzylmorphine | 9052 |\n\nSource: \n", "category": "Opium derivatives", "citation": "21 CFR 1308.11(c)(3)", "dea_code_number": "9052", "file": "benzylmorphine.md", "generated": true, "harvested": "2026-09-01", "id": "benzylmorphine", "quote_category": "(c) Opium derivatives.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(3) Benzylmorphine | 9052 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Benzylmorphine", "title": "Benzylmorphine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** beta-Hydroxy-3-methylfentanyl (N-[1-(2-hydroxy-2-phenylethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9831\n\n**CFR citation:** 21 CFR 1308.11(b)(16)\n\n> (16) beta-Hydroxy-3-methylfentanyl (N-[1-(2-hydroxy-2-phenylethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide) | 9831 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(16)", "dea_code_number": "9831", "file": "beta-hydroxy-3-methylfentanyl-n-1-2-hydroxy-2-phenylethyl-3-methyl-4-piperidinyl.md", "generated": true, "harvested": "2026-09-01", "id": "beta-hydroxy-3-methylfentanyl-n-1-2-hydroxy-2-phenylethyl-3-methyl-4-piperidinyl", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(16) beta-Hydroxy-3-methylfentanyl (N-[1-(2-hydroxy-2-phenylethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide) | 9831 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "beta-Hydroxy-3-methylfentanyl (N-[1-(2-hydroxy-2-phenylethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide)", "title": "beta-Hydroxy-3-methylfentanyl (N-[1-(2-hydroxy-2-phenylethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** beta-Hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9830\n\n**CFR citation:** 21 CFR 1308.11(b)(15)\n\n> (15) beta-Hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide) | 9830 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(15)", "dea_code_number": "9830", "file": "beta-hydroxyfentanyl-n-1-2-hydroxy-2-phenethyl-4-piperidinyl-n-phenylpropanamide.md", "generated": true, "harvested": "2026-09-01", "id": "beta-hydroxyfentanyl-n-1-2-hydroxy-2-phenethyl-4-piperidinyl-n-phenylpropanamide", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(15) beta-Hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide) | 9830 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "beta-Hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide)", "title": "beta-Hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** beta-Hydroxythiofentanyl (N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9836\n\n**CFR citation:** 21 CFR 1308.11(b)(17)\n\n> (17) beta-Hydroxythiofentanyl (N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide) | 9836 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(17)", "dea_code_number": "9836", "file": "beta-hydroxythiofentanyl-n-1-2-hydroxy-2-thiophen-2-yl-ethyl-piperidin-4-yl-n-ph.md", "generated": true, "harvested": "2026-09-01", "id": "beta-hydroxythiofentanyl-n-1-2-hydroxy-2-thiophen-2-yl-ethyl-piperidin-4-yl-n-ph", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(17) beta-Hydroxythiofentanyl (N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide) | 9836 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "beta-Hydroxythiofentanyl (N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide)", "title": "beta-Hydroxythiofentanyl (N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** beta-Methyl fentanyl (N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)propionamide; also known as \u03b2-methyl fentanyl)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9856\n\n**CFR citation:** 21 CFR 1308.11(b)(20)\n\n> (20) beta-Methyl fentanyl (N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)propionamide; also known as \u03b2-methyl fentanyl) | 9856 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(20)", "dea_code_number": "9856", "file": "beta-methyl-fentanyl-n-phenyl-n-1-2-phenylpropyl-piperidin-4-yl-propionamide-als.md", "generated": true, "harvested": "2026-09-01", "id": "beta-methyl-fentanyl-n-phenyl-n-1-2-phenylpropyl-piperidin-4-yl-propionamide-als", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(20) beta-Methyl fentanyl (N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)propionamide; also known as \u03b2-methyl fentanyl) | 9856 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "beta-Methyl fentanyl (N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)propionamide; also known as \u03b2-methyl fentanyl)", "title": "beta-Methyl fentanyl (N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)propionamide; also known as \u03b2-methyl fentanyl) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** beta-methylacetyl fentanyl (N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)acetamide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9868\n\n**CFR citation:** 21 CFR 1308.11(b)(21)\n\n> (21) beta-methylacetyl fentanyl (N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)acetamide) | 9868 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(21)", "dea_code_number": "9868", "file": "beta-methylacetyl-fentanyl-n-phenyl-n-1-2-phenylpropyl-piperidin-4-yl-acetamide.md", "generated": true, "harvested": "2026-09-01", "id": "beta-methylacetyl-fentanyl-n-phenyl-n-1-2-phenylpropyl-piperidin-4-yl-acetamide", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(21) beta-methylacetyl fentanyl (N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)acetamide) | 9868 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "beta-methylacetyl fentanyl (N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)acetamide)", "title": "beta-methylacetyl fentanyl (N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)acetamide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** beta\u2032-Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide; also known as \u03b2\u2032-phenyl fentanyl; 3-phenylpropanoyl fentanyl)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9842\n\n**CFR citation:** 21 CFR 1308.11(b)(22)\n\n> (22) beta\u2032-Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide; also known as \u03b2\u2032-phenyl fentanyl; 3-phenylpropanoyl fentanyl) | 9842 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(22)", "dea_code_number": "9842", "file": "beta-phenyl-fentanyl-n-1-phenethylpiperidin-4-yl-n-3-diphenylpropanamide-also-kn.md", "generated": true, "harvested": "2026-09-01", "id": "beta-phenyl-fentanyl-n-1-phenethylpiperidin-4-yl-n-3-diphenylpropanamide-also-kn", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(22) beta\u2032-Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide; also known as \u03b2\u2032-phenyl fentanyl; 3-phenylpropanoyl fentanyl) | 9842 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "beta\u2032-Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide; also known as \u03b2\u2032-phenyl fentanyl; 3-phenylpropanoyl fentanyl)", "title": "beta\u2032-Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide; also known as \u03b2\u2032-phenyl fentanyl; 3-phenylpropanoyl fentanyl) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Betacetylmethadol\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9607\n\n**CFR citation:** 21 CFR 1308.11(b)(14)\n\n> (14) Betacetylmethadol | 9607 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(14)", "dea_code_number": "9607", "file": "betacetylmethadol.md", "generated": true, "harvested": "2026-09-01", "id": "betacetylmethadol", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(14) Betacetylmethadol | 9607 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Betacetylmethadol", "title": "Betacetylmethadol \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Betameprodine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9608\n\n**CFR citation:** 21 CFR 1308.11(b)(18)\n\n> (18) Betameprodine | 9608 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(18)", "dea_code_number": "9608", "file": "betameprodine.md", "generated": true, "harvested": "2026-09-01", "id": "betameprodine", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(18) Betameprodine | 9608 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Betameprodine", "title": "Betameprodine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Betamethadol\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9609\n\n**CFR citation:** 21 CFR 1308.11(b)(19)\n\n> (19) Betamethadol | 9609 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(19)", "dea_code_number": "9609", "file": "betamethadol.md", "generated": true, "harvested": "2026-09-01", "id": "betamethadol", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(19) Betamethadol | 9609 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Betamethadol", "title": "Betamethadol \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Betaprodine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9611\n\n**CFR citation:** 21 CFR 1308.11(b)(23)\n\n> (23) Betaprodine | 9611 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(23)", "dea_code_number": "9611", "file": "betaprodine.md", "generated": true, "harvested": "2026-09-01", "id": "betaprodine", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(23) Betaprodine | 9611 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Betaprodine", "title": "Betaprodine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Bezitramide\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Opiates\n\n> (c) Opiates.\n\n**DEA code number:** 9800\n\n**CFR citation:** 21 CFR 1308.12(c)(4)\n\n> (4) Bezitramide | 9800 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.12(c)(4)", "dea_code_number": "9800", "file": "bezitramide.md", "generated": true, "harvested": "2026-09-01", "id": "bezitramide", "quote_category": "(c) Opiates.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(4) Bezitramide | 9800 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Bezitramide", "title": "Bezitramide \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** bolasterone (7\u03b1,17\u03b1-dimethyl-17\u03b2-hydroxyandrost-4-en-3-one)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(10)\n\n> (10) bolasterone (7\u03b1,17\u03b1-dimethyl-17\u03b2-hydroxyandrost-4-en-3-one);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(10)", "file": "bolasterone-7-17-dimethyl-17-hydroxyandrost-4-en-3-one.md", "generated": true, "harvested": "2026-09-01", "id": "bolasterone-7-17-dimethyl-17-hydroxyandrost-4-en-3-one", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(10) bolasterone (7\u03b1,17\u03b1-dimethyl-17\u03b2-hydroxyandrost-4-en-3-one);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "bolasterone (7\u03b1,17\u03b1-dimethyl-17\u03b2-hydroxyandrost-4-en-3-one)", "title": "bolasterone (7\u03b1,17\u03b1-dimethyl-17\u03b2-hydroxyandrost-4-en-3-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** boldenone (17\u03b2-hydroxyandrost-1,4-diene-3-one)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(11)\n\n> (11) boldenone (17\u03b2-hydroxyandrost-1,4-diene-3-one);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(11)", "file": "boldenone-17-hydroxyandrost-1-4-diene-3-one.md", "generated": true, "harvested": "2026-09-01", "id": "boldenone-17-hydroxyandrost-1-4-diene-3-one", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(11) boldenone (17\u03b2-hydroxyandrost-1,4-diene-3-one);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "boldenone (17\u03b2-hydroxyandrost-1,4-diene-3-one)", "title": "boldenone (17\u03b2-hydroxyandrost-1,4-diene-3-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** boldione (androsta-1,4-diene-3,17-dione)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(12)\n\n> (12) boldione (androsta-1,4-diene-3,17-dione);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(12)", "file": "boldione-androsta-1-4-diene-3-17-dione.md", "generated": true, "harvested": "2026-09-01", "id": "boldione-androsta-1-4-diene-3-17-dione", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(12) boldione (androsta-1,4-diene-3,17-dione);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "boldione (androsta-1,4-diene-3,17-dione)", "title": "boldione (androsta-1,4-diene-3,17-dione) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Brexanolone\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2400\n\n**CFR citation:** 21 CFR 1308.14(c)(4)\n\n> (4) Brexanolone | 2400 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(4)", "dea_code_number": "2400", "file": "brexanolone.md", "generated": true, "harvested": "2026-09-01", "id": "brexanolone", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(4) Brexanolone | 2400 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Brexanolone", "title": "Brexanolone \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Brivaracetam ((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl] butanamide) (also referred to as BRV; UCB-34714; Briviact) (including its salts)\n\n**Schedule:** Schedule V\n\n> \u00a7 1308.15 Schedule V.\n\n**Listed under:** Depressants\n\n> (e) Depressants.\n\n**DEA code number:** 2710\n\n**CFR citation:** 21 CFR 1308.15(e)(1)\n\n> (1) Brivaracetam ((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl] butanamide) (also referred to as BRV; UCB-34714; Briviact) (including its salts) | 2710 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.15(e)(1)", "dea_code_number": "2710", "file": "brivaracetam-2s-2-4r-2-oxo-4-propylpyrrolidin-1-yl-butanamide-also-referred-to-a.md", "generated": true, "harvested": "2026-09-01", "id": "brivaracetam-2s-2-4r-2-oxo-4-propylpyrrolidin-1-yl-butanamide-also-referred-to-a", "quote_category": "(e) Depressants.", "quote_schedule": "\u00a7 1308.15 Schedule V.", "schedule": "Schedule V", "source_quote": "(1) Brivaracetam ((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl] butanamide) (also referred to as BRV; UCB-34714; Briviact) (including its salts) | 2710 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Brivaracetam ((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl] butanamide) (also referred to as BRV; UCB-34714; Briviact) (including its salts)", "title": "Brivaracetam ((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl] butanamide) (also referred to as BRV; UCB-34714; Briviact) (including its salts) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Bromazepam\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2748\n\n**CFR citation:** 21 CFR 1308.14(c)(5)\n\n> (5) Bromazepam | 2748 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(5)", "dea_code_number": "2748", "file": "bromazepam.md", "generated": true, "harvested": "2026-09-01", "id": "bromazepam", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(5) Bromazepam | 2748 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Bromazepam", "title": "Bromazepam \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** brorphine (1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9098\n\n**CFR citation:** 21 CFR 1308.11(b)(24)\n\n> (24) brorphine (1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one) | 9098 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(24)", "dea_code_number": "9098", "file": "brorphine-1-1-1-4-bromophenyl-ethyl-piperidin-4-yl-1-3-dihydro-2h-benzo-d-imidaz.md", "generated": true, "harvested": "2026-09-01", "id": "brorphine-1-1-1-4-bromophenyl-ethyl-piperidin-4-yl-1-3-dihydro-2h-benzo-d-imidaz", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(24) brorphine (1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one) | 9098 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "brorphine (1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one)", "title": "brorphine (1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Bufotenine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7433\n\n**CFR citation:** 21 CFR 1308.11(d)(17)\n\n> (17) Bufotenine | 7433 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(17)", "dea_code_number": "7433", "file": "bufotenine.md", "generated": true, "harvested": "2026-09-01", "id": "bufotenine", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(17) Bufotenine | 7433 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Bufotenine", "title": "Bufotenine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Bulk dextropropoxyphene (non-dosage forms)\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Opiates\n\n> (c) Opiates.\n\n**DEA code number:** 9273\n\n**CFR citation:** 21 CFR 1308.12(c)(5)\n\n> (5) Bulk dextropropoxyphene (non-dosage forms) | 9273 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.12(c)(5)", "dea_code_number": "9273", "file": "bulk-dextropropoxyphene-non-dosage-forms.md", "generated": true, "harvested": "2026-09-01", "id": "bulk-dextropropoxyphene-non-dosage-forms", "quote_category": "(c) Opiates.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(5) Bulk dextropropoxyphene (non-dosage forms) | 9273 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Bulk dextropropoxyphene (non-dosage forms)", "title": "Bulk dextropropoxyphene (non-dosage forms) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Buprenorphine\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Narcotic drugs\n\n> (e) Narcotic drugs.\n\n**DEA code number:** 9064\n\n**CFR citation:** 21 CFR 1308.13(e)(2)(i)\n\n> (i) Buprenorphine | 9064 |\n\nSource: \n", "category": "Narcotic drugs", "citation": "21 CFR 1308.13(e)(2)(i)", "dea_code_number": "9064", "file": "buprenorphine.md", "generated": true, "harvested": "2026-09-01", "id": "buprenorphine", "quote_category": "(e) Narcotic drugs.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(i) Buprenorphine | 9064 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Buprenorphine", "title": "Buprenorphine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Butonitazene (2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9751\n\n**CFR citation:** 21 CFR 1308.11(b)(25)\n\n> (25) Butonitazene (2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine) | 9751 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(25)", "dea_code_number": "9751", "file": "butonitazene-2-2-4-butoxybenzyl-5-nitro-1h-benzimidazol-1-yl-n-n-diethylethan-1-.md", "generated": true, "harvested": "2026-09-01", "id": "butonitazene-2-2-4-butoxybenzyl-5-nitro-1h-benzimidazol-1-yl-n-n-diethylethan-1-", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(25) Butonitazene (2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine) | 9751 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Butonitazene (2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine)", "title": "Butonitazene (2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Butorphanol (including its optical isomers)\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Other substances\n\n> (g) Other substances.\n\n**DEA code number:** 9720\n\n**CFR citation:** 21 CFR 1308.14(g)(2)\n\n> (2) Butorphanol (including its optical isomers) | 9720 |\n\nSource: \n", "category": "Other substances", "citation": "21 CFR 1308.14(g)(2)", "dea_code_number": "9720", "file": "butorphanol-including-its-optical-isomers.md", "generated": true, "harvested": "2026-09-01", "id": "butorphanol-including-its-optical-isomers", "quote_category": "(g) Other substances.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(2) Butorphanol (including its optical isomers) | 9720 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Butorphanol (including its optical isomers)", "title": "Butorphanol (including its optical isomers) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Butyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9822\n\n**CFR citation:** 21 CFR 1308.11(b)(26)\n\n> (26) Butyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide) | 9822 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(26)", "dea_code_number": "9822", "file": "butyryl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylbutyramide.md", "generated": true, "harvested": "2026-09-01", "id": "butyryl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylbutyramide", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(26) Butyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide) | 9822 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Butyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide)", "title": "Butyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** calusterone (7\u03b2,17\u03b1-dimethyl-17\u03b2-hydroxyandrost-4-en-3-one)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(15)\n\n> (15) calusterone (7\u03b2,17\u03b1-dimethyl-17\u03b2-hydroxyandrost-4-en-3-one);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(15)", "file": "calusterone-7-17-dimethyl-17-hydroxyandrost-4-en-3-one.md", "generated": true, "harvested": "2026-09-01", "id": "calusterone-7-17-dimethyl-17-hydroxyandrost-4-en-3-one", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(15) calusterone (7\u03b2,17\u03b1-dimethyl-17\u03b2-hydroxyandrost-4-en-3-one);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "calusterone (7\u03b2,17\u03b1-dimethyl-17\u03b2-hydroxyandrost-4-en-3-one)", "title": "calusterone (7\u03b2,17\u03b1-dimethyl-17\u03b2-hydroxyandrost-4-en-3-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Camazepam\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2749\n\n**CFR citation:** 21 CFR 1308.14(c)(6)\n\n> (6) Camazepam | 2749 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(6)", "dea_code_number": "2749", "file": "camazepam.md", "generated": true, "harvested": "2026-09-01", "id": "camazepam", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(6) Camazepam | 2749 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Camazepam", "title": "Camazepam \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Cannabimimetic agents\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Cannabimimetic agents\n\n> (g) Cannabimimetic agents.\n\n**DEA code number:** 7000\n\n**CFR citation:** 21 CFR 1308.11(g)(1)\n\n> (1) Cannabimimetic agents | 7000 |\n\nSource: \n", "category": "Cannabimimetic agents", "citation": "21 CFR 1308.11(g)(1)", "dea_code_number": "7000", "file": "cannabimimetic-agents.md", "generated": true, "harvested": "2026-09-01", "id": "cannabimimetic-agents", "quote_category": "(g) Cannabimimetic agents.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(1) Cannabimimetic agents | 7000 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Cannabimimetic agents", "title": "Cannabimimetic agents \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Carfentanil\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Opiates\n\n> (c) Opiates.\n\n**DEA code number:** 9743\n\n**CFR citation:** 21 CFR 1308.12(c)(6)\n\n> (6) Carfentanil | 9743 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.12(c)(6)", "dea_code_number": "9743", "file": "carfentanil.md", "generated": true, "harvested": "2026-09-01", "id": "carfentanil", "quote_category": "(c) Opiates.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(6) Carfentanil | 9743 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Carfentanil", "title": "Carfentanil \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Carisoprodol\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 8192\n\n**CFR citation:** 21 CFR 1308.14(c)(7)\n\n> (7) Carisoprodol | 8192 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(7)", "dea_code_number": "8192", "file": "carisoprodol.md", "generated": true, "harvested": "2026-09-01", "id": "carisoprodol", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(7) Carisoprodol | 8192 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Carisoprodol", "title": "Carisoprodol \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Cathine ((+)-norpseudoephedrine)\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Stimulants\n\n> (f) Stimulants.\n\n**DEA code number:** 1230\n\n**CFR citation:** 21 CFR 1308.14(f)(1)\n\n> (1) Cathine ((+)-norpseudoephedrine) | 1230 |\n\nSource: \n", "category": "Stimulants", "citation": "21 CFR 1308.14(f)(1)", "dea_code_number": "1230", "file": "cathine-norpseudoephedrine.md", "generated": true, "harvested": "2026-09-01", "id": "cathine-norpseudoephedrine", "quote_category": "(f) Stimulants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(1) Cathine ((+)-norpseudoephedrine) | 1230 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Cathine ((+)-norpseudoephedrine)", "title": "Cathine ((+)-norpseudoephedrine) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Cathinone\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Stimulants\n\n> (f) Stimulants.\n\n**DEA code number:** 1235\n\n**CFR citation:** 21 CFR 1308.11(f)(4)\n\n> (4) Cathinone | 1235 |\n\nSource: \n", "category": "Stimulants", "citation": "21 CFR 1308.11(f)(4)", "dea_code_number": "1235", "file": "cathinone.md", "generated": true, "harvested": "2026-09-01", "id": "cathinone", "quote_category": "(f) Stimulants.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(4) Cathinone | 1235 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Cathinone", "title": "Cathinone \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Cenobamate ([(1R)-1-(2-chlorophenyl)-2-(tetrazol-2-yl)ethyl] carbamate; 2H-tetrazole-2-ethanol, alpha-(2-chlorophenyl)-, carbamate (ester), (alphaR)-; carbamic acid (R)-(+)-1-(2-chlorophenyl)-2-(2H-tetrazol-2-yl)ethyl ester)\n\n**Schedule:** Schedule V\n\n> \u00a7 1308.15 Schedule V.\n\n**Listed under:** Depressants\n\n> (e) Depressants.\n\n**DEA code number:** 2720\n\n**CFR citation:** 21 CFR 1308.15(e)(2)\n\n> (2) Cenobamate ([(1R)-1-(2-chlorophenyl)-2-(tetrazol-2-yl)ethyl] carbamate; 2H-tetrazole-2-ethanol, alpha-(2-chlorophenyl)-, carbamate (ester), (alphaR)-; carbamic acid (R)-(+)-1-(2-chlorophenyl)-2-(2H-tetrazol-2-yl)ethyl ester) | 2720 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.15(e)(2)", "dea_code_number": "2720", "file": "cenobamate-1r-1-2-chlorophenyl-2-tetrazol-2-yl-ethyl-carbamate-2h-tetrazole-2-et.md", "generated": true, "harvested": "2026-09-01", "id": "cenobamate-1r-1-2-chlorophenyl-2-tetrazol-2-yl-ethyl-carbamate-2h-tetrazole-2-et", "quote_category": "(e) Depressants.", "quote_schedule": "\u00a7 1308.15 Schedule V.", "schedule": "Schedule V", "source_quote": "(2) Cenobamate ([(1R)-1-(2-chlorophenyl)-2-(tetrazol-2-yl)ethyl] carbamate; 2H-tetrazole-2-ethanol, alpha-(2-chlorophenyl)-, carbamate (ester), (alphaR)-; carbamic acid (R)-(+)-1-(2-chlorophenyl)-2-(2H-tetrazol-2-yl)ethyl ester) | 2720 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Cenobamate ([(1R)-1-(2-chlorophenyl)-2-(tetrazol-2-yl)ethyl] carbamate; 2H-tetrazole-2-ethanol, alpha-(2-chlorophenyl)-, carbamate (ester), (alphaR)-; carbamic acid (R)-(+)-1-(2-chlorophenyl)-2-(2H-tetrazol-2-yl)ethyl ester)", "title": "Cenobamate ([(1R)-1-(2-chlorophenyl)-2-(tetrazol-2-yl)ethyl] carbamate; 2H-tetrazole-2-ethanol, alpha-(2-chlorophenyl)-, carbamate (ester), (alphaR)-; carbamic acid (R)-(+)-1-(2-chlorophenyl)-2-(2H-tetrazol-2-yl)ethyl ester) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Chloral betaine\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2460\n\n**CFR citation:** 21 CFR 1308.14(c)(8)\n\n> (8) Chloral betaine | 2460 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(8)", "dea_code_number": "2460", "file": "chloral-betaine.md", "generated": true, "harvested": "2026-09-01", "id": "chloral-betaine", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(8) Chloral betaine | 2460 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Chloral betaine", "title": "Chloral betaine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Chloral hydrate\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2465\n\n**CFR citation:** 21 CFR 1308.14(c)(9)\n\n> (9) Chloral hydrate | 2465 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(9)", "dea_code_number": "2465", "file": "chloral-hydrate.md", "generated": true, "harvested": "2026-09-01", "id": "chloral-hydrate", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(9) Chloral hydrate | 2465 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Chloral hydrate", "title": "Chloral hydrate \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Chlordiazepoxide\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2744\n\n**CFR citation:** 21 CFR 1308.14(c)(10)\n\n> (10) Chlordiazepoxide | 2744 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(10)", "dea_code_number": "2744", "file": "chlordiazepoxide.md", "generated": true, "harvested": "2026-09-01", "id": "chlordiazepoxide", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(10) Chlordiazepoxide | 2744 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Chlordiazepoxide", "title": "Chlordiazepoxide \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Chlorhexadol\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2510\n\n**CFR citation:** 21 CFR 1308.13(c)(4)\n\n> (4) Chlorhexadol | 2510 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.13(c)(4)", "dea_code_number": "2510", "file": "chlorhexadol.md", "generated": true, "harvested": "2026-09-01", "id": "chlorhexadol", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(4) Chlorhexadol | 2510 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Chlorhexadol", "title": "Chlorhexadol \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Chlorphentermine\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Stimulants\n\n> (b) Stimulants.\n\n**DEA code number:** 1645\n\n**CFR citation:** 21 CFR 1308.13(b)(3)\n\n> (3) Chlorphentermine | 1645 |\n\nSource: \n", "category": "Stimulants", "citation": "21 CFR 1308.13(b)(3)", "dea_code_number": "1645", "file": "chlorphentermine.md", "generated": true, "harvested": "2026-09-01", "id": "chlorphentermine", "quote_category": "(b) Stimulants.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(3) Chlorphentermine | 1645 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Chlorphentermine", "title": "Chlorphentermine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Cipepofol\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2139\n\n**CFR citation:** 21 CFR 1308.14(c)(11)\n\n> (11) Cipepofol | 2139 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(11)", "dea_code_number": "2139", "file": "cipepofol.md", "generated": true, "harvested": "2026-09-01", "id": "cipepofol", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(11) Cipepofol | 2139 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Cipepofol", "title": "Cipepofol \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** (\u00b1)cis-4-methylaminorex ((\u00b1)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Stimulants\n\n> (f) Stimulants.\n\n**DEA code number:** 1590\n\n**CFR citation:** 21 CFR 1308.11(f)(12)\n\n> (12) (\u00b1)cis-4-methylaminorex ((\u00b1)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine) | 1590 |\n\nSource: \n", "category": "Stimulants", "citation": "21 CFR 1308.11(f)(12)", "dea_code_number": "1590", "file": "cis-4-methylaminorex-cis-4-5-dihydro-4-methyl-5-phenyl-2-oxazolamine.md", "generated": true, "harvested": "2026-09-01", "id": "cis-4-methylaminorex-cis-4-5-dihydro-4-methyl-5-phenyl-2-oxazolamine", "quote_category": "(f) Stimulants.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(12) (\u00b1)cis-4-methylaminorex ((\u00b1)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine) | 1590 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "(\u00b1)cis-4-methylaminorex ((\u00b1)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine)", "title": "(\u00b1)cis-4-methylaminorex ((\u00b1)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Clobazam\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2751\n\n**CFR citation:** 21 CFR 1308.14(c)(12)\n\n> (12) Clobazam | 2751 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(12)", "dea_code_number": "2751", "file": "clobazam.md", "generated": true, "harvested": "2026-09-01", "id": "clobazam", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(12) Clobazam | 2751 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Clobazam", "title": "Clobazam \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Clonazepam\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2737\n\n**CFR citation:** 21 CFR 1308.14(c)(13)\n\n> (13) Clonazepam | 2737 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(13)", "dea_code_number": "2737", "file": "clonazepam.md", "generated": true, "harvested": "2026-09-01", "id": "clonazepam", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(13) Clonazepam | 2737 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Clonazepam", "title": "Clonazepam \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Clonazolam (Other name: 6-(2-chlorophenyl)-1-methyl-8-nitro-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Depressants\n\n> (e) Depressants.\n\n**DEA code number:** 2786\n\n**CFR citation:** 21 CFR 1308.11(e)(1)\n\n> (1) Clonazolam (Other name: 6-(2-chlorophenyl)-1-methyl-8-nitro-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine) | 2786 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.11(e)(1)", "dea_code_number": "2786", "file": "clonazolam-other-name-6-2-chlorophenyl-1-methyl-8-nitro-4h-benzo-f-1-2-4-triazol.md", "generated": true, "harvested": "2026-09-01", "id": "clonazolam-other-name-6-2-chlorophenyl-1-methyl-8-nitro-4h-benzo-f-1-2-4-triazol", "quote_category": "(e) Depressants.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(1) Clonazolam (Other name: 6-(2-chlorophenyl)-1-methyl-8-nitro-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine) | 2786 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Clonazolam (Other name: 6-(2-chlorophenyl)-1-methyl-8-nitro-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine)", "title": "Clonazolam (Other name: 6-(2-chlorophenyl)-1-methyl-8-nitro-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Clonitazene\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9612\n\n**CFR citation:** 21 CFR 1308.11(b)(27)\n\n> (27) Clonitazene | 9612 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(27)", "dea_code_number": "9612", "file": "clonitazene.md", "generated": true, "harvested": "2026-09-01", "id": "clonitazene", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(27) Clonitazene | 9612 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Clonitazene", "title": "Clonitazene \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Clorazepate\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2768\n\n**CFR citation:** 21 CFR 1308.14(c)(14)\n\n> (14) Clorazepate | 2768 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(14)", "dea_code_number": "2768", "file": "clorazepate.md", "generated": true, "harvested": "2026-09-01", "id": "clorazepate", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(14) Clorazepate | 2768 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Clorazepate", "title": "Clorazepate \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Clortermine\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Stimulants\n\n> (b) Stimulants.\n\n**DEA code number:** 1647\n\n**CFR citation:** 21 CFR 1308.13(b)(4)\n\n> (4) Clortermine | 1647 |\n\nSource: \n", "category": "Stimulants", "citation": "21 CFR 1308.13(b)(4)", "dea_code_number": "1647", "file": "clortermine.md", "generated": true, "harvested": "2026-09-01", "id": "clortermine", "quote_category": "(b) Stimulants.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(4) Clortermine | 1647 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Clortermine", "title": "Clortermine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** clostebol (4-chloro-17\u03b2-hydroxyandrost-4-en-3-one)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(20)\n\n> (20) clostebol (4-chloro-17\u03b2-hydroxyandrost-4-en-3-one);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(20)", "file": "clostebol-4-chloro-17-hydroxyandrost-4-en-3-one.md", "generated": true, "harvested": "2026-09-01", "id": "clostebol-4-chloro-17-hydroxyandrost-4-en-3-one", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(20) clostebol (4-chloro-17\u03b2-hydroxyandrost-4-en-3-one);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "clostebol (4-chloro-17\u03b2-hydroxyandrost-4-en-3-one)", "title": "clostebol (4-chloro-17\u03b2-hydroxyandrost-4-en-3-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Clotiazepam\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2752\n\n**CFR citation:** 21 CFR 1308.14(c)(15)\n\n> (15) Clotiazepam | 2752 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(15)", "dea_code_number": "2752", "file": "clotiazepam.md", "generated": true, "harvested": "2026-09-01", "id": "clotiazepam", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(15) Clotiazepam | 2752 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Clotiazepam", "title": "Clotiazepam \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Cloxazolam\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2753\n\n**CFR citation:** 21 CFR 1308.14(c)(16)\n\n> (16) Cloxazolam | 2753 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(16)", "dea_code_number": "2753", "file": "cloxazolam.md", "generated": true, "harvested": "2026-09-01", "id": "cloxazolam", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(16) Cloxazolam | 2753 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Cloxazolam", "title": "Cloxazolam \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Coca leaves\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Substances, vegetable origin or chemical synthesis\n\n> (b) Substances, vegetable origin or chemical synthesis.\n\n**DEA code number:** 9040\n\n**CFR citation:** 21 CFR 1308.12(b)(4)\n\n> Coca leaves (9040)\n\nSource: \n", "category": "Substances, vegetable origin or chemical synthesis", "citation": "21 CFR 1308.12(b)(4)", "dea_code_number": "9040", "file": "coca-leaves.md", "generated": true, "harvested": "2026-09-01", "id": "coca-leaves", "quote_category": "(b) Substances, vegetable origin or chemical synthesis.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "Coca leaves (9040)", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Coca leaves", "title": "Coca leaves \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** cocaine\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Substances, vegetable origin or chemical synthesis\n\n> (b) Substances, vegetable origin or chemical synthesis.\n\n**DEA code number:** 9041\n\n**CFR citation:** 21 CFR 1308.12(b)(4)\n\n> cocaine (9041)\n\nSource: \n", "category": "Substances, vegetable origin or chemical synthesis", "citation": "21 CFR 1308.12(b)(4)", "dea_code_number": "9041", "file": "cocaine.md", "generated": true, "harvested": "2026-09-01", "id": "cocaine", "quote_category": "(b) Substances, vegetable origin or chemical synthesis.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "cocaine (9041)", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "cocaine", "title": "cocaine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** codeine\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Narcotic drugs\n\n> (e) Narcotic drugs.\n\n**DEA code number:** 9803\n\n**Only when:** Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium\n\n**CFR citation:** 21 CFR 1308.13(e)(1)(i)\n\n> (i) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium | 9803 |\n\nSource: \n", "category": "Narcotic drugs", "citation": "21 CFR 1308.13(e)(1)(i)", "dea_code_number": "9803", "file": "codeine-2.md", "generated": true, "harvested": "2026-09-01", "id": "codeine-2", "quote_category": "(e) Narcotic drugs.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "scope_qualifier": "Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium", "source_quote": "(i) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium | 9803 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "codeine", "title": "codeine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** codeine\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Narcotic drugs\n\n> (e) Narcotic drugs.\n\n**DEA code number:** 9804\n\n**Only when:** Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts\n\n**CFR citation:** 21 CFR 1308.13(e)(1)(ii)\n\n> (ii) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts | 9804 |\n\nSource: \n", "category": "Narcotic drugs", "citation": "21 CFR 1308.13(e)(1)(ii)", "dea_code_number": "9804", "file": "codeine-3.md", "generated": true, "harvested": "2026-09-01", "id": "codeine-3", "quote_category": "(e) Narcotic drugs.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "scope_qualifier": "Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts", "source_quote": "(ii) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts | 9804 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "codeine", "title": "codeine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** codeine\n\n**Schedule:** Schedule V\n\n> \u00a7 1308.15 Schedule V.\n\n**Listed under:** Narcotic drugs containing non-narcotic active medicinal ingredients\n\n> (c) Narcotic drugs containing non-narcotic active medicinal ingredients.\n\n**Only when:** Not more than 200 milligrams of codeine per 100 milliliters or per 100 grams\n\n**CFR citation:** 21 CFR 1308.15(c)(1)\n\n> (1) Not more than 200 milligrams of codeine per 100 milliliters or per 100 grams.\n\nSource: \n", "category": "Narcotic drugs containing non-narcotic active medicinal ingredients", "citation": "21 CFR 1308.15(c)(1)", "file": "codeine-4.md", "generated": true, "harvested": "2026-09-01", "id": "codeine-4", "quote_category": "(c) Narcotic drugs containing non-narcotic active medicinal ingredients.", "quote_schedule": "\u00a7 1308.15 Schedule V.", "schedule": "Schedule V", "scope_qualifier": "Not more than 200 milligrams of codeine per 100 milliliters or per 100 grams", "source_quote": "(1) Not more than 200 milligrams of codeine per 100 milliliters or per 100 grams.", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "codeine", "title": "codeine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Codeine methylbromide\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opium derivatives\n\n> (c) Opium derivatives.\n\n**DEA code number:** 9070\n\n**CFR citation:** 21 CFR 1308.11(c)(4)\n\n> (4) Codeine methylbromide | 9070 |\n\nSource: \n", "category": "Opium derivatives", "citation": "21 CFR 1308.11(c)(4)", "dea_code_number": "9070", "file": "codeine-methylbromide.md", "generated": true, "harvested": "2026-09-01", "id": "codeine-methylbromide", "quote_category": "(c) Opium derivatives.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(4) Codeine methylbromide | 9070 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Codeine methylbromide", "title": "Codeine methylbromide \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Codeine-N-Oxide\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opium derivatives\n\n> (c) Opium derivatives.\n\n**DEA code number:** 9053\n\n**CFR citation:** 21 CFR 1308.11(c)(5)\n\n> (5) Codeine-N-Oxide | 9053 |\n\nSource: \n", "category": "Opium derivatives", "citation": "21 CFR 1308.11(c)(5)", "dea_code_number": "9053", "file": "codeine-n-oxide.md", "generated": true, "harvested": "2026-09-01", "id": "codeine-n-oxide", "quote_category": "(c) Opium derivatives.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(5) Codeine-N-Oxide | 9053 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Codeine-N-Oxide", "title": "Codeine-N-Oxide \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Codeine\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Substances, vegetable origin or chemical synthesis\n\n> (b) Substances, vegetable origin or chemical synthesis.\n\n**DEA code number:** 9050\n\n**CFR citation:** 21 CFR 1308.12(b)(1)(i)\n\n> (i) Codeine | 9050 |\n\nSource: \n", "category": "Substances, vegetable origin or chemical synthesis", "citation": "21 CFR 1308.12(b)(1)(i)", "dea_code_number": "9050", "file": "codeine.md", "generated": true, "harvested": "2026-09-01", "id": "codeine", "quote_category": "(b) Substances, vegetable origin or chemical synthesis.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(i) Codeine | 9050 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Codeine", "title": "Codeine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Concentrate of poppy straw\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Substances, vegetable origin or chemical synthesis\n\n> (b) Substances, vegetable origin or chemical synthesis.\n\n**DEA code number:** 9670\n\n**CFR citation:** 21 CFR 1308.12(b)(5)\n\n> (5) Concentrate of poppy straw (the crude extract of poppy straw in either liquid, solid or powder form which contains the phenanthrene alkaloids of the opium poppy), 9670.\n\nSource: \n", "category": "Substances, vegetable origin or chemical synthesis", "citation": "21 CFR 1308.12(b)(5)", "dea_code_number": "9670", "file": "concentrate-of-poppy-straw.md", "generated": true, "harvested": "2026-09-01", "id": "concentrate-of-poppy-straw", "quote_category": "(b) Substances, vegetable origin or chemical synthesis.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(5) Concentrate of poppy straw (the crude extract of poppy straw in either liquid, solid or powder form which contains the phenanthrene alkaloids of the opium poppy), 9670.", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Concentrate of poppy straw", "title": "Concentrate of poppy straw \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Crotonyl fentanyl ((E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9844\n\n**CFR citation:** 21 CFR 1308.11(b)(28)\n\n> (28) Crotonyl fentanyl ((E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide) | 9844 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(28)", "dea_code_number": "9844", "file": "crotonyl-fentanyl-e-n-1-phenethylpiperidin-4-yl-n-phenylbut-2-enamide.md", "generated": true, "harvested": "2026-09-01", "id": "crotonyl-fentanyl-e-n-1-phenethylpiperidin-4-yl-n-phenylbut-2-enamide", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(28) Crotonyl fentanyl ((E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide) | 9844 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Crotonyl fentanyl ((E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide)", "title": "Crotonyl fentanyl ((E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Cyclopentyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9847\n\n**CFR citation:** 21 CFR 1308.11(b)(29)\n\n> (29) Cyclopentyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide) | 9847 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(29)", "dea_code_number": "9847", "file": "cyclopentyl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylcyclopentanecarboxamide.md", "generated": true, "harvested": "2026-09-01", "id": "cyclopentyl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylcyclopentanecarboxamide", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(29) Cyclopentyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide) | 9847 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Cyclopentyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide)", "title": "Cyclopentyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Cyclopropyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9845\n\n**CFR citation:** 21 CFR 1308.11(b)(30)\n\n> (30) Cyclopropyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide) | 9845 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(30)", "dea_code_number": "9845", "file": "cyclopropyl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylcyclopropanecarboxamide.md", "generated": true, "harvested": "2026-09-01", "id": "cyclopropyl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylcyclopropanecarboxamide", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(30) Cyclopropyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide) | 9845 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Cyclopropyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide)", "title": "Cyclopropyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Cyprenorphine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opium derivatives\n\n> (c) Opium derivatives.\n\n**DEA code number:** 9054\n\n**CFR citation:** 21 CFR 1308.11(c)(6)\n\n> (6) Cyprenorphine | 9054 |\n\nSource: \n", "category": "Opium derivatives", "citation": "21 CFR 1308.11(c)(6)", "dea_code_number": "9054", "file": "cyprenorphine.md", "generated": true, "harvested": "2026-09-01", "id": "cyprenorphine", "quote_category": "(c) Opium derivatives.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(6) Cyprenorphine | 9054 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Cyprenorphine", "title": "Cyprenorphine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Daridorexant\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2410\n\n**CFR citation:** 21 CFR 1308.14(c)(17)\n\n> (17) Daridorexant | 2410 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(17)", "dea_code_number": "2410", "file": "daridorexant.md", "generated": true, "harvested": "2026-09-01", "id": "daridorexant", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(17) Daridorexant | 2410 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Daridorexant", "title": "Daridorexant \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** dehydrochloromethyltestosterone (4-chloro-17\u03b2-hydroxy-17\u03b1-methyl-androst-1,4-dien-3-one)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(21)\n\n> (21) dehydrochloromethyltestosterone (4-chloro-17\u03b2-hydroxy-17\u03b1-methyl-androst-1,4-dien-3-one);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(21)", "file": "dehydrochloromethyltestosterone-4-chloro-17-hydroxy-17-methyl-androst-1-4-dien-3.md", "generated": true, "harvested": "2026-09-01", "id": "dehydrochloromethyltestosterone-4-chloro-17-hydroxy-17-methyl-androst-1-4-dien-3", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(21) dehydrochloromethyltestosterone (4-chloro-17\u03b2-hydroxy-17\u03b1-methyl-androst-1,4-dien-3-one);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "dehydrochloromethyltestosterone (4-chloro-17\u03b2-hydroxy-17\u03b1-methyl-androst-1,4-dien-3-one)", "title": "dehydrochloromethyltestosterone (4-chloro-17\u03b2-hydroxy-17\u03b1-methyl-androst-1,4-dien-3-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Delorazepam\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2754\n\n**CFR citation:** 21 CFR 1308.14(c)(18)\n\n> (18) Delorazepam | 2754 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(18)", "dea_code_number": "2754", "file": "delorazepam.md", "generated": true, "harvested": "2026-09-01", "id": "delorazepam", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(18) Delorazepam | 2754 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Delorazepam", "title": "Delorazepam \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Desomorphine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opium derivatives\n\n> (c) Opium derivatives.\n\n**DEA code number:** 9055\n\n**CFR citation:** 21 CFR 1308.11(c)(7)\n\n> (7) Desomorphine | 9055 |\n\nSource: \n", "category": "Opium derivatives", "citation": "21 CFR 1308.11(c)(7)", "dea_code_number": "9055", "file": "desomorphine.md", "generated": true, "harvested": "2026-09-01", "id": "desomorphine", "quote_category": "(c) Opium derivatives.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(7) Desomorphine | 9055 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Desomorphine", "title": "Desomorphine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** desoxymethyltestosterone (17\u03b1-methyl-5\u03b1-androst-2-en-17\u03b2-ol) (a.k.a. \u201cmadol\u201d)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(22)\n\n> (22) desoxymethyltestosterone (17\u03b1-methyl-5\u03b1-androst-2-en-17\u03b2-ol) (a.k.a. \u201cmadol\u201d);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(22)", "file": "desoxymethyltestosterone-17-methyl-5-androst-2-en-17-ol-a-k-a-madol.md", "generated": true, "harvested": "2026-09-01", "id": "desoxymethyltestosterone-17-methyl-5-androst-2-en-17-ol-a-k-a-madol", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(22) desoxymethyltestosterone (17\u03b1-methyl-5\u03b1-androst-2-en-17\u03b2-ol) (a.k.a. \u201cmadol\u201d);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "desoxymethyltestosterone (17\u03b1-methyl-5\u03b1-androst-2-en-17\u03b2-ol) (a.k.a. \u201cmadol\u201d)", "title": "desoxymethyltestosterone (17\u03b1-methyl-5\u03b1-androst-2-en-17\u03b2-ol) (a.k.a. \u201cmadol\u201d) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Dextromoramide\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9613\n\n**CFR citation:** 21 CFR 1308.11(b)(31)\n\n> (31) Dextromoramide | 9613 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(31)", "dea_code_number": "9613", "file": "dextromoramide.md", "generated": true, "harvested": "2026-09-01", "id": "dextromoramide", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(31) Dextromoramide | 9613 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Dextromoramide", "title": "Dextromoramide \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Dextropropoxyphene (alpha-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-propionoxybutane)\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Narcotic drugs\n\n> (b) Narcotic drugs.\n\n**DEA code number:** 9278\n\n**CFR citation:** 21 CFR 1308.14(b)(2)\n\n> (2) Dextropropoxyphene (alpha-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-propionoxybutane) | 9278 |\n\nSource: \n", "category": "Narcotic drugs", "citation": "21 CFR 1308.14(b)(2)", "dea_code_number": "9278", "file": "dextropropoxyphene-alpha-4-dimethylamino-1-2-diphenyl-3-methyl-2-propionoxybutan.md", "generated": true, "harvested": "2026-09-01", "id": "dextropropoxyphene-alpha-4-dimethylamino-1-2-diphenyl-3-methyl-2-propionoxybutan", "quote_category": "(b) Narcotic drugs.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(2) Dextropropoxyphene (alpha-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-propionoxybutane) | 9278 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Dextropropoxyphene (alpha-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-propionoxybutane)", "title": "Dextropropoxyphene (alpha-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-propionoxybutane) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Diampromide\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9615\n\n**CFR citation:** 21 CFR 1308.11(b)(32)\n\n> (32) Diampromide | 9615 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(32)", "dea_code_number": "9615", "file": "diampromide.md", "generated": true, "harvested": "2026-09-01", "id": "diampromide", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(32) Diampromide | 9615 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Diampromide", "title": "Diampromide \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Diazepam\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2765\n\n**CFR citation:** 21 CFR 1308.14(c)(19)\n\n> (19) Diazepam | 2765 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(19)", "dea_code_number": "2765", "file": "diazepam.md", "generated": true, "harvested": "2026-09-01", "id": "diazepam", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(19) Diazepam | 2765 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Diazepam", "title": "Diazepam \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Dichloralphenazone\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2467\n\n**CFR citation:** 21 CFR 1308.14(c)(20)\n\n> (20) Dichloralphenazone | 2467 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(20)", "dea_code_number": "2467", "file": "dichloralphenazone.md", "generated": true, "harvested": "2026-09-01", "id": "dichloralphenazone", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(20) Dichloralphenazone | 2467 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Dichloralphenazone", "title": "Dichloralphenazone \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Diclazepam (Other name: 7-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Depressants\n\n> (e) Depressants.\n\n**DEA code number:** 2789\n\n**CFR citation:** 21 CFR 1308.11(e)(2)\n\n> (2) Diclazepam (Other name: 7-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one) | 2789 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.11(e)(2)", "dea_code_number": "2789", "file": "diclazepam-other-name-7-chloro-5-2-chlorophenyl-1-methyl-1-3-dihydro-2h-benzo-e-.md", "generated": true, "harvested": "2026-09-01", "id": "diclazepam-other-name-7-chloro-5-2-chlorophenyl-1-methyl-1-3-dihydro-2h-benzo-e-", "quote_category": "(e) Depressants.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(2) Diclazepam (Other name: 7-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one) | 2789 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Diclazepam (Other name: 7-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one)", "title": "Diclazepam (Other name: 7-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Diethylpropion\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Stimulants\n\n> (f) Stimulants.\n\n**DEA code number:** 1610\n\n**CFR citation:** 21 CFR 1308.14(f)(2)\n\n> (2) Diethylpropion | 1610 |\n\nSource: \n", "category": "Stimulants", "citation": "21 CFR 1308.14(f)(2)", "dea_code_number": "1610", "file": "diethylpropion.md", "generated": true, "harvested": "2026-09-01", "id": "diethylpropion", "quote_category": "(f) Stimulants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(2) Diethylpropion | 1610 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Diethylpropion", "title": "Diethylpropion \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Diethylthiambutene\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9616\n\n**CFR citation:** 21 CFR 1308.11(b)(33)\n\n> (33) Diethylthiambutene | 9616 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(33)", "dea_code_number": "9616", "file": "diethylthiambutene.md", "generated": true, "harvested": "2026-09-01", "id": "diethylthiambutene", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(33) Diethylthiambutene | 9616 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Diethylthiambutene", "title": "Diethylthiambutene \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Diethyltryptamine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7434\n\n**CFR citation:** 21 CFR 1308.11(d)(18)\n\n> (18) Diethyltryptamine | 7434 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(18)", "dea_code_number": "7434", "file": "diethyltryptamine.md", "generated": true, "harvested": "2026-09-01", "id": "diethyltryptamine", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(18) Diethyltryptamine | 7434 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Diethyltryptamine", "title": "Diethyltryptamine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** difenoxin\n\n**Schedule:** Schedule V\n\n> \u00a7 1308.15 Schedule V.\n\n**Listed under:** Narcotic drugs containing non-narcotic active medicinal ingredients\n\n> (c) Narcotic drugs containing non-narcotic active medicinal ingredients.\n\n**Only when:** Not more than 0.5 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit\n\n**CFR citation:** 21 CFR 1308.15(c)(6)\n\n> (6) Not more than 0.5 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit.\n\nSource: \n", "category": "Narcotic drugs containing non-narcotic active medicinal ingredients", "citation": "21 CFR 1308.15(c)(6)", "file": "difenoxin-2.md", "generated": true, "harvested": "2026-09-01", "id": "difenoxin-2", "quote_category": "(c) Narcotic drugs containing non-narcotic active medicinal ingredients.", "quote_schedule": "\u00a7 1308.15 Schedule V.", "schedule": "Schedule V", "scope_qualifier": "Not more than 0.5 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit", "source_quote": "(6) Not more than 0.5 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit.", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "difenoxin", "title": "difenoxin \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Difenoxin\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9168\n\n**CFR citation:** 21 CFR 1308.11(b)(34)\n\n> (34) Difenoxin | 9168 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(34)", "dea_code_number": "9168", "file": "difenoxin.md", "generated": true, "harvested": "2026-09-01", "id": "difenoxin", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(34) Difenoxin | 9168 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Difenoxin", "title": "Difenoxin \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** dihydrocodeine\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Narcotic drugs\n\n> (e) Narcotic drugs.\n\n**DEA code number:** 9807\n\n**Only when:** Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active nonnarcotic ingredients in recognized therapeutic amounts\n\n**CFR citation:** 21 CFR 1308.13(e)(1)(iii)\n\n> (iii) Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active nonnarcotic ingredients in recognized therapeutic amounts | 9807 |\n\nSource: \n", "category": "Narcotic drugs", "citation": "21 CFR 1308.13(e)(1)(iii)", "dea_code_number": "9807", "file": "dihydrocodeine-2.md", "generated": true, "harvested": "2026-09-01", "id": "dihydrocodeine-2", "quote_category": "(e) Narcotic drugs.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "scope_qualifier": "Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active nonnarcotic ingredients in recognized therapeutic amounts", "source_quote": "(iii) Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active nonnarcotic ingredients in recognized therapeutic amounts | 9807 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "dihydrocodeine", "title": "dihydrocodeine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** dihydrocodeine\n\n**Schedule:** Schedule V\n\n> \u00a7 1308.15 Schedule V.\n\n**Listed under:** Narcotic drugs containing non-narcotic active medicinal ingredients\n\n> (c) Narcotic drugs containing non-narcotic active medicinal ingredients.\n\n**Only when:** Not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams\n\n**CFR citation:** 21 CFR 1308.15(c)(2)\n\n> (2) Not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams.\n\nSource: \n", "category": "Narcotic drugs containing non-narcotic active medicinal ingredients", "citation": "21 CFR 1308.15(c)(2)", "file": "dihydrocodeine-3.md", "generated": true, "harvested": "2026-09-01", "id": "dihydrocodeine-3", "quote_category": "(c) Narcotic drugs containing non-narcotic active medicinal ingredients.", "quote_schedule": "\u00a7 1308.15 Schedule V.", "schedule": "Schedule V", "scope_qualifier": "Not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams", "source_quote": "(2) Not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams.", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "dihydrocodeine", "title": "dihydrocodeine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Dihydrocodeine\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Opiates\n\n> (c) Opiates.\n\n**DEA code number:** 9120\n\n**CFR citation:** 21 CFR 1308.12(c)(7)\n\n> (7) Dihydrocodeine | 9120 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.12(c)(7)", "dea_code_number": "9120", "file": "dihydrocodeine.md", "generated": true, "harvested": "2026-09-01", "id": "dihydrocodeine", "quote_category": "(c) Opiates.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(7) Dihydrocodeine | 9120 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Dihydrocodeine", "title": "Dihydrocodeine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Dihydroetorphine\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Substances, vegetable origin or chemical synthesis\n\n> (b) Substances, vegetable origin or chemical synthesis.\n\n**DEA code number:** 9334\n\n**CFR citation:** 21 CFR 1308.12(b)(1)(ii)\n\n> (ii) Dihydroetorphine | 9334 |\n\nSource: \n", "category": "Substances, vegetable origin or chemical synthesis", "citation": "21 CFR 1308.12(b)(1)(ii)", "dea_code_number": "9334", "file": "dihydroetorphine.md", "generated": true, "harvested": "2026-09-01", "id": "dihydroetorphine", "quote_category": "(b) Substances, vegetable origin or chemical synthesis.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(ii) Dihydroetorphine | 9334 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Dihydroetorphine", "title": "Dihydroetorphine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Dihydromorphine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opium derivatives\n\n> (c) Opium derivatives.\n\n**DEA code number:** 9145\n\n**CFR citation:** 21 CFR 1308.11(c)(8)\n\n> (8) Dihydromorphine | 9145 |\n\nSource: \n", "category": "Opium derivatives", "citation": "21 CFR 1308.11(c)(8)", "dea_code_number": "9145", "file": "dihydromorphine.md", "generated": true, "harvested": "2026-09-01", "id": "dihydromorphine", "quote_category": "(c) Opium derivatives.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(8) Dihydromorphine | 9145 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Dihydromorphine", "title": "Dihydromorphine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Dimenoxadol\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9617\n\n**CFR citation:** 21 CFR 1308.11(b)(35)\n\n> (35) Dimenoxadol | 9617 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(35)", "dea_code_number": "9617", "file": "dimenoxadol.md", "generated": true, "harvested": "2026-09-01", "id": "dimenoxadol", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(35) Dimenoxadol | 9617 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Dimenoxadol", "title": "Dimenoxadol \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Dimepheptanol\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9618\n\n**CFR citation:** 21 CFR 1308.11(b)(36)\n\n> (36) Dimepheptanol | 9618 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(36)", "dea_code_number": "9618", "file": "dimepheptanol.md", "generated": true, "harvested": "2026-09-01", "id": "dimepheptanol", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(36) Dimepheptanol | 9618 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Dimepheptanol", "title": "Dimepheptanol \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Dimethylthiambutene\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9619\n\n**CFR citation:** 21 CFR 1308.11(b)(38)\n\n> (38) Dimethylthiambutene | 9619 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(38)", "dea_code_number": "9619", "file": "dimethylthiambutene.md", "generated": true, "harvested": "2026-09-01", "id": "dimethylthiambutene", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(38) Dimethylthiambutene | 9619 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Dimethylthiambutene", "title": "Dimethylthiambutene \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Dimethyltryptamine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7435\n\n**CFR citation:** 21 CFR 1308.11(d)(19)\n\n> (19) Dimethyltryptamine | 7435 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(19)", "dea_code_number": "7435", "file": "dimethyltryptamine.md", "generated": true, "harvested": "2026-09-01", "id": "dimethyltryptamine", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(19) Dimethyltryptamine | 7435 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Dimethyltryptamine", "title": "Dimethyltryptamine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Dioxaphetyl butyrate\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9621\n\n**CFR citation:** 21 CFR 1308.11(b)(39)\n\n> (39) Dioxaphetyl butyrate | 9621 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(39)", "dea_code_number": "9621", "file": "dioxaphetyl-butyrate.md", "generated": true, "harvested": "2026-09-01", "id": "dioxaphetyl-butyrate", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(39) Dioxaphetyl butyrate | 9621 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Dioxaphetyl butyrate", "title": "Dioxaphetyl butyrate \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** diphenoxylate\n\n**Schedule:** Schedule V\n\n> \u00a7 1308.15 Schedule V.\n\n**Listed under:** Narcotic drugs containing non-narcotic active medicinal ingredients\n\n> (c) Narcotic drugs containing non-narcotic active medicinal ingredients.\n\n**Only when:** Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit\n\n**CFR citation:** 21 CFR 1308.15(c)(4)\n\n> (4) Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit.\n\nSource: \n", "category": "Narcotic drugs containing non-narcotic active medicinal ingredients", "citation": "21 CFR 1308.15(c)(4)", "file": "diphenoxylate-2.md", "generated": true, "harvested": "2026-09-01", "id": "diphenoxylate-2", "quote_category": "(c) Narcotic drugs containing non-narcotic active medicinal ingredients.", "quote_schedule": "\u00a7 1308.15 Schedule V.", "schedule": "Schedule V", "scope_qualifier": "Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit", "source_quote": "(4) Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit.", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "diphenoxylate", "title": "diphenoxylate \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Diphenoxylate\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Opiates\n\n> (c) Opiates.\n\n**DEA code number:** 9170\n\n**CFR citation:** 21 CFR 1308.12(c)(8)\n\n> (8) Diphenoxylate | 9170 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.12(c)(8)", "dea_code_number": "9170", "file": "diphenoxylate.md", "generated": true, "harvested": "2026-09-01", "id": "diphenoxylate", "quote_category": "(c) Opiates.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(8) Diphenoxylate | 9170 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Diphenoxylate", "title": "Diphenoxylate \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Dipipanone\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9622\n\n**CFR citation:** 21 CFR 1308.11(b)(40)\n\n> (40) Dipipanone | 9622 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(40)", "dea_code_number": "9622", "file": "dipipanone.md", "generated": true, "harvested": "2026-09-01", "id": "dipipanone", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(40) Dipipanone | 9622 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Dipipanone", "title": "Dipipanone \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Dronabinol [(-)-delta-9-trans tetrahydrocannabinol]\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Hallucinogenic substances\n\n> (f) Hallucinogenic substances.\n\n**DEA code number:** 7365\n\n**Only when:** in an oral solution in a drug product approved for marketing by the U.S. Food and Drug Administration\n\n**CFR citation:** 21 CFR 1308.12(f)(2)\n\n> (2) Dronabinol [(-)-delta-9-trans tetrahydrocannabinol] in an oral solution in a drug product approved for marketing by the U.S. Food and Drug Administration | (7365) |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.12(f)(2)", "dea_code_number": "7365", "file": "dronabinol-delta-9-trans-tetrahydrocannabinol.md", "generated": true, "harvested": "2026-09-01", "id": "dronabinol-delta-9-trans-tetrahydrocannabinol", "quote_category": "(f) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "scope_qualifier": "in an oral solution in a drug product approved for marketing by the U.S. Food and Drug Administration", "source_quote": "(2) Dronabinol [(-)-delta-9-trans tetrahydrocannabinol] in an oral solution in a drug product approved for marketing by the U.S. Food and Drug Administration | (7365) |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Dronabinol [(-)-delta-9-trans tetrahydrocannabinol]", "title": "Dronabinol [(-)-delta-9-trans tetrahydrocannabinol] \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Dronabinol (synthetic)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Hallucinogenic substances\n\n> (g) Hallucinogenic substances.\n\n**DEA code number:** 7369\n\n**Only when:** in sesame oil and encapsulated in a soft gelatin capsule in a U.S. Food and Drug Administration approved product\n\n**CFR citation:** 21 CFR 1308.13(g)(1)\n\n> (1) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a U.S. Food and Drug Administration approved product\u20147369. [Some other names for dronabinol: (6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo [b,d]pyran-1-ol] or (-)-delta-9-(trans)-tetrahydrocannabinol]\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.13(g)(1)", "dea_code_number": "7369", "file": "dronabinol-synthetic.md", "generated": true, "harvested": "2026-09-01", "id": "dronabinol-synthetic", "quote_category": "(g) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "scope_qualifier": "in sesame oil and encapsulated in a soft gelatin capsule in a U.S. Food and Drug Administration approved product", "source_quote": "(1) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a U.S. Food and Drug Administration approved product\u20147369. [Some other names for dronabinol: (6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo [b,d]pyran-1-ol] or (-)-delta-9-(trans)-tetrahydrocannabinol]", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Dronabinol (synthetic)", "title": "Dronabinol (synthetic) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** drostanolone (17\u03b2-hydroxy-2\u03b1-methyl-5\u03b1-androstan-3-one)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(28)\n\n> (28) drostanolone (17\u03b2-hydroxy-2\u03b1-methyl-5\u03b1-androstan-3-one);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(28)", "file": "drostanolone-17-hydroxy-2-methyl-5-androstan-3-one.md", "generated": true, "harvested": "2026-09-01", "id": "drostanolone-17-hydroxy-2-methyl-5-androstan-3-one", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(28) drostanolone (17\u03b2-hydroxy-2\u03b1-methyl-5\u03b1-androstan-3-one);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "drostanolone (17\u03b2-hydroxy-2\u03b1-methyl-5\u03b1-androstan-3-one)", "title": "drostanolone (17\u03b2-hydroxy-2\u03b1-methyl-5\u03b1-androstan-3-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Drotebanol\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opium derivatives\n\n> (c) Opium derivatives.\n\n**DEA code number:** 9335\n\n**CFR citation:** 21 CFR 1308.11(c)(9)\n\n> (9) Drotebanol | 9335 |\n\nSource: \n", "category": "Opium derivatives", "citation": "21 CFR 1308.11(c)(9)", "dea_code_number": "9335", "file": "drotebanol.md", "generated": true, "harvested": "2026-09-01", "id": "drotebanol", "quote_category": "(c) Opium derivatives.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(9) Drotebanol | 9335 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Drotebanol", "title": "Drotebanol \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** ecgonine\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Substances, vegetable origin or chemical synthesis\n\n> (b) Substances, vegetable origin or chemical synthesis.\n\n**DEA code number:** 9180\n\n**CFR citation:** 21 CFR 1308.12(b)(4)\n\n> ecgonine (9180)\n\nSource: \n", "category": "Substances, vegetable origin or chemical synthesis", "citation": "21 CFR 1308.12(b)(4)", "dea_code_number": "9180", "file": "ecgonine.md", "generated": true, "harvested": "2026-09-01", "id": "ecgonine", "quote_category": "(b) Substances, vegetable origin or chemical synthesis.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "ecgonine (9180)", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "ecgonine", "title": "ecgonine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Eluxadoline (5-[[[(2S)-2-amino-3-[4-aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic acid) (including its optical isomers) and its salts, isomers, and salts of isomers\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Other substances\n\n> (g) Other substances.\n\n**DEA code number:** 9725\n\n**CFR citation:** 21 CFR 1308.14(g)(3)\n\n> (3) Eluxadoline (5-[[[(2S)-2-amino-3-[4-aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic acid) (including its optical isomers) and its salts, isomers, and salts of isomers (9725). |\n\nSource: \n", "category": "Other substances", "citation": "21 CFR 1308.14(g)(3)", "dea_code_number": "9725", "file": "eluxadoline-5-2s-2-amino-3-4-aminocarbonyl-2-6-dimethylphenyl-1-oxopropyl-1s-1-4.md", "generated": true, "harvested": "2026-09-01", "id": "eluxadoline-5-2s-2-amino-3-4-aminocarbonyl-2-6-dimethylphenyl-1-oxopropyl-1s-1-4", "quote_category": "(g) Other substances.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(3) Eluxadoline (5-[[[(2S)-2-amino-3-[4-aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic acid) (including its optical isomers) and its salts, isomers, and salts of isomers (9725). |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Eluxadoline (5-[[[(2S)-2-amino-3-[4-aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic acid) (including its optical isomers) and its salts, isomers, and salts of isomers", "title": "Eluxadoline (5-[[[(2S)-2-amino-3-[4-aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic acid) (including its optical isomers) and its salts, isomers, and salts of isomers \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Embutramide\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2020\n\n**CFR citation:** 21 CFR 1308.13(c)(5)\n\n> (5) Embutramide | 2020 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.13(c)(5)", "dea_code_number": "2020", "file": "embutramide.md", "generated": true, "harvested": "2026-09-01", "id": "embutramide", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(5) Embutramide | 2020 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Embutramide", "title": "Embutramide \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Estazolam\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2756\n\n**CFR citation:** 21 CFR 1308.14(c)(21)\n\n> (21) Estazolam | 2756 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(21)", "dea_code_number": "2756", "file": "estazolam.md", "generated": true, "harvested": "2026-09-01", "id": "estazolam", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(21) Estazolam | 2756 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Estazolam", "title": "Estazolam \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** estra-4,9,11-triene-3,17-dione\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(30)\n\n> (30) estra-4,9,11-triene-3,17-dione;\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(30)", "file": "estra-4-9-11-triene-3-17-dione.md", "generated": true, "harvested": "2026-09-01", "id": "estra-4-9-11-triene-3-17-dione", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(30) estra-4,9,11-triene-3,17-dione;", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "estra-4,9,11-triene-3,17-dione", "title": "estra-4,9,11-triene-3,17-dione \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Ethchlorvynol\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2540\n\n**CFR citation:** 21 CFR 1308.14(c)(22)\n\n> (22) Ethchlorvynol | 2540 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(22)", "dea_code_number": "2540", "file": "ethchlorvynol.md", "generated": true, "harvested": "2026-09-01", "id": "ethchlorvynol", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(22) Ethchlorvynol | 2540 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Ethchlorvynol", "title": "Ethchlorvynol \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Ethinamate\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2545\n\n**CFR citation:** 21 CFR 1308.14(c)(23)\n\n> (23) Ethinamate | 2545 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(23)", "dea_code_number": "2545", "file": "ethinamate.md", "generated": true, "harvested": "2026-09-01", "id": "ethinamate", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(23) Ethinamate | 2545 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Ethinamate", "title": "Ethinamate \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (other name: 5F-EDMB-PINACA)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7036\n\n**CFR citation:** 21 CFR 1308.11(d)(89)\n\n> (89) ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (other name: 5F-EDMB-PINACA) | 7036 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(89)", "dea_code_number": "7036", "file": "ethyl-2-1-5-fluoropentyl-1h-indazole-3-carboxamido-3-3-dimethylbutanoate-other-n.md", "generated": true, "harvested": "2026-09-01", "id": "ethyl-2-1-5-fluoropentyl-1h-indazole-3-carboxamido-3-3-dimethylbutanoate-other-n", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(89) ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (other name: 5F-EDMB-PINACA) | 7036 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (other name: 5F-EDMB-PINACA)", "title": "ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (other name: 5F-EDMB-PINACA) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Ethyl 2-[[1-(5-fluoropentyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate (other names: 5F-EDMB-PICA; 5F-EDMB-2201)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7094\n\n**CFR citation:** 21 CFR 1308.11(d)(113)\n\n> (113) Ethyl 2-[[1-(5-fluoropentyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate (other names: 5F-EDMB-PICA; 5F-EDMB-2201) | 7094 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(113)", "dea_code_number": "7094", "file": "ethyl-2-1-5-fluoropentyl-indole-3-carbonyl-amino-3-3-dimethyl-butanoate-other-na.md", "generated": true, "harvested": "2026-09-01", "id": "ethyl-2-1-5-fluoropentyl-indole-3-carbonyl-amino-3-3-dimethyl-butanoate-other-na", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(113) Ethyl 2-[[1-(5-fluoropentyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate (other names: 5F-EDMB-PICA; 5F-EDMB-2201) | 7094 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Ethyl 2-[[1-(5-fluoropentyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate (other names: 5F-EDMB-PICA; 5F-EDMB-2201)", "title": "Ethyl 2-[[1-(5-fluoropentyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate (other names: 5F-EDMB-PICA; 5F-EDMB-2201) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Ethyl loflazepate\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2758\n\n**CFR citation:** 21 CFR 1308.14(c)(24)\n\n> (24) Ethyl loflazepate | 2758 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(24)", "dea_code_number": "2758", "file": "ethyl-loflazepate.md", "generated": true, "harvested": "2026-09-01", "id": "ethyl-loflazepate", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(24) Ethyl loflazepate | 2758 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Ethyl loflazepate", "title": "Ethyl loflazepate \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Ethylamine analog of phencyclidine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7455\n\n**CFR citation:** 21 CFR 1308.11(d)(32)\n\n> (32) Ethylamine analog of phencyclidine | 7455 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(32)", "dea_code_number": "7455", "file": "ethylamine-analog-of-phencyclidine.md", "generated": true, "harvested": "2026-09-01", "id": "ethylamine-analog-of-phencyclidine", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(32) Ethylamine analog of phencyclidine | 7455 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Ethylamine analog of phencyclidine", "title": "Ethylamine analog of phencyclidine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** ethylestrenol (17\u03b1-ethyl-17\u03b2-hydroxyestr-4-ene)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(32)\n\n> (32) ethylestrenol (17\u03b1-ethyl-17\u03b2-hydroxyestr-4-ene);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(32)", "file": "ethylestrenol-17-ethyl-17-hydroxyestr-4-ene.md", "generated": true, "harvested": "2026-09-01", "id": "ethylestrenol-17-ethyl-17-hydroxyestr-4-ene", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(32) ethylestrenol (17\u03b1-ethyl-17\u03b2-hydroxyestr-4-ene);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "ethylestrenol (17\u03b1-ethyl-17\u03b2-hydroxyestr-4-ene)", "title": "ethylestrenol (17\u03b1-ethyl-17\u03b2-hydroxyestr-4-ene) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Ethylmethylthiambutene\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9623\n\n**CFR citation:** 21 CFR 1308.11(b)(41)\n\n> (41) Ethylmethylthiambutene | 9623 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(41)", "dea_code_number": "9623", "file": "ethylmethylthiambutene.md", "generated": true, "harvested": "2026-09-01", "id": "ethylmethylthiambutene", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(41) Ethylmethylthiambutene | 9623 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Ethylmethylthiambutene", "title": "Ethylmethylthiambutene \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** ethylmorphine\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Narcotic drugs\n\n> (e) Narcotic drugs.\n\n**DEA code number:** 9808\n\n**Only when:** Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts\n\n**CFR citation:** 21 CFR 1308.13(e)(1)(iv)\n\n> (iv) Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts | 9808 |\n\nSource: \n", "category": "Narcotic drugs", "citation": "21 CFR 1308.13(e)(1)(iv)", "dea_code_number": "9808", "file": "ethylmorphine-2.md", "generated": true, "harvested": "2026-09-01", "id": "ethylmorphine-2", "quote_category": "(e) Narcotic drugs.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "scope_qualifier": "Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts", "source_quote": "(iv) Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts | 9808 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "ethylmorphine", "title": "ethylmorphine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** ethylmorphine\n\n**Schedule:** Schedule V\n\n> \u00a7 1308.15 Schedule V.\n\n**Listed under:** Narcotic drugs containing non-narcotic active medicinal ingredients\n\n> (c) Narcotic drugs containing non-narcotic active medicinal ingredients.\n\n**Only when:** Not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams\n\n**CFR citation:** 21 CFR 1308.15(c)(3)\n\n> (3) Not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams.\n\nSource: \n", "category": "Narcotic drugs containing non-narcotic active medicinal ingredients", "citation": "21 CFR 1308.15(c)(3)", "file": "ethylmorphine-3.md", "generated": true, "harvested": "2026-09-01", "id": "ethylmorphine-3", "quote_category": "(c) Narcotic drugs containing non-narcotic active medicinal ingredients.", "quote_schedule": "\u00a7 1308.15 Schedule V.", "schedule": "Schedule V", "scope_qualifier": "Not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams", "source_quote": "(3) Not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams.", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "ethylmorphine", "title": "ethylmorphine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Ethylmorphine\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Substances, vegetable origin or chemical synthesis\n\n> (b) Substances, vegetable origin or chemical synthesis.\n\n**DEA code number:** 9190\n\n**CFR citation:** 21 CFR 1308.12(b)(1)(iii)\n\n> (iii) Ethylmorphine | 9190 |\n\nSource: \n", "category": "Substances, vegetable origin or chemical synthesis", "citation": "21 CFR 1308.12(b)(1)(iii)", "dea_code_number": "9190", "file": "ethylmorphine.md", "generated": true, "harvested": "2026-09-01", "id": "ethylmorphine", "quote_category": "(b) Substances, vegetable origin or chemical synthesis.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(iii) Ethylmorphine | 9190 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Ethylmorphine", "title": "Ethylmorphine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Ethylphenidate (ethyl 2-phenyl-2-(piperidin-2-yl)acetate)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Stimulants\n\n> (f) Stimulants.\n\n**DEA code number:** 1727\n\n**CFR citation:** 21 CFR 1308.11(f)(6)\n\n> (6) Ethylphenidate (ethyl 2-phenyl-2-(piperidin-2-yl)acetate) | 1727 |\n\nSource: \n", "category": "Stimulants", "citation": "21 CFR 1308.11(f)(6)", "dea_code_number": "1727", "file": "ethylphenidate-ethyl-2-phenyl-2-piperidin-2-yl-acetate.md", "generated": true, "harvested": "2026-09-01", "id": "ethylphenidate-ethyl-2-phenyl-2-piperidin-2-yl-acetate", "quote_category": "(f) Stimulants.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(6) Ethylphenidate (ethyl 2-phenyl-2-(piperidin-2-yl)acetate) | 1727 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Ethylphenidate (ethyl 2-phenyl-2-(piperidin-2-yl)acetate)", "title": "Ethylphenidate (ethyl 2-phenyl-2-(piperidin-2-yl)acetate) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Etizolam (Other name: 4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Depressants\n\n> (e) Depressants.\n\n**DEA code number:** 2780\n\n**CFR citation:** 21 CFR 1308.11(e)(3)\n\n> (3) Etizolam (Other name: 4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine) | 2780 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.11(e)(3)", "dea_code_number": "2780", "file": "etizolam-other-name-4-2-chlorophenyl-2-ethyl-9-methyl-6h-thieno-3-2-f-1-2-4-tria.md", "generated": true, "harvested": "2026-09-01", "id": "etizolam-other-name-4-2-chlorophenyl-2-ethyl-9-methyl-6h-thieno-3-2-f-1-2-4-tria", "quote_category": "(e) Depressants.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(3) Etizolam (Other name: 4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine) | 2780 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Etizolam (Other name: 4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine)", "title": "Etizolam (Other name: 4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Etonitazene\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9624\n\n**CFR citation:** 21 CFR 1308.11(b)(43)\n\n> (43) Etonitazene | 9624 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(43)", "dea_code_number": "9624", "file": "etonitazene.md", "generated": true, "harvested": "2026-09-01", "id": "etonitazene", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(43) Etonitazene | 9624 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Etonitazene", "title": "Etonitazene \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Etorphine (except hydrochloride salt)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opium derivatives\n\n> (c) Opium derivatives.\n\n**DEA code number:** 9056\n\n**CFR citation:** 21 CFR 1308.11(c)(10)\n\n> (10) Etorphine (except hydrochloride salt) | 9056 |\n\nSource: \n", "category": "Opium derivatives", "citation": "21 CFR 1308.11(c)(10)", "dea_code_number": "9056", "file": "etorphine-except-hydrochloride-salt.md", "generated": true, "harvested": "2026-09-01", "id": "etorphine-except-hydrochloride-salt", "quote_category": "(c) Opium derivatives.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(10) Etorphine (except hydrochloride salt) | 9056 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Etorphine (except hydrochloride salt)", "title": "Etorphine (except hydrochloride salt) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Etorphine hydrochloride\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Substances, vegetable origin or chemical synthesis\n\n> (b) Substances, vegetable origin or chemical synthesis.\n\n**DEA code number:** 9059\n\n**CFR citation:** 21 CFR 1308.12(b)(1)(iv)\n\n> (iv) Etorphine hydrochloride | 9059 |\n\nSource: \n", "category": "Substances, vegetable origin or chemical synthesis", "citation": "21 CFR 1308.12(b)(1)(iv)", "dea_code_number": "9059", "file": "etorphine-hydrochloride.md", "generated": true, "harvested": "2026-09-01", "id": "etorphine-hydrochloride", "quote_category": "(b) Substances, vegetable origin or chemical synthesis.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(iv) Etorphine hydrochloride | 9059 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Etorphine hydrochloride", "title": "Etorphine hydrochloride \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Etoxeridine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9625\n\n**CFR citation:** 21 CFR 1308.11(b)(44)\n\n> (44) Etoxeridine | 9625 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(44)", "dea_code_number": "9625", "file": "etoxeridine.md", "generated": true, "harvested": "2026-09-01", "id": "etoxeridine", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(44) Etoxeridine | 9625 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Etoxeridine", "title": "Etoxeridine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Ezogabine [N-[2-amino-4-(4-fluorobenzylamino)-phenyl]-carbamic acid ethyl ester]\n\n**Schedule:** Schedule V\n\n> \u00a7 1308.15 Schedule V.\n\n**Listed under:** Depressants\n\n> (e) Depressants.\n\n**DEA code number:** 2779\n\n**CFR citation:** 21 CFR 1308.15(e)(3)\n\n> (3) Ezogabine [N-[2-amino-4-(4-fluorobenzylamino)-phenyl]-carbamic acid ethyl ester] | 2779 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.15(e)(3)", "dea_code_number": "2779", "file": "ezogabine-n-2-amino-4-4-fluorobenzylamino-phenyl-carbamic-acid-ethyl-ester.md", "generated": true, "harvested": "2026-09-01", "id": "ezogabine-n-2-amino-4-4-fluorobenzylamino-phenyl-carbamic-acid-ethyl-ester", "quote_category": "(e) Depressants.", "quote_schedule": "\u00a7 1308.15 Schedule V.", "schedule": "Schedule V", "source_quote": "(3) Ezogabine [N-[2-amino-4-(4-fluorobenzylamino)-phenyl]-carbamic acid ethyl ester] | 2779 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Ezogabine [N-[2-amino-4-(4-fluorobenzylamino)-phenyl]-carbamic acid ethyl ester]", "title": "Ezogabine [N-[2-amino-4-(4-fluorobenzylamino)-phenyl]-carbamic acid ethyl ester] \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Fencamfamin\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Stimulants\n\n> (f) Stimulants.\n\n**DEA code number:** 1760\n\n**CFR citation:** 21 CFR 1308.14(f)(3)\n\n> (3) Fencamfamin | 1760 |\n\nSource: \n", "category": "Stimulants", "citation": "21 CFR 1308.14(f)(3)", "dea_code_number": "1760", "file": "fencamfamin.md", "generated": true, "harvested": "2026-09-01", "id": "fencamfamin", "quote_category": "(f) Stimulants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(3) Fencamfamin | 1760 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Fencamfamin", "title": "Fencamfamin \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Fenethylline\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Stimulants\n\n> (f) Stimulants.\n\n**DEA code number:** 1503\n\n**CFR citation:** 21 CFR 1308.11(f)(7)\n\n> (7) Fenethylline | 1503 |\n\nSource: \n", "category": "Stimulants", "citation": "21 CFR 1308.11(f)(7)", "dea_code_number": "1503", "file": "fenethylline.md", "generated": true, "harvested": "2026-09-01", "id": "fenethylline", "quote_category": "(f) Stimulants.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(7) Fenethylline | 1503 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Fenethylline", "title": "Fenethylline \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Fenproporex\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Stimulants\n\n> (f) Stimulants.\n\n**DEA code number:** 1575\n\n**CFR citation:** 21 CFR 1308.14(f)(4)\n\n> (4) Fenproporex | 1575 |\n\nSource: \n", "category": "Stimulants", "citation": "21 CFR 1308.14(f)(4)", "dea_code_number": "1575", "file": "fenproporex.md", "generated": true, "harvested": "2026-09-01", "id": "fenproporex", "quote_category": "(f) Stimulants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(4) Fenproporex | 1575 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Fenproporex", "title": "Fenproporex \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Fentanyl carbamate (ethyl (1-phenethylpiperidin-4-yl)(phenyl)carbamate)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9851\n\n**CFR citation:** 21 CFR 1308.11(b)(45)\n\n> (45) Fentanyl carbamate (ethyl (1-phenethylpiperidin-4-yl)(phenyl)carbamate) | 9851 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(45)", "dea_code_number": "9851", "file": "fentanyl-carbamate-ethyl-1-phenethylpiperidin-4-yl-phenyl-carbamate.md", "generated": true, "harvested": "2026-09-01", "id": "fentanyl-carbamate-ethyl-1-phenethylpiperidin-4-yl-phenyl-carbamate", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(45) Fentanyl carbamate (ethyl (1-phenethylpiperidin-4-yl)(phenyl)carbamate) | 9851 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Fentanyl carbamate (ethyl (1-phenethylpiperidin-4-yl)(phenyl)carbamate)", "title": "Fentanyl carbamate (ethyl (1-phenethylpiperidin-4-yl)(phenyl)carbamate) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Fentanyl-related substances, their isomers, esters, ethers, salts and salts of isomers, esters and ethers\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Temporary listing of substances subject to emergency scheduling\n\n> (h) Temporary listing of substances subject to emergency scheduling.\n\n**DEA code number:** 9850\n\n**CFR citation:** 21 CFR 1308.11(h)(30)\n\n> (30) Fentanyl-related substances, their isomers, esters, ethers, salts and salts of isomers, esters and ethers | 9850 |\n\nSource: \n", "category": "Temporary listing of substances subject to emergency scheduling", "citation": "21 CFR 1308.11(h)(30)", "dea_code_number": "9850", "file": "fentanyl-related-substances-their-isomers-esters-ethers-salts-and-salts-of-isome.md", "generated": true, "harvested": "2026-09-01", "id": "fentanyl-related-substances-their-isomers-esters-ethers-salts-and-salts-of-isome", "quote_category": "(h) Temporary listing of substances subject to emergency scheduling.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(30) Fentanyl-related substances, their isomers, esters, ethers, salts and salts of isomers, esters and ethers | 9850 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Fentanyl-related substances, their isomers, esters, ethers, salts and salts of isomers, esters and ethers", "title": "Fentanyl-related substances, their isomers, esters, ethers, salts and salts of isomers, esters and ethers \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Fentanyl\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Opiates\n\n> (c) Opiates.\n\n**DEA code number:** 9801\n\n**CFR citation:** 21 CFR 1308.12(c)(9)\n\n> (9) Fentanyl | 9801 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.12(c)(9)", "dea_code_number": "9801", "file": "fentanyl.md", "generated": true, "harvested": "2026-09-01", "id": "fentanyl", "quote_category": "(c) Opiates.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(9) Fentanyl | 9801 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Fentanyl", "title": "Fentanyl \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Flualprazolam (Other name: 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Depressants\n\n> (e) Depressants.\n\n**DEA code number:** 2785\n\n**CFR citation:** 21 CFR 1308.11(e)(4)\n\n> (4) Flualprazolam (Other name: 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine) | 2785 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.11(e)(4)", "dea_code_number": "2785", "file": "flualprazolam-other-name-8-chloro-6-2-fluorophenyl-1-methyl-4h-benzo-f-1-2-4-tri.md", "generated": true, "harvested": "2026-09-01", "id": "flualprazolam-other-name-8-chloro-6-2-fluorophenyl-1-methyl-4h-benzo-f-1-2-4-tri", "quote_category": "(e) Depressants.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(4) Flualprazolam (Other name: 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine) | 2785 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Flualprazolam (Other name: 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine)", "title": "Flualprazolam (Other name: 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Flubromazolam (Other name: 8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Depressants\n\n> (e) Depressants.\n\n**DEA code number:** 2788\n\n**CFR citation:** 21 CFR 1308.11(e)(5)\n\n> (5) Flubromazolam (Other name: 8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine) | 2788 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.11(e)(5)", "dea_code_number": "2788", "file": "flubromazolam-other-name-8-bromo-6-2-fluorophenyl-1-methyl-4h-benzo-f-1-2-4-tria.md", "generated": true, "harvested": "2026-09-01", "id": "flubromazolam-other-name-8-bromo-6-2-fluorophenyl-1-methyl-4h-benzo-f-1-2-4-tria", "quote_category": "(e) Depressants.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(5) Flubromazolam (Other name: 8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine) | 2788 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Flubromazolam (Other name: 8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine)", "title": "Flubromazolam (Other name: 8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Fludiazepam\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2759\n\n**CFR citation:** 21 CFR 1308.14(c)(25)\n\n> (25) Fludiazepam | 2759 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(25)", "dea_code_number": "2759", "file": "fludiazepam.md", "generated": true, "harvested": "2026-09-01", "id": "fludiazepam", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(25) Fludiazepam | 2759 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Fludiazepam", "title": "Fludiazepam \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Flunitazene (N,N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9756\n\n**CFR citation:** 21 CFR 1308.11(b)(46)\n\n> (46) Flunitazene (N,N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) | 9756 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(46)", "dea_code_number": "9756", "file": "flunitazene-n-n-diethyl-2-2-4-fluorobenzyl-5-nitro-1h-benzimidazol-1-yl-ethan-1-.md", "generated": true, "harvested": "2026-09-01", "id": "flunitazene-n-n-diethyl-2-2-4-fluorobenzyl-5-nitro-1h-benzimidazol-1-yl-ethan-1-", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(46) Flunitazene (N,N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) | 9756 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Flunitazene (N,N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine)", "title": "Flunitazene (N,N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Flunitrazepam\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2763\n\n**CFR citation:** 21 CFR 1308.14(c)(26)\n\n> (26) Flunitrazepam | 2763 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(26)", "dea_code_number": "2763", "file": "flunitrazepam.md", "generated": true, "harvested": "2026-09-01", "id": "flunitrazepam", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(26) Flunitrazepam | 2763 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Flunitrazepam", "title": "Flunitrazepam \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** fluoxymesterone (9-fluoro-17\u03b1-methyl-11\u03b2,17\u03b2-dihydroxyandrost-4-en-3-one)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(33)\n\n> (33) fluoxymesterone (9-fluoro-17\u03b1-methyl-11\u03b2,17\u03b2-dihydroxyandrost-4-en-3-one);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(33)", "file": "fluoxymesterone-9-fluoro-17-methyl-11-17-dihydroxyandrost-4-en-3-one.md", "generated": true, "harvested": "2026-09-01", "id": "fluoxymesterone-9-fluoro-17-methyl-11-17-dihydroxyandrost-4-en-3-one", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(33) fluoxymesterone (9-fluoro-17\u03b1-methyl-11\u03b2,17\u03b2-dihydroxyandrost-4-en-3-one);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "fluoxymesterone (9-fluoro-17\u03b1-methyl-11\u03b2,17\u03b2-dihydroxyandrost-4-en-3-one)", "title": "fluoxymesterone (9-fluoro-17\u03b1-methyl-11\u03b2,17\u03b2-dihydroxyandrost-4-en-3-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Flurazepam\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2767\n\n**CFR citation:** 21 CFR 1308.14(c)(27)\n\n> (27) Flurazepam | 2767 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(27)", "dea_code_number": "2767", "file": "flurazepam.md", "generated": true, "harvested": "2026-09-01", "id": "flurazepam", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(27) Flurazepam | 2767 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Flurazepam", "title": "Flurazepam \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** formebolone (2-formyl-17\u03b1-methyl-11\u03b1,17\u03b2-dihydroxyandrost-1,4-dien-3-one)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(34)\n\n> (34) formebolone (2-formyl-17\u03b1-methyl-11\u03b1,17\u03b2-dihydroxyandrost-1,4-dien-3-one);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(34)", "file": "formebolone-2-formyl-17-methyl-11-17-dihydroxyandrost-1-4-dien-3-one.md", "generated": true, "harvested": "2026-09-01", "id": "formebolone-2-formyl-17-methyl-11-17-dihydroxyandrost-1-4-dien-3-one", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(34) formebolone (2-formyl-17\u03b1-methyl-11\u03b1,17\u03b2-dihydroxyandrost-1,4-dien-3-one);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "formebolone (2-formyl-17\u03b1-methyl-11\u03b1,17\u03b2-dihydroxyandrost-1,4-dien-3-one)", "title": "formebolone (2-formyl-17\u03b1-methyl-11\u03b1,17\u03b2-dihydroxyandrost-1,4-dien-3-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Fospropofol\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2138\n\n**CFR citation:** 21 CFR 1308.14(c)(28)\n\n> (28) Fospropofol | 2138 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(28)", "dea_code_number": "2138", "file": "fospropofol.md", "generated": true, "harvested": "2026-09-01", "id": "fospropofol", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(28) Fospropofol | 2138 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Fospropofol", "title": "Fospropofol \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9834\n\n**CFR citation:** 21 CFR 1308.11(b)(49)\n\n> (49) Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) | 9834 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(49)", "dea_code_number": "9834", "file": "furanyl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylfuran-2-carboxamide.md", "generated": true, "harvested": "2026-09-01", "id": "furanyl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylfuran-2-carboxamide", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(49) Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) | 9834 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide)", "title": "Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** furazabol (17\u03b1-methyl-17\u03b2-hydroxyandrostano[2,3-c]furazan)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(35)\n\n> (35) furazabol (17\u03b1-methyl-17\u03b2-hydroxyandrostano[2,3-c]furazan);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(35)", "file": "furazabol-17-methyl-17-hydroxyandrostano-2-3-c-furazan.md", "generated": true, "harvested": "2026-09-01", "id": "furazabol-17-methyl-17-hydroxyandrostano-2-3-c-furazan", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(35) furazabol (17\u03b1-methyl-17\u03b2-hydroxyandrostano[2,3-c]furazan);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "furazabol (17\u03b1-methyl-17\u03b2-hydroxyandrostano[2,3-c]furazan)", "title": "furazabol (17\u03b1-methyl-17\u03b2-hydroxyandrostano[2,3-c]furazan) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Furethidine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9626\n\n**CFR citation:** 21 CFR 1308.11(b)(51)\n\n> (51) Furethidine | 9626 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(51)", "dea_code_number": "9626", "file": "furethidine.md", "generated": true, "harvested": "2026-09-01", "id": "furethidine", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(51) Furethidine | 9626 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Furethidine", "title": "Furethidine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** gamma-hydroxybutyric acid (some other names include GHB; gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutanoic acid; sodium oxybate; sodium oxybutyrate)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Depressants\n\n> (e) Depressants.\n\n**DEA code number:** 2010\n\n**CFR citation:** 21 CFR 1308.11(e)(6)\n\n> (6) gamma-hydroxybutyric acid (some other names include GHB; gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutanoic acid; sodium oxybate; sodium oxybutyrate) | 2010 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.11(e)(6)", "dea_code_number": "2010", "file": "gamma-hydroxybutyric-acid-some-other-names-include-ghb-gamma-hydroxybutyrate-4-h.md", "generated": true, "harvested": "2026-09-01", "id": "gamma-hydroxybutyric-acid-some-other-names-include-ghb-gamma-hydroxybutyrate-4-h", "quote_category": "(e) Depressants.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(6) gamma-hydroxybutyric acid (some other names include GHB; gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutanoic acid; sodium oxybate; sodium oxybutyrate) | 2010 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "gamma-hydroxybutyric acid (some other names include GHB; gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutanoic acid; sodium oxybate; sodium oxybutyrate)", "title": "gamma-hydroxybutyric acid (some other names include GHB; gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutanoic acid; sodium oxybate; sodium oxybutyrate) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Ganaxolone (3\u03b1-hydroxy-3\u03b2-methyl-5\u03b1-pregnan-20-one)\n\n**Schedule:** Schedule V\n\n> \u00a7 1308.15 Schedule V.\n\n**Listed under:** Depressants\n\n> (e) Depressants.\n\n**DEA code number:** 2401\n\n**CFR citation:** 21 CFR 1308.15(e)(4)\n\n> (4) Ganaxolone (3\u03b1-hydroxy-3\u03b2-methyl-5\u03b1-pregnan-20-one) | 2401 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.15(e)(4)", "dea_code_number": "2401", "file": "ganaxolone-3-hydroxy-3-methyl-5-pregnan-20-one.md", "generated": true, "harvested": "2026-09-01", "id": "ganaxolone-3-hydroxy-3-methyl-5-pregnan-20-one", "quote_category": "(e) Depressants.", "quote_schedule": "\u00a7 1308.15 Schedule V.", "schedule": "Schedule V", "source_quote": "(4) Ganaxolone (3\u03b1-hydroxy-3\u03b2-methyl-5\u03b1-pregnan-20-one) | 2401 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Ganaxolone (3\u03b1-hydroxy-3\u03b2-methyl-5\u03b1-pregnan-20-one)", "title": "Ganaxolone (3\u03b1-hydroxy-3\u03b2-methyl-5\u03b1-pregnan-20-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Glutethimide\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Depressants\n\n> (e) Depressants.\n\n**DEA code number:** 2550\n\n**CFR citation:** 21 CFR 1308.12(e)(2)\n\n> (2) Glutethimide | 2550 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.12(e)(2)", "dea_code_number": "2550", "file": "glutethimide.md", "generated": true, "harvested": "2026-09-01", "id": "glutethimide", "quote_category": "(e) Depressants.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(2) Glutethimide | 2550 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Glutethimide", "title": "Glutethimide \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Granulated opium\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Substances, vegetable origin or chemical synthesis\n\n> (b) Substances, vegetable origin or chemical synthesis.\n\n**DEA code number:** 9640\n\n**CFR citation:** 21 CFR 1308.12(b)(1)(v)\n\n> (v) Granulated opium | 9640 |\n\nSource: \n", "category": "Substances, vegetable origin or chemical synthesis", "citation": "21 CFR 1308.12(b)(1)(v)", "dea_code_number": "9640", "file": "granulated-opium.md", "generated": true, "harvested": "2026-09-01", "id": "granulated-opium", "quote_category": "(b) Substances, vegetable origin or chemical synthesis.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(v) Granulated opium | 9640 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Granulated opium", "title": "Granulated opium \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Halazepam\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2762\n\n**CFR citation:** 21 CFR 1308.14(c)(29)\n\n> (29) Halazepam | 2762 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(29)", "dea_code_number": "2762", "file": "halazepam.md", "generated": true, "harvested": "2026-09-01", "id": "halazepam", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(29) Halazepam | 2762 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Halazepam", "title": "Halazepam \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Haloxazolam\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2771\n\n**CFR citation:** 21 CFR 1308.14(c)(30)\n\n> (30) Haloxazolam | 2771 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(30)", "dea_code_number": "2771", "file": "haloxazolam.md", "generated": true, "harvested": "2026-09-01", "id": "haloxazolam", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(30) Haloxazolam | 2771 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Haloxazolam", "title": "Haloxazolam \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Heroin\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opium derivatives\n\n> (c) Opium derivatives.\n\n**DEA code number:** 9200\n\n**CFR citation:** 21 CFR 1308.11(c)(11)\n\n> (11) Heroin | 9200 |\n\nSource: \n", "category": "Opium derivatives", "citation": "21 CFR 1308.11(c)(11)", "dea_code_number": "9200", "file": "heroin.md", "generated": true, "harvested": "2026-09-01", "id": "heroin", "quote_category": "(c) Opium derivatives.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(11) Heroin | 9200 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Heroin", "title": "Heroin \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Hydrocodone\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Substances, vegetable origin or chemical synthesis\n\n> (b) Substances, vegetable origin or chemical synthesis.\n\n**DEA code number:** 9193\n\n**CFR citation:** 21 CFR 1308.12(b)(1)(vi)\n\n> (vi) Hydrocodone | 9193 |\n\nSource: \n", "category": "Substances, vegetable origin or chemical synthesis", "citation": "21 CFR 1308.12(b)(1)(vi)", "dea_code_number": "9193", "file": "hydrocodone.md", "generated": true, "harvested": "2026-09-01", "id": "hydrocodone", "quote_category": "(b) Substances, vegetable origin or chemical synthesis.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(vi) Hydrocodone | 9193 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Hydrocodone", "title": "Hydrocodone \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Hydromorphinol\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opium derivatives\n\n> (c) Opium derivatives.\n\n**DEA code number:** 9301\n\n**CFR citation:** 21 CFR 1308.11(c)(12)\n\n> (12) Hydromorphinol | 9301 |\n\nSource: \n", "category": "Opium derivatives", "citation": "21 CFR 1308.11(c)(12)", "dea_code_number": "9301", "file": "hydromorphinol.md", "generated": true, "harvested": "2026-09-01", "id": "hydromorphinol", "quote_category": "(c) Opium derivatives.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(12) Hydromorphinol | 9301 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Hydromorphinol", "title": "Hydromorphinol \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Hydromorphone\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Substances, vegetable origin or chemical synthesis\n\n> (b) Substances, vegetable origin or chemical synthesis.\n\n**DEA code number:** 9150\n\n**CFR citation:** 21 CFR 1308.12(b)(1)(vii)\n\n> (vii) Hydromorphone | 9150 |\n\nSource: \n", "category": "Substances, vegetable origin or chemical synthesis", "citation": "21 CFR 1308.12(b)(1)(vii)", "dea_code_number": "9150", "file": "hydromorphone.md", "generated": true, "harvested": "2026-09-01", "id": "hydromorphone", "quote_category": "(b) Substances, vegetable origin or chemical synthesis.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(vii) Hydromorphone | 9150 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Hydromorphone", "title": "Hydromorphone \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Hydroxypethidine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9627\n\n**CFR citation:** 21 CFR 1308.11(b)(52)\n\n> (52) Hydroxypethidine | 9627 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(52)", "dea_code_number": "9627", "file": "hydroxypethidine.md", "generated": true, "harvested": "2026-09-01", "id": "hydroxypethidine", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(52) Hydroxypethidine | 9627 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Hydroxypethidine", "title": "Hydroxypethidine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Ibogaine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7260\n\n**CFR citation:** 21 CFR 1308.11(d)(21)\n\n> (21) Ibogaine | 7260 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(21)", "dea_code_number": "7260", "file": "ibogaine.md", "generated": true, "harvested": "2026-09-01", "id": "ibogaine", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(21) Ibogaine | 7260 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Ibogaine", "title": "Ibogaine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Isobutyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9827\n\n**CFR citation:** 21 CFR 1308.11(b)(53)\n\n> (53) Isobutyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide) | 9827 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(53)", "dea_code_number": "9827", "file": "isobutyryl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylisobutyramide.md", "generated": true, "harvested": "2026-09-01", "id": "isobutyryl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylisobutyramide", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(53) Isobutyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide) | 9827 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Isobutyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide)", "title": "Isobutyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Isomethadone\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Opiates\n\n> (c) Opiates.\n\n**DEA code number:** 9226\n\n**CFR citation:** 21 CFR 1308.12(c)(10)\n\n> (10) Isomethadone | 9226 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.12(c)(10)", "dea_code_number": "9226", "file": "isomethadone.md", "generated": true, "harvested": "2026-09-01", "id": "isomethadone", "quote_category": "(c) Opiates.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(10) Isomethadone | 9226 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Isomethadone", "title": "Isomethadone \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Isotonitazene (N,N-diethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9614\n\n**CFR citation:** 21 CFR 1308.11(b)(54)\n\n> (54) Isotonitazene (N,N-diethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) | 9614 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(54)", "dea_code_number": "9614", "file": "isotonitazene-n-n-diethyl-2-2-4-isopropoxybenzyl-5-nitro-1h-benzimidazol-1-yl-et.md", "generated": true, "harvested": "2026-09-01", "id": "isotonitazene-n-n-diethyl-2-2-4-isopropoxybenzyl-5-nitro-1h-benzimidazol-1-yl-et", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(54) Isotonitazene (N,N-diethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) | 9614 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Isotonitazene (N,N-diethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine)", "title": "Isotonitazene (N,N-diethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Isovaleryl fentanyl (3-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9862\n\n**CFR citation:** 21 CFR 1308.11(b)(55)\n\n> (55) Isovaleryl fentanyl (3-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide) | 9862 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(55)", "dea_code_number": "9862", "file": "isovaleryl-fentanyl-3-methyl-n-1-phenethylpiperidin-4-yl-n-phenylbutanamide.md", "generated": true, "harvested": "2026-09-01", "id": "isovaleryl-fentanyl-3-methyl-n-1-phenethylpiperidin-4-yl-n-phenylbutanamide", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(55) Isovaleryl fentanyl (3-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide) | 9862 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Isovaleryl fentanyl (3-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide)", "title": "Isovaleryl fentanyl (3-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Ketamine, its salts, isomers, and salts of isomers\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 7285\n\n**CFR citation:** 21 CFR 1308.13(c)(7)\n\n> (7) Ketamine, its salts, isomers, and salts of isomers | 7285 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.13(c)(7)", "dea_code_number": "7285", "file": "ketamine-its-salts-isomers-and-salts-of-isomers.md", "generated": true, "harvested": "2026-09-01", "id": "ketamine-its-salts-isomers-and-salts-of-isomers", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(7) Ketamine, its salts, isomers, and salts of isomers | 7285 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Ketamine, its salts, isomers, and salts of isomers", "title": "Ketamine, its salts, isomers, and salts of isomers \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Ketazolam\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2772\n\n**CFR citation:** 21 CFR 1308.14(c)(31)\n\n> (31) Ketazolam | 2772 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(31)", "dea_code_number": "2772", "file": "ketazolam.md", "generated": true, "harvested": "2026-09-01", "id": "ketazolam", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(31) Ketazolam | 2772 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Ketazolam", "title": "Ketazolam \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Ketobemidone\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9628\n\n**CFR citation:** 21 CFR 1308.11(b)(56)\n\n> (56) Ketobemidone | 9628 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(56)", "dea_code_number": "9628", "file": "ketobemidone.md", "generated": true, "harvested": "2026-09-01", "id": "ketobemidone", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(56) Ketobemidone | 9628 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Ketobemidone", "title": "Ketobemidone \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Lacosamide [(R)-2-acetoamido-N-benzyl-3-methoxy-propionamide]\n\n**Schedule:** Schedule V\n\n> \u00a7 1308.15 Schedule V.\n\n**Listed under:** Depressants\n\n> (e) Depressants.\n\n**DEA code number:** 2746\n\n**CFR citation:** 21 CFR 1308.15(e)(5)\n\n> (5) Lacosamide [(R)-2-acetoamido-N-benzyl-3-methoxy-propionamide] | 2746 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.15(e)(5)", "dea_code_number": "2746", "file": "lacosamide-r-2-acetoamido-n-benzyl-3-methoxy-propionamide.md", "generated": true, "harvested": "2026-09-01", "id": "lacosamide-r-2-acetoamido-n-benzyl-3-methoxy-propionamide", "quote_category": "(e) Depressants.", "quote_schedule": "\u00a7 1308.15 Schedule V.", "schedule": "Schedule V", "source_quote": "(5) Lacosamide [(R)-2-acetoamido-N-benzyl-3-methoxy-propionamide] | 2746 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Lacosamide [(R)-2-acetoamido-N-benzyl-3-methoxy-propionamide]", "title": "Lacosamide [(R)-2-acetoamido-N-benzyl-3-methoxy-propionamide] \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Lasmiditan [2,4,6-trifluoro-N-(6-(1-methylpiperidine-4-carbonyl)pyridine-2-yl-benzamide]\n\n**Schedule:** Schedule V\n\n> \u00a7 1308.15 Schedule V.\n\n**Listed under:** Depressants\n\n> (e) Depressants.\n\n**DEA code number:** 2790\n\n**CFR citation:** 21 CFR 1308.15(e)(6)\n\n> (6) Lasmiditan [2,4,6-trifluoro-N-(6-(1-methylpiperidine-4-carbonyl)pyridine-2-yl-benzamide] | 2790 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.15(e)(6)", "dea_code_number": "2790", "file": "lasmiditan-2-4-6-trifluoro-n-6-1-methylpiperidine-4-carbonyl-pyridine-2-yl-benza.md", "generated": true, "harvested": "2026-09-01", "id": "lasmiditan-2-4-6-trifluoro-n-6-1-methylpiperidine-4-carbonyl-pyridine-2-yl-benza", "quote_category": "(e) Depressants.", "quote_schedule": "\u00a7 1308.15 Schedule V.", "schedule": "Schedule V", "source_quote": "(6) Lasmiditan [2,4,6-trifluoro-N-(6-(1-methylpiperidine-4-carbonyl)pyridine-2-yl-benzamide] | 2790 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Lasmiditan [2,4,6-trifluoro-N-(6-(1-methylpiperidine-4-carbonyl)pyridine-2-yl-benzamide]", "title": "Lasmiditan [2,4,6-trifluoro-N-(6-(1-methylpiperidine-4-carbonyl)pyridine-2-yl-benzamide] \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Lemborexant\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2245\n\n**CFR citation:** 21 CFR 1308.14(c)(32)\n\n> (32) Lemborexant | 2245 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(32)", "dea_code_number": "2245", "file": "lemborexant.md", "generated": true, "harvested": "2026-09-01", "id": "lemborexant", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(32) Lemborexant | 2245 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Lemborexant", "title": "Lemborexant \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Levo-alphacetylmethadol\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Opiates\n\n> (c) Opiates.\n\n**DEA code number:** 9648\n\n**CFR citation:** 21 CFR 1308.12(c)(11)\n\n> (11) Levo-alphacetylmethadol | 9648 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.12(c)(11)", "dea_code_number": "9648", "file": "levo-alphacetylmethadol.md", "generated": true, "harvested": "2026-09-01", "id": "levo-alphacetylmethadol", "quote_category": "(c) Opiates.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(11) Levo-alphacetylmethadol | 9648 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Levo-alphacetylmethadol", "title": "Levo-alphacetylmethadol \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Levomethorphan\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Opiates\n\n> (c) Opiates.\n\n**DEA code number:** 9210\n\n**CFR citation:** 21 CFR 1308.12(c)(12)\n\n> (12) Levomethorphan | 9210 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.12(c)(12)", "dea_code_number": "9210", "file": "levomethorphan.md", "generated": true, "harvested": "2026-09-01", "id": "levomethorphan", "quote_category": "(c) Opiates.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(12) Levomethorphan | 9210 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Levomethorphan", "title": "Levomethorphan \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Levomoramide\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9629\n\n**CFR citation:** 21 CFR 1308.11(b)(57)\n\n> (57) Levomoramide | 9629 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(57)", "dea_code_number": "9629", "file": "levomoramide.md", "generated": true, "harvested": "2026-09-01", "id": "levomoramide", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(57) Levomoramide | 9629 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Levomoramide", "title": "Levomoramide \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Levophenacylmorphan\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9631\n\n**CFR citation:** 21 CFR 1308.11(b)(58)\n\n> (58) Levophenacylmorphan | 9631 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(58)", "dea_code_number": "9631", "file": "levophenacylmorphan.md", "generated": true, "harvested": "2026-09-01", "id": "levophenacylmorphan", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(58) Levophenacylmorphan | 9631 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Levophenacylmorphan", "title": "Levophenacylmorphan \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Levorphanol\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Opiates\n\n> (c) Opiates.\n\n**DEA code number:** 9220\n\n**CFR citation:** 21 CFR 1308.12(c)(13)\n\n> (13) Levorphanol | 9220 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.12(c)(13)", "dea_code_number": "9220", "file": "levorphanol.md", "generated": true, "harvested": "2026-09-01", "id": "levorphanol", "quote_category": "(c) Opiates.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(13) Levorphanol | 9220 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Levorphanol", "title": "Levorphanol \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Lisdexamfetamine, its salts, isomers, and salts of its isomers\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Stimulants\n\n> (d) Stimulants.\n\n**DEA code number:** 1205\n\n**CFR citation:** 21 CFR 1308.12(d)(5)\n\n> (5) Lisdexamfetamine, its salts, isomers, and salts of its isomers | 1205. |\n\nSource: \n", "category": "Stimulants", "citation": "21 CFR 1308.12(d)(5)", "dea_code_number": "1205", "file": "lisdexamfetamine-its-salts-isomers-and-salts-of-its-isomers.md", "generated": true, "harvested": "2026-09-01", "id": "lisdexamfetamine-its-salts-isomers-and-salts-of-its-isomers", "quote_category": "(d) Stimulants.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(5) Lisdexamfetamine, its salts, isomers, and salts of its isomers | 1205. |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Lisdexamfetamine, its salts, isomers, and salts of its isomers", "title": "Lisdexamfetamine, its salts, isomers, and salts of its isomers \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Loprazolam\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2773\n\n**CFR citation:** 21 CFR 1308.14(c)(33)\n\n> (33) Loprazolam | 2773 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(33)", "dea_code_number": "2773", "file": "loprazolam.md", "generated": true, "harvested": "2026-09-01", "id": "loprazolam", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(33) Loprazolam | 2773 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Loprazolam", "title": "Loprazolam \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Lorazepam\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2885\n\n**CFR citation:** 21 CFR 1308.14(c)(34)\n\n> (34) Lorazepam | 2885 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(34)", "dea_code_number": "2885", "file": "lorazepam.md", "generated": true, "harvested": "2026-09-01", "id": "lorazepam", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(34) Lorazepam | 2885 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Lorazepam", "title": "Lorazepam \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Lorcaserin\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Lorcaserin\n\n> (e) Lorcaserin.\n\n**DEA code number:** 1625\n\n**CFR citation:** 21 CFR 1308.14(e)(1)\n\n> (1) Lorcaserin | 1625 |\n\nSource: \n", "category": "Lorcaserin", "citation": "21 CFR 1308.14(e)(1)", "dea_code_number": "1625", "file": "lorcaserin.md", "generated": true, "harvested": "2026-09-01", "id": "lorcaserin", "quote_category": "(e) Lorcaserin.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(1) Lorcaserin | 1625 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Lorcaserin", "title": "Lorcaserin \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Lormetazepam\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2774\n\n**CFR citation:** 21 CFR 1308.14(c)(35)\n\n> (35) Lormetazepam | 2774 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(35)", "dea_code_number": "2774", "file": "lormetazepam.md", "generated": true, "harvested": "2026-09-01", "id": "lormetazepam", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(35) Lormetazepam | 2774 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Lormetazepam", "title": "Lormetazepam \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Lysergic acid amide\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 7310\n\n**CFR citation:** 21 CFR 1308.13(c)(9)\n\n> (9) Lysergic acid amide | 7310 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.13(c)(9)", "dea_code_number": "7310", "file": "lysergic-acid-amide.md", "generated": true, "harvested": "2026-09-01", "id": "lysergic-acid-amide", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(9) Lysergic acid amide | 7310 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Lysergic acid amide", "title": "Lysergic acid amide \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Lysergic acid diethylamide\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7315\n\n**CFR citation:** 21 CFR 1308.11(d)(22)\n\n> (22) Lysergic acid diethylamide | 7315 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(22)", "dea_code_number": "7315", "file": "lysergic-acid-diethylamide.md", "generated": true, "harvested": "2026-09-01", "id": "lysergic-acid-diethylamide", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(22) Lysergic acid diethylamide | 7315 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Lysergic acid diethylamide", "title": "Lysergic acid diethylamide \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Lysergic acid\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 7300\n\n**CFR citation:** 21 CFR 1308.13(c)(8)\n\n> (8) Lysergic acid | 7300 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.13(c)(8)", "dea_code_number": "7300", "file": "lysergic-acid.md", "generated": true, "harvested": "2026-09-01", "id": "lysergic-acid", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(8) Lysergic acid | 7300 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Lysergic acid", "title": "Lysergic acid \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Marihuana Extract\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7350\n\n**CFR citation:** 21 CFR 1308.11(d)(58)\n\n> (58) Marihuana Extract | 7350 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(58)", "dea_code_number": "7350", "file": "marihuana-extract.md", "generated": true, "harvested": "2026-09-01", "id": "marihuana-extract", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(58) Marihuana Extract | 7350 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Marihuana Extract", "title": "Marihuana Extract \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Marihuana\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7360\n\n**CFR citation:** 21 CFR 1308.11(d)(23)\n\n> (23) Marihuana | 7360 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(23)", "dea_code_number": "7360", "file": "marihuana.md", "generated": true, "harvested": "2026-09-01", "id": "marihuana", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(23) Marihuana | 7360 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Marihuana", "title": "Marihuana \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Marijuana extract\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Hallucinogenic substances\n\n> (g) Hallucinogenic substances.\n\n**Only when:** in a U.S. Food and Drug Administration approved product or subject to a state medical marijuana license\n\n**CFR citation:** 21 CFR 1308.13(g)(3)\n\n> (3) Marijuana extract, as defined in 21 CFR 1308.11(d)(58) , in a U.S. Food and Drug Administration approved product or subject to a state medical marijuana license\u2014XXXX\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.13(g)(3)", "file": "marijuana-extract.md", "generated": true, "harvested": "2026-09-01", "id": "marijuana-extract", "quote_category": "(g) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "scope_qualifier": "in a U.S. Food and Drug Administration approved product or subject to a state medical marijuana license", "source_quote": "(3) Marijuana extract, as defined in 21 CFR 1308.11(d)(58) , in a U.S. Food and Drug Administration approved product or subject to a state medical marijuana license\u2014XXXX", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Marijuana extract", "title": "Marijuana extract \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Marijuana\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Hallucinogenic substances\n\n> (g) Hallucinogenic substances.\n\n**Only when:** in a U.S. Food and Drug Administration approved product or subject to a state medical marijuana license\n\n**CFR citation:** 21 CFR 1308.13(g)(2)\n\n> (2) Marijuana, as defined in 21 U.S.C. 802(16) , in a U.S. Food and Drug Administration approved product or subject to a state medical marijuana license\u2014XXXX\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.13(g)(2)", "file": "marijuana.md", "generated": true, "harvested": "2026-09-01", "id": "marijuana", "quote_category": "(g) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "scope_qualifier": "in a U.S. Food and Drug Administration approved product or subject to a state medical marijuana license", "source_quote": "(2) Marijuana, as defined in 21 U.S.C. 802(16) , in a U.S. Food and Drug Administration approved product or subject to a state medical marijuana license\u2014XXXX", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Marijuana", "title": "Marijuana \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Mazindol\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Stimulants\n\n> (f) Stimulants.\n\n**DEA code number:** 1605\n\n**CFR citation:** 21 CFR 1308.14(f)(5)\n\n> (5) Mazindol | 1605 |\n\nSource: \n", "category": "Stimulants", "citation": "21 CFR 1308.14(f)(5)", "dea_code_number": "1605", "file": "mazindol.md", "generated": true, "harvested": "2026-09-01", "id": "mazindol", "quote_category": "(f) Stimulants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(5) Mazindol | 1605 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Mazindol", "title": "Mazindol \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Mebutamate\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2800\n\n**CFR citation:** 21 CFR 1308.14(c)(36)\n\n> (36) Mebutamate | 2800 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(36)", "dea_code_number": "2800", "file": "mebutamate.md", "generated": true, "harvested": "2026-09-01", "id": "mebutamate", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(36) Mebutamate | 2800 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Mebutamate", "title": "Mebutamate \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Mecloqualone\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Depressants\n\n> (e) Depressants.\n\n**DEA code number:** 2572\n\n**CFR citation:** 21 CFR 1308.11(e)(7)\n\n> (7) Mecloqualone | 2572 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.11(e)(7)", "dea_code_number": "2572", "file": "mecloqualone.md", "generated": true, "harvested": "2026-09-01", "id": "mecloqualone", "quote_category": "(e) Depressants.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(7) Mecloqualone | 2572 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Mecloqualone", "title": "Mecloqualone \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Medazepam\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2836\n\n**CFR citation:** 21 CFR 1308.14(c)(37)\n\n> (37) Medazepam | 2836 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(37)", "dea_code_number": "2836", "file": "medazepam.md", "generated": true, "harvested": "2026-09-01", "id": "medazepam", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(37) Medazepam | 2836 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Medazepam", "title": "Medazepam \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Mefenorex\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Stimulants\n\n> (f) Stimulants.\n\n**DEA code number:** 1580\n\n**CFR citation:** 21 CFR 1308.14(f)(6)\n\n> (6) Mefenorex | 1580 |\n\nSource: \n", "category": "Stimulants", "citation": "21 CFR 1308.14(f)(6)", "dea_code_number": "1580", "file": "mefenorex.md", "generated": true, "harvested": "2026-09-01", "id": "mefenorex", "quote_category": "(f) Stimulants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(6) Mefenorex | 1580 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Mefenorex", "title": "Mefenorex \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Meprobamate\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2820\n\n**CFR citation:** 21 CFR 1308.14(c)(388)\n\n> (388) Meprobamate | 2820 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(388)", "dea_code_number": "2820", "file": "meprobamate.md", "generated": true, "harvested": "2026-09-01", "id": "meprobamate", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(388) Meprobamate | 2820 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Meprobamate", "title": "Meprobamate \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Mescaline\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7381\n\n**CFR citation:** 21 CFR 1308.11(d)(24)\n\n> (24) Mescaline | 7381 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(24)", "dea_code_number": "7381", "file": "mescaline.md", "generated": true, "harvested": "2026-09-01", "id": "mescaline", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(24) Mescaline | 7381 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Mescaline", "title": "Mescaline \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Mesocarb (N-phenyl-N \u2032-(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl)carbamimidate)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Stimulants\n\n> (f) Stimulants.\n\n**DEA code number:** 1227\n\n**CFR citation:** 21 CFR 1308.11(f)(9)\n\n> (9) Mesocarb (N-phenyl-N \u2032-(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl)carbamimidate) | 1227 |\n\nSource: \n", "category": "Stimulants", "citation": "21 CFR 1308.11(f)(9)", "dea_code_number": "1227", "file": "mesocarb-n-phenyl-n-3-1-phenylpropan-2-yl-1-2-3-oxadiazol-3-ium-5-yl-carbamimida.md", "generated": true, "harvested": "2026-09-01", "id": "mesocarb-n-phenyl-n-3-1-phenylpropan-2-yl-1-2-3-oxadiazol-3-ium-5-yl-carbamimida", "quote_category": "(f) Stimulants.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(9) Mesocarb (N-phenyl-N \u2032-(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl)carbamimidate) | 1227 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Mesocarb (N-phenyl-N \u2032-(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl)carbamimidate)", "title": "Mesocarb (N-phenyl-N \u2032-(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl)carbamimidate) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** mestanolone (17\u03b1-methyl-17\u03b2-hydroxy-5\u03b1-androstan-3-one)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(44)\n\n> (44) mestanolone (17\u03b1-methyl-17\u03b2-hydroxy-5\u03b1-androstan-3-one);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(44)", "file": "mestanolone-17-methyl-17-hydroxy-5-androstan-3-one.md", "generated": true, "harvested": "2026-09-01", "id": "mestanolone-17-methyl-17-hydroxy-5-androstan-3-one", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(44) mestanolone (17\u03b1-methyl-17\u03b2-hydroxy-5\u03b1-androstan-3-one);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "mestanolone (17\u03b1-methyl-17\u03b2-hydroxy-5\u03b1-androstan-3-one)", "title": "mestanolone (17\u03b1-methyl-17\u03b2-hydroxy-5\u03b1-androstan-3-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** mesterolone (1\u03b1-methyl-17\u03b2-hydroxy-5\u03b1-androstan-3-one)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(45)\n\n> (45) mesterolone (1\u03b1-methyl-17\u03b2-hydroxy-5\u03b1-androstan-3-one);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(45)", "file": "mesterolone-1-methyl-17-hydroxy-5-androstan-3-one.md", "generated": true, "harvested": "2026-09-01", "id": "mesterolone-1-methyl-17-hydroxy-5-androstan-3-one", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(45) mesterolone (1\u03b1-methyl-17\u03b2-hydroxy-5\u03b1-androstan-3-one);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "mesterolone (1\u03b1-methyl-17\u03b2-hydroxy-5\u03b1-androstan-3-one)", "title": "mesterolone (1\u03b1-methyl-17\u03b2-hydroxy-5\u03b1-androstan-3-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** meta-Fluorofentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9857\n\n**CFR citation:** 21 CFR 1308.11(b)(59)\n\n> (59) meta-Fluorofentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide) | 9857 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(59)", "dea_code_number": "9857", "file": "meta-fluorofentanyl-n-3-fluorophenyl-n-1-phenethylpiperidin-4-yl-propionamide.md", "generated": true, "harvested": "2026-09-01", "id": "meta-fluorofentanyl-n-3-fluorophenyl-n-1-phenethylpiperidin-4-yl-propionamide", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(59) meta-Fluorofentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide) | 9857 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "meta-Fluorofentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide)", "title": "meta-Fluorofentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** meta-fluorofuranyl fentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9871\n\n**CFR citation:** 21 CFR 1308.11(b)(60)\n\n> (60) meta-fluorofuranyl fentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide) | 9871 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(60)", "dea_code_number": "9871", "file": "meta-fluorofuranyl-fentanyl-n-3-fluorophenyl-n-1-phenethylpiperidin-4-yl-furan-2.md", "generated": true, "harvested": "2026-09-01", "id": "meta-fluorofuranyl-fentanyl-n-3-fluorophenyl-n-1-phenethylpiperidin-4-yl-furan-2", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(60) meta-fluorofuranyl fentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide) | 9871 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "meta-fluorofuranyl fentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide)", "title": "meta-fluorofuranyl fentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** meta-Fluoroisobutyryl fentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9858\n\n**CFR citation:** 21 CFR 1308.11(b)(61)\n\n> (61) meta-Fluoroisobutyryl fentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) | 9858 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(61)", "dea_code_number": "9858", "file": "meta-fluoroisobutyryl-fentanyl-n-3-fluorophenyl-n-1-phenethylpiperidin-4-yl-isob.md", "generated": true, "harvested": "2026-09-01", "id": "meta-fluoroisobutyryl-fentanyl-n-3-fluorophenyl-n-1-phenethylpiperidin-4-yl-isob", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(61) meta-Fluoroisobutyryl fentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) | 9858 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "meta-Fluoroisobutyryl fentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide)", "title": "meta-Fluoroisobutyryl fentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Metazocine\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Opiates\n\n> (c) Opiates.\n\n**DEA code number:** 9240\n\n**CFR citation:** 21 CFR 1308.12(c)(14)\n\n> (14) Metazocine | 9240 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.12(c)(14)", "dea_code_number": "9240", "file": "metazocine.md", "generated": true, "harvested": "2026-09-01", "id": "metazocine", "quote_category": "(c) Opiates.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(14) Metazocine | 9240 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Metazocine", "title": "Metazocine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Methadone-Intermediate, 4-cyano-2-dimethylamino-4,4-diphenyl butane\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Opiates\n\n> (c) Opiates.\n\n**DEA code number:** 9254\n\n**CFR citation:** 21 CFR 1308.12(c)(16)\n\n> (16) Methadone-Intermediate, 4-cyano-2-dimethylamino-4,4-diphenyl butane | 9254 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.12(c)(16)", "dea_code_number": "9254", "file": "methadone-intermediate-4-cyano-2-dimethylamino-4-4-diphenyl-butane.md", "generated": true, "harvested": "2026-09-01", "id": "methadone-intermediate-4-cyano-2-dimethylamino-4-4-diphenyl-butane", "quote_category": "(c) Opiates.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(16) Methadone-Intermediate, 4-cyano-2-dimethylamino-4,4-diphenyl butane | 9254 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Methadone-Intermediate, 4-cyano-2-dimethylamino-4,4-diphenyl butane", "title": "Methadone-Intermediate, 4-cyano-2-dimethylamino-4,4-diphenyl butane \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Methadone\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Opiates\n\n> (c) Opiates.\n\n**DEA code number:** 9250\n\n**CFR citation:** 21 CFR 1308.12(c)(15)\n\n> (15) Methadone | 9250 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.12(c)(15)", "dea_code_number": "9250", "file": "methadone.md", "generated": true, "harvested": "2026-09-01", "id": "methadone", "quote_category": "(c) Opiates.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(15) Methadone | 9250 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Methadone", "title": "Methadone \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Methamphetamine, its salts, isomers, and salts of its isomers\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Stimulants\n\n> (d) Stimulants.\n\n**DEA code number:** 1105\n\n**CFR citation:** 21 CFR 1308.12(d)(2)\n\n> (2) Methamphetamine, its salts, isomers, and salts of its isomers | 1105 |\n\nSource: \n", "category": "Stimulants", "citation": "21 CFR 1308.12(d)(2)", "dea_code_number": "1105", "file": "methamphetamine-its-salts-isomers-and-salts-of-its-isomers.md", "generated": true, "harvested": "2026-09-01", "id": "methamphetamine-its-salts-isomers-and-salts-of-its-isomers", "quote_category": "(d) Stimulants.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(2) Methamphetamine, its salts, isomers, and salts of its isomers | 1105 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Methamphetamine, its salts, isomers, and salts of its isomers", "title": "Methamphetamine, its salts, isomers, and salts of its isomers \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** methandienone (17\u03b1-methyl-17\u03b2-hydroxyandrost-1,4-dien-3-one)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(46)\n\n> (46) methandienone (17\u03b1-methyl-17\u03b2-hydroxyandrost-1,4-dien-3-one);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(46)", "file": "methandienone-17-methyl-17-hydroxyandrost-1-4-dien-3-one.md", "generated": true, "harvested": "2026-09-01", "id": "methandienone-17-methyl-17-hydroxyandrost-1-4-dien-3-one", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(46) methandienone (17\u03b1-methyl-17\u03b2-hydroxyandrost-1,4-dien-3-one);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "methandienone (17\u03b1-methyl-17\u03b2-hydroxyandrost-1,4-dien-3-one)", "title": "methandienone (17\u03b1-methyl-17\u03b2-hydroxyandrost-1,4-dien-3-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** methandriol (17\u03b1-methyl-3\u03b2,17\u03b2-dihydroxyandrost-5-ene)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(47)\n\n> (47) methandriol (17\u03b1-methyl-3\u03b2,17\u03b2-dihydroxyandrost-5-ene);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(47)", "file": "methandriol-17-methyl-3-17-dihydroxyandrost-5-ene.md", "generated": true, "harvested": "2026-09-01", "id": "methandriol-17-methyl-3-17-dihydroxyandrost-5-ene", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(47) methandriol (17\u03b1-methyl-3\u03b2,17\u03b2-dihydroxyandrost-5-ene);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "methandriol (17\u03b1-methyl-3\u03b2,17\u03b2-dihydroxyandrost-5-ene)", "title": "methandriol (17\u03b1-methyl-3\u03b2,17\u03b2-dihydroxyandrost-5-ene) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Methaqualone\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Depressants\n\n> (e) Depressants.\n\n**DEA code number:** 2565\n\n**CFR citation:** 21 CFR 1308.11(e)(8)\n\n> (8) Methaqualone | 2565 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.11(e)(8)", "dea_code_number": "2565", "file": "methaqualone.md", "generated": true, "harvested": "2026-09-01", "id": "methaqualone", "quote_category": "(e) Depressants.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(8) Methaqualone | 2565 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Methaqualone", "title": "Methaqualone \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** methasterone (2\u03b1,17\u03b1-dimethyl-5\u03b1-androstan-17\u03b2-ol-3-one or 2\u03b1,17\u03b1-dimethyl-17\u03b2-hydroxy-5\u03b1-androstan-3-one)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(48)\n\n> (48) methasterone (2\u03b1,17\u03b1-dimethyl-5\u03b1-androstan-17\u03b2-ol-3-one or 2\u03b1,17\u03b1-dimethyl-17\u03b2-hydroxy-5\u03b1-androstan-3-one);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(48)", "file": "methasterone-2-17-dimethyl-5-androstan-17-ol-3-one-or-2-17-dimethyl-17-hydroxy-5.md", "generated": true, "harvested": "2026-09-01", "id": "methasterone-2-17-dimethyl-5-androstan-17-ol-3-one-or-2-17-dimethyl-17-hydroxy-5", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(48) methasterone (2\u03b1,17\u03b1-dimethyl-5\u03b1-androstan-17\u03b2-ol-3-one or 2\u03b1,17\u03b1-dimethyl-17\u03b2-hydroxy-5\u03b1-androstan-3-one);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "methasterone (2\u03b1,17\u03b1-dimethyl-5\u03b1-androstan-17\u03b2-ol-3-one or 2\u03b1,17\u03b1-dimethyl-17\u03b2-hydroxy-5\u03b1-androstan-3-one)", "title": "methasterone (2\u03b1,17\u03b1-dimethyl-5\u03b1-androstan-17\u03b2-ol-3-one or 2\u03b1,17\u03b1-dimethyl-17\u03b2-hydroxy-5\u03b1-androstan-3-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Methcathinone (Some other names: 2-(methylamino)-propiophenone; alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one; alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone; methylcathinone; AL-464; AL-422; AL-463 and UR1432), its salts, optical isomers and salts of optical isomers\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Stimulants\n\n> (f) Stimulants.\n\n**DEA code number:** 1237\n\n**CFR citation:** 21 CFR 1308.11(f)(10)\n\n> (10) Methcathinone (Some other names: 2-(methylamino)-propiophenone; alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one; alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone; methylcathinone; AL-464; AL-422; AL-463 and UR1432), its salts, optical isomers and salts of optical isomers | 1237 |\n\nSource: \n", "category": "Stimulants", "citation": "21 CFR 1308.11(f)(10)", "dea_code_number": "1237", "file": "methcathinone-some-other-names-2-methylamino-propiophenone-alpha-methylamino-pro.md", "generated": true, "harvested": "2026-09-01", "id": "methcathinone-some-other-names-2-methylamino-propiophenone-alpha-methylamino-pro", "quote_category": "(f) Stimulants.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(10) Methcathinone (Some other names: 2-(methylamino)-propiophenone; alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one; alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone; methylcathinone; AL-464; AL-422; AL-463 and UR1432), its salts, optical isomers and salts of optical isomers | 1237 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Methcathinone (Some other names: 2-(methylamino)-propiophenone; alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one; alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone; methylcathinone; AL-464; AL-422; AL-463 and UR1432), its salts, optical isomers and salts of optical isomers", "title": "Methcathinone (Some other names: 2-(methylamino)-propiophenone; alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one; alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone; methylcathinone; AL-464; AL-422; AL-463 and UR1432), its salts, optical isomers and salts of optical isomers \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** methenolone (1-methyl-17\u03b2-hydroxy-5\u03b1-androst-1-en-3-one)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(49)\n\n> (49) methenolone (1-methyl-17\u03b2-hydroxy-5\u03b1-androst-1-en-3-one);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(49)", "file": "methenolone-1-methyl-17-hydroxy-5-androst-1-en-3-one.md", "generated": true, "harvested": "2026-09-01", "id": "methenolone-1-methyl-17-hydroxy-5-androst-1-en-3-one", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(49) methenolone (1-methyl-17\u03b2-hydroxy-5\u03b1-androst-1-en-3-one);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "methenolone (1-methyl-17\u03b2-hydroxy-5\u03b1-androst-1-en-3-one)", "title": "methenolone (1-methyl-17\u03b2-hydroxy-5\u03b1-androst-1-en-3-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Methiopropamine (N-methyl-1-(thiophen-2-yl)propan-2-amine)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Stimulants\n\n> (f) Stimulants.\n\n**DEA code number:** 1478\n\n**CFR citation:** 21 CFR 1308.11(f)(11)\n\n> (11) Methiopropamine (N-methyl-1-(thiophen-2-yl)propan-2-amine) | 1478 |\n\nSource: \n", "category": "Stimulants", "citation": "21 CFR 1308.11(f)(11)", "dea_code_number": "1478", "file": "methiopropamine-n-methyl-1-thiophen-2-yl-propan-2-amine.md", "generated": true, "harvested": "2026-09-01", "id": "methiopropamine-n-methyl-1-thiophen-2-yl-propan-2-amine", "quote_category": "(f) Stimulants.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(11) Methiopropamine (N-methyl-1-(thiophen-2-yl)propan-2-amine) | 1478 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Methiopropamine (N-methyl-1-(thiophen-2-yl)propan-2-amine)", "title": "Methiopropamine (N-methyl-1-(thiophen-2-yl)propan-2-amine) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Methohexital\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2264\n\n**CFR citation:** 21 CFR 1308.14(c)(39)\n\n> (39) Methohexital | 2264 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(39)", "dea_code_number": "2264", "file": "methohexital.md", "generated": true, "harvested": "2026-09-01", "id": "methohexital", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(39) Methohexital | 2264 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Methohexital", "title": "Methohexital \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Methoxyacetyl fentanyl (2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9825\n\n**CFR citation:** 21 CFR 1308.11(b)(62)\n\n> (62) Methoxyacetyl fentanyl (2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) | 9825 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(62)", "dea_code_number": "9825", "file": "methoxyacetyl-fentanyl-2-methoxy-n-1-phenethylpiperidin-4-yl-n-phenylacetamide.md", "generated": true, "harvested": "2026-09-01", "id": "methoxyacetyl-fentanyl-2-methoxy-n-1-phenethylpiperidin-4-yl-n-phenylacetamide", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(62) Methoxyacetyl fentanyl (2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) | 9825 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Methoxyacetyl fentanyl (2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide)", "title": "Methoxyacetyl fentanyl (2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (Other names: MDMB-FUBINACA)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7020\n\n**CFR citation:** 21 CFR 1308.11(d)(78)\n\n> (78) methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (Other names: MDMB-FUBINACA) | 7020 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(78)", "dea_code_number": "7020", "file": "methyl-2-1-4-fluorobenzyl-1h-indazole-3-carboxamido-3-3-dimethylbutanoate-other-.md", "generated": true, "harvested": "2026-09-01", "id": "methyl-2-1-4-fluorobenzyl-1h-indazole-3-carboxamido-3-3-dimethylbutanoate-other-", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(78) methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (Other names: MDMB-FUBINACA) | 7020 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (Other names: MDMB-FUBINACA)", "title": "methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (Other names: MDMB-FUBINACA) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate, (FUB-AMB, MMB-FUBINACA, AMB-FUBINACA)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7021\n\n**CFR citation:** 21 CFR 1308.11(d)(79)\n\n> (79) methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate, (FUB-AMB, MMB-FUBINACA, AMB-FUBINACA) | (7021) |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(79)", "dea_code_number": "7021", "file": "methyl-2-1-4-fluorobenzyl-1h-indazole-3-carboxamido-3-methylbutanoate-fub-amb-mm.md", "generated": true, "harvested": "2026-09-01", "id": "methyl-2-1-4-fluorobenzyl-1h-indazole-3-carboxamido-3-methylbutanoate-fub-amb-mm", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(79) methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate, (FUB-AMB, MMB-FUBINACA, AMB-FUBINACA) | (7021) |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate, (FUB-AMB, MMB-FUBINACA, AMB-FUBINACA)", "title": "methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate, (FUB-AMB, MMB-FUBINACA, AMB-FUBINACA) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Methyl 2-(1-(4-fluorobenzyl)-1H-indole-3-carboxamido)-3-methyl butanoate (other name: MMB-FUBICA)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7095\n\n**CFR citation:** 21 CFR 1308.11(d)(114)\n\n> (114) Methyl 2-(1-(4-fluorobenzyl)-1H-indole-3-carboxamido)-3-methyl butanoate (other name: MMB-FUBICA) | 7095 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(114)", "dea_code_number": "7095", "file": "methyl-2-1-4-fluorobenzyl-1h-indole-3-carboxamido-3-methyl-butanoate-other-name-.md", "generated": true, "harvested": "2026-09-01", "id": "methyl-2-1-4-fluorobenzyl-1h-indole-3-carboxamido-3-methyl-butanoate-other-name-", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(114) Methyl 2-(1-(4-fluorobenzyl)-1H-indole-3-carboxamido)-3-methyl butanoate (other name: MMB-FUBICA) | 7095 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Methyl 2-(1-(4-fluorobenzyl)-1H-indole-3-carboxamido)-3-methyl butanoate (other name: MMB-FUBICA)", "title": "Methyl 2-(1-(4-fluorobenzyl)-1H-indole-3-carboxamido)-3-methyl butanoate (other name: MMB-FUBICA) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** methyl 2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (4F-MDMB-BINACA, 4F-MDMB-BUTINACA)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7043\n\n**CFR citation:** 21 CFR 1308.11(d)(87)\n\n> (87) methyl 2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (4F-MDMB-BINACA, 4F-MDMB-BUTINACA) | 7043 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(87)", "dea_code_number": "7043", "file": "methyl-2-1-4-fluorobutyl-1h-indazole-3-carboxamido-3-3-dimethylbutanoate-4f-mdmb.md", "generated": true, "harvested": "2026-09-01", "id": "methyl-2-1-4-fluorobutyl-1h-indazole-3-carboxamido-3-3-dimethylbutanoate-4f-mdmb", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(87) methyl 2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (4F-MDMB-BINACA, 4F-MDMB-BUTINACA) | 7043 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "methyl 2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (4F-MDMB-BINACA, 4F-MDMB-BUTINACA)", "title": "methyl 2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (4F-MDMB-BINACA, 4F-MDMB-BUTINACA) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Methyl 2-[[1-(4-fluorobutyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate (other names: 4F-MDMB-BUTICA; 4F-MDMB-BICA)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7091\n\n**CFR citation:** 21 CFR 1308.11(d)(111)\n\n> (111) Methyl 2-[[1-(4-fluorobutyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate (other names: 4F-MDMB-BUTICA; 4F-MDMB-BICA) | 7091 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(111)", "dea_code_number": "7091", "file": "methyl-2-1-4-fluorobutyl-indole-3-carbonyl-amino-3-3-dimethyl-butanoate-other-na.md", "generated": true, "harvested": "2026-09-01", "id": "methyl-2-1-4-fluorobutyl-indole-3-carbonyl-amino-3-3-dimethyl-butanoate-other-na", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(111) Methyl 2-[[1-(4-fluorobutyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate (other names: 4F-MDMB-BUTICA; 4F-MDMB-BICA) | 7091 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Methyl 2-[[1-(4-fluorobutyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate (other names: 4F-MDMB-BUTICA; 4F-MDMB-BICA)", "title": "Methyl 2-[[1-(4-fluorobutyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate (other names: 4F-MDMB-BUTICA; 4F-MDMB-BICA) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (Other names: 5F-ADB; 5F-MDMB-PINACA)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7034\n\n**CFR citation:** 21 CFR 1308.11(d)(73)\n\n> (73) methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (Other names: 5F-ADB; 5F-MDMB-PINACA) | 7034 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(73)", "dea_code_number": "7034", "file": "methyl-2-1-5-fluoropentyl-1h-indazole-3-carboxamido-3-3-dimethylbutanoate-other-.md", "generated": true, "harvested": "2026-09-01", "id": "methyl-2-1-5-fluoropentyl-1h-indazole-3-carboxamido-3-3-dimethylbutanoate-other-", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(73) methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (Other names: 5F-ADB; 5F-MDMB-PINACA) | 7034 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (Other names: 5F-ADB; 5F-MDMB-PINACA)", "title": "methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (Other names: 5F-ADB; 5F-MDMB-PINACA) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (Other names: 5F-AMB)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7033\n\n**CFR citation:** 21 CFR 1308.11(d)(74)\n\n> (74) methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (Other names: 5F-AMB) | 7033 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(74)", "dea_code_number": "7033", "file": "methyl-2-1-5-fluoropentyl-1h-indazole-3-carboxamido-3-methylbutanoate-other-name.md", "generated": true, "harvested": "2026-09-01", "id": "methyl-2-1-5-fluoropentyl-1h-indazole-3-carboxamido-3-methylbutanoate-other-name", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(74) methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (Other names: 5F-AMB) | 7033 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (Other names: 5F-AMB)", "title": "methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (Other names: 5F-AMB) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (other names: 5F-MDMB-PICA; 5F-MDMB-2201)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7041\n\n**CFR citation:** 21 CFR 1308.11(d)(90)\n\n> (90) methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (other names: 5F-MDMB-PICA; 5F-MDMB-2201) | 7041 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(90)", "dea_code_number": "7041", "file": "methyl-2-1-5-fluoropentyl-1h-indole-3-carboxamido-3-3-dimethylbutanoate-other-na.md", "generated": true, "harvested": "2026-09-01", "id": "methyl-2-1-5-fluoropentyl-1h-indole-3-carboxamido-3-3-dimethylbutanoate-other-na", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(90) methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (other names: 5F-MDMB-PICA; 5F-MDMB-2201) | 7041 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (other names: 5F-MDMB-PICA; 5F-MDMB-2201)", "title": "methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (other names: 5F-MDMB-PICA; 5F-MDMB-2201) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (Other names: MDMB-CHMICA, MMB-CHMINACA)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7042\n\n**CFR citation:** 21 CFR 1308.11(d)(77)\n\n> (77) methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (Other names: MDMB-CHMICA, MMB-CHMINACA) | 7042 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(77)", "dea_code_number": "7042", "file": "methyl-2-1-cyclohexylmethyl-1h-indole-3-carboxamido-3-3-dimethylbutanoate-other-.md", "generated": true, "harvested": "2026-09-01", "id": "methyl-2-1-cyclohexylmethyl-1h-indole-3-carboxamido-3-3-dimethylbutanoate-other-", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(77) methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (Other names: MDMB-CHMICA, MMB-CHMINACA) | 7042 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (Other names: MDMB-CHMICA, MMB-CHMINACA)", "title": "methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (Other names: MDMB-CHMICA, MMB-CHMINACA) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate (Other names: MMB-CHMICA; AMB-CHMICA)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7044\n\n**CFR citation:** 21 CFR 1308.11(d)(84)\n\n> (84) methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate (Other names: MMB-CHMICA; AMB-CHMICA) | 7044 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(84)", "dea_code_number": "7044", "file": "methyl-2-1-cyclohexylmethyl-1h-indole-3-carboxamido-3-methylbutanoate-other-name.md", "generated": true, "harvested": "2026-09-01", "id": "methyl-2-1-cyclohexylmethyl-1h-indole-3-carboxamido-3-methylbutanoate-other-name", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(84) methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate (Other names: MMB-CHMICA; AMB-CHMICA) | 7044 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate (Other names: MMB-CHMICA; AMB-CHMICA)", "title": "methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate (Other names: MMB-CHMICA; AMB-CHMICA) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido)butanoate (other name: MDMB-4en-PINACA)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7090\n\n**CFR citation:** 21 CFR 1308.11(d)(110)\n\n> (110) methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido)butanoate (other name: MDMB-4en-PINACA) | 7090 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(110)", "dea_code_number": "7090", "file": "methyl-3-3-dimethyl-2-1-pent-4-en-1-yl-1h-indazole-3-carboxamido-butanoate-other.md", "generated": true, "harvested": "2026-09-01", "id": "methyl-3-3-dimethyl-2-1-pent-4-en-1-yl-1h-indazole-3-carboxamido-butanoate-other", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(110) methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido)butanoate (other name: MDMB-4en-PINACA) | 7090 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido)butanoate (other name: MDMB-4en-PINACA)", "title": "methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido)butanoate (other name: MDMB-4en-PINACA) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Methyl (E)-2-((1\u2032S,6\u2032S,7\u2032S)-6\u2032-ethyl-4-methoxy-3-oxo-3\u2032,5\u2032,6\u2032,7\u2032,8\u2032,8a\u2032-hexahydro-2\u2032H-spiro[indoline-2,1\u2032-indolizine]-7\u2032-yl)-3-methoxyacrylate (commonly known as mitragynine pseudoindoxyl) including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible. Since nomenclature of this substance is not internationally standardized, compounds of this structure, regardless of numerical designation of atomic positions are covered\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Temporary listing of substances subject to emergency scheduling\n\n> (h) Temporary listing of substances subject to emergency scheduling.\n\n**DEA code number:** 9672\n\n**Temporary listing expires:** Aug. 26, 2028\n\n> adding paragraphs (h)(88) through (h)(91), effective Aug. 26, 2026 through Aug. 26, 2028\n\n**CFR citation:** 21 CFR 1308.11(h)(89)\n\n> (89) Methyl (E)-2-((1\u2032S,6\u2032S,7\u2032S)-6\u2032-ethyl-4-methoxy-3-oxo-3\u2032,5\u2032,6\u2032,7\u2032,8\u2032,8a\u2032-hexahydro-2\u2032H-spiro[indoline-2,1\u2032-indolizine]-7\u2032-yl)-3-methoxyacrylate (commonly known as mitragynine pseudoindoxyl) including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible. Since nomenclature of this substance is not internationally standardized, compounds of this structure, regardless of numerical designation of atomic positions are covered | 9672 |\n\nSource: \n", "category": "Temporary listing of substances subject to emergency scheduling", "citation": "21 CFR 1308.11(h)(89)", "dea_code_number": "9672", "file": "methyl-e-2-1-s-6-s-7-s-6-ethyl-4-methoxy-3-oxo-3-5-6-7-8-8a-hexahydro-2-h-spiro-.md", "generated": true, "harvested": "2026-09-01", "id": "methyl-e-2-1-s-6-s-7-s-6-ethyl-4-methoxy-3-oxo-3-5-6-7-8-8a-hexahydro-2-h-spiro-", "quote_category": "(h) Temporary listing of substances subject to emergency scheduling.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "quote_temporary_expiry": "adding paragraphs (h)(88) through (h)(91), effective Aug. 26, 2026 through Aug. 26, 2028", "schedule": "Schedule I", "source_quote": "(89) Methyl (E)-2-((1\u2032S,6\u2032S,7\u2032S)-6\u2032-ethyl-4-methoxy-3-oxo-3\u2032,5\u2032,6\u2032,7\u2032,8\u2032,8a\u2032-hexahydro-2\u2032H-spiro[indoline-2,1\u2032-indolizine]-7\u2032-yl)-3-methoxyacrylate (commonly known as mitragynine pseudoindoxyl) including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible. Since nomenclature of this substance is not internationally standardized, compounds of this structure, regardless of numerical designation of atomic positions are covered | 9672 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Methyl (E)-2-((1\u2032S,6\u2032S,7\u2032S)-6\u2032-ethyl-4-methoxy-3-oxo-3\u2032,5\u2032,6\u2032,7\u2032,8\u2032,8a\u2032-hexahydro-2\u2032H-spiro[indoline-2,1\u2032-indolizine]-7\u2032-yl)-3-methoxyacrylate (commonly known as mitragynine pseudoindoxyl) including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible. Since nomenclature of this substance is not internationally standardized, compounds of this structure, regardless of numerical designation of atomic positions are covered", "temporary_expiry": "Aug. 26, 2028", "title": "Methyl (E)-2-((1\u2032S,6\u2032S,7\u2032S)-6\u2032-ethyl-4-methoxy-3-oxo-3\u2032,5\u2032,6\u2032,7\u2032,8\u2032,8a\u2032-hexahydro-2\u2032H-spiro[indoline-2,1\u2032-indolizine]-7\u2032-yl)-3-methoxyacrylate (commonly known as mitragynine pseudoindoxyl) including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible. Since nomenclature of this substance is not internationally standardized, compounds of this structure, regardless of numerical designation of atomic positions are covered \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Methyl (E)-2-((2S,3S,7aS,12aR,12bS)-3-ethyl-7a-hydroxy-8-methoxy-1,2,3,4,6,7,7a,12,12a,12b-decahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate (commonly known as MGM-15; also known as dihydro-7-hydroxymitragynine) including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible. Since nomenclature of this substance is not internationally standardized, compounds of this structure, regardless of numerical designation of atomic positions are covered\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Temporary listing of substances subject to emergency scheduling\n\n> (h) Temporary listing of substances subject to emergency scheduling.\n\n**DEA code number:** 9673\n\n**Temporary listing expires:** Aug. 26, 2028\n\n> adding paragraphs (h)(88) through (h)(91), effective Aug. 26, 2026 through Aug. 26, 2028\n\n**CFR citation:** 21 CFR 1308.11(h)(90)\n\n> (90) Methyl (E)-2-((2S,3S,7aS,12aR,12bS)-3-ethyl-7a-hydroxy-8-methoxy-1,2,3,4,6,7,7a,12,12a,12b-decahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate (commonly known as MGM-15; also known as dihydro-7-hydroxymitragynine) including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible. Since nomenclature of this substance is not internationally standardized, compounds of this structure, regardless of numerical designation of atomic positions are covered | 9673 |\n\nSource: \n", "category": "Temporary listing of substances subject to emergency scheduling", "citation": "21 CFR 1308.11(h)(90)", "dea_code_number": "9673", "file": "methyl-e-2-2s-3s-7as-12ar-12bs-3-ethyl-7a-hydroxy-8-methoxy-1-2-3-4-6-7-7a-12-12.md", "generated": true, "harvested": "2026-09-01", "id": "methyl-e-2-2s-3s-7as-12ar-12bs-3-ethyl-7a-hydroxy-8-methoxy-1-2-3-4-6-7-7a-12-12", "quote_category": "(h) Temporary listing of substances subject to emergency scheduling.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "quote_temporary_expiry": "adding paragraphs (h)(88) through (h)(91), effective Aug. 26, 2026 through Aug. 26, 2028", "schedule": "Schedule I", "source_quote": "(90) Methyl (E)-2-((2S,3S,7aS,12aR,12bS)-3-ethyl-7a-hydroxy-8-methoxy-1,2,3,4,6,7,7a,12,12a,12b-decahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate (commonly known as MGM-15; also known as dihydro-7-hydroxymitragynine) including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible. Since nomenclature of this substance is not internationally standardized, compounds of this structure, regardless of numerical designation of atomic positions are covered | 9673 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Methyl (E)-2-((2S,3S,7aS,12aR,12bS)-3-ethyl-7a-hydroxy-8-methoxy-1,2,3,4,6,7,7a,12,12a,12b-decahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate (commonly known as MGM-15; also known as dihydro-7-hydroxymitragynine) including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible. Since nomenclature of this substance is not internationally standardized, compounds of this structure, regardless of numerical designation of atomic positions are covered", "temporary_expiry": "Aug. 26, 2028", "title": "Methyl (E)-2-((2S,3S,7aS,12aR,12bS)-3-ethyl-7a-hydroxy-8-methoxy-1,2,3,4,6,7,7a,12,12a,12b-decahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate (commonly known as MGM-15; also known as dihydro-7-hydroxymitragynine) including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible. Since nomenclature of this substance is not internationally standardized, compounds of this structure, regardless of numerical designation of atomic positions are covered \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Methyl (E)-2-((2S,3S,7aS,12aR,12bS)-3-ethyl-9-fluoro-7a-hydroxy-8- methoxy-1,2,3,4,6,7,7a,12,12a,12b-decahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate (commonly known as MGM-16; also known as 9-fluoro-dihydro-7-hydroxymitragynine; or 10-fluoro-dihydro-7-hydroxymitragynine (depending on numbering convention)) including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible. Since nomenclature of this substance is not internationally standardized, compounds of this structure, regardless of numerical designation of atomic positions are covered\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Temporary listing of substances subject to emergency scheduling\n\n> (h) Temporary listing of substances subject to emergency scheduling.\n\n**DEA code number:** 9674\n\n**Temporary listing expires:** Aug. 26, 2028\n\n> adding paragraphs (h)(88) through (h)(91), effective Aug. 26, 2026 through Aug. 26, 2028\n\n**CFR citation:** 21 CFR 1308.11(h)(91)\n\n> (91) Methyl (E)-2-((2S,3S,7aS,12aR,12bS)-3-ethyl-9-fluoro-7a-hydroxy-8- methoxy-1,2,3,4,6,7,7a,12,12a,12b-decahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate (commonly known as MGM-16; also known as 9-fluoro-dihydro-7-hydroxymitragynine; or 10-fluoro-dihydro-7-hydroxymitragynine (depending on numbering convention)) including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible. Since nomenclature of this substance is not internationally standardized, compounds of this structure, regardless of numerical designation of atomic positions are covered | 9674 |\n\nSource: \n", "category": "Temporary listing of substances subject to emergency scheduling", "citation": "21 CFR 1308.11(h)(91)", "dea_code_number": "9674", "file": "methyl-e-2-2s-3s-7as-12ar-12bs-3-ethyl-9-fluoro-7a-hydroxy-8-methoxy-1-2-3-4-6-7.md", "generated": true, "harvested": "2026-09-01", "id": "methyl-e-2-2s-3s-7as-12ar-12bs-3-ethyl-9-fluoro-7a-hydroxy-8-methoxy-1-2-3-4-6-7", "quote_category": "(h) Temporary listing of substances subject to emergency scheduling.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "quote_temporary_expiry": "adding paragraphs (h)(88) through (h)(91), effective Aug. 26, 2026 through Aug. 26, 2028", "schedule": "Schedule I", "source_quote": "(91) Methyl (E)-2-((2S,3S,7aS,12aR,12bS)-3-ethyl-9-fluoro-7a-hydroxy-8- methoxy-1,2,3,4,6,7,7a,12,12a,12b-decahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate (commonly known as MGM-16; also known as 9-fluoro-dihydro-7-hydroxymitragynine; or 10-fluoro-dihydro-7-hydroxymitragynine (depending on numbering convention)) including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible. Since nomenclature of this substance is not internationally standardized, compounds of this structure, regardless of numerical designation of atomic positions are covered | 9674 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Methyl (E)-2-((2S,3S,7aS,12aR,12bS)-3-ethyl-9-fluoro-7a-hydroxy-8- methoxy-1,2,3,4,6,7,7a,12,12a,12b-decahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate (commonly known as MGM-16; also known as 9-fluoro-dihydro-7-hydroxymitragynine; or 10-fluoro-dihydro-7-hydroxymitragynine (depending on numbering convention)) including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible. Since nomenclature of this substance is not internationally standardized, compounds of this structure, regardless of numerical designation of atomic positions are covered", "temporary_expiry": "Aug. 26, 2028", "title": "Methyl (E)-2-((2S,3S,7aS,12aR,12bS)-3-ethyl-9-fluoro-7a-hydroxy-8- methoxy-1,2,3,4,6,7,7a,12,12a,12b-decahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate (commonly known as MGM-16; also known as 9-fluoro-dihydro-7-hydroxymitragynine; or 10-fluoro-dihydro-7-hydroxymitragynine (depending on numbering convention)) including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible. Since nomenclature of this substance is not internationally standardized, compounds of this structure, regardless of numerical designation of atomic positions are covered \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Methyldesorphine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opium derivatives\n\n> (c) Opium derivatives.\n\n**DEA code number:** 9302\n\n**CFR citation:** 21 CFR 1308.11(c)(13)\n\n> (13) Methyldesorphine | 9302 |\n\nSource: \n", "category": "Opium derivatives", "citation": "21 CFR 1308.11(c)(13)", "dea_code_number": "9302", "file": "methyldesorphine.md", "generated": true, "harvested": "2026-09-01", "id": "methyldesorphine", "quote_category": "(c) Opium derivatives.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(13) Methyldesorphine | 9302 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Methyldesorphine", "title": "Methyldesorphine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** methyldienolone (17\u03b1-methyl-17\u03b2-hydroxyestra-4,9(10)-dien-3-one)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(59)\n\n> (59) methyldienolone (17\u03b1-methyl-17\u03b2-hydroxyestra-4,9(10)-dien-3-one);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(59)", "file": "methyldienolone-17-methyl-17-hydroxyestra-4-9-10-dien-3-one.md", "generated": true, "harvested": "2026-09-01", "id": "methyldienolone-17-methyl-17-hydroxyestra-4-9-10-dien-3-one", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(59) methyldienolone (17\u03b1-methyl-17\u03b2-hydroxyestra-4,9(10)-dien-3-one);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "methyldienolone (17\u03b1-methyl-17\u03b2-hydroxyestra-4,9(10)-dien-3-one)", "title": "methyldienolone (17\u03b1-methyl-17\u03b2-hydroxyestra-4,9(10)-dien-3-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Methyldihydromorphine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opium derivatives\n\n> (c) Opium derivatives.\n\n**DEA code number:** 9304\n\n**CFR citation:** 21 CFR 1308.11(c)(14)\n\n> (14) Methyldihydromorphine | 9304 |\n\nSource: \n", "category": "Opium derivatives", "citation": "21 CFR 1308.11(c)(14)", "dea_code_number": "9304", "file": "methyldihydromorphine.md", "generated": true, "harvested": "2026-09-01", "id": "methyldihydromorphine", "quote_category": "(c) Opium derivatives.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(14) Methyldihydromorphine | 9304 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Methyldihydromorphine", "title": "Methyldihydromorphine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Methylphenidate\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Stimulants\n\n> (d) Stimulants.\n\n**DEA code number:** 1724\n\n**CFR citation:** 21 CFR 1308.12(d)(4)\n\n> (4) Methylphenidate | 1724 |\n\nSource: \n", "category": "Stimulants", "citation": "21 CFR 1308.12(d)(4)", "dea_code_number": "1724", "file": "methylphenidate.md", "generated": true, "harvested": "2026-09-01", "id": "methylphenidate", "quote_category": "(d) Stimulants.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(4) Methylphenidate | 1724 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Methylphenidate", "title": "Methylphenidate \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Methylphenobarbital (mephobarbital)\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2250\n\n**CFR citation:** 21 CFR 1308.14(c)(40)\n\n> (40) Methylphenobarbital (mephobarbital) | 2250 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(40)", "dea_code_number": "2250", "file": "methylphenobarbital-mephobarbital.md", "generated": true, "harvested": "2026-09-01", "id": "methylphenobarbital-mephobarbital", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(40) Methylphenobarbital (mephobarbital) | 2250 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Methylphenobarbital (mephobarbital)", "title": "Methylphenobarbital (mephobarbital) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** methyltestosterone (17\u03b1-methyl-17\u03b2-hydroxyandrost-4-en-3-one)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(61)\n\n> (61) methyltestosterone (17\u03b1-methyl-17\u03b2-hydroxyandrost-4-en-3-one);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(61)", "file": "methyltestosterone-17-methyl-17-hydroxyandrost-4-en-3-one.md", "generated": true, "harvested": "2026-09-01", "id": "methyltestosterone-17-methyl-17-hydroxyandrost-4-en-3-one", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(61) methyltestosterone (17\u03b1-methyl-17\u03b2-hydroxyandrost-4-en-3-one);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "methyltestosterone (17\u03b1-methyl-17\u03b2-hydroxyandrost-4-en-3-one)", "title": "methyltestosterone (17\u03b1-methyl-17\u03b2-hydroxyandrost-4-en-3-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** methyltrienolone (17\u03b1-methyl-17\u03b2-hydroxyestra-4,9,11-trien-3-one)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(62)\n\n> (62) methyltrienolone (17\u03b1-methyl-17\u03b2-hydroxyestra-4,9,11-trien-3-one);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(62)", "file": "methyltrienolone-17-methyl-17-hydroxyestra-4-9-11-trien-3-one.md", "generated": true, "harvested": "2026-09-01", "id": "methyltrienolone-17-methyl-17-hydroxyestra-4-9-11-trien-3-one", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(62) methyltrienolone (17\u03b1-methyl-17\u03b2-hydroxyestra-4,9,11-trien-3-one);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "methyltrienolone (17\u03b1-methyl-17\u03b2-hydroxyestra-4,9,11-trien-3-one)", "title": "methyltrienolone (17\u03b1-methyl-17\u03b2-hydroxyestra-4,9,11-trien-3-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Methyprylon\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2575\n\n**CFR citation:** 21 CFR 1308.13(c)(10)\n\n> (10) Methyprylon | 2575 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.13(c)(10)", "dea_code_number": "2575", "file": "methyprylon.md", "generated": true, "harvested": "2026-09-01", "id": "methyprylon", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(10) Methyprylon | 2575 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Methyprylon", "title": "Methyprylon \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Metodesnitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9764\n\n**CFR citation:** 21 CFR 1308.11(b)(67)\n\n> (67) Metodesnitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine) | 9764 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(67)", "dea_code_number": "9764", "file": "metodesnitazene-n-n-diethyl-2-2-4-methoxybenzyl-1h-benzimidazol-1-yl-ethan-1-ami.md", "generated": true, "harvested": "2026-09-01", "id": "metodesnitazene-n-n-diethyl-2-2-4-methoxybenzyl-1h-benzimidazol-1-yl-ethan-1-ami", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(67) Metodesnitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine) | 9764 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Metodesnitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine)", "title": "Metodesnitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Metonitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9757\n\n**CFR citation:** 21 CFR 1308.11(b)(68)\n\n> (68) Metonitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) | 9757 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(68)", "dea_code_number": "9757", "file": "metonitazene-n-n-diethyl-2-2-4-methoxybenzyl-5-nitro-1h-benzimidazol-1-yl-ethan-.md", "generated": true, "harvested": "2026-09-01", "id": "metonitazene-n-n-diethyl-2-2-4-methoxybenzyl-5-nitro-1h-benzimidazol-1-yl-ethan-", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(68) Metonitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) | 9757 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Metonitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine)", "title": "Metonitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Metopon\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Substances, vegetable origin or chemical synthesis\n\n> (b) Substances, vegetable origin or chemical synthesis.\n\n**DEA code number:** 9260\n\n**CFR citation:** 21 CFR 1308.12(b)(1)(viii)\n\n> (viii) Metopon | 9260 |\n\nSource: \n", "category": "Substances, vegetable origin or chemical synthesis", "citation": "21 CFR 1308.12(b)(1)(viii)", "dea_code_number": "9260", "file": "metopon.md", "generated": true, "harvested": "2026-09-01", "id": "metopon", "quote_category": "(b) Substances, vegetable origin or chemical synthesis.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(viii) Metopon | 9260 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Metopon", "title": "Metopon \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** mibolerone (7\u03b1,17\u03b1-dimethyl-17\u03b2-hydroxyestr-4-en-3-one)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(63)\n\n> (63) mibolerone (7\u03b1,17\u03b1-dimethyl-17\u03b2-hydroxyestr-4-en-3-one);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(63)", "file": "mibolerone-7-17-dimethyl-17-hydroxyestr-4-en-3-one.md", "generated": true, "harvested": "2026-09-01", "id": "mibolerone-7-17-dimethyl-17-hydroxyestr-4-en-3-one", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(63) mibolerone (7\u03b1,17\u03b1-dimethyl-17\u03b2-hydroxyestr-4-en-3-one);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "mibolerone (7\u03b1,17\u03b1-dimethyl-17\u03b2-hydroxyestr-4-en-3-one)", "title": "mibolerone (7\u03b1,17\u03b1-dimethyl-17\u03b2-hydroxyestr-4-en-3-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Midazolam\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2884\n\n**CFR citation:** 21 CFR 1308.14(c)(41)\n\n> (41) Midazolam | 2884 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(41)", "dea_code_number": "2884", "file": "midazolam.md", "generated": true, "harvested": "2026-09-01", "id": "midazolam", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(41) Midazolam | 2884 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Midazolam", "title": "Midazolam \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Modafinil\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Stimulants\n\n> (f) Stimulants.\n\n**DEA code number:** 1680\n\n**CFR citation:** 21 CFR 1308.14(f)(7)\n\n> (7)Modafinil | 1680 |\n\nSource: \n", "category": "Stimulants", "citation": "21 CFR 1308.14(f)(7)", "dea_code_number": "1680", "file": "modafinil.md", "generated": true, "harvested": "2026-09-01", "id": "modafinil", "quote_category": "(f) Stimulants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(7)Modafinil | 1680 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Modafinil", "title": "Modafinil \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Opiates\n\n> (c) Opiates.\n\n**DEA code number:** 9802\n\n**CFR citation:** 21 CFR 1308.12(c)(17)\n\n> (17) Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid | 9802 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.12(c)(17)", "dea_code_number": "9802", "file": "moramide-intermediate-2-methyl-3-morpholino-1-1-diphenylpropane-carboxylic-acid.md", "generated": true, "harvested": "2026-09-01", "id": "moramide-intermediate-2-methyl-3-morpholino-1-1-diphenylpropane-carboxylic-acid", "quote_category": "(c) Opiates.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(17) Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid | 9802 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid", "title": "Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Morpheridine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9632\n\n**CFR citation:** 21 CFR 1308.11(b)(69)\n\n> (69) Morpheridine | 9632 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(69)", "dea_code_number": "9632", "file": "morpheridine.md", "generated": true, "harvested": "2026-09-01", "id": "morpheridine", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(69) Morpheridine | 9632 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Morpheridine", "title": "Morpheridine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** morphine\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Narcotic drugs\n\n> (e) Narcotic drugs.\n\n**DEA code number:** 9810\n\n**Only when:** Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts\n\n**CFR citation:** 21 CFR 1308.13(e)(1)(vi)\n\n> (vi) Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts | 9810 |\n\nSource: \n", "category": "Narcotic drugs", "citation": "21 CFR 1308.13(e)(1)(vi)", "dea_code_number": "9810", "file": "morphine-2.md", "generated": true, "harvested": "2026-09-01", "id": "morphine-2", "quote_category": "(e) Narcotic drugs.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "scope_qualifier": "Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts", "source_quote": "(vi) Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts | 9810 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "morphine", "title": "morphine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Morphine methylbromide\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opium derivatives\n\n> (c) Opium derivatives.\n\n**DEA code number:** 9305\n\n**CFR citation:** 21 CFR 1308.11(c)(15)\n\n> (15) Morphine methylbromide | 9305 |\n\nSource: \n", "category": "Opium derivatives", "citation": "21 CFR 1308.11(c)(15)", "dea_code_number": "9305", "file": "morphine-methylbromide.md", "generated": true, "harvested": "2026-09-01", "id": "morphine-methylbromide", "quote_category": "(c) Opium derivatives.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(15) Morphine methylbromide | 9305 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Morphine methylbromide", "title": "Morphine methylbromide \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Morphine methylsulfonate\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opium derivatives\n\n> (c) Opium derivatives.\n\n**DEA code number:** 9306\n\n**CFR citation:** 21 CFR 1308.11(c)(16)\n\n> (16) Morphine methylsulfonate | 9306 |\n\nSource: \n", "category": "Opium derivatives", "citation": "21 CFR 1308.11(c)(16)", "dea_code_number": "9306", "file": "morphine-methylsulfonate.md", "generated": true, "harvested": "2026-09-01", "id": "morphine-methylsulfonate", "quote_category": "(c) Opium derivatives.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(16) Morphine methylsulfonate | 9306 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Morphine methylsulfonate", "title": "Morphine methylsulfonate \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Morphine-N-Oxide\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opium derivatives\n\n> (c) Opium derivatives.\n\n**DEA code number:** 9307\n\n**CFR citation:** 21 CFR 1308.11(c)(17)\n\n> (17) Morphine-N-Oxide | 9307 |\n\nSource: \n", "category": "Opium derivatives", "citation": "21 CFR 1308.11(c)(17)", "dea_code_number": "9307", "file": "morphine-n-oxide.md", "generated": true, "harvested": "2026-09-01", "id": "morphine-n-oxide", "quote_category": "(c) Opium derivatives.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(17) Morphine-N-Oxide | 9307 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Morphine-N-Oxide", "title": "Morphine-N-Oxide \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Morphine\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Substances, vegetable origin or chemical synthesis\n\n> (b) Substances, vegetable origin or chemical synthesis.\n\n**DEA code number:** 9300\n\n**CFR citation:** 21 CFR 1308.12(b)(1)(ix)\n\n> (ix) Morphine | 9300 |\n\nSource: \n", "category": "Substances, vegetable origin or chemical synthesis", "citation": "21 CFR 1308.12(b)(1)(ix)", "dea_code_number": "9300", "file": "morphine.md", "generated": true, "harvested": "2026-09-01", "id": "morphine", "quote_category": "(b) Substances, vegetable origin or chemical synthesis.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(ix) Morphine | 9300 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Morphine", "title": "Morphine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** MPPP (1-methyl-4-phenyl-4-propionoxypiperidine)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9661\n\n**CFR citation:** 21 CFR 1308.11(b)(70)\n\n> (70) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine) | 9661 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(70)", "dea_code_number": "9661", "file": "mppp-1-methyl-4-phenyl-4-propionoxypiperidine.md", "generated": true, "harvested": "2026-09-01", "id": "mppp-1-methyl-4-phenyl-4-propionoxypiperidine", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(70) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine) | 9661 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "MPPP (1-methyl-4-phenyl-4-propionoxypiperidine)", "title": "MPPP (1-methyl-4-phenyl-4-propionoxypiperidine) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9560\n\n**CFR citation:** 21 CFR 1308.11(b)(71)\n\n> (71) MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine) | 9560 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(71)", "dea_code_number": "9560", "file": "mt-45-1-cyclohexyl-4-1-2-diphenylethyl-piperazine.md", "generated": true, "harvested": "2026-09-01", "id": "mt-45-1-cyclohexyl-4-1-2-diphenylethyl-piperazine", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(71) MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine) | 9560 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine)", "title": "MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Myrophine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opium derivatives\n\n> (c) Opium derivatives.\n\n**DEA code number:** 9308\n\n**CFR citation:** 21 CFR 1308.11(c)(18)\n\n> (18) Myrophine | 9308 |\n\nSource: \n", "category": "Opium derivatives", "citation": "21 CFR 1308.11(c)(18)", "dea_code_number": "9308", "file": "myrophine.md", "generated": true, "harvested": "2026-09-01", "id": "myrophine", "quote_category": "(c) Opium derivatives.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(18) Myrophine | 9308 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Myrophine", "title": "Myrophine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide (APINACA, AKB48)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7048\n\n**CFR citation:** 21 CFR 1308.11(d)(50)\n\n> (50) N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide (APINACA, AKB48) | (7048) |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(50)", "dea_code_number": "7048", "file": "n-1-adamantyl-1-pentyl-1h-indazole-3-carboxamide-apinaca-akb48.md", "generated": true, "harvested": "2026-09-01", "id": "n-1-adamantyl-1-pentyl-1h-indazole-3-carboxamide-apinaca-akb48", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(50) N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide (APINACA, AKB48) | (7048) |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide (APINACA, AKB48)", "title": "N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide (APINACA, AKB48) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (Other names: ADB-FUBINACA)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7010\n\n**CFR citation:** 21 CFR 1308.11(d)(76)\n\n> (76) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (Other names: ADB-FUBINACA) | 7010 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(76)", "dea_code_number": "7010", "file": "n-1-amino-3-3-dimethyl-1-oxobutan-2-yl-1-4-fluorobenzyl-1h-indazole-3-carboxamid.md", "generated": true, "harvested": "2026-09-01", "id": "n-1-amino-3-3-dimethyl-1-oxobutan-2-yl-1-4-fluorobenzyl-1h-indazole-3-carboxamid", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(76) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (Other names: ADB-FUBINACA) | 7010 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (Other names: ADB-FUBINACA)", "title": "N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (Other names: ADB-FUBINACA) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-butyl-1H-indazole-3-carboxamide (other name: ADB-BUTINACA)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7027\n\n**CFR citation:** 21 CFR 1308.11(d)(102)\n\n> (102) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-butyl-1H-indazole-3-carboxamide (other name: ADB-BUTINACA) | 7027 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(102)", "dea_code_number": "7027", "file": "n-1-amino-3-3-dimethyl-1-oxobutan-2-yl-1-butyl-1h-indazole-3-carboxamide-other-n.md", "generated": true, "harvested": "2026-09-01", "id": "n-1-amino-3-3-dimethyl-1-oxobutan-2-yl-1-butyl-1h-indazole-3-carboxamide-other-n", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(102) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-butyl-1H-indazole-3-carboxamide (other name: ADB-BUTINACA) | 7027 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-butyl-1H-indazole-3-carboxamide (other name: ADB-BUTINACA)", "title": "N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-butyl-1H-indazole-3-carboxamide (other name: ADB-BUTINACA) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (MAB-CHMINACA; ADB-CHMINACA)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7032\n\n**CFR citation:** 21 CFR 1308.11(d)(72)\n\n> (72) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (MAB-CHMINACA; ADB-CHMINACA) | (7032) |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(72)", "dea_code_number": "7032", "file": "n-1-amino-3-3-dimethyl-1-oxobutan-2-yl-1-cyclohexylmethyl-1h-indazole-3-carboxam.md", "generated": true, "harvested": "2026-09-01", "id": "n-1-amino-3-3-dimethyl-1-oxobutan-2-yl-1-cyclohexylmethyl-1h-indazole-3-carboxam", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(72) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (MAB-CHMINACA; ADB-CHMINACA) | (7032) |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (MAB-CHMINACA; ADB-CHMINACA)", "title": "N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (MAB-CHMINACA; ADB-CHMINACA) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-indazole-3-carboxamide (other name: ADB-4en-PINACA)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7092\n\n**CFR citation:** 21 CFR 1308.11(d)(112)\n\n> (112) N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-indazole-3-carboxamide (other name: ADB-4en-PINACA) | 7092 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(112)", "dea_code_number": "7092", "file": "n-1-amino-3-3-dimethyl-1-oxobutan-2-yl-1-pent-4-en-1-yl-1h-indazole-3-carboxamid.md", "generated": true, "harvested": "2026-09-01", "id": "n-1-amino-3-3-dimethyl-1-oxobutan-2-yl-1-pent-4-en-1-yl-1h-indazole-3-carboxamid", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(112) N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-indazole-3-carboxamide (other name: ADB-4en-PINACA) | 7092 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-indazole-3-carboxamide (other name: ADB-4en-PINACA)", "title": "N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-indazole-3-carboxamide (other name: ADB-4en-PINACA) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (ADB-PINACA)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7035\n\n**CFR citation:** 21 CFR 1308.11(d)(54)\n\n> (54) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (ADB-PINACA) | (7035) |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(54)", "dea_code_number": "7035", "file": "n-1-amino-3-3-dimethyl-1-oxobutan-2-yl-1-pentyl-1h-indazole-3-carboxamide-adb-pi.md", "generated": true, "harvested": "2026-09-01", "id": "n-1-amino-3-3-dimethyl-1-oxobutan-2-yl-1-pentyl-1h-indazole-3-carboxamide-adb-pi", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(54) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (ADB-PINACA) | (7035) |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (ADB-PINACA)", "title": "N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (ADB-PINACA) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7012\n\n**CFR citation:** 21 CFR 1308.11(d)(53)\n\n> (53) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA) | (7012) |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(53)", "dea_code_number": "7012", "file": "n-1-amino-3-methyl-1-oxobutan-2-yl-1-4-fluorobenzyl-1h-indazole-3-carboxamide-ab.md", "generated": true, "harvested": "2026-09-01", "id": "n-1-amino-3-methyl-1-oxobutan-2-yl-1-4-fluorobenzyl-1h-indazole-3-carboxamide-ab", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(53) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA) | (7012) |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA)", "title": "N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (Other name: 5F-AB-PINACA)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7025\n\n**CFR citation:** 21 CFR 1308.11(d)(82)\n\n> (82) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (Other name: 5F-AB-PINACA) | 7025 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(82)", "dea_code_number": "7025", "file": "n-1-amino-3-methyl-1-oxobutan-2-yl-1-5-fluoropentyl-1h-indazole-3-carboxamide-ot.md", "generated": true, "harvested": "2026-09-01", "id": "n-1-amino-3-methyl-1-oxobutan-2-yl-1-5-fluoropentyl-1h-indazole-3-carboxamide-ot", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(82) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (Other name: 5F-AB-PINACA) | 7025 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (Other name: 5F-AB-PINACA)", "title": "N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (Other name: 5F-AB-PINACA) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7031\n\n**CFR citation:** 21 CFR 1308.11(d)(69)\n\n> (69) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA) | (7031) |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(69)", "dea_code_number": "7031", "file": "n-1-amino-3-methyl-1-oxobutan-2-yl-1-cyclohexylmethyl-1h-indazole-3-carboxamide-.md", "generated": true, "harvested": "2026-09-01", "id": "n-1-amino-3-methyl-1-oxobutan-2-yl-1-cyclohexylmethyl-1h-indazole-3-carboxamide-", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(69) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA) | (7031) |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA)", "title": "N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7023\n\n**CFR citation:** 21 CFR 1308.11(d)(70)\n\n> (70) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) | (7023) |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(70)", "dea_code_number": "7023", "file": "n-1-amino-3-methyl-1-oxobutan-2-yl-1-pentyl-1h-indazole-3-carboxamide-ab-pinaca.md", "generated": true, "harvested": "2026-09-01", "id": "n-1-amino-3-methyl-1-oxobutan-2-yl-1-pentyl-1h-indazole-3-carboxamide-ab-pinaca", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(70) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) | (7023) |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA)", "title": "N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (other names: FUB-AKB48; FUB-APINACA; AKB48 N-(4-FLUOROBENZYL))\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7047\n\n**CFR citation:** 21 CFR 1308.11(d)(91)\n\n> (91) N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (other names: FUB-AKB48; FUB-APINACA; AKB48 N-(4-FLUOROBENZYL)) | 7047 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(91)", "dea_code_number": "7047", "file": "n-adamantan-1-yl-1-4-fluorobenzyl-1h-indazole-3-carboxamide-other-names-fub-akb4.md", "generated": true, "harvested": "2026-09-01", "id": "n-adamantan-1-yl-1-4-fluorobenzyl-1h-indazole-3-carboxamide-other-names-fub-akb4", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(91) N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (other names: FUB-AKB48; FUB-APINACA; AKB48 N-(4-FLUOROBENZYL)) | 7047 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (other names: FUB-AKB48; FUB-APINACA; AKB48 N-(4-FLUOROBENZYL))", "title": "N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (other names: FUB-AKB48; FUB-APINACA; AKB48 N-(4-FLUOROBENZYL)) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (Other names: 5F-APINACA, 5F-AKB48)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7049\n\n**CFR citation:** 21 CFR 1308.11(d)(75)\n\n> (75) N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (Other names: 5F-APINACA, 5F-AKB48) | 7049 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(75)", "dea_code_number": "7049", "file": "n-adamantan-1-yl-1-5-fluoropentyl-1h-indazole-3-carboxamide-other-names-5f-apina.md", "generated": true, "harvested": "2026-09-01", "id": "n-adamantan-1-yl-1-5-fluoropentyl-1h-indazole-3-carboxamide-other-names-5f-apina", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(75) N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (Other names: 5F-APINACA, 5F-AKB48) | 7049 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (Other names: 5F-APINACA, 5F-AKB48)", "title": "N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (Other names: 5F-APINACA, 5F-AKB48) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** N-Benzylpiperazine (some other names: BZP, 1-benzylpiperazine)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Stimulants\n\n> (f) Stimulants.\n\n**DEA code number:** 7493\n\n**CFR citation:** 21 CFR 1308.11(f)(3)\n\n> (3) N-Benzylpiperazine (some other names: BZP, 1-benzylpiperazine) | 7493 |\n\nSource: \n", "category": "Stimulants", "citation": "21 CFR 1308.11(f)(3)", "dea_code_number": "7493", "file": "n-benzylpiperazine-some-other-names-bzp-1-benzylpiperazine.md", "generated": true, "harvested": "2026-09-01", "id": "n-benzylpiperazine-some-other-names-bzp-1-benzylpiperazine", "quote_category": "(f) Stimulants.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(3) N-Benzylpiperazine (some other names: BZP, 1-benzylpiperazine) | 7493 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "N-Benzylpiperazine (some other names: BZP, 1-benzylpiperazine)", "title": "N-Benzylpiperazine (some other names: BZP, 1-benzylpiperazine) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** N-Desethyl isotonitazene (N-ethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9760\n\n**CFR citation:** 21 CFR 1308.11(b)(72)\n\n> (72) N-Desethyl isotonitazene (N-ethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) | 9760 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(72)", "dea_code_number": "9760", "file": "n-desethyl-isotonitazene-n-ethyl-2-2-4-isopropoxybenzyl-5-nitro-1h-benzimidazol-.md", "generated": true, "harvested": "2026-09-01", "id": "n-desethyl-isotonitazene-n-ethyl-2-2-4-isopropoxybenzyl-5-nitro-1h-benzimidazol-", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(72) N-Desethyl isotonitazene (N-ethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) | 9760 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "N-Desethyl isotonitazene (N-ethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine)", "title": "N-Desethyl isotonitazene (N-ethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** N-ethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N-desethyl protonitazene)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Temporary listing of substances subject to emergency scheduling\n\n> (h) Temporary listing of substances subject to emergency scheduling.\n\n**DEA code number:** 9769\n\n**Temporary listing expires:** Oct. 15, 2027\n\n> adding paragraphs (h)(79) through (85), effective Oct. 15, 2025, until Oct. 15, 2027\n\n**CFR citation:** 21 CFR 1308.11(h)(83)\n\n> (83) N-ethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N-desethyl protonitazene) | 9769 |\n\nSource: \n", "category": "Temporary listing of substances subject to emergency scheduling", "citation": "21 CFR 1308.11(h)(83)", "dea_code_number": "9769", "file": "n-ethyl-2-5-nitro-2-4-propoxybenzyl-1h-benzimidazol-1-yl-ethan-1-amine-its-isome.md", "generated": true, "harvested": "2026-09-01", "id": "n-ethyl-2-5-nitro-2-4-propoxybenzyl-1h-benzimidazol-1-yl-ethan-1-amine-its-isome", "quote_category": "(h) Temporary listing of substances subject to emergency scheduling.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "quote_temporary_expiry": "adding paragraphs (h)(79) through (85), effective Oct. 15, 2025, until Oct. 15, 2027", "schedule": "Schedule I", "source_quote": "(83) N-ethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N-desethyl protonitazene) | 9769 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "N-ethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N-desethyl protonitazene)", "temporary_expiry": "Oct. 15, 2027", "title": "N-ethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N-desethyl protonitazene) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** N-ethyl-3-piperidyl benzilate\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7482\n\n**CFR citation:** 21 CFR 1308.11(d)(27)\n\n> (27) N-ethyl-3-piperidyl benzilate | 7482 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(27)", "dea_code_number": "7482", "file": "n-ethyl-3-piperidyl-benzilate.md", "generated": true, "harvested": "2026-09-01", "id": "n-ethyl-3-piperidyl-benzilate", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(27) N-ethyl-3-piperidyl benzilate | 7482 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "N-ethyl-3-piperidyl benzilate", "title": "N-ethyl-3-piperidyl benzilate \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** N-ethylamphetamine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Stimulants\n\n> (f) Stimulants.\n\n**DEA code number:** 1475\n\n**CFR citation:** 21 CFR 1308.11(f)(13)\n\n> (13) N-ethylamphetamine | 1475 |\n\nSource: \n", "category": "Stimulants", "citation": "21 CFR 1308.11(f)(13)", "dea_code_number": "1475", "file": "n-ethylamphetamine.md", "generated": true, "harvested": "2026-09-01", "id": "n-ethylamphetamine", "quote_category": "(f) Stimulants.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(13) N-ethylamphetamine | 1475 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "N-ethylamphetamine", "title": "N-ethylamphetamine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** N-Ethylhexedrone (Other names: \u03b1-ethylaminohexanophenone; 2-(ethylamino)-1-phenylhexan-1-one)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7246\n\n**CFR citation:** 21 CFR 1308.11(d)(94)\n\n> (94) N-Ethylhexedrone (Other names: \u03b1-ethylaminohexanophenone; 2-(ethylamino)-1-phenylhexan-1-one) | 7246 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(94)", "dea_code_number": "7246", "file": "n-ethylhexedrone-other-names-ethylaminohexanophenone-2-ethylamino-1-phenylhexan-.md", "generated": true, "harvested": "2026-09-01", "id": "n-ethylhexedrone-other-names-ethylaminohexanophenone-2-ethylamino-1-phenylhexan-", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(94) N-Ethylhexedrone (Other names: \u03b1-ethylaminohexanophenone; 2-(ethylamino)-1-phenylhexan-1-one) | 7246 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "N-Ethylhexedrone (Other names: \u03b1-ethylaminohexanophenone; 2-(ethylamino)-1-phenylhexan-1-one)", "title": "N-Ethylhexedrone (Other names: \u03b1-ethylaminohexanophenone; 2-(ethylamino)-1-phenylhexan-1-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** N-ethylpentylone (Other names: ephylone, 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)pentan-1-one)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7543\n\n**CFR citation:** 21 CFR 1308.11(d)(86)\n\n> (86) N-ethylpentylone (Other names: ephylone, 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)pentan-1-one) | 7543 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(86)", "dea_code_number": "7543", "file": "n-ethylpentylone-other-names-ephylone-1-1-3-benzodioxol-5-yl-2-ethylamino-pentan.md", "generated": true, "harvested": "2026-09-01", "id": "n-ethylpentylone-other-names-ephylone-1-1-3-benzodioxol-5-yl-2-ethylamino-pentan", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(86) N-ethylpentylone (Other names: ephylone, 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)pentan-1-one) | 7543 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "N-ethylpentylone (Other names: ephylone, 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)pentan-1-one)", "title": "N-ethylpentylone (Other names: ephylone, 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)pentan-1-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** N-hydroxy-3,4-methylenedioxyamphetamine (also known as N-hydroxy-alpha-methyl-3,4(methylenedioxy)-phenethylamine, and N-hydroxy MDA\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7402\n\n**CFR citation:** 21 CFR 1308.11(d)(13)\n\n> (13) N-hydroxy-3,4-methylenedioxyamphetamine (also known as N-hydroxy-alpha-methyl-3,4(methylenedioxy)-phenethylamine, and N-hydroxy MDA | 7402 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(13)", "dea_code_number": "7402", "file": "n-hydroxy-3-4-methylenedioxyamphetamine-also-known-as-n-hydroxy-alpha-methyl-3-4.md", "generated": true, "harvested": "2026-09-01", "id": "n-hydroxy-3-4-methylenedioxyamphetamine-also-known-as-n-hydroxy-alpha-methyl-3-4", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(13) N-hydroxy-3,4-methylenedioxyamphetamine (also known as N-hydroxy-alpha-methyl-3,4(methylenedioxy)-phenethylamine, and N-hydroxy MDA | 7402 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "N-hydroxy-3,4-methylenedioxyamphetamine (also known as N-hydroxy-alpha-methyl-3,4(methylenedioxy)-phenethylamine, and N-hydroxy MDA", "title": "N-hydroxy-3,4-methylenedioxyamphetamine (also known as N-hydroxy-alpha-methyl-3,4(methylenedioxy)-phenethylamine, and N-hydroxy MDA \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** N-methyl-3-piperidyl benzilate\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7484\n\n**CFR citation:** 21 CFR 1308.11(d)(28)\n\n> (28) N-methyl-3-piperidyl benzilate | 7484 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(28)", "dea_code_number": "7484", "file": "n-methyl-3-piperidyl-benzilate.md", "generated": true, "harvested": "2026-09-01", "id": "n-methyl-3-piperidyl-benzilate", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(28) N-methyl-3-piperidyl benzilate | 7484 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "N-methyl-3-piperidyl benzilate", "title": "N-methyl-3-piperidyl benzilate \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine (Other name: protonitazene)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9759\n\n**CFR citation:** 21 CFR 1308.11(b)(111)\n\n> (111) N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine (Other name: protonitazene) | 9759 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(111)", "dea_code_number": "9759", "file": "n-n-diethyl-2-5-nitro-2-4-propoxybenzyl-1h-benzimidazol-1-yl-ethan-1-amine-other.md", "generated": true, "harvested": "2026-09-01", "id": "n-n-diethyl-2-5-nitro-2-4-propoxybenzyl-1h-benzimidazol-1-yl-ethan-1-amine-other", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(111) N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine (Other name: protonitazene) | 9759 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine (Other name: protonitazene)", "title": "N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine (Other name: protonitazene) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** N,N-dimethylamphetamine (also known as N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Stimulants\n\n> (f) Stimulants.\n\n**DEA code number:** 1480\n\n**CFR citation:** 21 CFR 1308.11(f)(14)\n\n> (14) N,N-dimethylamphetamine (also known as N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine) | 1480 |\n\nSource: \n", "category": "Stimulants", "citation": "21 CFR 1308.11(f)(14)", "dea_code_number": "1480", "file": "n-n-dimethylamphetamine-also-known-as-n-n-alpha-trimethyl-benzeneethanamine-n-n-.md", "generated": true, "harvested": "2026-09-01", "id": "n-n-dimethylamphetamine-also-known-as-n-n-alpha-trimethyl-benzeneethanamine-n-n-", "quote_category": "(f) Stimulants.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(14) N,N-dimethylamphetamine (also known as N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine) | 1480 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "N,N-dimethylamphetamine (also known as N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine)", "title": "N,N-dimethylamphetamine (also known as N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** N-phenyl-N-(piperidin-4-yl)propionamide (norfentanyl)\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Immediate precursors\n\n> (g) Immediate precursors.\n\n**DEA code number:** 8366\n\n**CFR citation:** 21 CFR 1308.12(g)(3)(ii)\n\n> (ii) N-phenyl-N-(piperidin-4-yl)propionamide (norfentanyl) | 8366 |\n\nSource: \n", "category": "Immediate precursors", "citation": "21 CFR 1308.12(g)(3)(ii)", "dea_code_number": "8366", "file": "n-phenyl-n-piperidin-4-yl-propionamide-norfentanyl.md", "generated": true, "harvested": "2026-09-01", "id": "n-phenyl-n-piperidin-4-yl-propionamide-norfentanyl", "quote_category": "(g) Immediate precursors.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(ii) N-phenyl-N-(piperidin-4-yl)propionamide (norfentanyl) | 8366 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "N-phenyl-N-(piperidin-4-yl)propionamide (norfentanyl)", "title": "N-phenyl-N-(piperidin-4-yl)propionamide (norfentanyl) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** N-Piperidinyl etonitazene (2-(4-ethoxybenzyl)-5-nitro-1-(2-(piperidin-1-yl)ethyl)-1H-benzimidazole (other names: etonitazepipne)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9761\n\n**CFR citation:** 21 CFR 1308.11(b)(77)\n\n> (77) N-Piperidinyl etonitazene (2-(4-ethoxybenzyl)-5-nitro-1-(2-(piperidin-1-yl)ethyl)-1H-benzimidazole (other names: etonitazepipne) | 9761 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(77)", "dea_code_number": "9761", "file": "n-piperidinyl-etonitazene-2-4-ethoxybenzyl-5-nitro-1-2-piperidin-1-yl-ethyl-1h-b.md", "generated": true, "harvested": "2026-09-01", "id": "n-piperidinyl-etonitazene-2-4-ethoxybenzyl-5-nitro-1-2-piperidin-1-yl-ethyl-1h-b", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(77) N-Piperidinyl etonitazene (2-(4-ethoxybenzyl)-5-nitro-1-(2-(piperidin-1-yl)ethyl)-1H-benzimidazole (other names: etonitazepipne) | 9761 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "N-Piperidinyl etonitazene (2-(4-ethoxybenzyl)-5-nitro-1-(2-(piperidin-1-yl)ethyl)-1H-benzimidazole (other names: etonitazepipne)", "title": "N-Piperidinyl etonitazene (2-(4-ethoxybenzyl)-5-nitro-1-(2-(piperidin-1-yl)ethyl)-1H-benzimidazole (other names: etonitazepipne) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Nabilone\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Hallucinogenic substances\n\n> (f) Hallucinogenic substances.\n\n**DEA code number:** 7379\n\n**CFR citation:** 21 CFR 1308.12(f)(1)\n\n> (1) Nabilone | 7379 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.12(f)(1)", "dea_code_number": "7379", "file": "nabilone.md", "generated": true, "harvested": "2026-09-01", "id": "nabilone", "quote_category": "(f) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(1) Nabilone | 7379 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Nabilone", "title": "Nabilone \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Nalorphine\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**DEA code number:** 9400\n\n**CFR citation:** 21 CFR 1308.13(d)\n\n> (d) Nalorphine 9400.\n\nSource: \n", "citation": "21 CFR 1308.13(d)", "dea_code_number": "9400", "file": "nalorphine.md", "generated": true, "harvested": "2026-09-01", "id": "nalorphine", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(d) Nalorphine 9400.", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Nalorphine", "title": "Nalorphine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** nandrolone (17\u03b2-hydroxyestr-4-en-3-one)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(64)\n\n> (64) nandrolone (17\u03b2-hydroxyestr-4-en-3-one);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(64)", "file": "nandrolone-17-hydroxyestr-4-en-3-one.md", "generated": true, "harvested": "2026-09-01", "id": "nandrolone-17-hydroxyestr-4-en-3-one", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(64) nandrolone (17\u03b2-hydroxyestr-4-en-3-one);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "nandrolone (17\u03b2-hydroxyestr-4-en-3-one)", "title": "nandrolone (17\u03b2-hydroxyestr-4-en-3-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (Other names: NM2201; CBL2201)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7221\n\n**CFR citation:** 21 CFR 1308.11(d)(81)\n\n> (81) Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (Other names: NM2201; CBL2201) | 7221 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(81)", "dea_code_number": "7221", "file": "naphthalen-1-yl-1-5-fluoropentyl-1h-indole-3-carboxylate-other-names-nm2201-cbl2.md", "generated": true, "harvested": "2026-09-01", "id": "naphthalen-1-yl-1-5-fluoropentyl-1h-indole-3-carboxylate-other-names-nm2201-cbl2", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(81) Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (Other names: NM2201; CBL2201) | 7221 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (Other names: NM2201; CBL2201)", "title": "Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (Other names: NM2201; CBL2201) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Naturally derived delta-9-tetrahydrocannabinols\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Hallucinogenic substances\n\n> (g) Hallucinogenic substances.\n\n**Only when:** in a U.S. Food and Drug Administration approved product or in marijuana subject to a state medical marijuana license\n\n**CFR citation:** 21 CFR 1308.13(g)(4)\n\n> (4) Naturally derived delta-9-tetrahydrocannabinols in a U.S. Food and Drug Administration approved product or in marijuana subject to a state medical marijuana license\u2014XXXX (i) Naturally derived delta-9-tetrahydrocannabinols means those delta-9-tetrahydrocannabinols, except as in paragraphs (g)(2) and (3) of this section, that are naturally contained in a plant of the genus Cannabis (cannabis plant). (ii) Naturally derived delta-9-tetrahydrocannabinols do not include any material, compound, mixture, or preparation that falls within the definition of hemp set forth in 7 U.S.C. 1639 o. (iii) Naturally derived delta-9-tetrahydrocannabinols do not include any delta-9-tetrahydrocannabinols contained in substances excluded from the definition of marijuana as set forth in 21 U.S.C. 802(16)(B)(ii) .\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.13(g)(4)", "file": "naturally-derived-delta-9-tetrahydrocannabinols.md", "generated": true, "harvested": "2026-09-01", "id": "naturally-derived-delta-9-tetrahydrocannabinols", "quote_category": "(g) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "scope_qualifier": "in a U.S. Food and Drug Administration approved product or in marijuana subject to a state medical marijuana license", "source_quote": "(4) Naturally derived delta-9-tetrahydrocannabinols in a U.S. Food and Drug Administration approved product or in marijuana subject to a state medical marijuana license\u2014XXXX (i) Naturally derived delta-9-tetrahydrocannabinols means those delta-9-tetrahydrocannabinols, except as in paragraphs (g)(2) and (3) of this section, that are naturally contained in a plant of the genus Cannabis (cannabis plant). (ii) Naturally derived delta-9-tetrahydrocannabinols do not include any material, compound, mixture, or preparation that falls within the definition of hemp set forth in 7 U.S.C. 1639 o. (iii) Naturally derived delta-9-tetrahydrocannabinols do not include any delta-9-tetrahydrocannabinols contained in substances excluded from the definition of marijuana as set forth in 21 U.S.C. 802(16)(B)(ii) .", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Naturally derived delta-9-tetrahydrocannabinols", "title": "Naturally derived delta-9-tetrahydrocannabinols \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Nicocodeine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opium derivatives\n\n> (c) Opium derivatives.\n\n**DEA code number:** 9309\n\n**CFR citation:** 21 CFR 1308.11(c)(19)\n\n> (19) Nicocodeine | 9309 |\n\nSource: \n", "category": "Opium derivatives", "citation": "21 CFR 1308.11(c)(19)", "dea_code_number": "9309", "file": "nicocodeine.md", "generated": true, "harvested": "2026-09-01", "id": "nicocodeine", "quote_category": "(c) Opium derivatives.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(19) Nicocodeine | 9309 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Nicocodeine", "title": "Nicocodeine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Nicomorphine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opium derivatives\n\n> (c) Opium derivatives.\n\n**DEA code number:** 9312\n\n**CFR citation:** 21 CFR 1308.11(c)(20)\n\n> (20) Nicomorphine | 9312 |\n\nSource: \n", "category": "Opium derivatives", "citation": "21 CFR 1308.11(c)(20)", "dea_code_number": "9312", "file": "nicomorphine.md", "generated": true, "harvested": "2026-09-01", "id": "nicomorphine", "quote_category": "(c) Opium derivatives.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(20) Nicomorphine | 9312 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Nicomorphine", "title": "Nicomorphine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Nimetazepam\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2837\n\n**CFR citation:** 21 CFR 1308.14(c)(42)\n\n> (42) Nimetazepam | 2837 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(42)", "dea_code_number": "2837", "file": "nimetazepam.md", "generated": true, "harvested": "2026-09-01", "id": "nimetazepam", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(42) Nimetazepam | 2837 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Nimetazepam", "title": "Nimetazepam \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Nitrazepam\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2834\n\n**CFR citation:** 21 CFR 1308.14(c)(43)\n\n> (43) Nitrazepam | 2834 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(43)", "dea_code_number": "2834", "file": "nitrazepam.md", "generated": true, "harvested": "2026-09-01", "id": "nitrazepam", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(43) Nitrazepam | 2834 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Nitrazepam", "title": "Nitrazepam \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Noracymethadol\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9633\n\n**CFR citation:** 21 CFR 1308.11(b)(73)\n\n> (73) Noracymethadol | 9633 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(73)", "dea_code_number": "9633", "file": "noracymethadol.md", "generated": true, "harvested": "2026-09-01", "id": "noracymethadol", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(73) Noracymethadol | 9633 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Noracymethadol", "title": "Noracymethadol \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** norbolethone (13\u03b2,17\u03b1-diethyl-17\u03b2-hydroxygon-4-en-3-one)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(72)\n\n> (72) norbolethone (13\u03b2,17\u03b1-diethyl-17\u03b2-hydroxygon-4-en-3-one);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(72)", "file": "norbolethone-13-17-diethyl-17-hydroxygon-4-en-3-one.md", "generated": true, "harvested": "2026-09-01", "id": "norbolethone-13-17-diethyl-17-hydroxygon-4-en-3-one", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(72) norbolethone (13\u03b2,17\u03b1-diethyl-17\u03b2-hydroxygon-4-en-3-one);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "norbolethone (13\u03b2,17\u03b1-diethyl-17\u03b2-hydroxygon-4-en-3-one)", "title": "norbolethone (13\u03b2,17\u03b1-diethyl-17\u03b2-hydroxygon-4-en-3-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** norclostebol (4-chloro-17\u03b2-hydroxyestr-4-en-3-one)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(73)\n\n> (73) norclostebol (4-chloro-17\u03b2-hydroxyestr-4-en-3-one);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(73)", "file": "norclostebol-4-chloro-17-hydroxyestr-4-en-3-one.md", "generated": true, "harvested": "2026-09-01", "id": "norclostebol-4-chloro-17-hydroxyestr-4-en-3-one", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(73) norclostebol (4-chloro-17\u03b2-hydroxyestr-4-en-3-one);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "norclostebol (4-chloro-17\u03b2-hydroxyestr-4-en-3-one)", "title": "norclostebol (4-chloro-17\u03b2-hydroxyestr-4-en-3-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Nordiazepam\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2838\n\n**CFR citation:** 21 CFR 1308.14(c)(44)\n\n> (44) Nordiazepam | 2838 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(44)", "dea_code_number": "2838", "file": "nordiazepam.md", "generated": true, "harvested": "2026-09-01", "id": "nordiazepam", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(44) Nordiazepam | 2838 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Nordiazepam", "title": "Nordiazepam \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** norethandrolone (17\u03b1-ethyl-17\u03b2-hydroxyestr-4-en-3-one)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(74)\n\n> (74) norethandrolone (17\u03b1-ethyl-17\u03b2-hydroxyestr-4-en-3-one);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(74)", "file": "norethandrolone-17-ethyl-17-hydroxyestr-4-en-3-one.md", "generated": true, "harvested": "2026-09-01", "id": "norethandrolone-17-ethyl-17-hydroxyestr-4-en-3-one", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(74) norethandrolone (17\u03b1-ethyl-17\u03b2-hydroxyestr-4-en-3-one);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "norethandrolone (17\u03b1-ethyl-17\u03b2-hydroxyestr-4-en-3-one)", "title": "norethandrolone (17\u03b1-ethyl-17\u03b2-hydroxyestr-4-en-3-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Norlevorphanol\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9634\n\n**CFR citation:** 21 CFR 1308.11(b)(74)\n\n> (74) Norlevorphanol | 9634 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(74)", "dea_code_number": "9634", "file": "norlevorphanol.md", "generated": true, "harvested": "2026-09-01", "id": "norlevorphanol", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(74) Norlevorphanol | 9634 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Norlevorphanol", "title": "Norlevorphanol \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Normethadone\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9635\n\n**CFR citation:** 21 CFR 1308.11(b)(75)\n\n> (75) Normethadone | 9635 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(75)", "dea_code_number": "9635", "file": "normethadone.md", "generated": true, "harvested": "2026-09-01", "id": "normethadone", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(75) Normethadone | 9635 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Normethadone", "title": "Normethadone \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** normethandrolone (17\u03b1-methyl-17\u03b2-hydroxyestr-4-en-3-one)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(75)\n\n> (75) normethandrolone (17\u03b1-methyl-17\u03b2-hydroxyestr-4-en-3-one);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(75)", "file": "normethandrolone-17-methyl-17-hydroxyestr-4-en-3-one.md", "generated": true, "harvested": "2026-09-01", "id": "normethandrolone-17-methyl-17-hydroxyestr-4-en-3-one", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(75) normethandrolone (17\u03b1-methyl-17\u03b2-hydroxyestr-4-en-3-one);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "normethandrolone (17\u03b1-methyl-17\u03b2-hydroxyestr-4-en-3-one)", "title": "normethandrolone (17\u03b1-methyl-17\u03b2-hydroxyestr-4-en-3-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Normorphine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opium derivatives\n\n> (c) Opium derivatives.\n\n**DEA code number:** 9313\n\n**CFR citation:** 21 CFR 1308.11(c)(21)\n\n> (21) Normorphine | 9313 |\n\nSource: \n", "category": "Opium derivatives", "citation": "21 CFR 1308.11(c)(21)", "dea_code_number": "9313", "file": "normorphine.md", "generated": true, "harvested": "2026-09-01", "id": "normorphine", "quote_category": "(c) Opium derivatives.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(21) Normorphine | 9313 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Normorphine", "title": "Normorphine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Noroxymorphone\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Substances, vegetable origin or chemical synthesis\n\n> (b) Substances, vegetable origin or chemical synthesis.\n\n**DEA code number:** 9668\n\n**CFR citation:** 21 CFR 1308.12(b)(1)(x)\n\n> (x) Noroxymorphone | 9668 |\n\nSource: \n", "category": "Substances, vegetable origin or chemical synthesis", "citation": "21 CFR 1308.12(b)(1)(x)", "dea_code_number": "9668", "file": "noroxymorphone.md", "generated": true, "harvested": "2026-09-01", "id": "noroxymorphone", "quote_category": "(b) Substances, vegetable origin or chemical synthesis.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(x) Noroxymorphone | 9668 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Noroxymorphone", "title": "Noroxymorphone \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Norpipanone\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9636\n\n**CFR citation:** 21 CFR 1308.11(b)(76)\n\n> (76) Norpipanone | 9636 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(76)", "dea_code_number": "9636", "file": "norpipanone.md", "generated": true, "harvested": "2026-09-01", "id": "norpipanone", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(76) Norpipanone | 9636 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Norpipanone", "title": "Norpipanone \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Not more than 1 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Narcotic drugs\n\n> (b) Narcotic drugs.\n\n**DEA code number:** 9167\n\n**CFR citation:** 21 CFR 1308.14(b)(1)\n\n> (1) Not more than 1 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit | 9167 |\n\nSource: \n", "category": "Narcotic drugs", "citation": "21 CFR 1308.14(b)(1)", "dea_code_number": "9167", "file": "not-more-than-1-milligram-of-difenoxin-and-not-less-than-25-micrograms-of-atropi.md", "generated": true, "harvested": "2026-09-01", "id": "not-more-than-1-milligram-of-difenoxin-and-not-less-than-25-micrograms-of-atropi", "quote_category": "(b) Narcotic drugs.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(1) Not more than 1 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit | 9167 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Not more than 1 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit", "title": "Not more than 1 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** O-Desmethyltramadol (other names: O-DSMT; desmetramadol; 3-[(1R,2R)-2-[(dimethylamino)methyl]-1-hydroxycyclohexyl]phenol)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Temporary listing of substances subject to emergency scheduling\n\n> (h) Temporary listing of substances subject to emergency scheduling.\n\n**DEA code number:** 9667\n\n**Temporary listing expires:** Aug. 26, 2028\n\n> adding paragraphs (h)(88) through (h)(91), effective Aug. 26, 2026 through Aug. 26, 2028\n\n**CFR citation:** 21 CFR 1308.11(h)(88)\n\n> (88) O-Desmethyltramadol (other names: O-DSMT; desmetramadol; 3-[(1R,2R)-2-[(dimethylamino)methyl]-1-hydroxycyclohexyl]phenol) | 9667 |\n\nSource: \n", "category": "Temporary listing of substances subject to emergency scheduling", "citation": "21 CFR 1308.11(h)(88)", "dea_code_number": "9667", "file": "o-desmethyltramadol-other-names-o-dsmt-desmetramadol-3-1r-2r-2-dimethylamino-met.md", "generated": true, "harvested": "2026-09-01", "id": "o-desmethyltramadol-other-names-o-dsmt-desmetramadol-3-1r-2r-2-dimethylamino-met", "quote_category": "(h) Temporary listing of substances subject to emergency scheduling.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "quote_temporary_expiry": "adding paragraphs (h)(88) through (h)(91), effective Aug. 26, 2026 through Aug. 26, 2028", "schedule": "Schedule I", "source_quote": "(88) O-Desmethyltramadol (other names: O-DSMT; desmetramadol; 3-[(1R,2R)-2-[(dimethylamino)methyl]-1-hydroxycyclohexyl]phenol) | 9667 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "O-Desmethyltramadol (other names: O-DSMT; desmetramadol; 3-[(1R,2R)-2-[(dimethylamino)methyl]-1-hydroxycyclohexyl]phenol)", "temporary_expiry": "Aug. 26, 2028", "title": "O-Desmethyltramadol (other names: O-DSMT; desmetramadol; 3-[(1R,2R)-2-[(dimethylamino)methyl]-1-hydroxycyclohexyl]phenol) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Ocfentanil (N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9838\n\n**CFR citation:** 21 CFR 1308.11(b)(81)\n\n> (81) Ocfentanil (N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide) | 9838 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(81)", "dea_code_number": "9838", "file": "ocfentanil-n-2-fluorophenyl-2-methoxy-n-1-phenethylpiperidin-4-yl-acetamide.md", "generated": true, "harvested": "2026-09-01", "id": "ocfentanil-n-2-fluorophenyl-2-methoxy-n-1-phenethylpiperidin-4-yl-acetamide", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(81) Ocfentanil (N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide) | 9838 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Ocfentanil (N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide)", "title": "Ocfentanil (N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Oliceridine (N-[(3-methoxythiophen-2-yl)methyl]({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro[4.5]decan-9-yl]ethyl})amine)\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Opiates\n\n> (c) Opiates.\n\n**DEA code number:** 9245\n\n**CFR citation:** 21 CFR 1308.12(c)(18)\n\n> (18) Oliceridine (N-[(3-methoxythiophen-2-yl)methyl]({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro[4.5]decan-9-yl]ethyl})amine) | 9245 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.12(c)(18)", "dea_code_number": "9245", "file": "oliceridine-n-3-methoxythiophen-2-yl-methyl-2-9r-9-pyridin-2-yl-6-oxaspiro-4-5-d.md", "generated": true, "harvested": "2026-09-01", "id": "oliceridine-n-3-methoxythiophen-2-yl-methyl-2-9r-9-pyridin-2-yl-6-oxaspiro-4-5-d", "quote_category": "(c) Opiates.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(18) Oliceridine (N-[(3-methoxythiophen-2-yl)methyl]({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro[4.5]decan-9-yl]ethyl})amine) | 9245 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Oliceridine (N-[(3-methoxythiophen-2-yl)methyl]({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro[4.5]decan-9-yl]ethyl})amine)", "title": "Oliceridine (N-[(3-methoxythiophen-2-yl)methyl]({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro[4.5]decan-9-yl]ethyl})amine) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** opium\n\n**Schedule:** Schedule V\n\n> \u00a7 1308.15 Schedule V.\n\n**Listed under:** Narcotic drugs containing non-narcotic active medicinal ingredients\n\n> (c) Narcotic drugs containing non-narcotic active medicinal ingredients.\n\n**Only when:** Not more than 100 milligrams of opium per 100 milliliters or per 100 grams\n\n**CFR citation:** 21 CFR 1308.15(c)(5)\n\n> (5) Not more than 100 milligrams of opium per 100 milliliters or per 100 grams.\n\nSource: \n", "category": "Narcotic drugs containing non-narcotic active medicinal ingredients", "citation": "21 CFR 1308.15(c)(5)", "file": "opium-2.md", "generated": true, "harvested": "2026-09-01", "id": "opium-2", "quote_category": "(c) Narcotic drugs containing non-narcotic active medicinal ingredients.", "quote_schedule": "\u00a7 1308.15 Schedule V.", "schedule": "Schedule V", "scope_qualifier": "Not more than 100 milligrams of opium per 100 milliliters or per 100 grams", "source_quote": "(5) Not more than 100 milligrams of opium per 100 milliliters or per 100 grams.", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "opium", "title": "opium \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Opium extracts\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Substances, vegetable origin or chemical synthesis\n\n> (b) Substances, vegetable origin or chemical synthesis.\n\n**DEA code number:** 9610\n\n**CFR citation:** 21 CFR 1308.12(b)(1)(xi)\n\n> (xi) Opium extracts | 9610 |\n\nSource: \n", "category": "Substances, vegetable origin or chemical synthesis", "citation": "21 CFR 1308.12(b)(1)(xi)", "dea_code_number": "9610", "file": "opium-extracts.md", "generated": true, "harvested": "2026-09-01", "id": "opium-extracts", "quote_category": "(b) Substances, vegetable origin or chemical synthesis.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(xi) Opium extracts | 9610 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Opium extracts", "title": "Opium extracts \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Opium fluid\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Substances, vegetable origin or chemical synthesis\n\n> (b) Substances, vegetable origin or chemical synthesis.\n\n**DEA code number:** 9620\n\n**CFR citation:** 21 CFR 1308.12(b)(1)(xii)\n\n> (xii) Opium fluid | 9620 |\n\nSource: \n", "category": "Substances, vegetable origin or chemical synthesis", "citation": "21 CFR 1308.12(b)(1)(xii)", "dea_code_number": "9620", "file": "opium-fluid.md", "generated": true, "harvested": "2026-09-01", "id": "opium-fluid", "quote_category": "(b) Substances, vegetable origin or chemical synthesis.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(xii) Opium fluid | 9620 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Opium fluid", "title": "Opium fluid \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Opium poppy and poppy straw\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Substances, vegetable origin or chemical synthesis\n\n> (b) Substances, vegetable origin or chemical synthesis.\n\n**CFR citation:** 21 CFR 1308.12(b)(3)\n\n> (3) Opium poppy and poppy straw.\n\nSource: \n", "category": "Substances, vegetable origin or chemical synthesis", "citation": "21 CFR 1308.12(b)(3)", "file": "opium-poppy-and-poppy-straw.md", "generated": true, "harvested": "2026-09-01", "id": "opium-poppy-and-poppy-straw", "quote_category": "(b) Substances, vegetable origin or chemical synthesis.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(3) Opium poppy and poppy straw.", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Opium poppy and poppy straw", "title": "Opium poppy and poppy straw \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** opium\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Narcotic drugs\n\n> (e) Narcotic drugs.\n\n**DEA code number:** 9809\n\n**Only when:** Not more than 500 milligrams of opium per 100 milliliters or per 100 grams or not more than 25 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts\n\n**CFR citation:** 21 CFR 1308.13(e)(1)(v)\n\n> (v) Not more than 500 milligrams of opium per 100 milliliters or per 100 grams or not more than 25 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts | 9809 |\n\nSource: \n", "category": "Narcotic drugs", "citation": "21 CFR 1308.13(e)(1)(v)", "dea_code_number": "9809", "file": "opium.md", "generated": true, "harvested": "2026-09-01", "id": "opium", "quote_category": "(e) Narcotic drugs.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "scope_qualifier": "Not more than 500 milligrams of opium per 100 milliliters or per 100 grams or not more than 25 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts", "source_quote": "(v) Not more than 500 milligrams of opium per 100 milliliters or per 100 grams or not more than 25 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts | 9809 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "opium", "title": "opium \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Oripavine\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Substances, vegetable origin or chemical synthesis\n\n> (b) Substances, vegetable origin or chemical synthesis.\n\n**DEA code number:** 9330\n\n**CFR citation:** 21 CFR 1308.12(b)(1)(xiii)\n\n> (xiii) Oripavine | 9330 |\n\nSource: \n", "category": "Substances, vegetable origin or chemical synthesis", "citation": "21 CFR 1308.12(b)(1)(xiii)", "dea_code_number": "9330", "file": "oripavine.md", "generated": true, "harvested": "2026-09-01", "id": "oripavine", "quote_category": "(b) Substances, vegetable origin or chemical synthesis.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(xiii) Oripavine | 9330 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Oripavine", "title": "Oripavine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** ortho-chlorofentanyl (N-(2-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9828\n\n**CFR citation:** 21 CFR 1308.11(b)(82)\n\n> (82) ortho-chlorofentanyl (N-(2-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide | 9828 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(82)", "dea_code_number": "9828", "file": "ortho-chlorofentanyl-n-2-chlorophenyl-n-1-phenethylpiperidin-4-yl-propionamide.md", "generated": true, "harvested": "2026-09-01", "id": "ortho-chlorofentanyl-n-2-chlorophenyl-n-1-phenethylpiperidin-4-yl-propionamide", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(82) ortho-chlorofentanyl (N-(2-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide | 9828 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "ortho-chlorofentanyl (N-(2-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide", "title": "ortho-chlorofentanyl (N-(2-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** ortho-Fluoroacryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)acrylamide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9852\n\n**CFR citation:** 21 CFR 1308.11(b)(83)\n\n> (83) ortho-Fluoroacryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)acrylamide) | 9852 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(83)", "dea_code_number": "9852", "file": "ortho-fluoroacryl-fentanyl-n-2-fluorophenyl-n-1-phenethylpiperidin-4-yl-acrylami.md", "generated": true, "harvested": "2026-09-01", "id": "ortho-fluoroacryl-fentanyl-n-2-fluorophenyl-n-1-phenethylpiperidin-4-yl-acrylami", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(83) ortho-Fluoroacryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)acrylamide) | 9852 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "ortho-Fluoroacryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)acrylamide)", "title": "ortho-Fluoroacryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)acrylamide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** ortho-Fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide; also known as 2-fluorobutyryl fentanyl)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9846\n\n**CFR citation:** 21 CFR 1308.11(b)(84)\n\n> (84) ortho-Fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide; also known as 2-fluorobutyryl fentanyl) | 9846 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(84)", "dea_code_number": "9846", "file": "ortho-fluorobutyryl-fentanyl-n-2-fluorophenyl-n-1-phenethylpiperidin-4-yl-butyra.md", "generated": true, "harvested": "2026-09-01", "id": "ortho-fluorobutyryl-fentanyl-n-2-fluorophenyl-n-1-phenethylpiperidin-4-yl-butyra", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(84) ortho-Fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide; also known as 2-fluorobutyryl fentanyl) | 9846 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "ortho-Fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide; also known as 2-fluorobutyryl fentanyl)", "title": "ortho-Fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide; also known as 2-fluorobutyryl fentanyl) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** ortho-Fluorofentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide); also known as 2-fluorofentanyl)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9816\n\n**CFR citation:** 21 CFR 1308.11(b)(85)\n\n> (85) ortho-Fluorofentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide); also known as 2-fluorofentanyl) | 9816 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(85)", "dea_code_number": "9816", "file": "ortho-fluorofentanyl-n-2-fluorophenyl-n-1-phenethylpiperidin-4-yl-propionamide-a.md", "generated": true, "harvested": "2026-09-01", "id": "ortho-fluorofentanyl-n-2-fluorophenyl-n-1-phenethylpiperidin-4-yl-propionamide-a", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(85) ortho-Fluorofentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide); also known as 2-fluorofentanyl) | 9816 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "ortho-Fluorofentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide); also known as 2-fluorofentanyl)", "title": "ortho-Fluorofentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide); also known as 2-fluorofentanyl) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** ortho-Fluorofuranyl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9863\n\n**CFR citation:** 21 CFR 1308.11(b)(86)\n\n> (86) ortho-Fluorofuranyl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide) | 9863 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(86)", "dea_code_number": "9863", "file": "ortho-fluorofuranyl-fentanyl-n-2-fluorophenyl-n-1-phenethylpiperidin-4-yl-furan-.md", "generated": true, "harvested": "2026-09-01", "id": "ortho-fluorofuranyl-fentanyl-n-2-fluorophenyl-n-1-phenethylpiperidin-4-yl-furan-", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(86) ortho-Fluorofuranyl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide) | 9863 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "ortho-Fluorofuranyl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide)", "title": "ortho-Fluorofuranyl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** ortho-Fluoroisobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9853\n\n**CFR citation:** 21 CFR 1308.11(b)(87)\n\n> (87) ortho-Fluoroisobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) | 9853 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(87)", "dea_code_number": "9853", "file": "ortho-fluoroisobutyryl-fentanyl-n-2-fluorophenyl-n-1-phenethylpiperidin-4-yl-iso.md", "generated": true, "harvested": "2026-09-01", "id": "ortho-fluoroisobutyryl-fentanyl-n-2-fluorophenyl-n-1-phenethylpiperidin-4-yl-iso", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(87) ortho-Fluoroisobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) | 9853 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "ortho-Fluoroisobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide)", "title": "ortho-Fluoroisobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** ortho-Methyl acetylfentanyl (N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide; also known as 2-methyl acetylfentanyl)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9848\n\n**CFR citation:** 21 CFR 1308.11(b)(88)\n\n> (88) ortho-Methyl acetylfentanyl (N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide; also known as 2-methyl acetylfentanyl) | 9848 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(88)", "dea_code_number": "9848", "file": "ortho-methyl-acetylfentanyl-n-2-methylphenyl-n-1-phenethylpiperidin-4-yl-acetami.md", "generated": true, "harvested": "2026-09-01", "id": "ortho-methyl-acetylfentanyl-n-2-methylphenyl-n-1-phenethylpiperidin-4-yl-acetami", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(88) ortho-Methyl acetylfentanyl (N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide; also known as 2-methyl acetylfentanyl) | 9848 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "ortho-Methyl acetylfentanyl (N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide; also known as 2-methyl acetylfentanyl)", "title": "ortho-Methyl acetylfentanyl (N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide; also known as 2-methyl acetylfentanyl) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** ortho-Methyl methoxyacetyl fentanyl (2-methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide; also known as 2-methyl methoxyacetyl fentanyl)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9820\n\n**CFR citation:** 21 CFR 1308.11(b)(90)\n\n> (90) ortho-Methyl methoxyacetyl fentanyl (2-methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide; also known as 2-methyl methoxyacetyl fentanyl) | 9820 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(90)", "dea_code_number": "9820", "file": "ortho-methyl-methoxyacetyl-fentanyl-2-methoxy-n-2-methylphenyl-n-1-phenethylpipe.md", "generated": true, "harvested": "2026-09-01", "id": "ortho-methyl-methoxyacetyl-fentanyl-2-methoxy-n-2-methylphenyl-n-1-phenethylpipe", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(90) ortho-Methyl methoxyacetyl fentanyl (2-methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide; also known as 2-methyl methoxyacetyl fentanyl) | 9820 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "ortho-Methyl methoxyacetyl fentanyl (2-methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide; also known as 2-methyl methoxyacetyl fentanyl)", "title": "ortho-Methyl methoxyacetyl fentanyl (2-methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide; also known as 2-methyl methoxyacetyl fentanyl) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** ortho-methylcyclopropyl fentanyl (N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)cyclopropanecarboxamide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9849\n\n**CFR citation:** 21 CFR 1308.11(b)(89)\n\n> (89) ortho-methylcyclopropyl fentanyl (N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)cyclopropanecarboxamide) | 9849 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(89)", "dea_code_number": "9849", "file": "ortho-methylcyclopropyl-fentanyl-n-2-methylphenyl-n-1-phenethylpiperidin-4-yl-cy.md", "generated": true, "harvested": "2026-09-01", "id": "ortho-methylcyclopropyl-fentanyl-n-2-methylphenyl-n-1-phenethylpiperidin-4-yl-cy", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(89) ortho-methylcyclopropyl fentanyl (N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)cyclopropanecarboxamide) | 9849 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "ortho-methylcyclopropyl fentanyl (N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)cyclopropanecarboxamide)", "title": "ortho-methylcyclopropyl fentanyl (N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)cyclopropanecarboxamide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** oxandrolone (17\u03b1-methyl-17\u03b2-hydroxy-2-oxa-5\u03b1-androstan-3-one)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(76)\n\n> (76) oxandrolone (17\u03b1-methyl-17\u03b2-hydroxy-2-oxa-5\u03b1-androstan-3-one);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(76)", "file": "oxandrolone-17-methyl-17-hydroxy-2-oxa-5-androstan-3-one.md", "generated": true, "harvested": "2026-09-01", "id": "oxandrolone-17-methyl-17-hydroxy-2-oxa-5-androstan-3-one", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(76) oxandrolone (17\u03b1-methyl-17\u03b2-hydroxy-2-oxa-5\u03b1-androstan-3-one);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "oxandrolone (17\u03b1-methyl-17\u03b2-hydroxy-2-oxa-5\u03b1-androstan-3-one)", "title": "oxandrolone (17\u03b1-methyl-17\u03b2-hydroxy-2-oxa-5\u03b1-androstan-3-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Oxazepam\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2835\n\n**CFR citation:** 21 CFR 1308.14(c)(45)\n\n> (45) Oxazepam | 2835 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(45)", "dea_code_number": "2835", "file": "oxazepam.md", "generated": true, "harvested": "2026-09-01", "id": "oxazepam", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(45) Oxazepam | 2835 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Oxazepam", "title": "Oxazepam \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Oxazolam\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2839\n\n**CFR citation:** 21 CFR 1308.14(c)(46)\n\n> (46) Oxazolam | 2839 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(46)", "dea_code_number": "2839", "file": "oxazolam.md", "generated": true, "harvested": "2026-09-01", "id": "oxazolam", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(46) Oxazolam | 2839 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Oxazolam", "title": "Oxazolam \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Oxycodone\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Substances, vegetable origin or chemical synthesis\n\n> (b) Substances, vegetable origin or chemical synthesis.\n\n**DEA code number:** 9143\n\n**CFR citation:** 21 CFR 1308.12(b)(1)(xiv)\n\n> (xiv) Oxycodone | 9143 |\n\nSource: \n", "category": "Substances, vegetable origin or chemical synthesis", "citation": "21 CFR 1308.12(b)(1)(xiv)", "dea_code_number": "9143", "file": "oxycodone.md", "generated": true, "harvested": "2026-09-01", "id": "oxycodone", "quote_category": "(b) Substances, vegetable origin or chemical synthesis.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(xiv) Oxycodone | 9143 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Oxycodone", "title": "Oxycodone \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** oxymesterone (17\u03b1-methyl-4,17\u03b2-dihydroxyandrost-4-en-3-one)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(77)\n\n> (77) oxymesterone (17\u03b1-methyl-4,17\u03b2-dihydroxyandrost-4-en-3-one);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(77)", "file": "oxymesterone-17-methyl-4-17-dihydroxyandrost-4-en-3-one.md", "generated": true, "harvested": "2026-09-01", "id": "oxymesterone-17-methyl-4-17-dihydroxyandrost-4-en-3-one", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(77) oxymesterone (17\u03b1-methyl-4,17\u03b2-dihydroxyandrost-4-en-3-one);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "oxymesterone (17\u03b1-methyl-4,17\u03b2-dihydroxyandrost-4-en-3-one)", "title": "oxymesterone (17\u03b1-methyl-4,17\u03b2-dihydroxyandrost-4-en-3-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** oxymetholone (17\u03b1-methyl-2-hydroxymethylene-17\u03b2-hydroxy-5\u03b1-androstan-3-one)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(78)\n\n> (78) oxymetholone (17\u03b1-methyl-2-hydroxymethylene-17\u03b2-hydroxy-5\u03b1-androstan-3-one);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(78)", "file": "oxymetholone-17-methyl-2-hydroxymethylene-17-hydroxy-5-androstan-3-one.md", "generated": true, "harvested": "2026-09-01", "id": "oxymetholone-17-methyl-2-hydroxymethylene-17-hydroxy-5-androstan-3-one", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(78) oxymetholone (17\u03b1-methyl-2-hydroxymethylene-17\u03b2-hydroxy-5\u03b1-androstan-3-one);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "oxymetholone (17\u03b1-methyl-2-hydroxymethylene-17\u03b2-hydroxy-5\u03b1-androstan-3-one)", "title": "oxymetholone (17\u03b1-methyl-2-hydroxymethylene-17\u03b2-hydroxy-5\u03b1-androstan-3-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Oxymorphone\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Substances, vegetable origin or chemical synthesis\n\n> (b) Substances, vegetable origin or chemical synthesis.\n\n**DEA code number:** 9652\n\n**CFR citation:** 21 CFR 1308.12(b)(1)(xv)\n\n> (xv) Oxymorphone | 9652 |\n\nSource: \n", "category": "Substances, vegetable origin or chemical synthesis", "citation": "21 CFR 1308.12(b)(1)(xv)", "dea_code_number": "9652", "file": "oxymorphone.md", "generated": true, "harvested": "2026-09-01", "id": "oxymorphone", "quote_category": "(b) Substances, vegetable origin or chemical synthesis.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(xv) Oxymorphone | 9652 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Oxymorphone", "title": "Oxymorphone \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** para-chlorofentanyl (N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9818\n\n**CFR citation:** 21 CFR 1308.11(b)(92)\n\n> (92) para-chlorofentanyl (N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide) | 9818 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(92)", "dea_code_number": "9818", "file": "para-chlorofentanyl-n-4-chlorophenyl-n-1-phenethylpiperidin-4-yl-propionamide.md", "generated": true, "harvested": "2026-09-01", "id": "para-chlorofentanyl-n-4-chlorophenyl-n-1-phenethylpiperidin-4-yl-propionamide", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(92) para-chlorofentanyl (N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide) | 9818 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "para-chlorofentanyl (N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide)", "title": "para-chlorofentanyl (N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** para-Chloroisobutyryl fentanyl (N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9826\n\n**CFR citation:** 21 CFR 1308.11(b)(91)\n\n> (91) para-Chloroisobutyryl fentanyl (N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) | 9826 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(91)", "dea_code_number": "9826", "file": "para-chloroisobutyryl-fentanyl-n-4-chlorophenyl-n-1-phenethylpiperidin-4-yl-isob.md", "generated": true, "harvested": "2026-09-01", "id": "para-chloroisobutyryl-fentanyl-n-4-chlorophenyl-n-1-phenethylpiperidin-4-yl-isob", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(91) para-Chloroisobutyryl fentanyl (N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) | 9826 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "para-Chloroisobutyryl fentanyl (N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide)", "title": "para-Chloroisobutyryl fentanyl (N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** para-Fluoro furanyl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9854\n\n**CFR citation:** 21 CFR 1308.11(b)(95)\n\n> (95) para-Fluoro furanyl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide) | 9854 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(95)", "dea_code_number": "9854", "file": "para-fluoro-furanyl-fentanyl-n-4-fluorophenyl-n-1-phenethylpiperidin-4-yl-furan-.md", "generated": true, "harvested": "2026-09-01", "id": "para-fluoro-furanyl-fentanyl-n-4-fluorophenyl-n-1-phenethylpiperidin-4-yl-furan-", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(95) para-Fluoro furanyl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide) | 9854 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "para-Fluoro furanyl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide)", "title": "para-Fluoro furanyl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** para-fluoro valeryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)pentanamide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9870\n\n**CFR citation:** 21 CFR 1308.11(b)(96)\n\n> (96) para-fluoro valeryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)pentanamide) | 9870 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(96)", "dea_code_number": "9870", "file": "para-fluoro-valeryl-fentanyl-n-4-fluorophenyl-n-1-phenethylpiperidin-4-yl-pentan.md", "generated": true, "harvested": "2026-09-01", "id": "para-fluoro-valeryl-fentanyl-n-4-fluorophenyl-n-1-phenethylpiperidin-4-yl-pentan", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(96) para-fluoro valeryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)pentanamide) | 9870 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "para-fluoro valeryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)pentanamide)", "title": "para-fluoro valeryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)pentanamide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** para-Fluorobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9823\n\n**CFR citation:** 21 CFR 1308.11(b)(93)\n\n> (93) para-Fluorobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide) | 9823 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(93)", "dea_code_number": "9823", "file": "para-fluorobutyryl-fentanyl-n-4-fluorophenyl-n-1-phenethylpiperidin-4-yl-butyram.md", "generated": true, "harvested": "2026-09-01", "id": "para-fluorobutyryl-fentanyl-n-4-fluorophenyl-n-1-phenethylpiperidin-4-yl-butyram", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(93) para-Fluorobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide) | 9823 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "para-Fluorobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide)", "title": "para-Fluorobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** para-Fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]propanamide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9812\n\n**CFR citation:** 21 CFR 1308.11(b)(94)\n\n> (94) para-Fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]propanamide) | 9812 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(94)", "dea_code_number": "9812", "file": "para-fluorofentanyl-n-4-fluorophenyl-n-1-2-phenylethyl-4-piperidinyl-propanamide.md", "generated": true, "harvested": "2026-09-01", "id": "para-fluorofentanyl-n-4-fluorophenyl-n-1-2-phenylethyl-4-piperidinyl-propanamide", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(94) para-Fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]propanamide) | 9812 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "para-Fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]propanamide)", "title": "para-Fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]propanamide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** para-Methoxybutyryl fentanyl (N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9837\n\n**CFR citation:** 21 CFR 1308.11(b)(97)\n\n> (97) para-Methoxybutyryl fentanyl (N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide) | 9837 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(97)", "dea_code_number": "9837", "file": "para-methoxybutyryl-fentanyl-n-4-methoxyphenyl-n-1-phenethylpiperidin-4-yl-butyr.md", "generated": true, "harvested": "2026-09-01", "id": "para-methoxybutyryl-fentanyl-n-4-methoxyphenyl-n-1-phenethylpiperidin-4-yl-butyr", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(97) para-Methoxybutyryl fentanyl (N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide) | 9837 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "para-Methoxybutyryl fentanyl (N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide)", "title": "para-Methoxybutyryl fentanyl (N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** para-Methoxyfuranyl fentanyl (N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9859\n\n**CFR citation:** 21 CFR 1308.11(b)(98)\n\n> (98) para-Methoxyfuranyl fentanyl (N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide | 9859 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(98)", "dea_code_number": "9859", "file": "para-methoxyfuranyl-fentanyl-n-4-methoxyphenyl-n-1-phenethylpiperidin-4-yl-furan.md", "generated": true, "harvested": "2026-09-01", "id": "para-methoxyfuranyl-fentanyl-n-4-methoxyphenyl-n-1-phenethylpiperidin-4-yl-furan", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(98) para-Methoxyfuranyl fentanyl (N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide | 9859 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "para-Methoxyfuranyl fentanyl (N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide", "title": "para-Methoxyfuranyl fentanyl (N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** para-Methylcyclopropyl fentanyl (N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)cyclopropanecarboxamide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9865\n\n**CFR citation:** 21 CFR 1308.11(b)(99)\n\n> (99) para-Methylcyclopropyl fentanyl (N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)cyclopropanecarboxamide) | 9865 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(99)", "dea_code_number": "9865", "file": "para-methylcyclopropyl-fentanyl-n-4-methylphenyl-n-1-phenethylpiperidin-4-yl-cyc.md", "generated": true, "harvested": "2026-09-01", "id": "para-methylcyclopropyl-fentanyl-n-4-methylphenyl-n-1-phenethylpiperidin-4-yl-cyc", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(99) para-Methylcyclopropyl fentanyl (N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)cyclopropanecarboxamide) | 9865 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "para-Methylcyclopropyl fentanyl (N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)cyclopropanecarboxamide)", "title": "para-Methylcyclopropyl fentanyl (N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)cyclopropanecarboxamide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** para-Methylfentanyl (N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)propionamide; also known as 4-methylfentanyl)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9817\n\n**CFR citation:** 21 CFR 1308.11(b)(100)\n\n> (100) para-Methylfentanyl (N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)propionamide; also known as 4-methylfentanyl) | 9817 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(100)", "dea_code_number": "9817", "file": "para-methylfentanyl-n-4-methylphenyl-n-1-phenethylpiperidin-4-yl-propionamide-al.md", "generated": true, "harvested": "2026-09-01", "id": "para-methylfentanyl-n-4-methylphenyl-n-1-phenethylpiperidin-4-yl-propionamide-al", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(100) para-Methylfentanyl (N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)propionamide; also known as 4-methylfentanyl) | 9817 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "para-Methylfentanyl (N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)propionamide; also known as 4-methylfentanyl)", "title": "para-Methylfentanyl (N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)propionamide; also known as 4-methylfentanyl) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Parahexyl\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7374\n\n**CFR citation:** 21 CFR 1308.11(d)(25)\n\n> (25) Parahexyl\u20147374\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(25)", "dea_code_number": "7374", "file": "parahexyl.md", "generated": true, "harvested": "2026-09-01", "id": "parahexyl", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(25) Parahexyl\u20147374", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Parahexyl", "title": "Parahexyl \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Paraldehyde\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2585\n\n**CFR citation:** 21 CFR 1308.14(c)(47)\n\n> (47) Paraldehyde | 2585 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(47)", "dea_code_number": "2585", "file": "paraldehyde.md", "generated": true, "harvested": "2026-09-01", "id": "paraldehyde", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(47) Paraldehyde | 2585 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Paraldehyde", "title": "Paraldehyde \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Pemoline (including organometallic complexes and chelates thereof)\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Stimulants\n\n> (f) Stimulants.\n\n**DEA code number:** 1530\n\n**CFR citation:** 21 CFR 1308.14(f)(8)\n\n> (8) Pemoline (including organometallic complexes and chelates thereof) | 1530 |\n\nSource: \n", "category": "Stimulants", "citation": "21 CFR 1308.14(f)(8)", "dea_code_number": "1530", "file": "pemoline-including-organometallic-complexes-and-chelates-thereof.md", "generated": true, "harvested": "2026-09-01", "id": "pemoline-including-organometallic-complexes-and-chelates-thereof", "quote_category": "(f) Stimulants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(8) Pemoline (including organometallic complexes and chelates thereof) | 1530 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Pemoline (including organometallic complexes and chelates thereof)", "title": "Pemoline (including organometallic complexes and chelates thereof) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Pentazocine\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Other substances\n\n> (g) Other substances.\n\n**DEA code number:** 9709\n\n**CFR citation:** 21 CFR 1308.14(g)(1)\n\n> (1) Pentazocine | 9709 |\n\nSource: \n", "category": "Other substances", "citation": "21 CFR 1308.14(g)(1)", "dea_code_number": "9709", "file": "pentazocine.md", "generated": true, "harvested": "2026-09-01", "id": "pentazocine", "quote_category": "(g) Other substances.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(1) Pentazocine | 9709 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Pentazocine", "title": "Pentazocine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Pentobarbital\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2271\n\n**Only when:** Any compound, mixture or preparation containing\n\n> (1) Any compound, mixture or preparation containing:\n\n**CFR citation:** 21 CFR 1308.13(c)(1)(iii)\n\n> (1) Any compound, mixture or preparation containing: | | (i) Amobarbital | 2126 | (ii) Secobarbital | 2316 | (iii) Pentobarbital | 2271 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.13(c)(1)(iii)", "dea_code_number": "2271", "file": "pentobarbital-2.md", "generated": true, "harvested": "2026-09-01", "id": "pentobarbital-2", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "quote_scope_qualifier": "(1) Any compound, mixture or preparation containing:", "schedule": "Schedule III", "scope_qualifier": "Any compound, mixture or preparation containing", "source_quote": "(1) Any compound, mixture or preparation containing: | | (i) Amobarbital | 2126 | (ii) Secobarbital | 2316 | (iii) Pentobarbital | 2271 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Pentobarbital", "title": "Pentobarbital \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Pentobarbital\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2271\n\n**Only when:** Any suppository dosage form containing\n\n> (2) Any suppository dosage form containing:\n\n**CFR citation:** 21 CFR 1308.13(c)(2)(iii)\n\n> (2) Any suppository dosage form containing: | | (i) Amobarbital | 2126 | (ii) Secobarbital | 2316 | (iii) Pentobarbital | 2271 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.13(c)(2)(iii)", "dea_code_number": "2271", "file": "pentobarbital-3.md", "generated": true, "harvested": "2026-09-01", "id": "pentobarbital-3", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "quote_scope_qualifier": "(2) Any suppository dosage form containing:", "schedule": "Schedule III", "scope_qualifier": "Any suppository dosage form containing", "source_quote": "(2) Any suppository dosage form containing: | | (i) Amobarbital | 2126 | (ii) Secobarbital | 2316 | (iii) Pentobarbital | 2271 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Pentobarbital", "title": "Pentobarbital \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Pentobarbital\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Depressants\n\n> (e) Depressants.\n\n**DEA code number:** 2270\n\n**CFR citation:** 21 CFR 1308.12(e)(3)\n\n> (3) Pentobarbital | 2270 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.12(e)(3)", "dea_code_number": "2270", "file": "pentobarbital.md", "generated": true, "harvested": "2026-09-01", "id": "pentobarbital", "quote_category": "(e) Depressants.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(3) Pentobarbital | 2270 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Pentobarbital", "title": "Pentobarbital \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** PEPAP (1-(2-phenylethyl)-4-phenyl-4-acetoxypiperidine)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9663\n\n**CFR citation:** 21 CFR 1308.11(b)(101)\n\n> (101) PEPAP (1-(2-phenylethyl)-4-phenyl-4-acetoxypiperidine) | 9663 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(101)", "dea_code_number": "9663", "file": "pepap-1-2-phenylethyl-4-phenyl-4-acetoxypiperidine.md", "generated": true, "harvested": "2026-09-01", "id": "pepap-1-2-phenylethyl-4-phenyl-4-acetoxypiperidine", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(101) PEPAP (1-(2-phenylethyl)-4-phenyl-4-acetoxypiperidine) | 9663 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "PEPAP (1-(2-phenylethyl)-4-phenyl-4-acetoxypiperidine)", "title": "PEPAP (1-(2-phenylethyl)-4-phenyl-4-acetoxypiperidine) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Perampanel, and its salts, isomers, and salts of isomers\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2261\n\n**CFR citation:** 21 CFR 1308.13(c)(11)\n\n> (11) Perampanel, and its salts, isomers, and salts of isomers | 2261 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.13(c)(11)", "dea_code_number": "2261", "file": "perampanel-and-its-salts-isomers-and-salts-of-isomers.md", "generated": true, "harvested": "2026-09-01", "id": "perampanel-and-its-salts-isomers-and-salts-of-isomers", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(11) Perampanel, and its salts, isomers, and salts of isomers | 2261 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Perampanel, and its salts, isomers, and salts of isomers", "title": "Perampanel, and its salts, isomers, and salts of isomers \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Opiates\n\n> (c) Opiates.\n\n**DEA code number:** 9232\n\n**CFR citation:** 21 CFR 1308.12(c)(20)\n\n> (20) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine | 9232 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.12(c)(20)", "dea_code_number": "9232", "file": "pethidine-intermediate-a-4-cyano-1-methyl-4-phenylpiperidine.md", "generated": true, "harvested": "2026-09-01", "id": "pethidine-intermediate-a-4-cyano-1-methyl-4-phenylpiperidine", "quote_category": "(c) Opiates.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(20) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine | 9232 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine", "title": "Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Opiates\n\n> (c) Opiates.\n\n**DEA code number:** 9233\n\n**CFR citation:** 21 CFR 1308.12(c)(21)\n\n> (21) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate | 9233 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.12(c)(21)", "dea_code_number": "9233", "file": "pethidine-intermediate-b-ethyl-4-phenylpiperidine-4-carboxylate.md", "generated": true, "harvested": "2026-09-01", "id": "pethidine-intermediate-b-ethyl-4-phenylpiperidine-4-carboxylate", "quote_category": "(c) Opiates.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(21) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate | 9233 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate", "title": "Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Opiates\n\n> (c) Opiates.\n\n**DEA code number:** 9234\n\n**CFR citation:** 21 CFR 1308.12(c)(22)\n\n> (22) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid | 9234 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.12(c)(22)", "dea_code_number": "9234", "file": "pethidine-intermediate-c-1-methyl-4-phenylpiperidine-4-carboxylic-acid.md", "generated": true, "harvested": "2026-09-01", "id": "pethidine-intermediate-c-1-methyl-4-phenylpiperidine-4-carboxylic-acid", "quote_category": "(c) Opiates.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(22) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid | 9234 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid", "title": "Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Pethidine (meperidine)\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Opiates\n\n> (c) Opiates.\n\n**DEA code number:** 9230\n\n**CFR citation:** 21 CFR 1308.12(c)(19)\n\n> (19) Pethidine (meperidine) | 9230 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.12(c)(19)", "dea_code_number": "9230", "file": "pethidine-meperidine.md", "generated": true, "harvested": "2026-09-01", "id": "pethidine-meperidine", "quote_category": "(c) Opiates.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(19) Pethidine (meperidine) | 9230 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Pethidine (meperidine)", "title": "Pethidine (meperidine) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Petrichloral\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2591\n\n**CFR citation:** 21 CFR 1308.14(c)(48)\n\n> (48) Petrichloral | 2591 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(48)", "dea_code_number": "2591", "file": "petrichloral.md", "generated": true, "harvested": "2026-09-01", "id": "petrichloral", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(48) Petrichloral | 2591 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Petrichloral", "title": "Petrichloral \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Peyote\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7415\n\n**CFR citation:** 21 CFR 1308.11(d)(26)\n\n> (26) Peyote | 7415 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(26)", "dea_code_number": "7415", "file": "peyote.md", "generated": true, "harvested": "2026-09-01", "id": "peyote", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(26) Peyote | 7415 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Peyote", "title": "Peyote \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Phenadoxone\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9637\n\n**CFR citation:** 21 CFR 1308.11(b)(102)\n\n> (102) Phenadoxone | 9637 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(102)", "dea_code_number": "9637", "file": "phenadoxone.md", "generated": true, "harvested": "2026-09-01", "id": "phenadoxone", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(102) Phenadoxone | 9637 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Phenadoxone", "title": "Phenadoxone \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Phenampromide\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9638\n\n**CFR citation:** 21 CFR 1308.11(b)(103)\n\n> (103) Phenampromide | 9638 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(103)", "dea_code_number": "9638", "file": "phenampromide.md", "generated": true, "harvested": "2026-09-01", "id": "phenampromide", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(103) Phenampromide | 9638 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Phenampromide", "title": "Phenampromide \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Phenazocine\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Opiates\n\n> (c) Opiates.\n\n**DEA code number:** 9715\n\n**CFR citation:** 21 CFR 1308.12(c)(23)\n\n> (23) Phenazocine | 9715 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.12(c)(23)", "dea_code_number": "9715", "file": "phenazocine.md", "generated": true, "harvested": "2026-09-01", "id": "phenazocine", "quote_category": "(c) Opiates.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(23) Phenazocine | 9715 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Phenazocine", "title": "Phenazocine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Phencyclidine\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Depressants\n\n> (e) Depressants.\n\n**DEA code number:** 7471\n\n**CFR citation:** 21 CFR 1308.12(e)(4)\n\n> (4) Phencyclidine | 7471 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.12(e)(4)", "dea_code_number": "7471", "file": "phencyclidine.md", "generated": true, "harvested": "2026-09-01", "id": "phencyclidine", "quote_category": "(e) Depressants.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(4) Phencyclidine | 7471 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Phencyclidine", "title": "Phencyclidine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Phendimetrazine\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Stimulants\n\n> (b) Stimulants.\n\n**DEA code number:** 1615\n\n**CFR citation:** 21 CFR 1308.13(b)(5)\n\n> (5) Phendimetrazine | 1615 |\n\nSource: \n", "category": "Stimulants", "citation": "21 CFR 1308.13(b)(5)", "dea_code_number": "1615", "file": "phendimetrazine.md", "generated": true, "harvested": "2026-09-01", "id": "phendimetrazine", "quote_category": "(b) Stimulants.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(5) Phendimetrazine | 1615 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Phendimetrazine", "title": "Phendimetrazine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Phenmetrazine and its salts\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Stimulants\n\n> (d) Stimulants.\n\n**DEA code number:** 1631\n\n**CFR citation:** 21 CFR 1308.12(d)(3)\n\n> (3) Phenmetrazine and its salts | 1631 |\n\nSource: \n", "category": "Stimulants", "citation": "21 CFR 1308.12(d)(3)", "dea_code_number": "1631", "file": "phenmetrazine-and-its-salts.md", "generated": true, "harvested": "2026-09-01", "id": "phenmetrazine-and-its-salts", "quote_category": "(d) Stimulants.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(3) Phenmetrazine and its salts | 1631 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Phenmetrazine and its salts", "title": "Phenmetrazine and its salts \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Phenobarbital\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2285\n\n**CFR citation:** 21 CFR 1308.14(c)(49)\n\n> (49) Phenobarbital | 2285 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(49)", "dea_code_number": "2285", "file": "phenobarbital.md", "generated": true, "harvested": "2026-09-01", "id": "phenobarbital", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(49) Phenobarbital | 2285 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Phenobarbital", "title": "Phenobarbital \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Phenomorphan\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9647\n\n**CFR citation:** 21 CFR 1308.11(b)(104)\n\n> (104) Phenomorphan | 9647 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(104)", "dea_code_number": "9647", "file": "phenomorphan.md", "generated": true, "harvested": "2026-09-01", "id": "phenomorphan", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(104) Phenomorphan | 9647 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Phenomorphan", "title": "Phenomorphan \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Phenoperidine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9641\n\n**CFR citation:** 21 CFR 1308.11(b)(105)\n\n> (105) Phenoperidine | 9641 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(105)", "dea_code_number": "9641", "file": "phenoperidine.md", "generated": true, "harvested": "2026-09-01", "id": "phenoperidine", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(105) Phenoperidine | 9641 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Phenoperidine", "title": "Phenoperidine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Phentermine\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Stimulants\n\n> (f) Stimulants.\n\n**DEA code number:** 1640\n\n**CFR citation:** 21 CFR 1308.14(f)(9)\n\n> (9) Phentermine | 1640 |\n\nSource: \n", "category": "Stimulants", "citation": "21 CFR 1308.14(f)(9)", "dea_code_number": "1640", "file": "phentermine.md", "generated": true, "harvested": "2026-09-01", "id": "phentermine", "quote_category": "(f) Stimulants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(9) Phentermine | 1640 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Phentermine", "title": "Phentermine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide; also known as benzoyl fentanyl)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9841\n\n**CFR citation:** 21 CFR 1308.11(b)(106)\n\n> (106) Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide; also known as benzoyl fentanyl) | 9841 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(106)", "dea_code_number": "9841", "file": "phenyl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylbenzamide-also-known-as-benz.md", "generated": true, "harvested": "2026-09-01", "id": "phenyl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylbenzamide-also-known-as-benz", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(106) Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide; also known as benzoyl fentanyl) | 9841 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide; also known as benzoyl fentanyl)", "title": "Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide; also known as benzoyl fentanyl) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Phenylacetone\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Immediate precursors\n\n> (g) Immediate precursors.\n\n**DEA code number:** 8501\n\n**CFR citation:** 21 CFR 1308.12(g)(1)(i)\n\n> (i) Phenylacetone | 8501 |\n\nSource: \n", "category": "Immediate precursors", "citation": "21 CFR 1308.12(g)(1)(i)", "dea_code_number": "8501", "file": "phenylacetone.md", "generated": true, "harvested": "2026-09-01", "id": "phenylacetone", "quote_category": "(g) Immediate precursors.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(i) Phenylacetone | 8501 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Phenylacetone", "title": "Phenylacetone \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Pholcodine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opium derivatives\n\n> (c) Opium derivatives.\n\n**DEA code number:** 9314\n\n**CFR citation:** 21 CFR 1308.11(c)(22)\n\n> (22) Pholcodine | 9314 |\n\nSource: \n", "category": "Opium derivatives", "citation": "21 CFR 1308.11(c)(22)", "dea_code_number": "9314", "file": "pholcodine.md", "generated": true, "harvested": "2026-09-01", "id": "pholcodine", "quote_category": "(c) Opium derivatives.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(22) Pholcodine | 9314 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Pholcodine", "title": "Pholcodine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Piminodine\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Opiates\n\n> (c) Opiates.\n\n**DEA code number:** 9730\n\n**CFR citation:** 21 CFR 1308.12(c)(24)\n\n> (24) Piminodine | 9730 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.12(c)(24)", "dea_code_number": "9730", "file": "piminodine.md", "generated": true, "harvested": "2026-09-01", "id": "piminodine", "quote_category": "(c) Opiates.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(24) Piminodine | 9730 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Piminodine", "title": "Piminodine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Pinazepam\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2883\n\n**CFR citation:** 21 CFR 1308.14(c)(50)\n\n> (50) Pinazepam | 2883 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(50)", "dea_code_number": "2883", "file": "pinazepam.md", "generated": true, "harvested": "2026-09-01", "id": "pinazepam", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(50) Pinazepam | 2883 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Pinazepam", "title": "Pinazepam \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Pipradrol\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Stimulants\n\n> (f) Stimulants.\n\n**DEA code number:** 1750\n\n**CFR citation:** 21 CFR 1308.14(f)(10)\n\n> (10) Pipradrol | 1750 |\n\nSource: \n", "category": "Stimulants", "citation": "21 CFR 1308.14(f)(10)", "dea_code_number": "1750", "file": "pipradrol.md", "generated": true, "harvested": "2026-09-01", "id": "pipradrol", "quote_category": "(f) Stimulants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(10) Pipradrol | 1750 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Pipradrol", "title": "Pipradrol \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Piritramide\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9642\n\n**CFR citation:** 21 CFR 1308.11(b)(107)\n\n> (107) Piritramide | 9642 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(107)", "dea_code_number": "9642", "file": "piritramide.md", "generated": true, "harvested": "2026-09-01", "id": "piritramide", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(107) Piritramide | 9642 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Piritramide", "title": "Piritramide \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Powdered opium\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Substances, vegetable origin or chemical synthesis\n\n> (b) Substances, vegetable origin or chemical synthesis.\n\n**DEA code number:** 9639\n\n**CFR citation:** 21 CFR 1308.12(b)(1)(xvi)\n\n> (xvi) Powdered opium | 9639 |\n\nSource: \n", "category": "Substances, vegetable origin or chemical synthesis", "citation": "21 CFR 1308.12(b)(1)(xvi)", "dea_code_number": "9639", "file": "powdered-opium.md", "generated": true, "harvested": "2026-09-01", "id": "powdered-opium", "quote_category": "(b) Substances, vegetable origin or chemical synthesis.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(xvi) Powdered opium | 9639 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Powdered opium", "title": "Powdered opium \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Prazepam\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2764\n\n**CFR citation:** 21 CFR 1308.14(c)(51)\n\n> (51) Prazepam | 2764 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(51)", "dea_code_number": "2764", "file": "prazepam.md", "generated": true, "harvested": "2026-09-01", "id": "prazepam", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(51) Prazepam | 2764 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Prazepam", "title": "Prazepam \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid]\n\n**Schedule:** Schedule V\n\n> \u00a7 1308.15 Schedule V.\n\n**Listed under:** Depressants\n\n> (e) Depressants.\n\n**DEA code number:** 2782\n\n**CFR citation:** 21 CFR 1308.15(e)(7)\n\n> (7) Pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid] | 2782 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.15(e)(7)", "dea_code_number": "2782", "file": "pregabalin-s-3-aminomethyl-5-methylhexanoic-acid.md", "generated": true, "harvested": "2026-09-01", "id": "pregabalin-s-3-aminomethyl-5-methylhexanoic-acid", "quote_category": "(e) Depressants.", "quote_schedule": "\u00a7 1308.15 Schedule V.", "schedule": "Schedule V", "source_quote": "(7) Pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid] | 2782 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid]", "title": "Pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid] \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Proheptazine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9643\n\n**CFR citation:** 21 CFR 1308.11(b)(108)\n\n> (108) Proheptazine | 9643 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(108)", "dea_code_number": "9643", "file": "proheptazine.md", "generated": true, "harvested": "2026-09-01", "id": "proheptazine", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(108) Proheptazine | 9643 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Proheptazine", "title": "Proheptazine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Properidine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9644\n\n**CFR citation:** 21 CFR 1308.11(b)(109)\n\n> (109) Properidine | 9644 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(109)", "dea_code_number": "9644", "file": "properidine.md", "generated": true, "harvested": "2026-09-01", "id": "properidine", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(109) Properidine | 9644 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Properidine", "title": "Properidine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Propiram\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9649\n\n**CFR citation:** 21 CFR 1308.11(b)(110)\n\n> (110) Propiram | 9649 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(110)", "dea_code_number": "9649", "file": "propiram.md", "generated": true, "harvested": "2026-09-01", "id": "propiram", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(110) Propiram | 9649 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Propiram", "title": "Propiram \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** prostanozol (17\u03b2-hydroxy-5\u03b1-androstano[3,2-c]pyrazole or [3,2-c]pyrazole-5\u03b1-androstan-17\u03b2-ol)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(79)\n\n> (79) prostanozol (17\u03b2-hydroxy-5\u03b1-androstano[3,2-c]pyrazole or [3,2-c]pyrazole-5\u03b1-androstan-17\u03b2-ol);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(79)", "file": "prostanozol-17-hydroxy-5-androstano-3-2-c-pyrazole-or-3-2-c-pyrazole-5-androstan.md", "generated": true, "harvested": "2026-09-01", "id": "prostanozol-17-hydroxy-5-androstano-3-2-c-pyrazole-or-3-2-c-pyrazole-5-androstan", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(79) prostanozol (17\u03b2-hydroxy-5\u03b1-androstano[3,2-c]pyrazole or [3,2-c]pyrazole-5\u03b1-androstan-17\u03b2-ol);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "prostanozol (17\u03b2-hydroxy-5\u03b1-androstano[3,2-c]pyrazole or [3,2-c]pyrazole-5\u03b1-androstan-17\u03b2-ol)", "title": "prostanozol (17\u03b2-hydroxy-5\u03b1-androstano[3,2-c]pyrazole or [3,2-c]pyrazole-5\u03b1-androstan-17\u03b2-ol) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Psilocybin\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7437\n\n**CFR citation:** 21 CFR 1308.11(d)(29)\n\n> (29) Psilocybin | 7437 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(29)", "dea_code_number": "7437", "file": "psilocybin.md", "generated": true, "harvested": "2026-09-01", "id": "psilocybin", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(29) Psilocybin | 7437 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Psilocybin", "title": "Psilocybin \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Psilocyn\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7438\n\n**CFR citation:** 21 CFR 1308.11(d)(30)\n\n> (30) Psilocyn | 7438 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(30)", "dea_code_number": "7438", "file": "psilocyn.md", "generated": true, "harvested": "2026-09-01", "id": "psilocyn", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(30) Psilocyn | 7438 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Psilocyn", "title": "Psilocyn \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Pyrovalerone\n\n**Schedule:** Schedule V\n\n> \u00a7 1308.15 Schedule V.\n\n**Listed under:** Stimulants\n\n> (d) Stimulants.\n\n**DEA code number:** 1485\n\n**CFR citation:** 21 CFR 1308.15(d)(1)\n\n> (1) Pyrovalerone | 1485. |\n\nSource: \n", "category": "Stimulants", "citation": "21 CFR 1308.15(d)(1)", "dea_code_number": "1485", "file": "pyrovalerone.md", "generated": true, "harvested": "2026-09-01", "id": "pyrovalerone", "quote_category": "(d) Stimulants.", "quote_schedule": "\u00a7 1308.15 Schedule V.", "schedule": "Schedule V", "source_quote": "(1) Pyrovalerone | 1485. |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Pyrovalerone", "title": "Pyrovalerone \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Pyrrolidine analog of phencyclidine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7458\n\n**CFR citation:** 21 CFR 1308.11(d)(33)\n\n> (33) Pyrrolidine analog of phencyclidine | 7458 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(33)", "dea_code_number": "7458", "file": "pyrrolidine-analog-of-phencyclidine.md", "generated": true, "harvested": "2026-09-01", "id": "pyrrolidine-analog-of-phencyclidine", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(33) Pyrrolidine analog of phencyclidine | 7458 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Pyrrolidine analog of phencyclidine", "title": "Pyrrolidine analog of phencyclidine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Quazepam\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2881\n\n**CFR citation:** 21 CFR 1308.14(c)(52)\n\n> (52) Quazepam | 2881 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(52)", "dea_code_number": "2881", "file": "quazepam.md", "generated": true, "harvested": "2026-09-01", "id": "quazepam", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(52) Quazepam | 2881 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Quazepam", "title": "Quazepam \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (5-fluoro-PB-22; 5F-PB-22)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7225\n\n**CFR citation:** 21 CFR 1308.11(d)(52)\n\n> (52) quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (5-fluoro-PB-22; 5F-PB-22) | (7225) |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(52)", "dea_code_number": "7225", "file": "quinolin-8-yl-1-5-fluoropentyl-1h-indole-3-carboxylate-5-fluoro-pb-22-5f-pb-22.md", "generated": true, "harvested": "2026-09-01", "id": "quinolin-8-yl-1-5-fluoropentyl-1h-indole-3-carboxylate-5-fluoro-pb-22-5f-pb-22", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(52) quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (5-fluoro-PB-22; 5F-PB-22) | (7225) |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (5-fluoro-PB-22; 5F-PB-22)", "title": "quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (5-fluoro-PB-22; 5F-PB-22) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate (PB-22; QUPIC)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7222\n\n**CFR citation:** 21 CFR 1308.11(d)(51)\n\n> (51) quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate (PB-22; QUPIC) | (7222) |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(51)", "dea_code_number": "7222", "file": "quinolin-8-yl-1-pentyl-1h-indole-3-carboxylate-pb-22-qupic.md", "generated": true, "harvested": "2026-09-01", "id": "quinolin-8-yl-1-pentyl-1h-indole-3-carboxylate-pb-22-qupic", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(51) quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate (PB-22; QUPIC) | (7222) |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate (PB-22; QUPIC)", "title": "quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate (PB-22; QUPIC) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Racemethorphan\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Opiates\n\n> (c) Opiates.\n\n**DEA code number:** 9732\n\n**CFR citation:** 21 CFR 1308.12(c)(25)\n\n> (25) Racemethorphan | 9732 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.12(c)(25)", "dea_code_number": "9732", "file": "racemethorphan.md", "generated": true, "harvested": "2026-09-01", "id": "racemethorphan", "quote_category": "(c) Opiates.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(25) Racemethorphan | 9732 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Racemethorphan", "title": "Racemethorphan \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Racemoramide\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9645\n\n**CFR citation:** 21 CFR 1308.11(b)(112)\n\n> (112) Racemoramide | 9645 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(112)", "dea_code_number": "9645", "file": "racemoramide.md", "generated": true, "harvested": "2026-09-01", "id": "racemoramide", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(112) Racemoramide | 9645 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Racemoramide", "title": "Racemoramide \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Racemorphan\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Opiates\n\n> (c) Opiates.\n\n**DEA code number:** 9733\n\n**CFR citation:** 21 CFR 1308.12(c)(26)\n\n> (26) Racemorphan | 9733 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.12(c)(26)", "dea_code_number": "9733", "file": "racemorphan.md", "generated": true, "harvested": "2026-09-01", "id": "racemorphan", "quote_category": "(c) Opiates.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(26) Racemorphan | 9733 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Racemorphan", "title": "Racemorphan \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Raw opium\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Substances, vegetable origin or chemical synthesis\n\n> (b) Substances, vegetable origin or chemical synthesis.\n\n**DEA code number:** 9600\n\n**CFR citation:** 21 CFR 1308.12(b)(1)(xvii)\n\n> (xvii) Raw opium | 9600 |\n\nSource: \n", "category": "Substances, vegetable origin or chemical synthesis", "citation": "21 CFR 1308.12(b)(1)(xvii)", "dea_code_number": "9600", "file": "raw-opium.md", "generated": true, "harvested": "2026-09-01", "id": "raw-opium", "quote_category": "(b) Substances, vegetable origin or chemical synthesis.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(xvii) Raw opium | 9600 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Raw opium", "title": "Raw opium \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Remifentanil\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Opiates\n\n> (c) Opiates.\n\n**DEA code number:** 9739\n\n**CFR citation:** 21 CFR 1308.12(c)(27)\n\n> (27) Remifentanil | 9739 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.12(c)(27)", "dea_code_number": "9739", "file": "remifentanil.md", "generated": true, "harvested": "2026-09-01", "id": "remifentanil", "quote_category": "(c) Opiates.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(27) Remifentanil | 9739 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Remifentanil", "title": "Remifentanil \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Remimazolam\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2846\n\n**CFR citation:** 21 CFR 1308.14(c)(53)\n\n> (53) Remimazolam | 2846 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(53)", "dea_code_number": "2846", "file": "remimazolam.md", "generated": true, "harvested": "2026-09-01", "id": "remimazolam", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(53) Remimazolam | 2846 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Remimazolam", "title": "Remimazolam \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Secobarbital\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2316\n\n**Only when:** Any compound, mixture or preparation containing\n\n> (1) Any compound, mixture or preparation containing:\n\n**CFR citation:** 21 CFR 1308.13(c)(1)(ii)\n\n> (1) Any compound, mixture or preparation containing: | | (i) Amobarbital | 2126 | (ii) Secobarbital | 2316 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.13(c)(1)(ii)", "dea_code_number": "2316", "file": "secobarbital-2.md", "generated": true, "harvested": "2026-09-01", "id": "secobarbital-2", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "quote_scope_qualifier": "(1) Any compound, mixture or preparation containing:", "schedule": "Schedule III", "scope_qualifier": "Any compound, mixture or preparation containing", "source_quote": "(1) Any compound, mixture or preparation containing: | | (i) Amobarbital | 2126 | (ii) Secobarbital | 2316 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Secobarbital", "title": "Secobarbital \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Secobarbital\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2316\n\n**Only when:** Any suppository dosage form containing\n\n> (2) Any suppository dosage form containing:\n\n**CFR citation:** 21 CFR 1308.13(c)(2)(ii)\n\n> (2) Any suppository dosage form containing: | | (i) Amobarbital | 2126 | (ii) Secobarbital | 2316 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.13(c)(2)(ii)", "dea_code_number": "2316", "file": "secobarbital-3.md", "generated": true, "harvested": "2026-09-01", "id": "secobarbital-3", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "quote_scope_qualifier": "(2) Any suppository dosage form containing:", "schedule": "Schedule III", "scope_qualifier": "Any suppository dosage form containing", "source_quote": "(2) Any suppository dosage form containing: | | (i) Amobarbital | 2126 | (ii) Secobarbital | 2316 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Secobarbital", "title": "Secobarbital \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Secobarbital\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Depressants\n\n> (e) Depressants.\n\n**DEA code number:** 2315\n\n**CFR citation:** 21 CFR 1308.12(e)(5)\n\n> (5) Secobarbital | 2315 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.12(e)(5)", "dea_code_number": "2315", "file": "secobarbital.md", "generated": true, "harvested": "2026-09-01", "id": "secobarbital", "quote_category": "(e) Depressants.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(5) Secobarbital | 2315 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Secobarbital", "title": "Secobarbital \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Serdexmethylphenidate\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Stimulants\n\n> (f) Stimulants.\n\n**DEA code number:** 1729\n\n**CFR citation:** 21 CFR 1308.14(f)(11)\n\n> (11) Serdexmethylphenidate | 1729 |\n\nSource: \n", "category": "Stimulants", "citation": "21 CFR 1308.14(f)(11)", "dea_code_number": "1729", "file": "serdexmethylphenidate.md", "generated": true, "harvested": "2026-09-01", "id": "serdexmethylphenidate", "quote_category": "(f) Stimulants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(11) Serdexmethylphenidate | 1729 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Serdexmethylphenidate", "title": "Serdexmethylphenidate \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Sibutramine\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Stimulants\n\n> (f) Stimulants.\n\n**DEA code number:** 1675\n\n**CFR citation:** 21 CFR 1308.14(f)(12)\n\n> (12) Sibutramine | 1675 |\n\nSource: \n", "category": "Stimulants", "citation": "21 CFR 1308.14(f)(12)", "dea_code_number": "1675", "file": "sibutramine.md", "generated": true, "harvested": "2026-09-01", "id": "sibutramine", "quote_category": "(f) Stimulants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(12) Sibutramine | 1675 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Sibutramine", "title": "Sibutramine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Solriamfetol (2-amino-3-phenylpropyl carbamate; benzenepropanol, beta-amino-, carbamate (ester))\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Stimulants\n\n> (f) Stimulants.\n\n**DEA code number:** 1650\n\n**CFR citation:** 21 CFR 1308.14(f)(13)\n\n> (13) Solriamfetol (2-amino-3-phenylpropyl carbamate; benzenepropanol, beta-amino-, carbamate (ester)) | 1650 |\n\nSource: \n", "category": "Stimulants", "citation": "21 CFR 1308.14(f)(13)", "dea_code_number": "1650", "file": "solriamfetol-2-amino-3-phenylpropyl-carbamate-benzenepropanol-beta-amino-carbama.md", "generated": true, "harvested": "2026-09-01", "id": "solriamfetol-2-amino-3-phenylpropyl-carbamate-benzenepropanol-beta-amino-carbama", "quote_category": "(f) Stimulants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(13) Solriamfetol (2-amino-3-phenylpropyl carbamate; benzenepropanol, beta-amino-, carbamate (ester)) | 1650 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Solriamfetol (2-amino-3-phenylpropyl carbamate; benzenepropanol, beta-amino-, carbamate (ester))", "title": "Solriamfetol (2-amino-3-phenylpropyl carbamate; benzenepropanol, beta-amino-, carbamate (ester)) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** SPA ((-)-1-dimethylamino- 1,2-diphenylethane)\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Stimulants\n\n> (f) Stimulants.\n\n**DEA code number:** 1635\n\n**CFR citation:** 21 CFR 1308.14(f)(14)\n\n> (14) SPA ((-)-1-dimethylamino- 1,2-diphenylethane) | 1635 |\n\nSource: \n", "category": "Stimulants", "citation": "21 CFR 1308.14(f)(14)", "dea_code_number": "1635", "file": "spa-1-dimethylamino-1-2-diphenylethane.md", "generated": true, "harvested": "2026-09-01", "id": "spa-1-dimethylamino-1-2-diphenylethane", "quote_category": "(f) Stimulants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(14) SPA ((-)-1-dimethylamino- 1,2-diphenylethane) | 1635 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "SPA ((-)-1-dimethylamino- 1,2-diphenylethane)", "title": "SPA ((-)-1-dimethylamino- 1,2-diphenylethane) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** stanozolol (17\u03b1-methyl-17\u03b2-hydroxy-5\u03b1-androst-2-eno[3,2-c]-pyrazole)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(81)\n\n> (81) stanozolol (17\u03b1-methyl-17\u03b2-hydroxy-5\u03b1-androst-2-eno[3,2-c]-pyrazole);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(81)", "file": "stanozolol-17-methyl-17-hydroxy-5-androst-2-eno-3-2-c-pyrazole.md", "generated": true, "harvested": "2026-09-01", "id": "stanozolol-17-methyl-17-hydroxy-5-androst-2-eno-3-2-c-pyrazole", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(81) stanozolol (17\u03b1-methyl-17\u03b2-hydroxy-5\u03b1-androst-2-eno[3,2-c]-pyrazole);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "stanozolol (17\u03b1-methyl-17\u03b2-hydroxy-5\u03b1-androst-2-eno[3,2-c]-pyrazole)", "title": "stanozolol (17\u03b1-methyl-17\u03b2-hydroxy-5\u03b1-androst-2-eno[3,2-c]-pyrazole) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** stenbolone (17\u03b2-hydroxy-2-methyl-5\u03b1-androst-1-en-3-one)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(82)\n\n> (82) stenbolone (17\u03b2-hydroxy-2-methyl-5\u03b1-androst-1-en-3-one);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(82)", "file": "stenbolone-17-hydroxy-2-methyl-5-androst-1-en-3-one.md", "generated": true, "harvested": "2026-09-01", "id": "stenbolone-17-hydroxy-2-methyl-5-androst-1-en-3-one", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(82) stenbolone (17\u03b2-hydroxy-2-methyl-5\u03b1-androst-1-en-3-one);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "stenbolone (17\u03b2-hydroxy-2-methyl-5\u03b1-androst-1-en-3-one)", "title": "stenbolone (17\u03b2-hydroxy-2-methyl-5\u03b1-androst-1-en-3-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Sufentanil\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Opiates\n\n> (c) Opiates.\n\n**DEA code number:** 9740\n\n**CFR citation:** 21 CFR 1308.12(c)(28)\n\n> (28) Sufentanil | 9740 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.12(c)(28)", "dea_code_number": "9740", "file": "sufentanil.md", "generated": true, "harvested": "2026-09-01", "id": "sufentanil", "quote_category": "(c) Opiates.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(28) Sufentanil | 9740 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Sufentanil", "title": "Sufentanil \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Sulfondiethylmethane\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2600\n\n**CFR citation:** 21 CFR 1308.13(c)(12)\n\n> (12) Sulfondiethylmethane | 2600 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.13(c)(12)", "dea_code_number": "2600", "file": "sulfondiethylmethane.md", "generated": true, "harvested": "2026-09-01", "id": "sulfondiethylmethane", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(12) Sulfondiethylmethane | 2600 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Sulfondiethylmethane", "title": "Sulfondiethylmethane \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Sulfonethylmethane\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2605\n\n**CFR citation:** 21 CFR 1308.13(c)(13)\n\n> (13) Sulfonethylmethane | 2605 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.13(c)(13)", "dea_code_number": "2605", "file": "sulfonethylmethane.md", "generated": true, "harvested": "2026-09-01", "id": "sulfonethylmethane", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(13) Sulfonethylmethane | 2605 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Sulfonethylmethane", "title": "Sulfonethylmethane \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Sulfonmethane\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2610\n\n**CFR citation:** 21 CFR 1308.13(c)(14)\n\n> (14) Sulfonmethane | 2610 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.13(c)(14)", "dea_code_number": "2610", "file": "sulfonmethane.md", "generated": true, "harvested": "2026-09-01", "id": "sulfonmethane", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(14) Sulfonmethane | 2610 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Sulfonmethane", "title": "Sulfonmethane \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Suvorexant\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2223\n\n**CFR citation:** 21 CFR 1308.14(c)(54)\n\n> (54) Suvorexant | 2223 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(54)", "dea_code_number": "2223", "file": "suvorexant.md", "generated": true, "harvested": "2026-09-01", "id": "suvorexant", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(54) Suvorexant | 2223 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Suvorexant", "title": "Suvorexant \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Tapentadol\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Opiates\n\n> (c) Opiates.\n\n**DEA code number:** 9780\n\n**CFR citation:** 21 CFR 1308.12(c)(29)\n\n> (29) Tapentadol | 9780 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.12(c)(29)", "dea_code_number": "9780", "file": "tapentadol.md", "generated": true, "harvested": "2026-09-01", "id": "tapentadol", "quote_category": "(c) Opiates.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(29) Tapentadol | 9780 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Tapentadol", "title": "Tapentadol \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Temazepam\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2925\n\n**CFR citation:** 21 CFR 1308.14(c)(55)\n\n> (55) Temazepam | 2925 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(55)", "dea_code_number": "2925", "file": "temazepam.md", "generated": true, "harvested": "2026-09-01", "id": "temazepam", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(55) Temazepam | 2925 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Temazepam", "title": "Temazepam \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** testolactone (13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid lactone)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(83)\n\n> (83) testolactone (13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid lactone);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(83)", "file": "testolactone-13-hydroxy-3-oxo-13-17-secoandrosta-1-4-dien-17-oic-acid-lactone.md", "generated": true, "harvested": "2026-09-01", "id": "testolactone-13-hydroxy-3-oxo-13-17-secoandrosta-1-4-dien-17-oic-acid-lactone", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(83) testolactone (13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid lactone);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "testolactone (13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid lactone)", "title": "testolactone (13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid lactone) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** testosterone (17\u03b2-hydroxyandrost-4-en-3-one)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(84)\n\n> (84) testosterone (17\u03b2-hydroxyandrost-4-en-3-one);\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(84)", "file": "testosterone-17-hydroxyandrost-4-en-3-one.md", "generated": true, "harvested": "2026-09-01", "id": "testosterone-17-hydroxyandrost-4-en-3-one", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(84) testosterone (17\u03b2-hydroxyandrost-4-en-3-one);", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "testosterone (17\u03b2-hydroxyandrost-4-en-3-one)", "title": "testosterone (17\u03b2-hydroxyandrost-4-en-3-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Tetrahydrocannabinols\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7370\n\n**CFR citation:** 21 CFR 1308.11(d)(31)\n\n> (31) Tetrahydrocannabinols | 7370 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(31)", "dea_code_number": "7370", "file": "tetrahydrocannabinols.md", "generated": true, "harvested": "2026-09-01", "id": "tetrahydrocannabinols", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(31) Tetrahydrocannabinols | 7370 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Tetrahydrocannabinols", "title": "Tetrahydrocannabinols \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Tetrahydrofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9843\n\n**CFR citation:** 21 CFR 1308.11(b)(113)\n\n> (113) Tetrahydrofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide) | 9843 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(113)", "dea_code_number": "9843", "file": "tetrahydrofuranyl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenyltetrahydrofuran-2.md", "generated": true, "harvested": "2026-09-01", "id": "tetrahydrofuranyl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenyltetrahydrofuran-2", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(113) Tetrahydrofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide) | 9843 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Tetrahydrofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide)", "title": "Tetrahydrofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** tetrahydrogestrinone (13\u03b2,17\u03b1-diethyl-17\u03b2-hydroxygon-4,9,11-trien-3-one)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(85)\n\n> (85) tetrahydrogestrinone (13\u03b2,17\u03b1-diethyl-17\u03b2-hydroxygon-4,9,11-trien-3-one); and\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(85)", "file": "tetrahydrogestrinone-13-17-diethyl-17-hydroxygon-4-9-11-trien-3-one.md", "generated": true, "harvested": "2026-09-01", "id": "tetrahydrogestrinone-13-17-diethyl-17-hydroxygon-4-9-11-trien-3-one", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(85) tetrahydrogestrinone (13\u03b2,17\u03b1-diethyl-17\u03b2-hydroxygon-4,9,11-trien-3-one); and", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "tetrahydrogestrinone (13\u03b2,17\u03b1-diethyl-17\u03b2-hydroxygon-4,9,11-trien-3-one)", "title": "tetrahydrogestrinone (13\u03b2,17\u03b1-diethyl-17\u03b2-hydroxygon-4,9,11-trien-3-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** tetrahydrothiofuranyl fentanyl (also known as: tetrahydrothiophene fentanyl) (N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrothiophene-2-carboxamide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9869\n\n**CFR citation:** 21 CFR 1308.11(b)(114)\n\n> (114) tetrahydrothiofuranyl fentanyl (also known as: tetrahydrothiophene fentanyl) (N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrothiophene-2-carboxamide) | 9869 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(114)", "dea_code_number": "9869", "file": "tetrahydrothiofuranyl-fentanyl-also-known-as-tetrahydrothiophene-fentanyl-n-1-ph.md", "generated": true, "harvested": "2026-09-01", "id": "tetrahydrothiofuranyl-fentanyl-also-known-as-tetrahydrothiophene-fentanyl-n-1-ph", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(114) tetrahydrothiofuranyl fentanyl (also known as: tetrahydrothiophene fentanyl) (N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrothiophene-2-carboxamide) | 9869 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "tetrahydrothiofuranyl fentanyl (also known as: tetrahydrothiophene fentanyl) (N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrothiophene-2-carboxamide)", "title": "tetrahydrothiofuranyl fentanyl (also known as: tetrahydrothiophene fentanyl) (N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrothiophene-2-carboxamide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Tetrazepam\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2886\n\n**CFR citation:** 21 CFR 1308.14(c)(56)\n\n> (56) Tetrazepam | 2886 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(56)", "dea_code_number": "2886", "file": "tetrazepam.md", "generated": true, "harvested": "2026-09-01", "id": "tetrazepam", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(56) Tetrazepam | 2886 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Tetrazepam", "title": "Tetrazepam \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Thebacon\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opium derivatives\n\n> (c) Opium derivatives.\n\n**DEA code number:** 9315\n\n**CFR citation:** 21 CFR 1308.11(c)(23)\n\n> (23) Thebacon | 9315 |\n\nSource: \n", "category": "Opium derivatives", "citation": "21 CFR 1308.11(c)(23)", "dea_code_number": "9315", "file": "thebacon.md", "generated": true, "harvested": "2026-09-01", "id": "thebacon", "quote_category": "(c) Opium derivatives.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(23) Thebacon | 9315 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Thebacon", "title": "Thebacon \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Thebaine\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Substances, vegetable origin or chemical synthesis\n\n> (b) Substances, vegetable origin or chemical synthesis.\n\n**DEA code number:** 9333\n\n**CFR citation:** 21 CFR 1308.12(b)(1)(xviii)\n\n> (xviii) Thebaine | 9333 |\n\nSource: \n", "category": "Substances, vegetable origin or chemical synthesis", "citation": "21 CFR 1308.12(b)(1)(xviii)", "dea_code_number": "9333", "file": "thebaine.md", "generated": true, "harvested": "2026-09-01", "id": "thebaine", "quote_category": "(b) Substances, vegetable origin or chemical synthesis.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(xviii) Thebaine | 9333 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Thebaine", "title": "Thebaine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Thiafentanil\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Opiates\n\n> (c) Opiates.\n\n**DEA code number:** 9729\n\n**CFR citation:** 21 CFR 1308.12(c)(30)\n\n> (30) Thiafentanil | 9729 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.12(c)(30)", "dea_code_number": "9729", "file": "thiafentanil.md", "generated": true, "harvested": "2026-09-01", "id": "thiafentanil", "quote_category": "(c) Opiates.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(30) Thiafentanil | 9729 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Thiafentanil", "title": "Thiafentanil \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]propanamide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9835\n\n**CFR citation:** 21 CFR 1308.11(b)(115)\n\n> (115) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]propanamide) | 9835 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(115)", "dea_code_number": "9835", "file": "thiofentanyl-n-phenyl-n-1-2-thienyl-ethyl-4-piperidinyl-propanamide.md", "generated": true, "harvested": "2026-09-01", "id": "thiofentanyl-n-phenyl-n-1-2-thienyl-ethyl-4-piperidinyl-propanamide", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(115) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]propanamide) | 9835 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]propanamide)", "title": "Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]propanamide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Thiofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylthiophene-2-carboxamide; also known as 2-thiofuranyl fentanyl; thiophene fentanyl)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9839\n\n**CFR citation:** 21 CFR 1308.11(b)(116)\n\n> (116) Thiofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylthiophene-2-carboxamide; also known as 2-thiofuranyl fentanyl; thiophene fentanyl) | 9839 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(116)", "dea_code_number": "9839", "file": "thiofuranyl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylthiophene-2-carboxamide.md", "generated": true, "harvested": "2026-09-01", "id": "thiofuranyl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylthiophene-2-carboxamide", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(116) Thiofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylthiophene-2-carboxamide; also known as 2-thiofuranyl fentanyl; thiophene fentanyl) | 9839 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Thiofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylthiophene-2-carboxamide; also known as 2-thiofuranyl fentanyl; thiophene fentanyl)", "title": "Thiofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylthiophene-2-carboxamide; also known as 2-thiofuranyl fentanyl; thiophene fentanyl) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Thiophene analog of phencyclidine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Hallucinogenic substances\n\n> (d) Hallucinogenic substances.\n\n**DEA code number:** 7470\n\n**CFR citation:** 21 CFR 1308.11(d)(34)\n\n> (34) Thiophene analog of phencyclidine | 7470 |\n\nSource: \n", "category": "Hallucinogenic substances", "citation": "21 CFR 1308.11(d)(34)", "dea_code_number": "7470", "file": "thiophene-analog-of-phencyclidine.md", "generated": true, "harvested": "2026-09-01", "id": "thiophene-analog-of-phencyclidine", "quote_category": "(d) Hallucinogenic substances.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(34) Thiophene analog of phencyclidine | 7470 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Thiophene analog of phencyclidine", "title": "Thiophene analog of phencyclidine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Those compounds, mixtures, or preparations in dosage unit form containing any stimulant substances listed in schedule II which compounds, mixtures, or preparations were listed on August 25, 1971, as excepted compounds under \u00a7 1308.32 , and any other drug of the quantitative composition shown in that list for those drugs or which is the same except that it contains a lesser quantity of controlled substances\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Stimulants\n\n> (b) Stimulants.\n\n**DEA code number:** 1405\n\n**CFR citation:** 21 CFR 1308.13(b)(1)\n\n> (1) Those compounds, mixtures, or preparations in dosage unit form containing any stimulant substances listed in schedule II which compounds, mixtures, or preparations were listed on August 25, 1971, as excepted compounds under \u00a7 1308.32 , and any other drug of the quantitative composition shown in that list for those drugs or which is the same except that it contains a lesser quantity of controlled substances | 1405 |\n\nSource: \n", "category": "Stimulants", "citation": "21 CFR 1308.13(b)(1)", "dea_code_number": "1405", "file": "those-compounds-mixtures-or-preparations-in-dosage-unit-form-containing-any-stim.md", "generated": true, "harvested": "2026-09-01", "id": "those-compounds-mixtures-or-preparations-in-dosage-unit-form-containing-any-stim", "quote_category": "(b) Stimulants.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(1) Those compounds, mixtures, or preparations in dosage unit form containing any stimulant substances listed in schedule II which compounds, mixtures, or preparations were listed on August 25, 1971, as excepted compounds under \u00a7 1308.32 , and any other drug of the quantitative composition shown in that list for those drugs or which is the same except that it contains a lesser quantity of controlled substances | 1405 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Those compounds, mixtures, or preparations in dosage unit form containing any stimulant substances listed in schedule II which compounds, mixtures, or preparations were listed on August 25, 1971, as excepted compounds under \u00a7 1308.32 , and any other drug of the quantitative composition shown in that list for those drugs or which is the same except that it contains a lesser quantity of controlled substances", "title": "Those compounds, mixtures, or preparations in dosage unit form containing any stimulant substances listed in schedule II which compounds, mixtures, or preparations were listed on August 25, 1971, as excepted compounds under \u00a7 1308.32 , and any other drug of the quantitative composition shown in that list for those drugs or which is the same except that it contains a lesser quantity of controlled substances \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Tiletamine and zolazepam or any salt thereof\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 7295\n\n**CFR citation:** 21 CFR 1308.13(c)(15)\n\n> (15) Tiletamine and zolazepam or any salt thereof | 7295 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.13(c)(15)", "dea_code_number": "7295", "file": "tiletamine-and-zolazepam-or-any-salt-thereof.md", "generated": true, "harvested": "2026-09-01", "id": "tiletamine-and-zolazepam-or-any-salt-thereof", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(15) Tiletamine and zolazepam or any salt thereof | 7295 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Tiletamine and zolazepam or any salt thereof", "title": "Tiletamine and zolazepam or any salt thereof \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Tilidine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9750\n\n**CFR citation:** 21 CFR 1308.11(b)(117)\n\n> (117) Tilidine | 9750 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(117)", "dea_code_number": "9750", "file": "tilidine.md", "generated": true, "harvested": "2026-09-01", "id": "tilidine", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(117) Tilidine | 9750 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Tilidine", "title": "Tilidine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Tincture of opium\n\n**Schedule:** Schedule II\n\n> \u00a7 1308.12 Schedule II.\n\n**Listed under:** Substances, vegetable origin or chemical synthesis\n\n> (b) Substances, vegetable origin or chemical synthesis.\n\n**DEA code number:** 9630\n\n**CFR citation:** 21 CFR 1308.12(b)(1)(xix)\n\n> (xix) Tincture of opium | 9630 |\n\nSource: \n", "category": "Substances, vegetable origin or chemical synthesis", "citation": "21 CFR 1308.12(b)(1)(xix)", "dea_code_number": "9630", "file": "tincture-of-opium.md", "generated": true, "harvested": "2026-09-01", "id": "tincture-of-opium", "quote_category": "(b) Substances, vegetable origin or chemical synthesis.", "quote_schedule": "\u00a7 1308.12 Schedule II.", "schedule": "Schedule II", "source_quote": "(xix) Tincture of opium | 9630 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Tincture of opium", "title": "Tincture of opium \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** trenbolone (17\u03b2-hydroxyestr-4,9,11-trien-3-one)\n\n**Schedule:** Schedule III\n\n> \u00a7 1308.13 Schedule III.\n\n**Listed under:** Anabolic steroids\n\n> (f) Anabolic steroids.\n\n**CFR citation:** 21 CFR 1308.13(f)(86)\n\n> (86) trenbolone (17\u03b2-hydroxyestr-4,9,11-trien-3-one).\n\nSource: \n", "category": "Anabolic steroids", "citation": "21 CFR 1308.13(f)(86)", "file": "trenbolone-17-hydroxyestr-4-9-11-trien-3-one.md", "generated": true, "harvested": "2026-09-01", "id": "trenbolone-17-hydroxyestr-4-9-11-trien-3-one", "quote_category": "(f) Anabolic steroids.", "quote_schedule": "\u00a7 1308.13 Schedule III.", "schedule": "Schedule III", "source_quote": "(86) trenbolone (17\u03b2-hydroxyestr-4,9,11-trien-3-one).", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "trenbolone (17\u03b2-hydroxyestr-4,9,11-trien-3-one)", "title": "trenbolone (17\u03b2-hydroxyestr-4,9,11-trien-3-one) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Triazolam\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2887\n\n**CFR citation:** 21 CFR 1308.14(c)(57)\n\n> (57) Triazolam | 2887 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(57)", "dea_code_number": "2887", "file": "triazolam.md", "generated": true, "harvested": "2026-09-01", "id": "triazolam", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(57) Triazolam | 2887 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Triazolam", "title": "Triazolam \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Trimeperidine\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9646\n\n**CFR citation:** 21 CFR 1308.11(b)(118)\n\n> (118) Trimeperidine | 9646 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(118)", "dea_code_number": "9646", "file": "trimeperidine.md", "generated": true, "harvested": "2026-09-01", "id": "trimeperidine", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(118) Trimeperidine | 9646 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Trimeperidine", "title": "Trimeperidine \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9547\n\n**CFR citation:** 21 CFR 1308.11(b)(119)\n\n> (119) U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) | 9547 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(119)", "dea_code_number": "9547", "file": "u-47700-3-4-dichloro-n-2-dimethylamino-cyclohexyl-n-methylbenzamide.md", "generated": true, "harvested": "2026-09-01", "id": "u-47700-3-4-dichloro-n-2-dimethylamino-cyclohexyl-n-methylbenzamide", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(119) U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) | 9547 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide)", "title": "U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Valeryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9840\n\n**CFR citation:** 21 CFR 1308.11(b)(120)\n\n> (120) Valeryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide) | 9840 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(120)", "dea_code_number": "9840", "file": "valeryl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylpentanamide.md", "generated": true, "harvested": "2026-09-01", "id": "valeryl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylpentanamide", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(120) Valeryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide) | 9840 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Valeryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide)", "title": "Valeryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Zaleplon\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2781\n\n**CFR citation:** 21 CFR 1308.14(c)(58)\n\n> (58) Zaleplon | 2781 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(58)", "dea_code_number": "2781", "file": "zaleplon.md", "generated": true, "harvested": "2026-09-01", "id": "zaleplon", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(58) Zaleplon | 2781 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Zaleplon", "title": "Zaleplon \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Zipeprol (1-methoxy-3-[4-(2-methoxy-2-phenylethyl)piperazin-1-yl]-1-phenylpropan-2-ol)\n\n**Schedule:** Schedule I\n\n> \u00a7 1308.11 Schedule I.\n\n**Listed under:** Opiates\n\n> (b) Opiates.\n\n**DEA code number:** 9873\n\n**CFR citation:** 21 CFR 1308.11(b)(121)\n\n> (121) Zipeprol (1-methoxy-3-[4-(2-methoxy-2-phenylethyl)piperazin-1-yl]-1-phenylpropan-2-ol) | 9873 |\n\nSource: \n", "category": "Opiates", "citation": "21 CFR 1308.11(b)(121)", "dea_code_number": "9873", "file": "zipeprol-1-methoxy-3-4-2-methoxy-2-phenylethyl-piperazin-1-yl-1-phenylpropan-2-o.md", "generated": true, "harvested": "2026-09-01", "id": "zipeprol-1-methoxy-3-4-2-methoxy-2-phenylethyl-piperazin-1-yl-1-phenylpropan-2-o", "quote_category": "(b) Opiates.", "quote_schedule": "\u00a7 1308.11 Schedule I.", "schedule": "Schedule I", "source_quote": "(121) Zipeprol (1-methoxy-3-[4-(2-methoxy-2-phenylethyl)piperazin-1-yl]-1-phenylpropan-2-ol) | 9873 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Zipeprol (1-methoxy-3-[4-(2-methoxy-2-phenylethyl)piperazin-1-yl]-1-phenylpropan-2-ol)", "title": "Zipeprol (1-methoxy-3-[4-(2-methoxy-2-phenylethyl)piperazin-1-yl]-1-phenylpropan-2-ol) \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Zolpidem\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2783\n\n**CFR citation:** 21 CFR 1308.14(c)(59)\n\n> (59) Zolpidem | 2783 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(59)", "dea_code_number": "2783", "file": "zolpidem.md", "generated": true, "harvested": "2026-09-01", "id": "zolpidem", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(59) Zolpidem | 2783 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Zolpidem", "title": "Zolpidem \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Zopiclone\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2784\n\n**CFR citation:** 21 CFR 1308.14(c)(60)\n\n> (60) Zopiclone | 2784 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(60)", "dea_code_number": "2784", "file": "zopiclone.md", "generated": true, "harvested": "2026-09-01", "id": "zopiclone", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(60) Zopiclone | 2784 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Zopiclone", "title": "Zopiclone \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false} {"asset": "dea-controlled-substance-schedule-by-drug", "body": "**Substance:** Zuranolone\n\n**Schedule:** Schedule IV\n\n> \u00a7 1308.14 Schedule IV.\n\n**Listed under:** Depressants\n\n> (c) Depressants.\n\n**DEA code number:** 2420\n\n**CFR citation:** 21 CFR 1308.14(c)(61)\n\n> (61) Zuranolone | 2420 |\n\nSource: \n", "category": "Depressants", "citation": "21 CFR 1308.14(c)(61)", "dea_code_number": "2420", "file": "zuranolone.md", "generated": true, "harvested": "2026-09-01", "id": "zuranolone", "quote_category": "(c) Depressants.", "quote_schedule": "\u00a7 1308.14 Schedule IV.", "schedule": "Schedule IV", "source_quote": "(61) Zuranolone | 2420 |", "sources": ["https://www.ecfr.gov/current/title-21/chapter-II/part-1308"], "stale_after": "2026-12-30", "substance_name": "Zuranolone", "title": "Zuranolone \u2014 Federal controlled substance schedule (I-V) by drug, with DEA code number", "type": "classification", "verified": false}